data_2mkl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mkl _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tp . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 5.2 m -115.45 111.56 20.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.192 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . 0.627 HG22 HG23 ' C' ' 31' ' ' ILE . 29.1 t -106.43 114.51 45.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.117 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -125.49 123.75 39.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' C' ' 28' ' ' VAL . 44.2 mt -99.24 135.07 41.19 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . 0.538 ' HB3' HG21 ' C' ' 28' ' ' VAL . 3.3 tm? -108.58 125.19 51.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -94.92 153.66 39.88 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.473 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . 0.611 ' HD3' HD12 ' C' ' 27' ' ' ILE . 60.0 Cg_endo . . . . . 0 C--O 1.235 0.356 0 C-N-CA 123.046 2.497 . . . . 0.0 112.853 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' THR . . . . . 0.437 HG21 ' HD2' ' C' ' 71' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.083 0 N-CA-C 110.851 -0.055 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' ILE . . . . . 0.611 HD12 ' HD3' ' C' ' 14' ' ' PRO . 20.9 mm -112.75 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 163.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' C' ' 12' ' ' LEU . 0.6 OUTLIER -119.13 142.83 32.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.685 -169.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' CYS . . . . . 0.454 ' HA ' HD22 ' C' ' 11' ' ' LEU . 41.1 t -115.18 113.48 23.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.306 170.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.23 123.39 46.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' ILE . . . . . 0.627 HG23 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.86 130.54 73.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.932 0.872 . . . . 0.0 111.648 -178.522 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.75 129.38 66.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.5 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.33 161.49 27.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.373 0.42 . . . . 0.0 110.748 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' SER . . . . . 0.427 ' HB3' ' HA ' ' C' ' 65' ' ' LYS . 6.0 p -144.04 150.89 38.91 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.3 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' C' ' 34' ' ' SER . 67.1 m-20 75.38 11.04 3.45 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.524 0.515 . . . . 0.0 112.22 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 16.7 mt -91.51 168.14 11.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.554 0.692 . . . . 0.0 111.821 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -96.53 171.81 8.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.151 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -56.94 115.48 2.63 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 123.801 1.763 . . . . 0.0 109.005 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.517 ' CG2' HG13 ' C' ' 89' ' ' VAL . 4.6 mp -74.11 144.46 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 111.247 -2.706 . . . . 0.0 113.069 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 22.4 tptm -106.63 124.34 49.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.802 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.9 139.27 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.559 0.218 . . . . 0.0 110.618 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -135.53 141.1 45.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 111.44 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' TRP . . . . . 0.771 ' HB2' ' HD2' ' C' ' 50' ' ' ARG . 51.9 m95 -129.7 136.78 50.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . 0.529 ' OE1' ' HA2' ' C' ' 47' ' ' GLY . 8.3 tt0 -121.47 129.31 52.88 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 21.5 t -120.92 108.06 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 58.03 37.06 26.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 111.09 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . 0.529 ' HA2' ' OE1' ' C' ' 44' ' ' GLN . . . 78.13 -6.93 47.69 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.94 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.53 130.98 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.956 0.407 . . . . 0.0 111.172 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.4 136.34 57.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.846 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' ARG . . . . . 0.771 ' HD2' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -91.74 146.9 23.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.917 0.865 . . . . 0.0 112.412 -170.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -66.14 161.4 21.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.162 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.586 ' HG2' ' H ' ' C' ' 53' ' ' GLY . 39.4 tttm -53.92 164.33 0.61 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.698 0.761 . . . . 0.0 110.611 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . 0.586 ' H ' ' HG2' ' C' ' 52' ' ' LYS . . . 115.8 -13.28 17.55 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -159.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.522 ' HA ' HD22 ' C' ' 72' ' ' LEU . 2.6 p -82.81 129.1 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 112.898 -1.651 . . . . 0.0 107.752 163.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -141.8 114.75 8.63 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.503 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 28.4 m -89.09 126.06 35.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.93 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.524 ' HB2' HG12 ' C' ' 69' ' ' VAL . 48.1 mt-30 -90.99 149.23 21.93 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' ASN . . . . . 0.424 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.3 t30 -56.39 138.73 74.85 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.134 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' C' ' 58' ' ' ASN . 53.6 Cg_exo -47.52 135.84 20.83 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 124.194 3.263 . . . . 0.0 113.616 -174.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' GLU . . . . . 0.517 ' HB3' ' HB ' ' C' ' 67' ' ' THR . 34.4 tt0 . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' C' ' 34' ' ' SER . 35.5 mmtm . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.465 0.65 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 10.2 m -105.6 150.54 25.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.675 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' C' ' 60' ' ' GLU . 66.8 m -134.39 121.62 21.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.275 0.56 . . . . 0.0 110.939 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . 0.5 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.5 mp -112.09 133.47 57.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -127.75 136.36 60.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.794 0.33 . . . . 0.0 110.779 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.9 p -129.34 125.04 35.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.28 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.437 ' HD2' HG21 ' C' ' 26' ' ' THR . 52.9 mtmt -107.72 139.33 42.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.17 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.531 HD13 ' HG3' ' C' ' 50' ' ' ARG . 0.2 OUTLIER -110.29 127.52 55.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.912 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.1 116.75 29.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . 0.473 HG11 ' CE1' ' C' ' 85' ' ' TYR . 34.5 m -134.77 163.39 36.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 -169.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 91.1 mmm -81.52 128.67 34.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.172 0.51 . . . . 0.0 110.107 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.91 -48.78 42.27 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.946 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 50.4 m -61.75 -29.54 70.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.457 0.571 . . . . 0.0 111.919 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -52.2 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' TRP . . . . . 0.431 ' HZ3' HG23 ' C' ' 102' ' ' ILE . 66.0 t-105 -56.85 -46.92 81.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.06 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' ASP . . . . . 0.528 ' HA ' ' HD3' ' C' ' 104' ' ' LYS . 22.5 t70 -69.5 -15.05 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.222 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -79.1 -5.4 53.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.3 18.92 65.61 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 8.3 m -65.58 138.55 58.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.436 0.636 . . . . 0.0 111.393 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.9 mt-10 -74.76 133.52 41.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.541 -172.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' TYR . . . . . 0.563 ' O ' HG21 ' C' ' 102' ' ' ILE . 82.0 m-85 -129.54 115.1 16.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' C' ' 101' ' ' SER . 0.3 OUTLIER -132.4 140.27 48.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 121.376 0.608 . . . . 0.0 111.298 -176.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 7.6 t -106.87 126.74 52.7 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.4 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -117.32 144.35 44.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' VAL . . . . . 0.602 ' HB ' ' CG1' ' C' ' 98' ' ' VAL . 54.6 t -116.76 135.33 57.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' C' ' 40' ' ' LYS . 36.3 tt0 -125.28 130.33 51.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . 0.501 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 15.7 t70 -150.67 144.65 25.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.186 0.517 . . . . 0.0 110.046 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.5 t -66.17 -19.27 65.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.859 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . 0.432 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 6.6 mm-40 -92.09 -6.67 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 38.7 mt -89.76 145.96 34.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.44 -35.16 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.325 2.683 . . . . 0.0 111.68 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -146.21 154.04 49.45 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.102 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.56 148.81 73.39 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.739 1.626 . . . . 0.0 111.359 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' VAL . . . . . 0.602 ' CG1' ' HB ' ' C' ' 89' ' ' VAL . 10.7 p -110.56 140.01 31.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.547 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 8.6 ptpp? -137.85 151.73 48.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 0.0 111.775 -171.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.85 127.58 4.72 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.434 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' SER . . . . . 0.523 ' HB3' ' HB ' ' C' ' 86' ' ' VAL . 72.2 p -107.48 160.63 15.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.133 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.563 HG21 ' O ' ' C' ' 85' ' ' TYR . 3.6 tp -121.77 139.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.077 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -114.84 145.46 42.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.054 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' C' ' 80' ' ' ASP . 33.9 ttpt -73.61 110.35 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.189 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.143 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' ILE . . . . . 0.703 HG12 HG13 ' C' ' 98' ' ' VAL . 3.3 tp . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 121.169 0.509 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 16.3 m -114.73 106.75 14.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.556 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.05 113.66 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.023 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -112.24 110.2 20.31 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.544 ' CD2' ' HB ' ' C' ' 102' ' ' ILE . 57.8 tp -99.53 117.5 34.06 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.45 118.45 35.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.162 0.506 . . . . 0.0 110.706 -167.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . 0.541 ' HB3' HD11 ' C' ' 102' ' ' ILE . 14.4 ptpt -79.53 147.5 67.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.146 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.462 -0.325 0 C-N-CA 122.477 2.118 . . . . 0.0 111.568 -179.626 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' THR . . . . . 0.758 ' HA ' HG12 ' C' ' 74' ' ' VAL . 5.8 t . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 121.802 0.811 . . . . 0.0 112.283 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' ILE . . . . . 0.525 HG13 HG13 ' C' ' 74' ' ' VAL . 40.1 mt -97.33 154.74 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.704 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.548 HG22 ' HG2' ' C' ' 71' ' ' LYS . 84.1 t -130.61 133.93 62.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.745 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' CYS . . . . . 0.408 ' HB2' ' CZ2' ' C' ' 43' ' ' TRP . 19.3 t -115.78 112.36 21.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -104.97 123.33 47.59 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' ILE . . . . . 0.549 HG12 HG21 ' C' ' 89' ' ' VAL . 0.1 OUTLIER -121.78 136.06 59.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.445 0.64 . . . . 0.0 111.007 -176.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 17.9 t -114.94 132.24 64.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.084 -176.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.604 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.88 167.61 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.236 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 41.8 t -141.01 150.32 42.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' C' ' 34' ' ' SER . 7.2 m-20 76.81 11.59 2.5 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.479 0.487 . . . . 0.0 112.085 170.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -96.35 164.33 12.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.902 0.858 . . . . 0.0 112.351 -175.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' C' ' 38' ' ' ASN . 11.3 tp10 -91.81 174.1 7.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.394 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.416 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 1.2 m-80 -56.36 114.09 1.85 Allowed 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.131 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.606 HG22 HG13 ' C' ' 89' ' ' VAL . 5.0 mp -73.83 144.57 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 112.448 -2.16 . . . . 0.0 113.266 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.86 122.94 46.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.79 144.12 14.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.0 110.908 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.5 t80 -135.06 143.85 46.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' TRP . . . . . 0.461 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 51.7 m95 -127.6 139.5 52.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . 0.469 ' HG2' ' HB ' ' C' ' 86' ' ' VAL . 4.0 pt20 -132.77 131.02 40.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.628 0.728 . . . . 0.0 111.11 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 0.2 OUTLIER -120.25 122.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.54 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 53.77 34.83 19.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.02 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.65 -16.36 25.96 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.443 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -87.72 134.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.22 139.36 58.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.195 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -89.31 117.23 28.11 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -53.29 158.45 1.63 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.912 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.68 164.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.723 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.18 3.97 20.89 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -155.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.23 132.44 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.116 -1.542 . . . . 0.0 108.351 174.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 86.8 tt0 -125.49 108.86 12.04 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.83 0.348 . . . . 0.0 110.459 -172.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 16.0 p -98.45 122.64 41.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.812 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.615 ' HB2' HG13 ' C' ' 69' ' ' VAL . 42.5 mt-30 -103.06 176.27 5.2 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.236 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.31 150.78 85.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 0.0 110.744 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' PRO . . . . . 0.479 ' HB3' HD12 ' C' ' 68' ' ' ILE . 43.9 Cg_endo -65.48 148.09 87.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.553 2.835 . . . . 0.0 112.989 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' GLU . . . . . 0.556 ' HG3' ' HB ' ' C' ' 67' ' ' THR . 14.4 pt-20 . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . 0.458 ' HE2' HG11 ' C' ' 32' ' ' VAL . 46.6 mtpt . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.559 0.695 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -115.59 149.06 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.577 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.556 ' HB ' ' HG3' ' C' ' 60' ' ' GLU . 46.2 m -132.37 122.16 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.397 0.618 . . . . 0.0 110.813 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . 0.604 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -110.06 132.48 58.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.379 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.9 p -108.5 122.47 63.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.552 0.692 . . . . 0.0 110.878 176.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.1 m -120.74 122.19 39.86 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.548 ' HG2' HG22 ' C' ' 28' ' ' VAL . 6.8 mtpm? -106.0 152.54 23.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.952 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' C' ' 72' ' ' LEU . 0.2 OUTLIER -119.84 114.93 22.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' LYS . . . . . 0.678 ' HB2' ' HZ2' ' C' ' 73' ' ' LYS . 4.9 ttmp? -78.36 112.1 15.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 173.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' C' ' 26' ' ' THR . 12.9 p -128.63 153.09 37.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.951 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' MET . . . . . 0.64 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 97.0 mmm -72.03 129.47 38.61 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.689 0.757 . . . . 0.0 110.614 -175.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.17 -34.11 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.793 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -70.56 -35.27 72.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.283 0.633 . . . . 0.0 111.397 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 59.7 mt-10 -68.58 -52.49 31.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -58.2 -42.47 86.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.801 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' ASP . . . . . 0.768 ' HA ' ' HZ2' ' C' ' 104' ' ' LYS . 21.3 t70 -62.37 -26.03 68.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.325 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 51.0 m -87.05 -2.39 58.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.843 0.354 . . . . 0.0 111.299 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.59 28.79 72.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.521 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' THR . . . . . 0.618 HG22 ' HB3' ' C' ' 78' ' ' GLU . 14.6 t -64.88 150.82 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 32.5 mt-10 -80.64 141.86 34.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.069 0.461 . . . . 0.0 111.32 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' TYR . . . . . 0.653 ' HH ' HG23 ' C' ' 74' ' ' VAL . 9.7 m-85 -137.75 127.86 25.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.754 173.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . 0.604 HG11 ' HE2' ' C' ' 99' ' ' LYS . 20.9 t -120.48 138.76 49.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 29.2 t -111.46 118.5 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.713 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.3 mp -113.28 147.06 38.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.677 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' VAL . . . . . 0.606 HG13 HG22 ' C' ' 39' ' ' ILE . 25.1 t -135.29 125.69 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 122.91 0.484 . . . . 0.0 109.806 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' C' ' 97' ' ' PRO . 12.9 pt-20 -133.64 145.48 50.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . 0.537 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 14.5 t70 -136.75 158.48 44.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 34.0 t -52.79 -41.7 64.37 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.386 0.429 . . . . 0.0 110.825 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -86.98 -1.73 58.09 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . 0.537 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 42.8 mt -92.02 128.74 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 109.988 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -35.09 37.03 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 123.051 2.501 . . . . 0.0 112.206 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -147.52 153.67 43.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.944 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' PRO . . . . . 0.425 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 37.6 Cg_endo -68.83 153.39 72.97 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.27 1.98 . . . . 0.0 111.503 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' VAL . . . . . 0.703 HG13 HG12 ' C' ' 7' ' ' ILE . 13.7 p -116.79 146.53 21.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.713 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 14.1 ptmm? -141.03 156.5 46.01 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.304 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.81 140.52 19.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 32.2 t -118.03 153.75 33.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.134 0.492 . . . . 0.0 111.063 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.544 ' HB ' ' CD2' ' C' ' 11' ' ' LEU . 8.0 tp -124.21 149.48 28.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.774 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -142.07 152.96 43.81 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' LYS . . . . . 0.768 ' HZ2' ' HA ' ' C' ' 80' ' ' ASP . 39.4 ttpt -78.38 108.39 11.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.184 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.854 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.707 -177.827 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tp . . . . . 0 N--CA 1.444 -0.74 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' SER . . . . . 0.623 ' HB2' ' CG1' ' C' ' 32' ' ' VAL . 51.0 m -110.31 104.49 13.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.374 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.54 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.27 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 16.0 m -121.01 127.31 51.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.546 HD22 ' HB3' ' C' ' 87' ' ' CYS . 72.2 mt -99.8 127.23 45.97 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.255 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.06 114.69 28.41 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . 0.656 ' HB3' HD11 ' C' ' 102' ' ' ILE . 18.9 ptpt -76.26 154.79 84.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.303 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . 0.537 ' HD3' HD12 ' C' ' 27' ' ' ILE . 19.0 Cg_endo . . . . . 0 N--CA 1.464 -0.249 0 C-N-CA 122.4 2.067 . . . . 0.0 111.685 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' THR . . . . . 0.42 ' HA ' HG23 ' C' ' 74' ' ' VAL . 5.9 t . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.543 0.687 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' ILE . . . . . 0.537 HD12 ' HD3' ' C' ' 14' ' ' PRO . 15.8 mm -88.87 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.192 -174.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.41 132.96 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.321 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.05 114.54 21.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.624 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.52 128.54 54.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' ILE . . . . . 0.576 HG13 ' HH ' ' C' ' 33' ' ' TYR . 0.0 OUTLIER -126.53 133.51 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.483 0.659 . . . . 0.0 111.373 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.623 ' CG1' ' HB2' ' C' ' 8' ' ' SER . 2.1 p -129.05 134.73 63.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.516 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.576 ' HH ' HG13 ' C' ' 31' ' ' ILE . 0.1 OUTLIER -163.5 168.18 20.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.723 -171.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' SER . . . . . 0.534 ' HB3' ' HD3' ' C' ' 65' ' ' LYS . 18.9 p -141.99 149.88 40.63 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.42 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' C' ' 34' ' ' SER . 4.9 m-20 77.59 11.02 2.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.756 0.66 . . . . 0.0 112.166 171.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -96.18 177.51 5.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.996 0.903 . . . . 0.0 112.793 -170.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' GLU . . . . . 0.706 ' O ' HG13 ' C' ' 39' ' ' ILE . 20.4 mm-40 -105.8 173.47 6.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.595 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.76 112.73 1.94 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 123.927 1.822 . . . . 0.0 108.773 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.706 HG13 ' O ' ' C' ' 37' ' ' GLU . 51.0 mt -87.56 147.3 5.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 110.864 -2.88 . . . . 0.0 114.126 -171.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -100.33 126.49 46.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.156 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.58 137.97 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.671 ' CB ' ' HG ' ' C' ' 88' ' ' LEU . 0.1 OUTLIER -119.31 147.84 43.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.929 -0.123 . . . . 0.0 110.897 -176.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' TRP . . . . . 0.808 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 65.7 m95 -137.18 132.66 34.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . 0.75 HE21 ' HA ' ' C' ' 44' ' ' GLN . 0.0 OUTLIER -123.27 131.3 53.62 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 177.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' VAL . . . . . 0.51 HG13 ' ND2' ' C' ' 46' ' ' ASN . 21.6 t -124.96 118.26 52.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.151 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . 0.51 ' ND2' HG13 ' C' ' 45' ' ' VAL . 57.1 m-80 57.99 33.83 23.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 -175.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.7 -1.2 31.28 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.003 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 p -116.62 138.64 46.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.255 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.11 122.21 13.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.263 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' ARG . . . . . 0.509 ' HD2' HG23 ' C' ' 45' ' ' VAL . 7.9 ptm85 -92.86 167.54 11.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.4 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.65 159.47 21.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.991 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.63 166.56 0.05 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.107 176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.9 7.7 12.7 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -162.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.519 ' HA ' HD23 ' C' ' 72' ' ' LEU . 3.4 p -88.25 126.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' C' ' 70' ' ' SER . 39.9 mt-10 -121.0 109.62 15.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 5.6 p -101.13 116.88 33.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.954 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -87.47 150.17 23.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.27 0.557 . . . . 0.0 111.074 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.89 138.18 97.32 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.334 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' PRO . . . . . 0.564 ' HB3' HD13 ' C' ' 68' ' ' ILE . 19.4 Cg_endo -61.68 136.31 61.77 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.525 2.817 . . . . 0.0 113.608 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.541 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . 0.534 ' HD3' ' HB3' ' C' ' 34' ' ' SER . 72.3 mmtt . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.165 0.507 . . . . 0.0 111.4 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' SER . . . . . 0.497 ' O ' HG21 ' C' ' 32' ' ' VAL . 9.6 m -115.99 149.13 39.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -130.67 121.46 25.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.984 0.421 . . . . 0.0 110.827 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . 0.564 HD13 ' HB3' ' C' ' 59' ' ' PRO . 1.5 mp -108.8 137.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.85 129.59 64.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.594 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 43.7 m -124.89 110.33 14.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 0.0 110.137 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -106.64 145.16 32.29 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.6 118.85 27.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.934 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.633 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' C' ' 85' ' ' TYR . 24.5 m -136.41 159.66 38.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.699 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.0 mtt -76.74 131.98 39.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.98 -51.6 29.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 10.5 m -59.08 -30.17 67.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' C' ' 83' ' ' THR . 6.6 tp10 -69.96 -51.18 34.77 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' TRP . . . . . 0.421 ' HE3' ' CE2' ' C' ' 85' ' ' TYR . 50.8 t-105 -56.5 -44.05 80.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.173 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.14 -6.37 42.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.238 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' C' ' 78' ' ' GLU . 30.5 t -83.82 -7.9 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.335 0.588 . . . . 0.0 109.957 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.22 21.16 68.09 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.058 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' THR . . . . . 0.485 HG23 ' HG3' ' C' ' 78' ' ' GLU . 14.9 t -69.88 157.24 37.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.278 0.561 . . . . 0.0 110.324 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -81.25 138.97 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.159 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' TYR . . . . . 0.591 ' CE1' HG12 ' C' ' 74' ' ' VAL . 75.8 m-85 -126.21 116.92 22.05 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.0 169.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 33.3 t -118.57 129.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' CYS . . . . . 0.546 ' HB3' HD22 ' C' ' 11' ' ' LEU . 8.7 t -116.0 124.4 50.42 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.671 ' HG ' ' CB ' ' C' ' 42' ' ' PHE . 1.7 pp -137.39 154.78 49.92 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.327 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' VAL . . . . . 0.704 HG11 HG22 ' C' ' 39' ' ' ILE . 6.3 t -122.13 135.11 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.273 -173.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -131.02 138.35 49.61 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . 0.537 ' HB2' HG12 ' C' ' 39' ' ' ILE . 17.3 t70 -146.67 151.52 37.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.676 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -64.45 -20.67 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.162 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -90.84 -8.15 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . 0.431 ' HA ' ' HD3' ' C' ' 95' ' ' PRO . 50.4 mt -94.24 147.77 33.94 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.958 0.408 . . . . 0.0 110.574 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 4.2 Cg_exo -82.12 -30.74 1.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.384 2.722 . . . . 0.0 111.481 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 26.2 p -142.7 154.3 62.59 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.203 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' C' ' 88' ' ' LEU . 41.4 Cg_endo -68.49 150.34 75.3 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.925 1.75 . . . . 0.0 110.971 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 47.0 t -109.06 106.14 20.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.58 ' HA ' ' CB ' ' C' ' 88' ' ' LEU . 14.8 ptpt -111.35 149.95 30.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.327 -171.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.6 129.8 12.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.116 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' SER . . . . . 0.466 ' HB2' HG23 ' C' ' 86' ' ' VAL . 42.0 t -110.74 152.76 26.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 111.734 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' C' ' 13' ' ' LYS . 11.6 tt -131.08 148.27 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.457 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -137.17 158.43 44.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.633 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -64.04 110.4 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.234 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.493 179.34 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' ILE . . . . . 0.552 HG12 HG13 ' C' ' 98' ' ' VAL . 2.8 tp . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.554 0.693 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 37.5 m -126.62 120.51 29.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.851 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.51 119.41 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.136 0.493 . . . . 0.0 110.864 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -110.09 118.03 35.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' C' ' 87' ' ' CYS . 44.1 mt -99.79 121.78 41.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.827 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 57.4 tp -109.97 116.16 31.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' C' ' 105' ' ' ALA . 22.3 ptmt -77.9 150.3 78.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.658 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.46 -0.49 0 C-N-CA 123.083 2.522 . . . . 0.0 111.642 175.799 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.903 0.859 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 27.6 mt -93.52 153.53 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.759 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.74 133.76 67.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.309 0.576 . . . . 0.0 111.67 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 45.4 t -118.4 112.05 19.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . 0.683 ' HG3' HG22 ' C' ' 69' ' ' VAL . 28.2 tt0 -113.29 120.22 40.4 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.73 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.427 0.632 . . . . 0.0 111.262 -166.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 130.35 72.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.761 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.761 ' HE1' HD11 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -160.55 164.69 31.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -144.27 147.32 33.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 78.14 9.0 2.27 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.67 0.606 . . . . 0.0 111.297 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 19.1 mt -93.44 157.88 16.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.4 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -83.59 174.11 10.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.219 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -57.19 113.05 1.56 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 123.969 1.842 . . . . 0.0 108.373 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.655 HG21 HG12 ' C' ' 89' ' ' VAL . 5.2 mp -73.57 147.33 9.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 110.941 -2.845 . . . . 0.0 113.144 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.434 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 23.6 ttmm -118.42 136.47 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.966 170.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.88 138.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.066 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.568 ' HB3' HD21 ' C' ' 88' ' ' LEU . 5.3 t80 -119.56 150.35 40.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.427 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' TRP . . . . . 0.754 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 56.9 m95 -132.52 131.89 42.06 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.11 130.72 48.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.224 0.466 . . . . 0.0 111.046 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.15 111.16 34.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.65 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . 0.44 HD21 ' HA ' ' C' ' 46' ' ' ASN . 0.7 OUTLIER 58.79 37.29 24.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 110.396 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.51 -9.85 33.21 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.569 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 131.87 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 117.088 0.444 . . . . 0.0 110.348 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.99 137.91 56.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.196 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' ARG . . . . . 0.485 ' HD3' ' N ' ' C' ' 51' ' ' LYS . 1.0 OUTLIER -89.75 136.34 33.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.943 -174.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' LYS . . . . . 0.485 ' N ' ' HD3' ' C' ' 50' ' ' ARG . 13.5 mptt -66.93 157.15 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.745 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -45.31 165.79 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.884 0.849 . . . . 0.0 112.987 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.53 7.86 15.3 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -158.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.95 134.57 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.268 -1.466 . . . . 0.0 108.076 173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.644 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 33.6 tt0 -129.03 109.12 10.94 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -98.69 121.68 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -96.83 152.55 18.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 110.097 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.75 133.06 94.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.247 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' PRO . . . . . 0.561 ' HB3' ' CD1' ' C' ' 68' ' ' ILE . 13.2 Cg_endo -59.96 141.85 97.3 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.731 2.954 . . . . 0.0 113.488 -171.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 N--CA 1.45 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.827 174.651 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 53.6 mttp . . . . . 0 C--O 1.224 -0.245 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 6.0 m -118.95 150.77 39.35 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 94.1 m -131.04 120.05 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.896 0.379 . . . . 0.0 110.983 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . 0.761 HD11 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.46 125.31 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' VAL . . . . . 0.683 HG22 ' HG3' ' C' ' 30' ' ' GLU . 47.0 t -106.01 122.49 59.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 36.2 m -120.11 130.35 54.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 110.803 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.644 ' HB2' ' HB3' ' C' ' 55' ' ' GLU . 59.2 mttp -105.73 147.88 28.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.64 HD11 HG11 ' C' ' 74' ' ' VAL . 0.2 OUTLIER -125.5 114.6 19.0 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -93.89 112.67 24.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . 0.64 HG11 HD11 ' C' ' 72' ' ' LEU . 4.5 m -122.01 168.54 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.353 -170.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' MET . . . . . 0.541 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 81.0 mtp -73.43 132.08 42.56 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.531 0.681 . . . . 0.0 109.458 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.43 -31.34 61.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.407 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -72.43 -31.66 65.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.769 0.828 . . . . 0.0 111.16 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' GLU . . . . . 0.541 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 69.3 mt-10 -65.56 -52.24 53.83 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.526 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.75 -18.82 65.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.244 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -87.06 -5.57 59.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.301 0.572 . . . . 0.0 109.801 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.29 28.89 72.19 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.345 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 152.58 43.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.064 0.459 . . . . 0.0 110.33 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.87 135.1 41.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.757 -173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -131.6 127.08 36.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 41.0 t -120.55 136.4 57.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' CYS . . . . . 0.517 ' HB3' HD23 ' C' ' 11' ' ' LEU . 12.4 t -115.65 130.48 56.88 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.614 ' HB2' ' HA ' ' C' ' 99' ' ' LYS . 0.0 OUTLIER -146.85 147.41 30.81 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.636 -167.032 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' VAL . . . . . 0.655 HG12 HG21 ' C' ' 39' ' ' ILE . 55.6 t -115.5 137.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 122.924 0.489 . . . . 0.0 111.193 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.504 ' HA ' HD21 ' C' ' 94' ' ' LEU . 4.9 pt-20 -129.71 133.12 46.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . 0.508 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 17.0 t70 -148.32 149.42 31.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.981 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 17.2 m -47.0 -47.32 22.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.203 0.525 . . . . 0.0 111.532 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . 0.475 ' HB3' ' OD2' ' C' ' 91' ' ' ASP . 11.2 tp10 -83.85 -5.26 59.17 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.308 -167.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . 0.624 HD11 ' O ' ' C' ' 94' ' ' LEU . 2.2 pp -92.97 150.55 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.133 -0.979 . . . . 0.0 111.265 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 -35.41 1.25 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.674 2.916 . . . . 0.0 112.44 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 5.5 p -147.78 151.19 38.19 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.26 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' PRO . . . . . 0.496 ' HB2' HD11 ' C' ' 88' ' ' LEU . 30.5 Cg_endo -61.78 144.69 97.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.579 2.186 . . . . 0.0 111.498 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' VAL . . . . . 0.552 HG13 HG12 ' C' ' 7' ' ' ILE . 41.8 t -107.07 102.5 14.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.614 ' HA ' ' HB2' ' C' ' 88' ' ' LEU . 10.6 ptpp? -108.36 151.29 26.22 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.833 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.76 127.63 9.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 29.0 t -111.4 157.5 20.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.464 0.65 . . . . 0.0 111.393 -172.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.443 ' HB ' HD12 ' C' ' 11' ' ' LEU . 5.5 tp -122.08 149.26 25.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.969 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' ARG . . . . . 0.457 ' HD3' ' N ' ' C' ' 103' ' ' ARG . 0.0 OUTLIER -131.98 151.2 51.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -76.0 138.89 41.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.18 0.514 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' ALA . . . . . 0.472 ' HB2' ' NZ ' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.246 0.892 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' ILE . . . . . 0.796 HG12 HG21 ' C' ' 98' ' ' VAL . 2.8 tp . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 121.759 0.79 . . . . 0.0 108.892 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -120.84 116.04 24.41 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.114 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . 0.529 HG21 HG22 ' C' ' 31' ' ' ILE . 43.8 t -103.73 114.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.957 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 4.0 m -105.84 109.3 21.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.52 ' CD2' ' HB ' ' C' ' 102' ' ' ILE . 55.6 tp -103.02 117.13 33.9 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.745 -174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 65.6 tp -113.84 123.69 50.41 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.111 0.481 . . . . 0.0 110.43 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' C' ' 102' ' ' ILE . 21.6 pttp -86.52 152.87 55.35 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.908 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo . . . . . 0 N--CA 1.461 -0.408 0 C-N-CA 122.332 2.021 . . . . 0.0 111.508 -178.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' THR . . . . . 0.707 HG22 ' HA ' ' C' ' 73' ' ' LYS . 68.0 p . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.247 0.546 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 13.6 mm -89.4 152.3 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.664 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.561 HG22 ' HG2' ' C' ' 71' ' ' LYS . 77.5 t -133.72 132.95 57.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.745 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 35.8 t -120.42 114.2 21.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.51 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -106.96 127.85 53.81 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' ILE . . . . . 0.622 HG23 HG21 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.46 133.33 69.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.683 -177.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.34 130.08 66.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.761 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.718 ' HE1' HD11 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.25 164.9 27.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.113 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t -139.2 150.09 45.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.985 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 75.78 12.25 3.02 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.515 0.509 . . . . 0.0 112.322 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.03 159.77 14.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.714 0.769 . . . . 0.0 111.525 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -92.72 173.17 7.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.568 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -55.46 115.65 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.849 1.785 . . . . 0.0 109.176 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.612 ' CG2' HG12 ' C' ' 89' ' ' VAL . 5.0 mp -76.41 146.37 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.18 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.461 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 55.0 tptt -104.4 127.63 52.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.732 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.11 140.04 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.6 t80 -133.17 144.36 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 111.559 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' TRP . . . . . 0.595 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 69.1 m95 -127.09 140.7 52.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -128.09 131.05 49.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 111.195 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' VAL . . . . . 0.711 HG21 ' HE ' ' C' ' 50' ' ' ARG . 21.2 t -116.99 116.01 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.484 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.58 36.62 27.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.213 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.07 -15.64 26.41 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.754 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.56 137.28 25.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.626 -0.338 . . . . 0.0 110.608 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.46 136.51 57.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' ARG . . . . . 0.711 ' HE ' HG21 ' C' ' 45' ' ' VAL . 17.7 tpp180 -91.74 122.15 34.03 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.991 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.88 162.42 5.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.655 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -42.72 164.52 0.01 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.283 1.04 . . . . 0.0 113.613 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.37 -1.03 23.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 -155.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 6.7 p -88.79 131.98 34.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 113.205 -1.497 . . . . 0.0 108.281 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' C' ' 71' ' ' LYS . 45.7 mt-10 -126.25 109.24 12.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.0 110.626 -172.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 15.9 m -95.08 117.24 29.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.519 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.79 165.95 11.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.849 0.357 . . . . 0.0 110.438 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' ASN . . . . . 0.485 ' ND2' ' HD2' ' C' ' 59' ' ' PRO . 29.3 t-20 -69.18 134.47 89.35 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.899 0.857 . . . . 0.0 112.456 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' C' ' 67' ' ' THR . 23.5 Cg_exo -55.19 134.8 65.88 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 124.173 3.249 . . . . 0.0 112.586 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 . . . . . 0 N--CA 1.451 -0.417 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.421 175.533 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -113.68 154.03 27.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.994 -0.441 . . . . 0.0 110.962 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 85.4 m -136.45 123.46 21.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.407 . . . . 0.0 111.166 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . 0.718 HD11 ' HE1' ' C' ' 33' ' ' TYR . 1.6 mp -108.7 132.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.3 122.1 64.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.006 0.431 . . . . 0.0 110.489 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 27.4 t -118.17 122.78 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.628 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.561 ' HG2' HG22 ' C' ' 28' ' ' VAL . 32.1 mtpt -106.17 154.51 20.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.818 0.342 . . . . 0.0 110.426 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.447 ' HG ' ' CE1' ' C' ' 85' ' ' TYR . 0.2 OUTLIER -119.97 117.73 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' LYS . . . . . 0.707 ' HA ' HG22 ' C' ' 26' ' ' THR . 71.1 tttt -85.07 112.26 20.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' C' ' 26' ' ' THR . 12.5 p -133.62 155.99 40.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -166.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.9 mtm -80.24 130.37 35.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.861 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.04 -53.07 17.52 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.442 0.464 . . . . 0.0 111.762 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 41.3 t -57.72 -32.87 67.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.909 0.484 . . . . 0.0 112.066 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' GLU . . . . . 0.529 ' HG3' HG23 ' C' ' 83' ' ' THR . 3.8 tp10 -66.11 -54.73 21.98 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' C' ' 104' ' ' LYS . 62.1 t-105 -59.31 -48.88 79.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.863 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' ASP . . . . . 0.462 ' HA ' ' HG3' ' C' ' 104' ' ' LYS . 5.5 t70 -70.27 -6.49 35.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.901 -174.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -81.23 -5.78 58.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 109.883 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' C' ' 104' ' ' LYS . . . 82.83 20.01 62.23 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' THR . . . . . 0.529 HG23 ' HG3' ' C' ' 78' ' ' GLU . 0.6 OUTLIER -63.47 145.87 54.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.231 -177.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 33.8 mt-10 -81.58 135.61 35.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 111.767 -176.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' TYR . . . . . 0.568 ' HH ' ' CG2' ' C' ' 74' ' ' VAL . 1.8 m-85 -134.13 124.75 26.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.956 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 0.2 OUTLIER -133.26 142.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 111.424 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 18.9 t -112.37 124.53 52.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.412 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.887 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.5 mp -114.73 147.6 39.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' VAL . . . . . 0.622 HG21 HG23 ' C' ' 31' ' ' ILE . 11.4 t -126.44 131.62 71.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.234 0.613 . . . . 0.0 109.958 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 8.3 pt-20 -136.09 134.95 38.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.175 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 7.9 t70 -147.0 151.83 37.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.142 0.496 . . . . 0.0 110.571 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 66.4 m -68.35 -8.13 37.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.636 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 58.0 mm-40 -99.99 -4.57 29.77 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 111.163 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . 0.714 ' C ' HD11 ' C' ' 94' ' ' LEU . 2.4 pp -108.09 158.51 33.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.962 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.57 ' HD2' ' H ' ' C' ' 96' ' ' THR . 5.3 Cg_endo -91.03 -34.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.831 3.687 . . . . 0.0 112.784 -173.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.57 ' H ' ' HD2' ' C' ' 95' ' ' PRO . 33.2 p -141.38 145.84 39.79 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.53 148.47 66.66 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.954 1.769 . . . . 0.0 111.142 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' VAL . . . . . 0.796 HG21 HG12 ' C' ' 7' ' ' ILE . 40.3 t -110.61 139.11 35.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.887 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 24.9 pttm -144.15 157.53 44.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.467 0.651 . . . . 0.0 112.593 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.06 137.02 11.46 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.862 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 75.2 p -114.65 149.94 35.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.994 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' C' ' 13' ' ' LYS . 3.9 tp -122.71 153.2 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' ARG . . . . . 0.45 ' N ' HG13 ' C' ' 102' ' ' ILE . 12.8 ptp180 -125.14 156.67 37.98 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' LYS . . . . . 0.518 ' HB3' ' HA2' ' C' ' 82' ' ' GLY . 8.1 tmtm? -78.84 122.88 26.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.998 0.428 . . . . 0.0 110.968 -173.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' ALA . . . . . 0.483 ' HB2' ' HE2' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 172.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 tp . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.305 0.574 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 26.8 t -120.87 121.1 37.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.441 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . 0.792 HG22 HG22 ' C' ' 31' ' ' ILE . 41.2 t -119.0 123.72 71.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.499 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -146.89 146.66 30.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.473 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.45 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.2 mm? -97.1 145.08 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.323 0.582 . . . . 0.0 111.104 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 63.0 tp -115.24 117.59 30.9 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . 0.447 ' HB3' HD13 ' C' ' 102' ' ' ILE . 43.3 pttt -91.12 155.31 44.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.797 0.332 . . . . 0.0 110.475 -177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . 0.577 ' HD3' HD11 ' C' ' 27' ' ' ILE . 74.5 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 C-N-CA 122.805 2.337 . . . . 0.0 111.161 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.667 0.27 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' ILE . . . . . 0.577 HD11 ' HD3' ' C' ' 14' ' ' PRO . 22.8 mm -117.37 117.89 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 79.3 t -112.64 134.78 54.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.103 -170.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 52.3 t -111.62 114.45 27.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.108 171.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -96.15 125.42 40.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' ILE . . . . . 0.792 HG22 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.59 124.59 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.985 0.898 . . . . 0.0 111.48 176.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -114.18 128.85 70.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.699 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.551 ' CE2' HD12 ' C' ' 68' ' ' ILE . 49.0 p90 -147.41 165.11 31.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.421 0.629 . . . . 0.0 111.732 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 12.7 t -143.77 143.67 31.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.873 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 79.62 9.56 1.53 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.605 0.565 . . . . 0.0 112.298 171.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.25 160.58 14.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 0.0 112.217 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' GLU . . . . . 0.575 ' O ' HG13 ' C' ' 39' ' ' ILE . 6.2 tp10 -99.74 172.96 6.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.496 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.419 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 2.7 m-80 -55.03 110.81 0.72 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 123.604 1.669 . . . . 0.0 109.109 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.575 HG13 ' O ' ' C' ' 37' ' ' GLU . 17.3 mt -77.3 142.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.165 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . 0.639 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 29.2 tptp -105.42 123.68 48.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.823 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.15 139.03 21.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.282 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.455 ' CE1' ' HG2' ' C' ' 49' ' ' GLU . 47.5 t80 -133.24 139.83 47.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.048 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -125.37 137.48 54.03 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -126.94 129.66 48.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.933 0.333 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 25.0 t -120.83 116.72 50.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.323 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . 0.516 ' HA ' ' OE1' ' C' ' 84' ' ' GLU . 3.2 m120 54.53 37.17 27.42 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.123 0.487 . . . . 0.0 111.808 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.04 -16.3 38.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.277 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.64 142.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.624 0.712 . . . . 0.0 110.721 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . 0.455 ' HG2' ' CE1' ' C' ' 42' ' ' PHE . 41.5 mt-10 -60.4 138.17 58.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.407 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' ARG . . . . . 0.482 ' HB2' HG23 ' C' ' 45' ' ' VAL . 13.2 tpp180 -91.29 124.27 35.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.362 0.601 . . . . 0.0 110.077 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -59.76 162.71 5.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.738 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -41.77 163.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.05 0.929 . . . . 0.0 112.898 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.68 -0.48 23.23 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -158.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.5 ' HA ' HD21 ' C' ' 72' ' ' LEU . 3.5 p -89.74 129.68 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 113.637 -1.281 . . . . 0.0 108.133 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.587 ' HB3' ' HG3' ' C' ' 71' ' ' LYS . 31.0 tt0 -141.88 110.29 6.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.082 0.468 . . . . 0.0 110.179 -169.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -94.81 134.22 37.67 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.95 149.39 22.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -58.26 145.78 73.2 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.169 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' PRO . . . . . 0.506 ' HB3' HD11 ' C' ' 68' ' ' ILE . 19.1 Cg_endo -57.74 136.64 76.77 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.728 2.952 . . . . 0.0 113.474 -174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.808 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt . . . . . 0 C--O 1.233 0.184 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 8.8 m -102.09 146.51 27.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.037 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -133.31 119.72 20.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.106 0.479 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . 0.551 HD12 ' CE2' ' C' ' 33' ' ' TYR . 1.7 mp -115.13 127.14 72.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.172 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -105.17 121.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.692 ' HG ' HD13 ' C' ' 31' ' ' ILE . 38.9 m -111.79 113.02 25.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.587 ' HG3' ' HB3' ' C' ' 55' ' ' GLU . 13.0 ptmt -106.17 139.82 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.156 0.503 . . . . 0.0 110.241 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.5 HD21 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -113.5 127.13 55.98 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.921 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -87.91 116.95 26.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . 0.404 HG12 HD11 ' C' ' 72' ' ' LEU . 21.3 m -130.52 157.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.621 -171.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' MET . . . . . 0.453 ' O ' ' HB2' ' C' ' 78' ' ' GLU . 55.2 mtt -83.1 135.49 34.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.216 0.323 . . . . 0.0 110.57 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -47.59 -54.91 10.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' C' ' 81' ' ' SER . 5.3 m -57.09 -29.38 63.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.718 0.407 . . . . 0.0 112.093 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' C' ' 75' ' ' MET . 5.5 mm-40 -65.37 -54.12 33.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -58.78 -44.8 90.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.764 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.54 -19.82 64.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.043 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' C' ' 77' ' ' SER . 6.6 t -80.89 -4.98 56.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.14 26.71 70.03 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.024 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' THR . . . . . 0.445 HG23 ' CE2' ' C' ' 85' ' ' TYR . 12.8 t -64.83 144.99 56.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.367 0.604 . . . . 0.0 110.377 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' GLU . . . . . 0.516 ' OE1' ' HA ' ' C' ' 46' ' ' ASN . 12.7 mt-10 -74.84 133.7 41.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.323 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' TYR . . . . . 0.645 ' HB2' ' CG2' ' C' ' 102' ' ' ILE . 83.5 m-85 -126.24 118.08 24.4 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.62 133.3 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 32.5 t -108.72 116.24 31.62 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.842 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.8 mp -110.56 145.1 38.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.069 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' VAL . . . . . 0.607 HG22 HG23 ' C' ' 31' ' ' ILE . 40.8 t -125.65 131.29 72.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 123.38 0.672 . . . . 0.0 109.469 176.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.639 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 9.7 pt-20 -131.17 137.13 48.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.924 0.393 . . . . 0.0 110.28 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . 0.493 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 14.6 t0 -149.89 154.23 38.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.535 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.4 m -67.76 -7.72 29.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.634 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -100.5 -9.3 22.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . 0.637 HD13 ' O ' ' C' ' 94' ' ' LEU . 2.4 pp -97.75 149.22 35.5 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.627 -175.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.27 -33.19 1.47 Allowed 'Trans proline' 0 C--N 1.334 -0.193 0 C-N-CA 123.941 3.094 . . . . 0.0 112.88 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.447 ' O ' HD12 ' C' ' 94' ' ' LEU . 4.7 p -144.85 152.81 53.02 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.437 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.46 139.94 55.77 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.007 1.804 . . . . 0.0 111.283 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 27.4 t -102.05 124.36 55.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.842 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 22.6 pttp -134.39 156.55 48.33 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.24 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.13 138.1 17.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.255 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t -117.45 151.49 36.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.115 0.483 . . . . 0.0 111.718 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.645 ' CG2' ' HB2' ' C' ' 85' ' ' TYR . 3.6 tp -123.95 143.92 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.652 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -133.26 157.11 46.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.3 105.63 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.078 0.861 . . . . 0.0 109.203 -174.92 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 1.7 tp . . . . . 0 N--CA 1.441 -0.909 0 CA-C-O 121.698 0.761 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 26.9 t -131.73 134.42 45.86 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.414 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -119.29 123.37 71.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.042 0.449 . . . . 0.0 110.236 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 11.7 m -117.89 123.33 45.59 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.527 ' HB3' HD13 ' C' ' 102' ' ' ILE . 91.1 mt -99.76 126.18 45.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.473 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . 0.484 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 49.6 tp -104.42 114.93 29.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . 0.807 ' HB3' HD11 ' C' ' 102' ' ' ILE . 9.6 ptpp? -91.37 150.77 41.94 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.455 -0.771 0 C-N-CA 121.934 1.756 . . . . 0.0 110.632 175.515 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 121.819 0.818 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.21 148.59 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.586 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 45.6 t -128.47 131.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.338 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -114.99 111.68 21.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.72 121.93 43.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' ILE . . . . . 0.641 HD13 ' HH ' ' C' ' 33' ' ' TYR . 0.1 OUTLIER -124.68 130.79 73.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.849 0.833 . . . . 0.0 111.227 -176.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' C' ' 7' ' ' ILE . 60.2 t -110.6 131.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.496 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.641 ' HH ' HD13 ' C' ' 31' ' ' ILE . 0.1 OUTLIER -164.67 161.92 21.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.403 0.439 . . . . 0.0 110.529 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' SER . . . . . 0.544 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 11.6 t -142.59 155.34 44.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' C' ' 34' ' ' SER . 0.9 OUTLIER 81.6 9.96 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.814 0.697 . . . . 0.0 111.832 177.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.22 142.9 34.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.456 0.645 . . . . 0.0 112.105 -172.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' GLU . . . . . 0.55 ' O ' HG13 ' C' ' 39' ' ' ILE . 29.8 mm-40 -95.95 179.11 5.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.585 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.65 ' N ' HD21 ' C' ' 38' ' ' ASN . 0.7 OUTLIER -54.26 112.36 0.96 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 124.053 1.882 . . . . 0.0 109.654 -156.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.55 HG13 ' O ' ' C' ' 37' ' ' GLU . 11.1 mt -83.17 146.83 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 110.15 -3.205 . . . . 0.0 112.584 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -112.37 134.68 53.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.634 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.0 131.43 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.43 ' HE1' ' HG2' ' C' ' 49' ' ' GLU . 53.2 t80 -122.66 142.17 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.136 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' TRP . . . . . 0.57 ' CD2' HD21 ' C' ' 72' ' ' LEU . 50.3 m95 -132.02 137.55 47.89 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -124.84 131.24 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.155 -0.341 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' VAL . . . . . 0.477 HG21 ' HD2' ' C' ' 50' ' ' ARG . 60.6 t -123.03 117.26 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 55.69 35.89 26.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.62 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.21 -15.85 36.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.331 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.16 145.19 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.492 0.646 . . . . 0.0 111.645 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . 0.43 ' HG2' ' HE1' ' C' ' 42' ' ' PHE . 47.8 mt-10 -61.14 127.54 32.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.646 172.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' ARG . . . . . 0.477 ' HD2' HG21 ' C' ' 45' ' ' VAL . 5.4 ptm180 -92.15 166.13 12.8 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.373 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' C' ' 51' ' ' LYS . 31.7 tptt -75.67 163.01 27.74 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.494 ' HG3' ' H ' ' C' ' 53' ' ' GLY . 22.4 tptp -45.51 164.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.84 0.828 . . . . 0.0 111.914 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . 0.494 ' H ' ' HG3' ' C' ' 52' ' ' LYS . . . 115.36 -9.17 20.17 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -161.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.919 HG23 HD23 ' C' ' 72' ' ' LEU . 48.8 t -77.27 118.73 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 113.339 -1.431 . . . . 0.0 107.794 165.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -133.47 144.29 49.36 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.19 -170.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -130.25 130.09 44.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.57 158.14 18.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.453 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.05 150.28 51.68 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.482 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' PRO . . . . . 0.531 ' HB3' HD12 ' C' ' 68' ' ' ILE . 37.4 Cg_endo -63.12 139.74 74.48 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.147 2.565 . . . . 0.0 113.133 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.326 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -113.68 152.73 30.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.427 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 64.4 m -135.31 120.44 18.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.377 0.608 . . . . 0.0 111.009 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . 0.581 ' O ' HD11 ' C' ' 31' ' ' ILE . 1.6 mp -110.81 130.94 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.888 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.6 122.54 60.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.394 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -111.3 122.82 48.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -106.86 143.76 34.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.919 HD23 HG23 ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.71 114.57 19.48 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.032 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -84.44 114.59 22.02 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' C' ' 85' ' ' TYR . 16.4 m -133.19 161.61 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.719 -173.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.8 mtt -77.75 128.71 34.48 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.539 0.685 . . . . 0.0 109.589 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.96 87.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.078 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -61.9 -30.5 70.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.527 0.331 . . . . 0.0 111.435 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.32 -51.66 42.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' TRP . . . . . 0.435 ' HZ3' HG22 ' C' ' 102' ' ' ILE . 63.4 t-105 -57.62 -44.15 85.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.766 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.1 -17.01 64.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.347 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -81.73 -4.71 57.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.905 0.383 . . . . 0.0 110.772 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.84 21.72 65.4 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 41.5 m -66.22 143.41 57.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.874 -0.663 . . . . 0.0 112.01 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -71.16 131.81 44.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.824 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' TYR . . . . . 0.489 ' CE1' HG11 ' C' ' 74' ' ' VAL . 67.3 m-85 -130.53 116.21 17.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 169.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 11.3 t -120.43 135.93 59.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.09 127.66 54.33 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.524 HD12 ' O ' ' C' ' 98' ' ' VAL . 1.9 mm? -123.13 144.84 49.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.823 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' VAL . . . . . 0.606 ' HB ' ' HB ' ' C' ' 98' ' ' VAL . 69.7 t -122.89 132.78 70.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.115 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -127.85 133.82 49.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.523 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . 0.637 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 28.4 t70 -153.16 150.44 29.07 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.253 0.549 . . . . 0.0 110.575 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 21.9 t -66.24 -15.17 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.752 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -95.62 -7.65 37.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.243 0.474 . . . . 0.0 112.156 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.5 pp -92.62 149.39 37.96 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.108 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.36 -35.17 0.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.86 3.04 . . . . 0.0 112.453 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.418 ' O ' HD13 ' C' ' 94' ' ' LEU . 16.0 p -142.6 149.32 50.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.256 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' PRO . . . . . 0.478 ' HB2' HD13 ' C' ' 88' ' ' LEU . 52.0 Cg_endo -66.24 143.34 70.43 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.308 2.005 . . . . 0.0 111.258 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' VAL . . . . . 0.606 ' HB ' ' HB ' ' C' ' 89' ' ' VAL . 47.7 t -91.39 106.54 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 11.1 ptpp? -107.84 142.81 37.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.422 -174.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.65 120.14 5.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 39.4 t -105.51 156.37 18.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.047 0.451 . . . . 0.0 110.69 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.807 HD11 ' HB3' ' C' ' 13' ' ' LYS . 14.0 tt -123.83 147.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.008 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -133.68 144.51 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.293 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -85.19 143.61 28.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.96 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.702 173.197 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' ILE . . . . . 0.508 HG12 HG12 ' C' ' 98' ' ' VAL . 3.7 tp . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 13.7 m -116.33 114.95 25.03 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.922 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 t -114.27 115.01 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -131.88 132.53 43.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.075 0.464 . . . . 0.0 109.88 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' C' ' 102' ' ' ILE . 17.5 mt -99.5 136.56 39.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.293 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 61.6 tp -110.86 115.19 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -77.24 150.43 80.33 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.975 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . 0.494 ' HD3' HG12 ' C' ' 27' ' ' ILE . 82.6 Cg_exo . . . . . 0 CA--C 1.542 0.91 0 C-N-CA 122.924 2.416 . . . . 0.0 113.39 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' C' ' 72' ' ' LEU . 10.1 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' ILE . . . . . 0.784 HG13 HG13 ' C' ' 74' ' ' VAL . 60.6 mt -120.19 152.36 23.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.08 135.55 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.911 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 51.3 t -107.82 117.71 34.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -105.12 118.39 36.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.57 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' ILE . . . . . 0.643 HG13 ' HH ' ' C' ' 33' ' ' TYR . 0.0 OUTLIER -120.01 130.86 73.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.677 0.751 . . . . 0.0 111.309 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 21.7 t -117.72 132.59 67.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.254 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.945 ' HE1' HD11 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -151.79 170.03 20.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' SER . . . . . 0.511 ' HB2' ' HG2' ' C' ' 65' ' ' LYS . 32.2 t -124.09 141.48 52.01 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.396 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 t0 71.01 11.11 7.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.184 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mt -111.69 129.64 56.04 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.28 -0.888 . . . . 0.0 110.708 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.33 91.28 2.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.705 160.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' C' ' 91' ' ' ASP . 0.5 OUTLIER -147.29 106.38 3.87 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 136.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.424 HD11 ' CZ ' ' C' ' 33' ' ' TYR . 5.5 mm -115.28 112.53 40.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.977 -1.089 . . . . 0.0 113.721 -169.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -108.16 123.57 48.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.138 172.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.67 142.78 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.415 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.3 t80 -129.88 143.55 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -128.94 137.94 51.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . 0.403 ' CG ' ' HB ' ' C' ' 86' ' ' VAL . 4.4 pt20 -131.23 131.45 43.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.229 0.538 . . . . 0.0 111.409 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' C' ' 50' ' ' ARG . 13.8 t -104.08 109.14 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.858 177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.31 42.26 31.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.635 0.731 . . . . 0.0 110.693 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.62 -16.98 16.51 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.922 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . 0.55 HG12 ' O ' ' C' ' 45' ' ' VAL . 10.0 p -97.85 138.58 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 118.297 1.049 . . . . 0.0 110.521 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -57.72 139.44 53.84 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.379 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' ARG . . . . . 0.624 ' HB2' HG23 ' C' ' 45' ' ' VAL . 16.2 tpt180 -90.98 124.13 34.99 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.845 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' LYS . . . . . 0.58 ' HD2' ' H ' ' C' ' 51' ' ' LYS . 3.1 mptp? -70.45 161.31 30.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.966 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' C' ' 52' ' ' LYS . 45.5 mmtm -42.19 162.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.484 1.135 . . . . 0.0 114.011 -170.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -158.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.505 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.3 p -87.77 128.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 113.707 -1.246 . . . . 0.0 109.095 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -140.02 110.29 6.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.054 0.454 . . . . 0.0 110.17 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -89.22 130.95 35.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.585 ' HB2' HG12 ' C' ' 69' ' ' VAL . 23.7 mt-30 -105.31 172.57 6.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -175.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -76.92 153.19 82.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.827 0.346 . . . . 0.0 110.293 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' C' ' 67' ' ' THR . 60.6 Cg_endo -70.21 149.43 64.01 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.537 2.825 . . . . 0.0 113.424 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 170.207 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . 0.511 ' HG2' ' HB2' ' C' ' 34' ' ' SER . 84.3 mttt . . . . . 0 C--O 1.225 -0.221 0 CA-C-O 120.844 0.354 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.8 m -118.2 148.21 42.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.638 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 93.9 m -132.71 121.07 22.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . 0.945 HD11 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.62 127.89 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.889 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' C' ' 57' ' ' GLN . 0.7 OUTLIER -111.46 122.87 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.726 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -111.28 125.43 53.82 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.706 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.22 138.52 43.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' C' ' 26' ' ' THR . 0.2 OUTLIER -120.07 122.1 40.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' LYS . . . . . 0.428 ' HA ' ' HD2' ' C' ' 73' ' ' LYS . 3.5 mmmp? -77.87 121.0 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . 0.784 HG13 HG13 ' C' ' 27' ' ' ILE . 9.9 p -143.37 148.94 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.716 -170.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' MET . . . . . 0.449 ' HE3' ' OE1' ' C' ' 78' ' ' GLU . 3.4 mpp? -89.81 140.1 29.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.874 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -43.99 -55.39 4.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -57.03 -33.86 67.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.557 0.617 . . . . 0.0 112.285 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' GLU . . . . . 0.449 ' OE1' ' HE3' ' C' ' 75' ' ' MET . 56.3 mt-10 -63.94 -53.76 45.24 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 176.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -58.09 -44.03 87.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.768 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' ASP . . . . . 0.525 ' HA ' ' HD2' ' C' ' 104' ' ' LYS . 24.5 t70 -70.25 -17.24 63.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.323 -176.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 66.3 m -86.38 -3.01 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.68 28.87 70.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.184 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.8 t -64.71 143.18 58.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.041 0.448 . . . . 0.0 109.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.8 mt-10 -75.49 130.1 38.34 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' TYR . . . . . 0.673 ' HH ' HG22 ' C' ' 74' ' ' VAL . 7.8 m-85 -128.05 120.79 28.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.325 175.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . 0.465 HG23 ' HB2' ' C' ' 101' ' ' SER . 26.7 t -120.25 135.76 59.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 19.5 p -115.39 129.2 56.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.637 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.9 mp -120.24 148.61 43.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.287 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' VAL . . . . . 0.53 HG12 HG21 ' C' ' 31' ' ' ILE . 5.9 p -143.72 127.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.354 0.597 . . . . 0.0 111.448 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -110.77 153.39 25.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.053 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . 0.617 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 11.3 t70 -142.69 148.03 36.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -62.31 -21.31 65.16 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -97.2 0.09 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . 0.692 ' C ' HD12 ' C' ' 94' ' ' LEU . 2.6 pp -103.86 158.64 31.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.452 ' HD2' ' H ' ' C' ' 96' ' ' THR . 1.8 Cg_endo -88.21 -35.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.874 3.049 . . . . 0.0 113.294 -168.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.452 ' H ' ' HD2' ' C' ' 95' ' ' PRO . 16.7 p -147.28 153.64 44.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.43 151.99 79.71 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.294 1.996 . . . . 0.0 112.112 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 19.2 m -122.19 147.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.689 ' HB3' ' HZ2' ' C' ' 99' ' ' LYS . 0.4 OUTLIER -135.08 161.48 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.181 0.515 . . . . 0.0 112.367 -169.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.18 140.99 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' SER . . . . . 0.465 ' HB2' HG23 ' C' ' 86' ' ' VAL . 39.7 t -120.56 149.14 42.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.989 0.358 . . . . 0.0 110.708 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.552 ' HB ' HD13 ' C' ' 11' ' ' LEU . 2.9 tp -125.03 142.12 42.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.181 0.515 . . . . 0.0 110.879 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -123.69 153.91 40.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' LYS . . . . . 0.525 ' HD2' ' HA ' ' C' ' 80' ' ' ASP . 76.0 tttt -64.39 107.04 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.454 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.407 -176.869 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' ILE . . . . . 0.549 HG12 HG13 ' C' ' 98' ' ' VAL . 3.3 tp . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.949 0.404 . . . . 0.0 110.656 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 47.2 t -120.47 125.06 46.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . 0.43 ' HB ' HG21 ' C' ' 31' ' ' ILE . 3.0 p -128.57 125.32 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.108 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -148.28 148.61 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.053 -0.404 . . . . 0.0 110.539 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.5 mm? -96.11 146.7 24.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.905 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -115.3 115.38 26.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.712 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -78.1 154.58 80.02 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.203 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.46 -0.486 0 C-N-CA 122.721 2.281 . . . . 0.0 111.579 175.628 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' THR . . . . . 0.488 ' HA ' HG11 ' C' ' 74' ' ' VAL . 3.4 t . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 122.226 1.012 . . . . 0.0 112.302 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mt -102.32 155.52 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.541 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' C' ' 71' ' ' LYS . 56.0 t -127.95 135.17 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.943 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -111.16 127.03 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 124.62 52.28 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' ILE . . . . . 0.589 HG22 HG23 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.97 131.13 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.651 179.249 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.24 129.7 66.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.748 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.625 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -165.54 160.62 17.88 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' SER . . . . . 0.493 ' OG ' ' HA ' ' C' ' 65' ' ' LYS . 14.7 m -144.2 153.94 42.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.792 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' C' ' 34' ' ' SER . 1.1 m-20 78.8 9.22 1.91 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.454 0.472 . . . . 0.0 112.056 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.23 163.99 13.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.624 0.726 . . . . 0.0 112.059 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -83.0 173.82 11.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.291 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -57.62 114.5 2.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.535 1.636 . . . . 0.0 107.784 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.576 ' CG2' HG11 ' C' ' 89' ' ' VAL . 4.6 mp -74.55 146.06 10.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 111.559 -2.564 . . . . 0.0 112.506 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.87 172.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.19 140.1 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -134.36 137.81 44.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.939 0.399 . . . . 0.0 110.94 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' TRP . . . . . 0.538 ' HE3' ' HD2' ' C' ' 85' ' ' TYR . 55.2 m95 -125.77 133.94 51.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -124.8 130.22 51.97 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' C' ' 50' ' ' ARG . 23.5 t -118.31 111.78 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.939 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.18 37.24 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.875 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.76 -14.3 25.91 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.1 134.16 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.22 138.52 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.102 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' ARG . . . . . 0.46 ' HB2' HG23 ' C' ' 45' ' ' VAL . 15.8 tpp180 -90.96 127.11 36.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.479 0.657 . . . . 0.0 110.879 -173.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -57.67 160.4 4.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.844 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -40.65 163.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.301 1.048 . . . . 0.0 113.307 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.51 -0.47 23.46 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -163.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' C' ' 72' ' ' LEU . 5.4 p -87.29 127.25 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.314 172.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 34.8 mt-10 -124.08 108.76 12.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -172.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 6.3 m -93.43 117.75 30.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . 0.588 ' HB2' HG13 ' C' ' 69' ' ' VAL . 47.1 mt-30 -100.39 171.42 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.463 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.2 144.4 89.65 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 0.0 110.651 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' C' ' 67' ' ' THR . 27.3 Cg_endo -63.08 151.23 85.83 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.557 2.838 . . . . 0.0 114.072 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.072 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . 0.493 ' HA ' ' OG ' ' C' ' 34' ' ' SER . 74.4 mmtt . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -109.11 150.53 27.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.053 0.454 . . . . 0.0 110.795 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 57.5 m -137.04 126.73 25.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.96 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . 0.625 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -112.05 134.16 55.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.872 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' VAL . . . . . 0.588 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -115.61 127.32 73.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.365 0.602 . . . . 0.0 110.697 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 40.9 p -115.41 129.62 56.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.534 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 48.1 tttp -107.09 144.62 33.52 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -120.03 116.54 25.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.027 0.441 . . . . 0.0 110.251 177.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -77.76 112.59 14.77 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . 0.984 HG22 ' HH ' ' C' ' 85' ' ' TYR . 9.3 p -119.98 151.71 22.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.342 0.592 . . . . 0.0 110.602 -168.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' MET . . . . . 0.857 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 65.9 mtt -84.04 137.43 33.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.251 -176.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.32 -35.98 60.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.824 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 14.5 t -70.74 -28.31 64.61 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.368 0.267 . . . . 0.0 111.627 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' GLU . . . . . 0.857 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 7.7 mm-40 -71.44 -54.75 9.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.712 0.767 . . . . 0.0 109.137 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -64.95 -38.63 91.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.238 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.86 -18.47 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.41 . . . . 0.0 111.039 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 18.6 t -90.16 -4.48 57.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.546 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.58 25.29 70.47 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.34 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -62.22 138.82 58.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.116 0.484 . . . . 0.0 111.145 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.17 149.68 24.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.265 -172.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' TYR . . . . . 0.984 ' HH ' HG22 ' C' ' 74' ' ' VAL . 16.4 m-85 -132.7 131.05 40.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.198 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . 0.535 HG11 ' HE2' ' C' ' 99' ' ' LYS . 25.3 t -119.87 130.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 34.4 t -108.6 120.48 42.56 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 5.8 mp -116.23 147.52 41.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.63 0.581 . . . . 0.0 110.166 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' VAL . . . . . 0.589 HG23 HG22 ' C' ' 31' ' ' ILE . 12.3 t -134.0 127.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.54 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.06 144.94 51.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.082 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . 0.504 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 27.1 t70 -148.17 156.7 42.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.339 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 37.9 t -65.37 -21.68 66.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -91.9 -11.55 35.99 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 122.192 -0.318 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 40.8 mt -84.12 146.57 48.69 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.668 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 1.7 Cg_endo -84.34 -29.26 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.512 2.808 . . . . 0.0 111.651 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 27.1 p -147.19 151.62 41.23 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.903 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.42 148.05 47.86 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.532 1.488 . . . . 0.0 110.651 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 27.6 m -108.57 141.1 24.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.654 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 13.7 ptmm? -142.79 153.51 43.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.32 22.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 33.5 t -121.91 149.74 42.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.409 0.624 . . . . 0.0 111.888 -173.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.484 ' HB ' ' HG ' ' C' ' 11' ' ' LEU . 4.8 tp -124.03 145.64 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.413 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -130.86 162.68 29.08 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -80.14 108.5 13.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.338 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.156 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.631 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 19.5 m -117.82 114.58 23.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.249 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.82 117.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.19 0.519 . . . . 0.0 110.661 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m -123.15 130.92 53.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' LEU . . . . . 0.519 HD11 ' HB ' ' C' ' 102' ' ' ILE . 46.8 mt -99.0 130.07 45.32 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 tp -111.47 113.8 26.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -83.23 147.59 53.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo . . . . . 0 C--N 1.349 0.594 0 C-N-CA 125.08 3.854 . . . . 0.0 114.533 -172.227 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 121.978 0.894 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.44 153.96 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.699 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.93 134.38 63.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.216 0.531 . . . . 0.0 111.554 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' CYS . . . . . 0.526 ' HB2' ' CH2' ' C' ' 43' ' ' TRP . 35.7 t -108.88 112.85 25.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.29 115.89 31.0 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' ILE . . . . . 0.647 HG23 HG21 ' C' ' 89' ' ' VAL . 0.2 OUTLIER -126.25 128.65 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 53.8 t -114.69 131.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.744 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' TYR . . . . . 0.525 ' HH ' HD11 ' C' ' 31' ' ' ILE . 0.1 OUTLIER -161.13 163.63 31.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.418 -178.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -142.34 150.94 41.42 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 37.6 t70 78.67 10.99 1.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.811 0.695 . . . . 0.0 111.6 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 17.4 mt -97.97 164.66 12.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.003 0.906 . . . . 0.0 112.654 -172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -94.36 170.84 9.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.83 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.14 114.92 2.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.72 1.724 . . . . 0.0 108.257 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' ILE . . . . . 0.637 HG23 HG11 ' C' ' 89' ' ' VAL . 4.7 mp -70.12 141.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.177 -2.738 . . . . 0.0 113.555 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -103.43 124.05 48.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -108.73 141.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -173.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.411 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.5 t80 -132.5 143.6 49.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' TRP . . . . . 0.606 ' HB2' ' HD3' ' C' ' 50' ' ' ARG . 58.0 m95 -130.45 137.85 50.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -125.9 130.07 50.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.792 0.269 . . . . 0.0 111.191 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 27.6 t -121.66 113.03 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 56.89 36.17 27.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.14 0.495 . . . . 0.0 110.979 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.49 15.1 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.818 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.54 133.96 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.61 138.04 58.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' ARG . . . . . 0.606 ' HD3' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -89.92 156.14 18.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.346 -172.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -69.79 156.08 39.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.077 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -53.14 166.85 0.21 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.776 0.798 . . . . 0.0 112.321 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.15 7.31 12.71 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -160.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' VAL . . . . . 0.428 ' HA ' HD21 ' C' ' 72' ' ' LEU . 23.8 t -84.61 129.21 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.044 -1.578 . . . . 0.0 107.874 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 41.1 mt-10 -128.71 108.9 10.85 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 7.0 p -92.11 123.12 35.22 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -89.04 144.43 26.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' ASN . . . . . 0.405 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.1 t30 -58.37 137.4 85.29 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.774 -175.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' PRO . . . . . 0.442 ' HB3' HD12 ' C' ' 68' ' ' ILE . 31.1 Cg_exo -48.09 134.88 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.781 2.987 . . . . 0.0 112.849 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 N--CA 1.446 -0.625 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.183 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 121.185 0.517 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -101.14 146.79 27.02 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -131.58 119.11 21.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.112 0.482 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ILE . . . . . 0.582 ' O ' HD12 ' C' ' 31' ' ' ILE . 1.6 mp -114.89 133.09 62.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.922 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.31 121.62 61.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 0.0 110.391 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' C' ' 29' ' ' CYS . 40.8 m -108.96 111.12 22.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.695 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 81.8 tttt -105.37 144.56 31.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.978 -174.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' LEU . . . . . 0.428 HD21 ' HA ' ' C' ' 54' ' ' VAL . 0.5 OUTLIER -122.49 119.59 31.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 174.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -91.53 111.17 22.57 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' VAL . . . . . 0.415 HG21 ' CE2' ' C' ' 85' ' ' TYR . 8.3 p -134.33 163.62 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.095 0.474 . . . . 0.0 110.864 -168.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' MET . . . . . 0.74 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 63.2 mtt -74.16 129.1 37.17 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.442 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.38 82.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.812 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 26.0 t -59.7 -32.72 70.78 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.916 0.486 . . . . 0.0 111.477 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' GLU . . . . . 0.74 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 26.2 mm-40 -67.38 -51.67 49.18 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -57.84 -44.26 86.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.087 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' ASP . . . . . 0.526 ' HA ' ' HE2' ' C' ' 104' ' ' LYS . 26.7 t70 -70.88 -11.55 61.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 9.9 t -87.71 -3.68 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.5 26.28 68.15 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.487 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -65.58 149.77 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 111.057 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 27.5 mt-10 -71.24 129.08 37.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.115 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' TYR . . . . . 0.529 ' HD1' ' HE3' ' C' ' 43' ' ' TRP . 0.4 OUTLIER -128.9 119.41 24.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 16.7 t -120.48 136.39 57.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' CYS . . . . . 0.424 ' HB3' HD21 ' C' ' 11' ' ' LEU . 10.8 t -111.54 126.38 54.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' LEU . . . . . 0.652 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -119.25 146.02 45.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.882 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' VAL . . . . . 0.647 HG21 HG23 ' C' ' 31' ' ' ILE . 39.2 t -123.54 131.09 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.8 136.56 54.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.976 0.417 . . . . 0.0 111.016 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' ASP . . . . . 0.654 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 15.1 t70 -149.3 145.18 26.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -63.09 -18.46 63.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.119 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -101.53 5.07 41.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.9 pp -99.14 148.42 34.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.05 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.4 -34.74 1.89 Allowed 'Trans proline' 0 N--CA 1.469 0.057 0 C-N-CA 123.83 3.02 . . . . 0.0 112.841 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' THR . . . . . 0.478 ' O ' HD12 ' C' ' 94' ' ' LEU . 20.1 p -144.66 148.7 40.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.37 144.78 91.81 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.325 2.016 . . . . 0.0 111.254 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 44.1 t -94.72 116.66 36.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' LYS . . . . . 0.485 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 18.6 ptpt -127.66 149.18 50.31 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.091 -174.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.401 ' O ' HD13 ' C' ' 11' ' ' LEU . . . -155.76 135.76 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.906 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.4 t -112.8 154.61 25.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.943 0.401 . . . . 0.0 111.179 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.519 ' HB ' HD11 ' C' ' 11' ' ' LEU . 5.7 tp -122.92 144.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.156 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -133.57 150.15 51.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.422 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' C' ' 80' ' ' ASP . 21.6 ttpp -90.65 136.81 32.83 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.576 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.738 0.304 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.33 -173.36 54.87 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.489 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 64.14 57.39 1.27 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.571 0.748 . . . . 0.0 111.218 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.521 ' HG3' ' HG1' ' C' ' 5' ' ' THR . 3.1 pt20 -79.64 -25.35 41.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' THR . . . . . 0.521 ' HG1' ' HG3' ' C' ' 4' ' ' GLN . 3.9 m -103.66 90.12 3.56 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.851 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.512 ' HB2' ' HE3' ' C' ' 65' ' ' LYS . 4.4 m-20 -93.38 113.17 25.27 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 162.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tp -122.18 109.83 25.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.042 172.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 5.2 m -115.45 111.56 20.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.192 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . 0.627 HG22 HG23 ' C' ' 31' ' ' ILE . 29.1 t -106.43 114.51 45.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.117 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -125.49 123.75 39.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.495 ' HA ' ' O ' ' C' ' 28' ' ' VAL . 44.2 mt -99.24 135.07 41.19 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.538 ' HB3' HG21 ' C' ' 28' ' ' VAL . 3.3 tm? -108.58 125.19 51.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -94.92 153.66 39.88 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.473 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . 0.611 ' HD3' HD12 ' C' ' 27' ' ' ILE . 60.0 Cg_endo -72.56 140.68 33.31 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.046 2.497 . . . . 0.0 112.853 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.68 153.21 76.62 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.792 2.328 . . . . 0.0 111.498 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -113.65 -179.65 3.7 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.308 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.79 -77.48 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.799 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -144.4 -84.19 0.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.741 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 47.3 mt -97.18 -41.9 11.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.328 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -87.96 156.0 19.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.229 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' C' ' 22' ' ' GLN . 28.2 p -104.38 112.71 25.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.881 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' C' ' 21' ' ' THR . 14.4 mm-40 -166.66 78.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.31 . . . . 0.0 111.069 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -169.73 138.75 1.88 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.716 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 4.9 t -110.65 130.69 55.5 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.359 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.428 ' O ' HG22 ' C' ' 26' ' ' THR . . . -128.43 -54.05 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.41 170.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' THR . . . . . 0.437 HG21 ' HD2' ' C' ' 71' ' ' LYS . 0.6 OUTLIER -166.48 145.2 5.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 177.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ILE . . . . . 0.611 HD12 ' HD3' ' C' ' 14' ' ' PRO . 20.9 mm -112.75 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 163.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.538 HG21 ' HB3' ' C' ' 12' ' ' LEU . 0.6 OUTLIER -119.13 142.83 32.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.685 -169.154 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' CYS . . . . . 0.454 ' HA ' HD22 ' C' ' 11' ' ' LEU . 41.1 t -115.18 113.48 23.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.306 170.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.23 123.39 46.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ILE . . . . . 0.627 HG23 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.86 130.54 73.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.932 0.872 . . . . 0.0 111.648 -178.522 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.75 129.38 66.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.5 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.33 161.49 27.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.373 0.42 . . . . 0.0 110.748 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' SER . . . . . 0.427 ' HB3' ' HA ' ' C' ' 65' ' ' LYS . 6.0 p -144.04 150.89 38.91 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.3 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' C' ' 34' ' ' SER . 67.1 m-20 75.38 11.04 3.45 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.524 0.515 . . . . 0.0 112.22 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 16.7 mt -91.51 168.14 11.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.554 0.692 . . . . 0.0 111.821 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -96.53 171.81 8.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.151 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -56.94 115.48 2.63 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 123.801 1.763 . . . . 0.0 109.005 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.517 ' CG2' HG13 ' C' ' 89' ' ' VAL . 4.6 mp -74.11 144.46 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 111.247 -2.706 . . . . 0.0 113.069 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 22.4 tptm -106.63 124.34 49.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.802 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.9 139.27 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.559 0.218 . . . . 0.0 110.618 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -135.53 141.1 45.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 111.44 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' TRP . . . . . 0.771 ' HB2' ' HD2' ' C' ' 50' ' ' ARG . 51.9 m95 -129.7 136.78 50.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . 0.529 ' OE1' ' HA2' ' C' ' 47' ' ' GLY . 8.3 tt0 -121.47 129.31 52.88 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 21.5 t -120.92 108.06 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 58.03 37.06 26.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 111.09 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . 0.529 ' HA2' ' OE1' ' C' ' 44' ' ' GLN . . . 78.13 -6.93 47.69 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.94 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.53 130.98 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.956 0.407 . . . . 0.0 111.172 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.4 136.34 57.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.846 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' ARG . . . . . 0.771 ' HD2' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -91.74 146.9 23.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.917 0.865 . . . . 0.0 112.412 -170.308 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -66.14 161.4 21.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.162 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.586 ' HG2' ' H ' ' C' ' 53' ' ' GLY . 39.4 tttm -53.92 164.33 0.61 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.698 0.761 . . . . 0.0 110.611 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . 0.586 ' H ' ' HG2' ' C' ' 52' ' ' LYS . . . 115.8 -13.28 17.55 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -159.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.522 ' HA ' HD22 ' C' ' 72' ' ' LEU . 2.6 p -82.81 129.1 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 112.898 -1.651 . . . . 0.0 107.752 163.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -141.8 114.75 8.63 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.503 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 28.4 m -89.09 126.06 35.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.93 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.524 ' HB2' HG12 ' C' ' 69' ' ' VAL . 48.1 mt-30 -90.99 149.23 21.93 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' ASN . . . . . 0.424 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.3 t30 -56.39 138.73 74.85 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.134 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' C' ' 58' ' ' ASN . 53.6 Cg_exo -47.52 135.84 20.83 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 124.194 3.263 . . . . 0.0 113.616 -174.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' GLU . . . . . 0.517 ' HB3' ' HB ' ' C' ' 67' ' ' THR . 34.4 tt0 -102.38 141.31 35.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -122.15 113.06 18.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.218 0.532 . . . . 0.0 111.381 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 46.0 m -126.44 106.95 9.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.878 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.84 -114.45 5.06 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.444 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 19.0 m -111.35 1.29 16.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.321 0.581 . . . . 0.0 109.641 173.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . 0.512 ' HE3' ' HB2' ' C' ' 6' ' ' ASP . 35.5 mmtm -97.4 138.92 34.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.13 -175.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 10.2 m -105.6 150.54 25.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.675 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.517 ' HB ' ' HB3' ' C' ' 60' ' ' GLU . 66.8 m -134.39 121.62 21.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.275 0.56 . . . . 0.0 110.939 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.5 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.5 mp -112.09 133.47 57.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . 0.524 HG12 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -127.75 136.36 60.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.794 0.33 . . . . 0.0 110.779 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.9 p -129.34 125.04 35.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.28 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.437 ' HD2' HG21 ' C' ' 26' ' ' THR . 52.9 mtmt -107.72 139.33 42.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.17 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.531 HD13 ' HG3' ' C' ' 50' ' ' ARG . 0.2 OUTLIER -110.29 127.52 55.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.912 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.1 116.75 29.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.473 HG11 ' CE1' ' C' ' 85' ' ' TYR . 34.5 m -134.77 163.39 36.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 -169.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 91.1 mmm -81.52 128.67 34.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.172 0.51 . . . . 0.0 110.107 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.91 -48.78 42.27 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.946 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 50.4 m -61.75 -29.54 70.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.457 0.571 . . . . 0.0 111.919 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -52.2 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' TRP . . . . . 0.431 ' HZ3' HG23 ' C' ' 102' ' ' ILE . 66.0 t-105 -56.85 -46.92 81.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.06 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' ASP . . . . . 0.528 ' HA ' ' HD3' ' C' ' 104' ' ' LYS . 22.5 t70 -69.5 -15.05 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.222 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -79.1 -5.4 53.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.3 18.92 65.61 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 8.3 m -65.58 138.55 58.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.436 0.636 . . . . 0.0 111.393 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.9 mt-10 -74.76 133.52 41.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.541 -172.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' TYR . . . . . 0.563 ' O ' HG21 ' C' ' 102' ' ' ILE . 82.0 m-85 -129.54 115.1 16.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . 0.523 ' HB ' ' HB3' ' C' ' 101' ' ' SER . 0.3 OUTLIER -132.4 140.27 48.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 121.376 0.608 . . . . 0.0 111.298 -176.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 7.6 t -106.87 126.74 52.7 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.4 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.584 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -117.32 144.35 44.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' VAL . . . . . 0.602 ' HB ' ' CG1' ' C' ' 98' ' ' VAL . 54.6 t -116.76 135.33 57.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.514 ' HB3' ' HB3' ' C' ' 40' ' ' LYS . 36.3 tt0 -125.28 130.33 51.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . 0.501 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 15.7 t70 -150.67 144.65 25.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.186 0.517 . . . . 0.0 110.046 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.5 t -66.17 -19.27 65.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.859 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . 0.432 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 6.6 mm-40 -92.09 -6.67 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 38.7 mt -89.76 145.96 34.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.44 -35.16 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.325 2.683 . . . . 0.0 111.68 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -146.21 154.04 49.45 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.102 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.56 148.81 73.39 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.739 1.626 . . . . 0.0 111.359 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' VAL . . . . . 0.602 ' CG1' ' HB ' ' C' ' 89' ' ' VAL . 10.7 p -110.56 140.01 31.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.547 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 8.6 ptpp? -137.85 151.73 48.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 0.0 111.775 -171.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.85 127.58 4.72 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.434 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' SER . . . . . 0.523 ' HB3' ' HB ' ' C' ' 86' ' ' VAL . 72.2 p -107.48 160.63 15.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.133 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.563 HG21 ' O ' ' C' ' 85' ' ' TYR . 3.6 tp -121.77 139.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.077 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -114.84 145.46 42.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.054 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' LYS . . . . . 0.528 ' HD3' ' HA ' ' C' ' 80' ' ' ASP . 33.9 ttpt -73.61 110.35 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.189 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.143 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.03 167.49 22.87 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.944 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -107.72 124.91 50.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 69.61 -67.21 0.23 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.849 0.718 . . . . 0.0 109.879 -173.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' THR . . . . . 0.472 ' O ' HG22 ' C' ' 5' ' ' THR . 7.7 t -91.3 90.72 7.86 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.796 1.284 . . . . 0.0 109.943 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.05 115.28 29.38 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' ILE . . . . . 0.703 HG12 HG13 ' C' ' 98' ' ' VAL . 3.3 tp -126.37 122.1 60.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.8 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' SER . . . . . 0.557 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 16.3 m -114.73 106.75 14.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.556 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.05 113.66 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.023 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -112.24 110.2 20.31 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.544 ' CD2' ' HB ' ' C' ' 102' ' ' ILE . 57.8 tp -99.53 117.5 34.06 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.45 118.45 35.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.162 0.506 . . . . 0.0 110.706 -167.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.541 ' HB3' HD11 ' C' ' 102' ' ' ILE . 14.4 ptpt -79.53 147.5 67.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.146 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.0 123.87 13.38 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.477 2.118 . . . . 0.0 111.568 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.03 69.02 2.38 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.336 2.691 . . . . 0.0 113.0 -175.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 72.66 153.39 0.13 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.391 0.677 . . . . 0.0 111.845 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.45 -14.31 20.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.146 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 62.44 -165.97 0.23 Allowed 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.703 0.627 . . . . 0.0 111.402 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 48.5 mm -79.38 -43.55 23.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -109.99 114.17 27.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.94 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 4.2 t -75.94 133.81 40.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -67.26 -27.46 67.22 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.702 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -166.35 -63.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 8.7 t -164.7 -178.58 5.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.353 0.597 . . . . 0.0 110.984 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.22 28.2 0.19 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.056 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' THR . . . . . 0.758 ' HA ' HG12 ' C' ' 74' ' ' VAL . 5.8 t -57.46 130.33 45.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.802 0.811 . . . . 0.0 112.283 -166.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' ILE . . . . . 0.525 HG13 HG13 ' C' ' 74' ' ' VAL . 40.1 mt -97.33 154.74 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.704 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.548 HG22 ' HG2' ' C' ' 71' ' ' LYS . 84.1 t -130.61 133.93 62.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.745 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' CYS . . . . . 0.408 ' HB2' ' CZ2' ' C' ' 43' ' ' TRP . 19.3 t -115.78 112.36 21.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -104.97 123.33 47.59 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' ILE . . . . . 0.549 HG12 HG21 ' C' ' 89' ' ' VAL . 0.1 OUTLIER -121.78 136.06 59.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.445 0.64 . . . . 0.0 111.007 -176.069 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.557 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 17.9 t -114.94 132.24 64.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.084 -176.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.604 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.88 167.61 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.236 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 41.8 t -141.01 150.32 42.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' C' ' 34' ' ' SER . 7.2 m-20 76.81 11.59 2.5 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.479 0.487 . . . . 0.0 112.085 170.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -96.35 164.33 12.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.902 0.858 . . . . 0.0 112.351 -175.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' C' ' 38' ' ' ASN . 11.3 tp10 -91.81 174.1 7.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.394 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.416 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 1.2 m-80 -56.36 114.09 1.85 Allowed 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.131 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.606 HG22 HG13 ' C' ' 89' ' ' VAL . 5.0 mp -73.83 144.57 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 112.448 -2.16 . . . . 0.0 113.266 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.86 122.94 46.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.79 144.12 14.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.0 110.908 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.5 t80 -135.06 143.85 46.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' TRP . . . . . 0.461 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 51.7 m95 -127.6 139.5 52.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . 0.469 ' HG2' ' HB ' ' C' ' 86' ' ' VAL . 4.0 pt20 -132.77 131.02 40.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.628 0.728 . . . . 0.0 111.11 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 0.2 OUTLIER -120.25 122.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.54 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 53.77 34.83 19.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.02 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.65 -16.36 25.96 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.443 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -87.72 134.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.22 139.36 58.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.195 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -89.31 117.23 28.11 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -53.29 158.45 1.63 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.912 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.68 164.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.723 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.18 3.97 20.89 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -155.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.23 132.44 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.116 -1.542 . . . . 0.0 108.351 174.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.464 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 86.8 tt0 -125.49 108.86 12.04 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.83 0.348 . . . . 0.0 110.459 -172.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 16.0 p -98.45 122.64 41.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.812 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.615 ' HB2' HG13 ' C' ' 69' ' ' VAL . 42.5 mt-30 -103.06 176.27 5.2 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.236 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.31 150.78 85.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 0.0 110.744 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' PRO . . . . . 0.479 ' HB3' HD12 ' C' ' 68' ' ' ILE . 43.9 Cg_endo -65.48 148.09 87.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.553 2.835 . . . . 0.0 112.989 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' GLU . . . . . 0.556 ' HG3' ' HB ' ' C' ' 67' ' ' THR . 14.4 pt-20 -117.57 149.53 40.5 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -110.58 127.58 55.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.261 0.553 . . . . 0.0 112.301 -170.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 55.4 p -128.17 101.64 6.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.148 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.03 -130.16 47.2 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.489 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -84.45 -6.44 59.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.846 0.355 . . . . 0.0 110.706 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . 0.458 ' HE2' HG11 ' C' ' 32' ' ' VAL . 46.6 mtpt -97.12 153.17 18.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.559 0.695 . . . . 0.0 111.12 -175.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -115.59 149.06 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.577 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.556 ' HB ' ' HG3' ' C' ' 60' ' ' GLU . 46.2 m -132.37 122.16 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.397 0.618 . . . . 0.0 110.813 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.604 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -110.06 132.48 58.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.379 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.9 p -108.5 122.47 63.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.552 0.692 . . . . 0.0 110.878 176.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.1 m -120.74 122.19 39.86 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.548 ' HG2' HG22 ' C' ' 28' ' ' VAL . 6.8 mtpm? -106.0 152.54 23.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.952 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.424 HD21 ' HA ' ' C' ' 72' ' ' LEU . 0.2 OUTLIER -119.84 114.93 22.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' LYS . . . . . 0.678 ' HB2' ' HZ2' ' C' ' 73' ' ' LYS . 4.9 ttmp? -78.36 112.1 15.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 173.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.758 HG12 ' HA ' ' C' ' 26' ' ' THR . 12.9 p -128.63 153.09 37.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.951 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' MET . . . . . 0.64 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 97.0 mmm -72.03 129.47 38.61 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.689 0.757 . . . . 0.0 110.614 -175.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.17 -34.11 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.793 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -70.56 -35.27 72.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.283 0.633 . . . . 0.0 111.397 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' GLU . . . . . 0.64 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 59.7 mt-10 -68.58 -52.49 31.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -58.2 -42.47 86.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.801 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' ASP . . . . . 0.768 ' HA ' ' HZ2' ' C' ' 104' ' ' LYS . 21.3 t70 -62.37 -26.03 68.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.325 177.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 51.0 m -87.05 -2.39 58.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.843 0.354 . . . . 0.0 111.299 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.59 28.79 72.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.521 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' THR . . . . . 0.618 HG22 ' HB3' ' C' ' 78' ' ' GLU . 14.6 t -64.88 150.82 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 32.5 mt-10 -80.64 141.86 34.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.069 0.461 . . . . 0.0 111.32 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' TYR . . . . . 0.653 ' HH ' HG23 ' C' ' 74' ' ' VAL . 9.7 m-85 -137.75 127.86 25.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.754 173.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . 0.604 HG11 ' HE2' ' C' ' 99' ' ' LYS . 20.9 t -120.48 138.76 49.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 29.2 t -111.46 118.5 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.713 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.3 mp -113.28 147.06 38.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.677 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' VAL . . . . . 0.606 HG13 HG22 ' C' ' 39' ' ' ILE . 25.1 t -135.29 125.69 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 122.91 0.484 . . . . 0.0 109.806 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.425 ' HB3' ' HB3' ' C' ' 97' ' ' PRO . 12.9 pt-20 -133.64 145.48 50.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . 0.537 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 14.5 t70 -136.75 158.48 44.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 34.0 t -52.79 -41.7 64.37 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.386 0.429 . . . . 0.0 110.825 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -86.98 -1.73 58.09 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.537 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 42.8 mt -92.02 128.74 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 109.988 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -35.09 37.03 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 123.051 2.501 . . . . 0.0 112.206 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -147.52 153.67 43.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.944 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' PRO . . . . . 0.425 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 37.6 Cg_endo -68.83 153.39 72.97 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.27 1.98 . . . . 0.0 111.503 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' VAL . . . . . 0.703 HG13 HG12 ' C' ' 7' ' ' ILE . 13.7 p -116.79 146.53 21.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.713 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 14.1 ptmm? -141.03 156.5 46.01 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.304 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.81 140.52 19.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 32.2 t -118.03 153.75 33.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.134 0.492 . . . . 0.0 111.063 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.544 ' HB ' ' CD2' ' C' ' 11' ' ' LEU . 8.0 tp -124.21 149.48 28.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.774 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -142.07 152.96 43.81 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' LYS . . . . . 0.768 ' HZ2' ' HA ' ' C' ' 80' ' ' ASP . 39.4 ttpt -78.38 108.39 11.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.184 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.854 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.707 -177.827 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.81 56.08 4.26 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.327 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? 53.77 65.67 1.45 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -90.48 130.77 36.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.591 -172.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -72.72 96.6 2.05 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 122.244 1.021 . . . . 0.0 112.391 -175.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.414 ' HB2' ' HZ1' ' C' ' 65' ' ' LYS . 10.4 m-20 -96.97 112.65 24.31 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 161.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tp -125.21 110.75 25.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.673 169.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' SER . . . . . 0.623 ' HB2' ' CG1' ' C' ' 32' ' ' VAL . 51.0 m -110.31 104.49 13.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.374 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.54 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.27 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 16.0 m -121.01 127.31 51.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.546 HD22 ' HB3' ' C' ' 87' ' ' CYS . 72.2 mt -99.8 127.23 45.97 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.255 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.06 114.69 28.41 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.656 ' HB3' HD11 ' C' ' 102' ' ' ILE . 18.9 ptpt -76.26 154.79 84.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.303 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . 0.537 ' HD3' HD12 ' C' ' 27' ' ' ILE . 19.0 Cg_endo -59.97 122.83 12.02 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.4 2.067 . . . . 0.0 111.685 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' C' ' 14' ' ' PRO . 17.2 Cg_endo -57.76 140.48 93.76 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.892 2.395 . . . . 0.0 111.997 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -109.87 88.74 2.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.6 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . 0.58 ' HG3' ' HB2' ' C' ' 20' ' ' TRP . 0.4 OUTLIER -104.87 157.84 16.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -119.86 -19.86 7.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.345 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 76.1 mt -80.72 -36.14 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.148 0.499 . . . . 0.0 110.223 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.58 ' HB2' ' HG3' ' C' ' 17' ' ' GLU . 84.4 m95 -111.98 172.35 6.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.265 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 41.6 m -146.98 115.07 6.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.079 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -85.38 -167.64 1.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.76 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -61.77 -63.21 1.34 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.671 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' THR . . . . . 0.425 ' C ' ' H ' ' C' ' 26' ' ' THR . 14.8 t -165.61 -176.4 3.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.853 -174.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.53 ' CB ' ' HA ' ' C' ' 76' ' ' ALA . . . -71.47 26.62 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.032 0.933 . . . . 0.0 112.751 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' THR . . . . . 0.425 ' H ' ' C ' ' C' ' 24' ' ' THR . 5.9 t -59.3 129.4 41.87 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.543 0.687 . . . . 0.0 111.518 -171.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' ILE . . . . . 0.537 HD12 ' HD3' ' C' ' 14' ' ' PRO . 15.8 mm -88.87 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.192 -174.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.41 132.96 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.321 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.05 114.54 21.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.624 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.52 128.54 54.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' ILE . . . . . 0.576 HG13 ' HH ' ' C' ' 33' ' ' TYR . 0.0 OUTLIER -126.53 133.51 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.483 0.659 . . . . 0.0 111.373 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.623 ' CG1' ' HB2' ' C' ' 8' ' ' SER . 2.1 p -129.05 134.73 63.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.516 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.576 ' HH ' HG13 ' C' ' 31' ' ' ILE . 0.1 OUTLIER -163.5 168.18 20.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.723 -171.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' SER . . . . . 0.534 ' HB3' ' HD3' ' C' ' 65' ' ' LYS . 18.9 p -141.99 149.88 40.63 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.42 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' C' ' 34' ' ' SER . 4.9 m-20 77.59 11.02 2.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.756 0.66 . . . . 0.0 112.166 171.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -96.18 177.51 5.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.996 0.903 . . . . 0.0 112.793 -170.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' GLU . . . . . 0.706 ' O ' HG13 ' C' ' 39' ' ' ILE . 20.4 mm-40 -105.8 173.47 6.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.595 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.76 112.73 1.94 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 123.927 1.822 . . . . 0.0 108.773 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.706 HG13 ' O ' ' C' ' 37' ' ' GLU . 51.0 mt -87.56 147.3 5.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 110.864 -2.88 . . . . 0.0 114.126 -171.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -100.33 126.49 46.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.156 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.58 137.97 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.671 ' CB ' ' HG ' ' C' ' 88' ' ' LEU . 0.1 OUTLIER -119.31 147.84 43.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.929 -0.123 . . . . 0.0 110.897 -176.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' TRP . . . . . 0.808 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 65.7 m95 -137.18 132.66 34.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . 0.75 HE21 ' HA ' ' C' ' 44' ' ' GLN . 0.0 OUTLIER -123.27 131.3 53.62 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 177.041 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' VAL . . . . . 0.51 HG13 ' ND2' ' C' ' 46' ' ' ASN . 21.6 t -124.96 118.26 52.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.151 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . 0.51 ' ND2' HG13 ' C' ' 45' ' ' VAL . 57.1 m-80 57.99 33.83 23.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 -175.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.7 -1.2 31.28 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.003 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 p -116.62 138.64 46.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.255 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.11 122.21 13.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.263 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' ARG . . . . . 0.509 ' HD2' HG23 ' C' ' 45' ' ' VAL . 7.9 ptm85 -92.86 167.54 11.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.4 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.65 159.47 21.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.991 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.63 166.56 0.05 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.107 176.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.9 7.7 12.7 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -162.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.519 ' HA ' HD23 ' C' ' 72' ' ' LEU . 3.4 p -88.25 126.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' C' ' 70' ' ' SER . 39.9 mt-10 -121.0 109.62 15.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 5.6 p -101.13 116.88 33.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.954 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -87.47 150.17 23.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.27 0.557 . . . . 0.0 111.074 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.89 138.18 97.32 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.334 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' PRO . . . . . 0.564 ' HB3' HD13 ' C' ' 68' ' ' ILE . 19.4 Cg_endo -61.68 136.31 61.77 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.525 2.817 . . . . 0.0 113.608 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -121.27 129.84 53.36 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -86.21 139.99 30.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.056 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 45.8 t -140.04 103.81 4.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.052 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.1 -105.67 1.69 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.506 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 9.5 t -112.66 2.74 16.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 109.945 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . 0.534 ' HD3' ' HB3' ' C' ' 34' ' ' SER . 72.3 mmtt -119.4 162.4 18.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.165 0.507 . . . . 0.0 111.4 -173.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' SER . . . . . 0.497 ' O ' HG21 ' C' ' 32' ' ' VAL . 9.6 m -115.99 149.13 39.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -130.67 121.46 25.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.984 0.421 . . . . 0.0 110.827 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.564 HD13 ' HB3' ' C' ' 59' ' ' PRO . 1.5 mp -108.8 137.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 61.7 t -109.85 129.59 64.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.594 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 43.7 m -124.89 110.33 14.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 0.0 110.137 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -106.64 145.16 32.29 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.6 118.85 27.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.934 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.633 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.591 HG12 ' CE1' ' C' ' 85' ' ' TYR . 24.5 m -136.41 159.66 38.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.699 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.0 mtt -76.74 131.98 39.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . 0.53 ' HA ' ' CB ' ' C' ' 25' ' ' ALA . . . -48.98 -51.6 29.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 10.5 m -59.08 -30.17 67.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' GLU . . . . . 0.485 ' HG3' HG23 ' C' ' 83' ' ' THR . 6.6 tp10 -69.96 -51.18 34.77 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' TRP . . . . . 0.421 ' HE3' ' CE2' ' C' ' 85' ' ' TYR . 50.8 t-105 -56.5 -44.05 80.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.173 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.14 -6.37 42.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.238 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.421 ' HB3' ' O ' ' C' ' 78' ' ' GLU . 30.5 t -83.82 -7.9 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.335 0.588 . . . . 0.0 109.957 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.22 21.16 68.09 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.058 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' THR . . . . . 0.485 HG23 ' HG3' ' C' ' 78' ' ' GLU . 14.9 t -69.88 157.24 37.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.278 0.561 . . . . 0.0 110.324 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -81.25 138.97 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.159 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' TYR . . . . . 0.591 ' CE1' HG12 ' C' ' 74' ' ' VAL . 75.8 m-85 -126.21 116.92 22.05 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.0 169.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 33.3 t -118.57 129.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' CYS . . . . . 0.546 ' HB3' HD22 ' C' ' 11' ' ' LEU . 8.7 t -116.0 124.4 50.42 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.671 ' HG ' ' CB ' ' C' ' 42' ' ' PHE . 1.7 pp -137.39 154.78 49.92 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.327 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' VAL . . . . . 0.704 HG11 HG22 ' C' ' 39' ' ' ILE . 6.3 t -122.13 135.11 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.273 -173.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -131.02 138.35 49.61 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . 0.537 ' HB2' HG12 ' C' ' 39' ' ' ILE . 17.3 t70 -146.67 151.52 37.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.676 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -64.45 -20.67 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.162 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -90.84 -8.15 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.431 ' HA ' ' HD3' ' C' ' 95' ' ' PRO . 50.4 mt -94.24 147.77 33.94 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.958 0.408 . . . . 0.0 110.574 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 4.2 Cg_exo -82.12 -30.74 1.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.384 2.722 . . . . 0.0 111.481 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 26.2 p -142.7 154.3 62.59 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.203 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' C' ' 88' ' ' LEU . 41.4 Cg_endo -68.49 150.34 75.3 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.925 1.75 . . . . 0.0 110.971 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 47.0 t -109.06 106.14 20.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -176.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.58 ' HA ' ' CB ' ' C' ' 88' ' ' LEU . 14.8 ptpt -111.35 149.95 30.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.327 -171.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.6 129.8 12.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.116 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' SER . . . . . 0.466 ' HB2' HG23 ' C' ' 86' ' ' VAL . 42.0 t -110.74 152.76 26.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 111.734 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.656 HD11 ' HB3' ' C' ' 13' ' ' LYS . 11.6 tt -131.08 148.27 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.457 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -137.17 158.43 44.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.633 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -64.04 110.4 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.234 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.493 179.34 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.975 0.417 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.63 22.64 12.11 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -170.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' C' ' 3' ' ' ARG . 10.1 tpt180 -83.82 -52.56 6.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.912 -0.644 . . . . 0.0 110.893 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -179.41 -71.65 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' THR . . . . . 0.465 HG23 ' O ' ' C' ' 5' ' ' THR . 9.0 t -96.09 91.16 5.81 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 123.052 1.406 . . . . 0.0 109.883 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -101.51 111.79 24.13 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.608 -1.633 . . . . 0.0 106.785 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' ILE . . . . . 0.552 HG12 HG13 ' C' ' 98' ' ' VAL . 2.8 tp -121.48 119.34 58.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.264 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 37.5 m -126.62 120.51 29.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.851 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.51 119.41 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.136 0.493 . . . . 0.0 110.864 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -110.09 118.03 35.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.517 HD23 ' HB3' ' C' ' 87' ' ' CYS . 44.1 mt -99.79 121.78 41.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.827 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 57.4 tp -109.97 116.16 31.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' C' ' 105' ' ' ALA . 22.3 ptmt -77.9 150.3 78.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.658 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.77 136.8 17.28 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.083 2.522 . . . . 0.0 111.642 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.648 ' HB2' ' HG3' ' C' ' 17' ' ' GLU . 86.7 Cg_endo -80.52 165.3 20.7 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.75 2.3 . . . . 0.0 112.169 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -108.83 37.85 2.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . 0.648 ' HG3' ' HB2' ' C' ' 15' ' ' PRO . 40.3 mt-10 -78.85 104.02 9.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.826 -175.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.42 3.26 21.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.776 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . 0.541 HG21 ' HB3' ' C' ' 17' ' ' GLU . 7.0 tp -66.26 -29.82 47.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.268 0.556 . . . . 0.0 109.726 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.428 ' CD1' ' HB2' ' C' ' 17' ' ' GLU . 45.5 m95 -83.6 113.22 20.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 12.5 p -76.38 113.3 13.81 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.57 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 66.68 94.03 0.07 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.998 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -138.42 175.96 9.11 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 11.8 p -121.84 159.55 26.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.196 0.522 . . . . 0.0 111.64 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.637 ' HB3' ' HA ' ' C' ' 76' ' ' ALA . . . -78.1 26.71 0.2 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.258 -176.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t -60.59 124.76 21.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.903 0.859 . . . . 0.0 111.62 -171.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 27.6 mt -93.52 153.53 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.759 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.74 133.76 67.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.309 0.576 . . . . 0.0 111.67 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 45.4 t -118.4 112.05 19.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . 0.683 ' HG3' HG22 ' C' ' 69' ' ' VAL . 28.2 tt0 -113.29 120.22 40.4 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.73 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.427 0.632 . . . . 0.0 111.262 -166.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 130.35 72.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.761 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.761 ' HE1' HD11 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -160.55 164.69 31.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 8.7 t -144.27 147.32 33.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 78.14 9.0 2.27 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.67 0.606 . . . . 0.0 111.297 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 19.1 mt -93.44 157.88 16.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.4 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -83.59 174.11 10.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.219 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -57.19 113.05 1.56 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 123.969 1.842 . . . . 0.0 108.373 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.655 HG21 HG12 ' C' ' 89' ' ' VAL . 5.2 mp -73.57 147.33 9.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 110.941 -2.845 . . . . 0.0 113.144 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.434 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 23.6 ttmm -118.42 136.47 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.966 170.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.88 138.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.066 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.568 ' HB3' HD21 ' C' ' 88' ' ' LEU . 5.3 t80 -119.56 150.35 40.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.427 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' TRP . . . . . 0.754 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 56.9 m95 -132.52 131.89 42.06 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.11 130.72 48.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.224 0.466 . . . . 0.0 111.046 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.15 111.16 34.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.65 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . 0.44 HD21 ' HA ' ' C' ' 46' ' ' ASN . 0.7 OUTLIER 58.79 37.29 24.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 110.396 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.51 -9.85 33.21 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.569 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 131.87 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 117.088 0.444 . . . . 0.0 110.348 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.99 137.91 56.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.196 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' ARG . . . . . 0.485 ' HD3' ' N ' ' C' ' 51' ' ' LYS . 1.0 OUTLIER -89.75 136.34 33.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.943 -174.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' LYS . . . . . 0.485 ' N ' ' HD3' ' C' ' 50' ' ' ARG . 13.5 mptt -66.93 157.15 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.745 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -45.31 165.79 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.884 0.849 . . . . 0.0 112.987 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.53 7.86 15.3 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -158.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.95 134.57 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.268 -1.466 . . . . 0.0 108.076 173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.644 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 33.6 tt0 -129.03 109.12 10.94 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -98.69 121.68 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -96.83 152.55 18.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 110.097 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.75 133.06 94.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.247 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' PRO . . . . . 0.561 ' HB3' ' CD1' ' C' ' 68' ' ' ILE . 13.2 Cg_endo -59.96 141.85 97.3 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.731 2.954 . . . . 0.0 113.488 -171.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -152.92 105.68 2.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.827 174.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' TRP . . . . . 0.634 ' HB3' ' O ' ' C' ' 65' ' ' LYS . 31.3 t-105 -141.98 163.72 32.12 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 166.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 39.1 m -53.86 142.84 22.91 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 168.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -49.86 -13.77 0.63 Allowed Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.567 1.387 . . . . 0.0 116.567 -168.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -76.29 -23.89 54.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.025 0.912 . . . . 0.0 111.744 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . 0.634 ' O ' ' HB3' ' C' ' 61' ' ' TRP . 53.6 mttp -145.93 165.84 27.78 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 6.0 m -118.95 150.77 39.35 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 94.1 m -131.04 120.05 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.896 0.379 . . . . 0.0 110.983 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.761 HD11 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.46 125.31 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . 0.683 HG22 ' HG3' ' C' ' 30' ' ' GLU . 47.0 t -106.01 122.49 59.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 36.2 m -120.11 130.35 54.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 110.803 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.644 ' HB2' ' HB3' ' C' ' 55' ' ' GLU . 59.2 mttp -105.73 147.88 28.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.64 HD11 HG11 ' C' ' 74' ' ' VAL . 0.2 OUTLIER -125.5 114.6 19.0 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -93.89 112.67 24.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.64 HG11 HD11 ' C' ' 72' ' ' LEU . 4.5 m -122.01 168.54 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.353 -170.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' MET . . . . . 0.541 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 81.0 mtp -73.43 132.08 42.56 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.531 0.681 . . . . 0.0 109.458 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' C' ' 25' ' ' ALA . . . -55.43 -31.34 61.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.407 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -72.43 -31.66 65.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.769 0.828 . . . . 0.0 111.16 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' GLU . . . . . 0.541 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 69.3 mt-10 -65.56 -52.24 53.83 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.526 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.75 -18.82 65.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.244 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -87.06 -5.57 59.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.301 0.572 . . . . 0.0 109.801 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.29 28.89 72.19 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.345 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 152.58 43.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.064 0.459 . . . . 0.0 110.33 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.87 135.1 41.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.757 -173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -131.6 127.08 36.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . 0.754 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 41.0 t -120.55 136.4 57.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' CYS . . . . . 0.517 ' HB3' HD23 ' C' ' 11' ' ' LEU . 12.4 t -115.65 130.48 56.88 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.614 ' HB2' ' HA ' ' C' ' 99' ' ' LYS . 0.0 OUTLIER -146.85 147.41 30.81 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.636 -167.032 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' VAL . . . . . 0.655 HG12 HG21 ' C' ' 39' ' ' ILE . 55.6 t -115.5 137.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 122.924 0.489 . . . . 0.0 111.193 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.504 ' HA ' HD21 ' C' ' 94' ' ' LEU . 4.9 pt-20 -129.71 133.12 46.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . 0.508 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 17.0 t70 -148.32 149.42 31.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.981 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 17.2 m -47.0 -47.32 22.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.203 0.525 . . . . 0.0 111.532 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . 0.475 ' HB3' ' OD2' ' C' ' 91' ' ' ASP . 11.2 tp10 -83.85 -5.26 59.17 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.308 -167.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.624 HD11 ' O ' ' C' ' 94' ' ' LEU . 2.2 pp -92.97 150.55 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.133 -0.979 . . . . 0.0 111.265 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 -35.41 1.25 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.674 2.916 . . . . 0.0 112.44 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 5.5 p -147.78 151.19 38.19 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.26 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' PRO . . . . . 0.496 ' HB2' HD11 ' C' ' 88' ' ' LEU . 30.5 Cg_endo -61.78 144.69 97.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.579 2.186 . . . . 0.0 111.498 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' VAL . . . . . 0.552 HG13 HG12 ' C' ' 7' ' ' ILE . 41.8 t -107.07 102.5 14.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.614 ' HA ' ' HB2' ' C' ' 88' ' ' LEU . 10.6 ptpp? -108.36 151.29 26.22 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.833 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.76 127.63 9.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 29.0 t -111.4 157.5 20.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.464 0.65 . . . . 0.0 111.393 -172.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.443 ' HB ' HD12 ' C' ' 11' ' ' LEU . 5.5 tp -122.08 149.26 25.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.969 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' ARG . . . . . 0.457 ' HD3' ' N ' ' C' ' 103' ' ' ARG . 0.0 OUTLIER -131.98 151.2 51.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -76.0 138.89 41.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.18 0.514 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . 0.472 ' HB2' ' NZ ' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.246 0.892 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.888 0.375 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.54 168.1 31.68 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.887 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . 0.469 ' H ' ' HD2' ' C' ' 3' ' ' ARG . 0.0 OUTLIER -124.74 36.76 4.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.592 0.71 . . . . 0.0 109.855 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -64.27 -28.46 69.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.476 178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 8.4 m -84.91 89.55 7.6 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.598 1.19 . . . . 0.0 111.232 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' C' ' 33' ' ' TYR . 8.4 m-20 -117.83 115.98 26.06 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.158 -1.837 . . . . 0.0 106.286 161.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' ILE . . . . . 0.796 HG12 HG21 ' C' ' 98' ' ' VAL . 2.8 tp -114.0 108.08 24.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-O 121.759 0.79 . . . . 0.0 108.892 169.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 49.2 m -120.84 116.04 24.41 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.114 -175.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . 0.529 HG21 HG22 ' C' ' 31' ' ' ILE . 43.8 t -103.73 114.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.957 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 4.0 m -105.84 109.3 21.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.52 ' CD2' ' HB ' ' C' ' 102' ' ' ILE . 55.6 tp -103.02 117.13 33.9 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.745 -174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 65.6 tp -113.84 123.69 50.41 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.111 0.481 . . . . 0.0 110.43 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.584 ' HB3' HD13 ' C' ' 102' ' ' ILE . 21.6 pttp -86.52 152.87 55.35 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.908 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -64.78 122.22 9.99 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.332 2.021 . . . . 0.0 111.508 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.51 121.79 10.65 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.008 2.472 . . . . 0.0 112.169 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -79.26 82.59 5.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.784 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.42 113.6 24.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.558 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 62.85 -165.35 0.24 Allowed 'General case' 0 C--O 1.233 0.204 0 O-C-N 123.933 0.77 . . . . 0.0 110.921 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 57.6 mt -83.35 -41.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.287 0.565 . . . . 0.0 110.301 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -91.11 126.32 36.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.404 -173.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 12.4 p -77.63 114.2 16.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.892 172.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -77.49 -24.7 50.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.146 0.498 . . . . 0.0 110.241 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -129.77 -157.34 0.81 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.619 175.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 11.3 p -93.56 175.84 6.59 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.481 0.657 . . . . 0.0 111.613 -174.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.36 26.37 3.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.919 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' THR . . . . . 0.707 HG22 ' HA ' ' C' ' 73' ' ' LYS . 68.0 p -59.13 132.12 53.08 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.247 0.546 . . . . 0.0 112.131 -168.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 13.6 mm -89.4 152.3 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.664 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.561 HG22 ' HG2' ' C' ' 71' ' ' LYS . 77.5 t -133.72 132.95 57.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.745 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 35.8 t -120.42 114.2 21.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.51 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -106.96 127.85 53.81 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' ILE . . . . . 0.622 HG23 HG21 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.46 133.33 69.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.683 -177.114 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 47.6 t -112.34 130.08 66.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.761 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.718 ' HE1' HD11 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.25 164.9 27.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.113 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t -139.2 150.09 45.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.985 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 75.78 12.25 3.02 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.515 0.509 . . . . 0.0 112.322 172.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.03 159.77 14.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.714 0.769 . . . . 0.0 111.525 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -92.72 173.17 7.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.568 174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -55.46 115.65 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.849 1.785 . . . . 0.0 109.176 -173.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.612 ' CG2' HG12 ' C' ' 89' ' ' VAL . 5.0 mp -76.41 146.37 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.18 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.461 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 55.0 tptt -104.4 127.63 52.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.732 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.11 140.04 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.459 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.6 t80 -133.17 144.36 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 111.559 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' TRP . . . . . 0.595 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 69.1 m95 -127.09 140.7 52.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -128.09 131.05 49.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 111.195 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' VAL . . . . . 0.711 HG21 ' HE ' ' C' ' 50' ' ' ARG . 21.2 t -116.99 116.01 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.484 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.58 36.62 27.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.213 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.07 -15.64 26.41 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.754 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.56 137.28 25.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.626 -0.338 . . . . 0.0 110.608 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.46 136.51 57.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' ARG . . . . . 0.711 ' HE ' HG21 ' C' ' 45' ' ' VAL . 17.7 tpp180 -91.74 122.15 34.03 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.991 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.88 162.42 5.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.655 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -42.72 164.52 0.01 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.283 1.04 . . . . 0.0 113.613 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.37 -1.03 23.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 -155.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . . . . . . . . . 6.7 p -88.79 131.98 34.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 113.205 -1.497 . . . . 0.0 108.281 174.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.435 ' HB2' ' HB2' ' C' ' 71' ' ' LYS . 45.7 mt-10 -126.25 109.24 12.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.0 110.626 -172.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 15.9 m -95.08 117.24 29.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.519 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.79 165.95 11.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.849 0.357 . . . . 0.0 110.438 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' ASN . . . . . 0.485 ' ND2' ' HD2' ' C' ' 59' ' ' PRO . 29.3 t-20 -69.18 134.47 89.35 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.899 0.857 . . . . 0.0 112.456 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' C' ' 67' ' ' THR . 23.5 Cg_exo -55.19 134.8 65.88 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 124.173 3.249 . . . . 0.0 112.586 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -153.46 107.45 3.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.421 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' TRP . . . . . 0.601 ' HB3' ' O ' ' C' ' 65' ' ' LYS . 65.0 t-105 -140.63 163.92 31.57 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 166.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' SER . . . . . 0.405 ' C ' ' H ' ' C' ' 64' ' ' SER . 48.4 m -48.19 141.74 6.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 166.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.16 33.69 0.19 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 115.575 0.99 . . . . 0.0 115.575 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' SER . . . . . 0.405 ' H ' ' C ' ' C' ' 62' ' ' SER . 37.1 m -112.82 -26.29 8.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 117.424 0.612 . . . . 0.0 109.725 171.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . 0.601 ' O ' ' HB3' ' C' ' 61' ' ' TRP . 12.6 mtpp -141.58 164.87 29.05 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -113.68 154.03 27.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.994 -0.441 . . . . 0.0 110.962 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 85.4 m -136.45 123.46 21.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.407 . . . . 0.0 111.166 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.718 HD11 ' HE1' ' C' ' 33' ' ' TYR . 1.6 mp -108.7 132.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.3 122.1 64.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.006 0.431 . . . . 0.0 110.489 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 27.4 t -118.17 122.78 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.628 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.561 ' HG2' HG22 ' C' ' 28' ' ' VAL . 32.1 mtpt -106.17 154.51 20.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.818 0.342 . . . . 0.0 110.426 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.447 ' HG ' ' CE1' ' C' ' 85' ' ' TYR . 0.2 OUTLIER -119.97 117.73 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' LYS . . . . . 0.707 ' HA ' HG22 ' C' ' 26' ' ' THR . 71.1 tttt -85.07 112.26 20.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' C' ' 26' ' ' THR . 12.5 p -133.62 155.99 40.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -166.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.9 mtm -80.24 130.37 35.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.861 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.04 -53.07 17.52 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.442 0.464 . . . . 0.0 111.762 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 41.3 t -57.72 -32.87 67.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.909 0.484 . . . . 0.0 112.066 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' GLU . . . . . 0.529 ' HG3' HG23 ' C' ' 83' ' ' THR . 3.8 tp10 -66.11 -54.73 21.98 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' TRP . . . . . 0.458 ' CZ2' ' HA ' ' C' ' 104' ' ' LYS . 62.1 t-105 -59.31 -48.88 79.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.863 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' ASP . . . . . 0.462 ' HA ' ' HG3' ' C' ' 104' ' ' LYS . 5.5 t70 -70.27 -6.49 35.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.901 -174.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -81.23 -5.78 58.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 109.883 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.518 ' HA2' ' HB3' ' C' ' 104' ' ' LYS . . . 82.83 20.01 62.23 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' THR . . . . . 0.529 HG23 ' HG3' ' C' ' 78' ' ' GLU . 0.6 OUTLIER -63.47 145.87 54.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.231 -177.517 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 33.8 mt-10 -81.58 135.61 35.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 111.767 -176.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' TYR . . . . . 0.568 ' HH ' ' CG2' ' C' ' 74' ' ' VAL . 1.8 m-85 -134.13 124.75 26.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.956 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 0.2 OUTLIER -133.26 142.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 111.424 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 18.9 t -112.37 124.53 52.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.412 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.887 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.5 mp -114.73 147.6 39.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' VAL . . . . . 0.622 HG21 HG23 ' C' ' 31' ' ' ILE . 11.4 t -126.44 131.62 71.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.234 0.613 . . . . 0.0 109.958 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.461 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 8.3 pt-20 -136.09 134.95 38.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.175 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . 0.509 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 7.9 t70 -147.0 151.83 37.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.142 0.496 . . . . 0.0 110.571 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 66.4 m -68.35 -8.13 37.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.636 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . 0.449 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 58.0 mm-40 -99.99 -4.57 29.77 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 111.163 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.714 ' C ' HD11 ' C' ' 94' ' ' LEU . 2.4 pp -108.09 158.51 33.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.962 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.57 ' HD2' ' H ' ' C' ' 96' ' ' THR . 5.3 Cg_endo -91.03 -34.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.831 3.687 . . . . 0.0 112.784 -173.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.57 ' H ' ' HD2' ' C' ' 95' ' ' PRO . 33.2 p -141.38 145.84 39.79 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.53 148.47 66.66 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.954 1.769 . . . . 0.0 111.142 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' VAL . . . . . 0.796 HG21 HG12 ' C' ' 7' ' ' ILE . 40.3 t -110.61 139.11 35.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.887 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 24.9 pttm -144.15 157.53 44.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.467 0.651 . . . . 0.0 112.593 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.06 137.02 11.46 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.862 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 75.2 p -114.65 149.94 35.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.994 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.584 HD13 ' HB3' ' C' ' 13' ' ' LYS . 3.9 tp -122.71 153.2 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' ARG . . . . . 0.45 ' N ' HG13 ' C' ' 102' ' ' ILE . 12.8 ptp180 -125.14 156.67 37.98 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' LYS . . . . . 0.518 ' HB3' ' HA2' ' C' ' 82' ' ' GLY . 8.1 tmtm? -78.84 122.88 26.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.998 0.428 . . . . 0.0 110.968 -173.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . 0.483 ' HB2' ' HE2' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 172.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.27 50.77 48.57 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.849 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -110.93 156.08 21.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 61.65 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.676 0.61 . . . . 0.0 110.895 -174.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 10.6 m -116.13 95.67 5.2 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.029 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' C' ' 33' ' ' TYR . 30.3 t70 -112.63 120.54 41.9 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.325 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 tp -142.48 129.34 18.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.101 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' SER . . . . . 0.567 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 26.8 t -120.87 121.1 37.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.441 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . 0.792 HG22 HG22 ' C' ' 31' ' ' ILE . 41.2 t -119.0 123.72 71.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.499 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -146.89 146.66 30.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.473 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.45 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.2 mm? -97.1 145.08 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.323 0.582 . . . . 0.0 111.104 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.505 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 63.0 tp -115.24 117.59 30.9 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.447 ' HB3' HD13 ' C' ' 102' ' ' ILE . 43.3 pttt -91.12 155.31 44.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.797 0.332 . . . . 0.0 110.475 -177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . 0.577 ' HD3' HD11 ' C' ' 27' ' ' ILE . 74.5 Cg_endo -79.97 132.46 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.805 2.337 . . . . 0.0 111.161 176.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' C' ' 14' ' ' PRO . 7.4 Cg_exo -73.4 177.62 7.69 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.868 2.378 . . . . 0.0 112.114 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . 0.561 ' O ' ' HA ' ' C' ' 21' ' ' THR . 46.4 m-85 65.48 46.69 2.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.397 0.618 . . . . 0.0 111.564 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . 0.865 ' HG2' ' HE1' ' C' ' 79' ' ' TRP . 0.0 OUTLIER -127.06 -12.34 5.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.961 171.036 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.82 -79.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.101 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 64.0 mt -101.97 -56.4 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.304 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -102.26 134.75 45.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.644 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' THR . . . . . 0.561 ' HA ' ' O ' ' C' ' 16' ' ' PHE . 11.6 p -99.89 153.95 18.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.034 0.445 . . . . 0.0 112.096 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -150.16 50.14 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.556 0.693 . . . . 0.0 109.63 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 57.22 -148.83 0.48 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.312 178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' THR . . . . . 0.631 ' HB ' ' CA ' ' C' ' 76' ' ' ALA . 8.8 t -116.95 147.9 41.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.435 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.42 -53.32 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.835 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -169.78 160.33 8.56 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.667 0.27 . . . . 0.0 111.669 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' ILE . . . . . 0.577 HD11 ' HD3' ' C' ' 14' ' ' PRO . 22.8 mm -117.37 117.89 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 79.3 t -112.64 134.78 54.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.103 -170.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 52.3 t -111.62 114.45 27.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.108 171.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -96.15 125.42 40.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' ILE . . . . . 0.792 HG22 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.59 124.59 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.985 0.898 . . . . 0.0 111.48 176.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -114.18 128.85 70.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.699 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.551 ' CE2' HD12 ' C' ' 68' ' ' ILE . 49.0 p90 -147.41 165.11 31.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.421 0.629 . . . . 0.0 111.732 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 12.7 t -143.77 143.67 31.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.873 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 79.62 9.56 1.53 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.605 0.565 . . . . 0.0 112.298 171.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.25 160.58 14.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 0.0 112.217 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' GLU . . . . . 0.575 ' O ' HG13 ' C' ' 39' ' ' ILE . 6.2 tp10 -99.74 172.96 6.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.496 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.419 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 2.7 m-80 -55.03 110.81 0.72 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 123.604 1.669 . . . . 0.0 109.109 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.575 HG13 ' O ' ' C' ' 37' ' ' GLU . 17.3 mt -77.3 142.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.165 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . 0.639 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 29.2 tptp -105.42 123.68 48.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.823 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.15 139.03 21.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.282 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.455 ' CE1' ' HG2' ' C' ' 49' ' ' GLU . 47.5 t80 -133.24 139.83 47.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.048 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -125.37 137.48 54.03 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -126.94 129.66 48.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.933 0.333 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 25.0 t -120.83 116.72 50.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.323 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . 0.516 ' HA ' ' OE1' ' C' ' 84' ' ' GLU . 3.2 m120 54.53 37.17 27.42 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.123 0.487 . . . . 0.0 111.808 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.04 -16.3 38.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.277 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.64 142.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.624 0.712 . . . . 0.0 110.721 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . 0.455 ' HG2' ' CE1' ' C' ' 42' ' ' PHE . 41.5 mt-10 -60.4 138.17 58.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.407 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' ARG . . . . . 0.482 ' HB2' HG23 ' C' ' 45' ' ' VAL . 13.2 tpp180 -91.29 124.27 35.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.362 0.601 . . . . 0.0 110.077 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -59.76 162.71 5.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.738 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -41.77 163.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.05 0.929 . . . . 0.0 112.898 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.68 -0.48 23.23 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -158.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.5 ' HA ' HD21 ' C' ' 72' ' ' LEU . 3.5 p -89.74 129.68 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 113.637 -1.281 . . . . 0.0 108.133 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.587 ' HB3' ' HG3' ' C' ' 71' ' ' LYS . 31.0 tt0 -141.88 110.29 6.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.082 0.468 . . . . 0.0 110.179 -169.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -94.81 134.22 37.67 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.95 149.39 22.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -58.26 145.78 73.2 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.169 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' PRO . . . . . 0.506 ' HB3' HD11 ' C' ' 68' ' ' ILE . 19.1 Cg_endo -57.74 136.64 76.77 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.728 2.952 . . . . 0.0 113.474 -174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -107.54 129.28 54.99 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -108.09 120.65 42.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.924 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 22.7 t -124.47 102.31 7.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.363 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.87 -113.34 5.68 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.388 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 78.3 p -110.69 5.45 20.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.078 0.466 . . . . 0.0 110.594 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -98.53 130.84 45.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.847 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 8.8 m -102.09 146.51 27.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.037 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -133.31 119.72 20.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.106 0.479 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.551 HD12 ' CE2' ' C' ' 33' ' ' TYR . 1.7 mp -115.13 127.14 72.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.172 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -105.17 121.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.692 ' HG ' HD13 ' C' ' 31' ' ' ILE . 38.9 m -111.79 113.02 25.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.052 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.587 ' HG3' ' HB3' ' C' ' 55' ' ' GLU . 13.0 ptmt -106.17 139.82 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.156 0.503 . . . . 0.0 110.241 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.5 HD21 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -113.5 127.13 55.98 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.921 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -87.91 116.95 26.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.404 HG12 HD11 ' C' ' 72' ' ' LEU . 21.3 m -130.52 157.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.621 -171.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' MET . . . . . 0.453 ' O ' ' HB2' ' C' ' 78' ' ' GLU . 55.2 mtt -83.1 135.49 34.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.216 0.323 . . . . 0.0 110.57 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . 0.631 ' CA ' ' HB ' ' C' ' 24' ' ' THR . . . -47.59 -54.91 10.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' SER . . . . . 0.46 ' O ' ' HB2' ' C' ' 81' ' ' SER . 5.3 m -57.09 -29.38 63.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.718 0.407 . . . . 0.0 112.093 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' C' ' 75' ' ' MET . 5.5 mm-40 -65.37 -54.12 33.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' TRP . . . . . 0.865 ' HE1' ' HG2' ' C' ' 17' ' ' GLU . 53.2 t-105 -58.78 -44.8 90.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.764 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.54 -19.82 64.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.043 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' C' ' 77' ' ' SER . 6.6 t -80.89 -4.98 56.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.14 26.71 70.03 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.024 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' THR . . . . . 0.445 HG23 ' CE2' ' C' ' 85' ' ' TYR . 12.8 t -64.83 144.99 56.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.367 0.604 . . . . 0.0 110.377 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' GLU . . . . . 0.516 ' OE1' ' HA ' ' C' ' 46' ' ' ASN . 12.7 mt-10 -74.84 133.7 41.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.323 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' TYR . . . . . 0.645 ' HB2' ' CG2' ' C' ' 102' ' ' ILE . 83.5 m-85 -126.24 118.08 24.4 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.62 133.3 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 32.5 t -108.72 116.24 31.62 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.842 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.8 mp -110.56 145.1 38.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.069 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' VAL . . . . . 0.607 HG22 HG23 ' C' ' 31' ' ' ILE . 40.8 t -125.65 131.29 72.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 123.38 0.672 . . . . 0.0 109.469 176.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.639 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 9.7 pt-20 -131.17 137.13 48.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.924 0.393 . . . . 0.0 110.28 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . 0.493 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 14.6 t0 -149.89 154.23 38.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.535 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.4 m -67.76 -7.72 29.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.634 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -100.5 -9.3 22.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.637 HD13 ' O ' ' C' ' 94' ' ' LEU . 2.4 pp -97.75 149.22 35.5 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.627 -175.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.27 -33.19 1.47 Allowed 'Trans proline' 0 C--N 1.334 -0.193 0 C-N-CA 123.941 3.094 . . . . 0.0 112.88 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.447 ' O ' HD12 ' C' ' 94' ' ' LEU . 4.7 p -144.85 152.81 53.02 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.437 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.46 139.94 55.77 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.007 1.804 . . . . 0.0 111.283 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 27.4 t -102.05 124.36 55.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.842 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 22.6 pttp -134.39 156.55 48.33 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.24 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.13 138.1 17.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.255 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t -117.45 151.49 36.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.115 0.483 . . . . 0.0 111.718 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.645 ' CG2' ' HB2' ' C' ' 85' ' ' TYR . 3.6 tp -123.95 143.92 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.652 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -133.26 157.11 46.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' LYS . . . . . 0.479 ' HE3' ' HB2' ' C' ' 17' ' ' GLU . 81.8 tttt -68.3 105.63 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.078 0.861 . . . . 0.0 109.203 -174.92 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.112 0.482 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.66 -115.89 2.38 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.453 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -84.22 67.75 9.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.377 0.608 . . . . 0.0 110.564 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -92.62 -27.34 17.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.141 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 8.3 m -115.65 91.24 3.54 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.283 -173.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . 0.699 ' O ' ' HA ' ' C' ' 33' ' ' TYR . 1.6 m-20 -96.41 112.86 24.46 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 165.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' ILE . . . . . 0.477 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 1.7 tp -115.1 108.24 24.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.184 165.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 26.9 t -131.73 134.42 45.86 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.414 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -119.29 123.37 71.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.042 0.449 . . . . 0.0 110.236 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 11.7 m -117.89 123.33 45.59 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.527 ' HB3' HD13 ' C' ' 102' ' ' ILE . 91.1 mt -99.76 126.18 45.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.473 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . 0.484 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 49.6 tp -104.42 114.93 29.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . 0.807 ' HB3' HD11 ' C' ' 102' ' ' ILE . 9.6 ptpp? -91.37 150.77 41.94 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' C' ' 15' ' ' PRO . 37.0 Cg_endo -70.55 119.37 6.29 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.934 1.756 . . . . 0.0 110.632 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' C' ' 14' ' ' PRO . 8.6 Cg_exo -72.11 52.34 1.84 Allowed 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.45 2.767 . . . . 0.0 112.383 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . 0.459 ' HA ' ' O ' ' C' ' 20' ' ' TRP . 59.9 t80 -60.97 -56.98 14.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.686 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 66.1 -65.87 0.18 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.67 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -177.27 -43.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.579 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 tp -101.16 -16.47 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.154 -173.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.459 ' O ' ' HA ' ' C' ' 16' ' ' PHE . 97.5 m95 -93.8 114.6 26.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 111.316 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 48.6 m -122.68 114.03 20.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.621 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -110.96 72.42 0.78 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 68.41 -68.13 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.041 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 13.8 p -137.81 170.38 16.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.557 0.694 . . . . 0.0 111.433 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.548 ' CB ' ' HA ' ' C' ' 76' ' ' ALA . . . -85.51 27.35 0.84 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.659 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 8.4 t -59.0 130.0 44.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.819 0.818 . . . . 0.0 111.607 -168.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.21 148.59 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.586 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.484 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 45.6 t -128.47 131.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.338 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -114.99 111.68 21.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.72 121.93 43.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' ILE . . . . . 0.641 HD13 ' HH ' ' C' ' 33' ' ' TYR . 0.1 OUTLIER -124.68 130.79 73.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.849 0.833 . . . . 0.0 111.227 -176.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' C' ' 7' ' ' ILE . 60.2 t -110.6 131.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.496 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.699 ' HA ' ' O ' ' C' ' 6' ' ' ASP . 0.1 OUTLIER -164.67 161.92 21.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.403 0.439 . . . . 0.0 110.529 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' SER . . . . . 0.544 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 11.6 t -142.59 155.34 44.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' C' ' 34' ' ' SER . 0.9 OUTLIER 81.6 9.96 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.814 0.697 . . . . 0.0 111.832 177.412 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 22.8 mt -105.22 142.9 34.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.456 0.645 . . . . 0.0 112.105 -172.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' GLU . . . . . 0.55 ' O ' HG13 ' C' ' 39' ' ' ILE . 29.8 mm-40 -95.95 179.11 5.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.585 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.65 ' N ' HD21 ' C' ' 38' ' ' ASN . 0.7 OUTLIER -54.26 112.36 0.96 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 124.053 1.882 . . . . 0.0 109.654 -156.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.55 HG13 ' O ' ' C' ' 37' ' ' GLU . 11.1 mt -83.17 146.83 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 110.15 -3.205 . . . . 0.0 112.584 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -112.37 134.68 53.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.634 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.0 131.43 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.43 ' HE1' ' HG2' ' C' ' 49' ' ' GLU . 53.2 t80 -122.66 142.17 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.136 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' TRP . . . . . 0.57 ' CD2' HD21 ' C' ' 72' ' ' LEU . 50.3 m95 -132.02 137.55 47.89 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -124.84 131.24 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.155 -0.341 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' VAL . . . . . 0.477 HG21 ' HD2' ' C' ' 50' ' ' ARG . 60.6 t -123.03 117.26 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 55.69 35.89 26.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.62 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.21 -15.85 36.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.331 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.16 145.19 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.492 0.646 . . . . 0.0 111.645 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . 0.43 ' HG2' ' HE1' ' C' ' 42' ' ' PHE . 47.8 mt-10 -61.14 127.54 32.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.646 172.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' ARG . . . . . 0.477 ' HD2' HG21 ' C' ' 45' ' ' VAL . 5.4 ptm180 -92.15 166.13 12.8 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.373 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' LYS . . . . . 0.456 ' HA ' ' HD2' ' C' ' 51' ' ' LYS . 31.7 tptt -75.67 163.01 27.74 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.494 ' HG3' ' H ' ' C' ' 53' ' ' GLY . 22.4 tptp -45.51 164.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.84 0.828 . . . . 0.0 111.914 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . 0.494 ' H ' ' HG3' ' C' ' 52' ' ' LYS . . . 115.36 -9.17 20.17 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -161.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.919 HG23 HD23 ' C' ' 72' ' ' LEU . 48.8 t -77.27 118.73 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 113.339 -1.431 . . . . 0.0 107.794 165.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -133.47 144.29 49.36 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.19 -170.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -130.25 130.09 44.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.57 158.14 18.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.453 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.05 150.28 51.68 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.482 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' PRO . . . . . 0.531 ' HB3' HD12 ' C' ' 68' ' ' ILE . 37.4 Cg_endo -63.12 139.74 74.48 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.147 2.565 . . . . 0.0 113.133 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -114.09 149.07 36.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -111.69 132.31 54.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.101 0.477 . . . . 0.0 111.548 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 27.7 m -135.37 103.77 5.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.698 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.25 -110.74 3.44 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 42.3 m -111.01 6.49 21.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 109.803 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -106.21 160.2 15.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.146 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -113.68 152.73 30.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.427 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 64.4 m -135.31 120.44 18.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.377 0.608 . . . . 0.0 111.009 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.581 ' O ' HD11 ' C' ' 31' ' ' ILE . 1.6 mp -110.81 130.94 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.888 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.6 122.54 60.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.394 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -111.3 122.82 48.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -106.86 143.76 34.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.919 HD23 HG23 ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.71 114.57 19.48 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.032 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -84.44 114.59 22.02 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.489 HG11 ' CE1' ' C' ' 85' ' ' TYR . 16.4 m -133.19 161.61 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.719 -173.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.8 mtt -77.75 128.71 34.48 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.539 0.685 . . . . 0.0 109.589 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . 0.548 ' HA ' ' CB ' ' C' ' 25' ' ' ALA . . . -58.21 -42.96 87.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.078 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -61.9 -30.5 70.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.527 0.331 . . . . 0.0 111.435 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.32 -51.66 42.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' TRP . . . . . 0.435 ' HZ3' HG22 ' C' ' 102' ' ' ILE . 63.4 t-105 -57.62 -44.15 85.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.766 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.1 -17.01 64.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.347 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -81.73 -4.71 57.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.905 0.383 . . . . 0.0 110.772 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.84 21.72 65.4 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 41.5 m -66.22 143.41 57.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.874 -0.663 . . . . 0.0 112.01 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -71.16 131.81 44.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.824 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' TYR . . . . . 0.489 ' CE1' HG11 ' C' ' 74' ' ' VAL . 67.3 m-85 -130.53 116.21 17.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 169.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 11.3 t -120.43 135.93 59.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.09 127.66 54.33 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.524 HD12 ' O ' ' C' ' 98' ' ' VAL . 1.9 mm? -123.13 144.84 49.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.823 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' VAL . . . . . 0.606 ' HB ' ' HB ' ' C' ' 98' ' ' VAL . 69.7 t -122.89 132.78 70.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.115 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -127.85 133.82 49.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.523 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . 0.637 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 28.4 t70 -153.16 150.44 29.07 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.253 0.549 . . . . 0.0 110.575 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 21.9 t -66.24 -15.17 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.752 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -95.62 -7.65 37.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.243 0.474 . . . . 0.0 112.156 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.5 pp -92.62 149.39 37.96 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.108 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.36 -35.17 0.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.86 3.04 . . . . 0.0 112.453 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.418 ' O ' HD13 ' C' ' 94' ' ' LEU . 16.0 p -142.6 149.32 50.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.256 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' PRO . . . . . 0.478 ' HB2' HD13 ' C' ' 88' ' ' LEU . 52.0 Cg_endo -66.24 143.34 70.43 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.308 2.005 . . . . 0.0 111.258 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' VAL . . . . . 0.606 ' HB ' ' HB ' ' C' ' 89' ' ' VAL . 47.7 t -91.39 106.54 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . . . . . . . . . 11.1 ptpp? -107.84 142.81 37.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.422 -174.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.65 120.14 5.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' SER . . . . . 0.444 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 39.4 t -105.51 156.37 18.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.047 0.451 . . . . 0.0 110.69 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.807 HD11 ' HB3' ' C' ' 13' ' ' LYS . 14.0 tt -123.83 147.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.008 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -133.68 144.51 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.293 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -85.19 143.61 28.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.96 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.702 173.197 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptp . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.761 0.315 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.77 -166.37 33.14 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.778 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' C' ' 3' ' ' ARG . 4.8 mmp_? 53.76 69.5 0.7 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.335 0.254 . . . . 0.0 110.441 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -50.21 110.0 0.36 Allowed 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.635 0.585 . . . . 0.0 111.491 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' THR . . . . . 0.448 ' O ' HG21 ' C' ' 5' ' ' THR . 5.8 t -88.73 91.32 8.77 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 122.98 1.371 . . . . 0.0 110.557 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -99.72 115.92 30.6 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.809 -1.541 . . . . 0.0 107.519 168.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' ILE . . . . . 0.508 HG12 HG12 ' C' ' 98' ' ' VAL . 3.7 tp -129.33 115.18 34.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 112.595 -2.093 . . . . 0.0 109.094 172.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' SER . . . . . 0.513 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 13.7 m -116.33 114.95 25.03 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.922 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 t -114.27 115.01 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -131.88 132.53 43.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.075 0.464 . . . . 0.0 109.88 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.552 HD13 ' HB ' ' C' ' 102' ' ' ILE . 17.5 mt -99.5 136.56 39.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.293 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 61.6 tp -110.86 115.19 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -77.24 150.43 80.33 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.975 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . 0.537 ' HB2' ' HD3' ' C' ' 15' ' ' PRO . 82.6 Cg_exo -41.75 -52.62 3.78 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.924 2.416 . . . . 0.0 113.39 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' C' ' 14' ' ' PRO . 55.0 Cg_endo -71.72 94.3 0.7 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.436 1.424 . . . . 0.0 111.959 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -53.7 -36.41 62.2 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.109 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . 0.457 ' HG3' HG22 ' C' ' 19' ' ' ILE . 9.0 tp10 -117.71 136.68 53.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -70.26 -7.68 44.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -169.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . 0.457 HG22 ' HG3' ' C' ' 17' ' ' GLU . 10.7 tp -83.71 -17.78 10.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.86 0.362 . . . . 0.0 111.092 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -107.69 114.09 27.82 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 34.1 m -103.61 113.26 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -127.62 164.2 22.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.249 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -58.26 132.58 54.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.149 0.499 . . . . 0.0 109.887 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' THR . . . . . 1.021 ' HB ' ' HA ' ' C' ' 76' ' ' ALA . 58.6 m -93.58 132.35 37.98 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.165 -168.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.07 -18.04 5.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.556 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' C' ' 72' ' ' LEU . 10.1 t -161.41 144.33 12.39 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -175.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' ILE . . . . . 0.784 HG13 HG13 ' C' ' 74' ' ' VAL . 60.6 mt -120.19 152.36 23.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.08 135.55 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.911 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 51.3 t -107.82 117.71 34.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -105.12 118.39 36.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.57 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' ILE . . . . . 0.643 HG13 ' HH ' ' C' ' 33' ' ' TYR . 0.0 OUTLIER -120.01 130.86 73.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.677 0.751 . . . . 0.0 111.309 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 21.7 t -117.72 132.59 67.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.254 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.945 ' HE1' HD11 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -151.79 170.03 20.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' SER . . . . . 0.511 ' HB2' ' HG2' ' C' ' 65' ' ' LYS . 32.2 t -124.09 141.48 52.01 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.396 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 t0 71.01 11.11 7.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.184 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mt -111.69 129.64 56.04 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.28 -0.888 . . . . 0.0 110.708 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.33 91.28 2.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.705 160.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' C' ' 91' ' ' ASP . 0.5 OUTLIER -147.29 106.38 3.87 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 136.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.424 HD11 ' CZ ' ' C' ' 33' ' ' TYR . 5.5 mm -115.28 112.53 40.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.977 -1.089 . . . . 0.0 113.721 -169.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -108.16 123.57 48.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.138 172.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.67 142.78 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.415 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.3 t80 -129.88 143.55 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -128.94 137.94 51.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . 0.403 ' CG ' ' HB ' ' C' ' 86' ' ' VAL . 4.4 pt20 -131.23 131.45 43.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.229 0.538 . . . . 0.0 111.409 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' VAL . . . . . 0.624 HG23 ' HB2' ' C' ' 50' ' ' ARG . 13.8 t -104.08 109.14 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.858 177.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.31 42.26 31.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.635 0.731 . . . . 0.0 110.693 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.62 -16.98 16.51 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.922 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . 0.55 HG12 ' O ' ' C' ' 45' ' ' VAL . 10.0 p -97.85 138.58 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 118.297 1.049 . . . . 0.0 110.521 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -57.72 139.44 53.84 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.379 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' ARG . . . . . 0.624 ' HB2' HG23 ' C' ' 45' ' ' VAL . 16.2 tpt180 -90.98 124.13 34.99 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.845 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' LYS . . . . . 0.58 ' HD2' ' H ' ' C' ' 51' ' ' LYS . 3.1 mptp? -70.45 161.31 30.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.966 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' C' ' 52' ' ' LYS . 45.5 mmtm -42.19 162.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.484 1.135 . . . . 0.0 114.011 -170.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -158.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.505 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.3 p -87.77 128.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 113.707 -1.246 . . . . 0.0 109.095 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -140.02 110.29 6.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.054 0.454 . . . . 0.0 110.17 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -89.22 130.95 35.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.585 ' HB2' HG12 ' C' ' 69' ' ' VAL . 23.7 mt-30 -105.31 172.57 6.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -175.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -76.92 153.19 82.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.827 0.346 . . . . 0.0 110.293 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' C' ' 67' ' ' THR . 60.6 Cg_endo -70.21 149.43 64.01 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.537 2.825 . . . . 0.0 113.424 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -154.25 106.64 2.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 170.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' TRP . . . . . 0.631 ' HB3' ' O ' ' C' ' 65' ' ' LYS . 26.8 t-105 -140.89 165.83 26.44 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 165.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 10.7 t -52.72 155.34 2.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 168.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.36 0.44 1.37 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 115.611 1.005 . . . . 0.0 115.611 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 5.3 p -89.28 -25.8 21.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.759 0.78 . . . . 0.0 111.705 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . 0.631 ' O ' ' HB3' ' C' ' 61' ' ' TRP . 84.3 mttt -145.47 167.62 22.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.844 0.354 . . . . 0.0 110.57 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.8 m -118.2 148.21 42.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.638 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 93.9 m -132.71 121.07 22.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.945 HD11 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.62 127.89 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.889 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . 0.585 HG12 ' HB2' ' C' ' 57' ' ' GLN . 0.7 OUTLIER -111.46 122.87 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.726 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -111.28 125.43 53.82 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.706 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.22 138.52 43.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' C' ' 26' ' ' THR . 0.2 OUTLIER -120.07 122.1 40.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.153 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' LYS . . . . . 0.428 ' HA ' ' HD2' ' C' ' 73' ' ' LYS . 3.5 mmmp? -77.87 121.0 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.784 HG13 HG13 ' C' ' 27' ' ' ILE . 9.9 p -143.37 148.94 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.716 -170.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' MET . . . . . 0.449 ' HE3' ' OE1' ' C' ' 78' ' ' GLU . 3.4 mpp? -89.81 140.1 29.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.874 -176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . 1.021 ' HA ' ' HB ' ' C' ' 24' ' ' THR . . . -43.99 -55.39 4.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -57.03 -33.86 67.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.557 0.617 . . . . 0.0 112.285 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' GLU . . . . . 0.449 ' OE1' ' HE3' ' C' ' 75' ' ' MET . 56.3 mt-10 -63.94 -53.76 45.24 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 176.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -58.09 -44.03 87.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.768 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' ASP . . . . . 0.525 ' HA ' ' HD2' ' C' ' 104' ' ' LYS . 24.5 t70 -70.25 -17.24 63.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.323 -176.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 66.3 m -86.38 -3.01 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.68 28.87 70.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.184 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.8 t -64.71 143.18 58.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.041 0.448 . . . . 0.0 109.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.8 mt-10 -75.49 130.1 38.34 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' TYR . . . . . 0.673 ' HH ' HG22 ' C' ' 74' ' ' VAL . 7.8 m-85 -128.05 120.79 28.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.325 175.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . 0.465 HG23 ' HB2' ' C' ' 101' ' ' SER . 26.7 t -120.25 135.76 59.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 19.5 p -115.39 129.2 56.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.637 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.9 mp -120.24 148.61 43.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.287 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' VAL . . . . . 0.53 HG12 HG21 ' C' ' 31' ' ' ILE . 5.9 p -143.72 127.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.354 0.597 . . . . 0.0 111.448 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -110.77 153.39 25.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.053 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . 0.617 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 11.3 t70 -142.69 148.03 36.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -62.31 -21.31 65.16 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -97.2 0.09 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.692 ' C ' HD12 ' C' ' 94' ' ' LEU . 2.6 pp -103.86 158.64 31.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.452 ' HD2' ' H ' ' C' ' 96' ' ' THR . 1.8 Cg_endo -88.21 -35.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.874 3.049 . . . . 0.0 113.294 -168.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.452 ' H ' ' HD2' ' C' ' 95' ' ' PRO . 16.7 p -147.28 153.64 44.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.43 151.99 79.71 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.294 1.996 . . . . 0.0 112.112 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 19.2 m -122.19 147.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.689 ' HB3' ' HZ2' ' C' ' 99' ' ' LYS . 0.4 OUTLIER -135.08 161.48 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.181 0.515 . . . . 0.0 112.367 -169.692 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.18 140.99 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' SER . . . . . 0.465 ' HB2' HG23 ' C' ' 86' ' ' VAL . 39.7 t -120.56 149.14 42.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.989 0.358 . . . . 0.0 110.708 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.552 ' HB ' HD13 ' C' ' 11' ' ' LEU . 2.9 tp -125.03 142.12 42.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.181 0.515 . . . . 0.0 110.879 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -123.69 153.91 40.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' LYS . . . . . 0.525 ' HD2' ' HA ' ' C' ' 80' ' ' ASP . 76.0 tttt -64.39 107.04 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.454 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.407 -176.869 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.737 0.303 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.01 170.46 14.22 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -140.93 -80.64 0.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.045 0.423 . . . . 0.0 110.023 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -100.89 -16.31 17.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.332 0.587 . . . . 0.0 109.94 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -93.0 151.12 20.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.339 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -111.05 122.34 47.65 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.645 0.736 . . . . 0.0 109.191 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' ILE . . . . . 0.549 HG12 HG13 ' C' ' 98' ' ' VAL . 3.3 tp -134.69 124.11 43.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.656 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 47.2 t -120.47 125.06 46.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . 0.43 ' HB ' HG21 ' C' ' 31' ' ' ILE . 3.0 p -128.57 125.32 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.108 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -148.28 148.61 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.053 -0.404 . . . . 0.0 110.539 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.484 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.5 mm? -96.11 146.7 24.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.905 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -115.3 115.38 26.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.712 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -78.1 154.58 80.02 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.203 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . 0.441 ' HG3' ' O ' ' C' ' 25' ' ' ALA . 73.8 Cg_endo -75.68 118.42 5.09 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.721 2.281 . . . . 0.0 111.579 175.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.03 144.75 71.06 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.611 2.207 . . . . 0.0 111.521 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -79.45 74.8 6.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -78.65 101.91 7.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.618 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 67.16 -179.04 0.21 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.263 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 8.3 tp -101.06 -21.58 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.561 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -98.42 121.88 40.91 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 5.3 t -155.35 135.64 13.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.975 0.417 . . . . 0.0 111.02 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -110.11 15.25 22.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.936 0.874 . . . . 0.0 109.136 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -111.27 167.55 10.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.547 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 17.1 p -96.49 171.79 8.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.536 0.684 . . . . 0.0 111.258 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' C' ' 14' ' ' PRO . . . -78.08 30.31 0.17 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.927 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' THR . . . . . 0.488 ' HA ' HG11 ' C' ' 74' ' ' VAL . 3.4 t -55.46 129.09 37.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.226 1.012 . . . . 0.0 112.302 -164.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mt -102.32 155.52 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.541 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . 0.509 HG23 ' HG3' ' C' ' 71' ' ' LYS . 56.0 t -127.95 135.17 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.943 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -111.16 127.03 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 124.62 52.28 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' ILE . . . . . 0.589 HG22 HG23 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.97 131.13 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.651 179.249 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.24 129.7 66.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.748 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.625 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -165.54 160.62 17.88 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' SER . . . . . 0.493 ' OG ' ' HA ' ' C' ' 65' ' ' LYS . 14.7 m -144.2 153.94 42.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.792 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' C' ' 34' ' ' SER . 1.1 m-20 78.8 9.22 1.91 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.454 0.472 . . . . 0.0 112.056 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.23 163.99 13.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.624 0.726 . . . . 0.0 112.059 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -83.0 173.82 11.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.291 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -57.62 114.5 2.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.535 1.636 . . . . 0.0 107.784 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.576 ' CG2' HG11 ' C' ' 89' ' ' VAL . 4.6 mp -74.55 146.06 10.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 111.559 -2.564 . . . . 0.0 112.506 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.87 172.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.19 140.1 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -134.36 137.81 44.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.939 0.399 . . . . 0.0 110.94 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' TRP . . . . . 0.538 ' HE3' ' HD2' ' C' ' 85' ' ' TYR . 55.2 m95 -125.77 133.94 51.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -124.8 130.22 51.97 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' C' ' 50' ' ' ARG . 23.5 t -118.31 111.78 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.939 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.18 37.24 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.875 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.76 -14.3 25.91 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.1 134.16 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.22 138.52 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.102 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' ARG . . . . . 0.46 ' HB2' HG23 ' C' ' 45' ' ' VAL . 15.8 tpp180 -90.96 127.11 36.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.479 0.657 . . . . 0.0 110.879 -173.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -57.67 160.4 4.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.844 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -40.65 163.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.301 1.048 . . . . 0.0 113.307 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.51 -0.47 23.46 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -163.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.433 ' HA ' HD23 ' C' ' 72' ' ' LEU . 5.4 p -87.29 127.25 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.314 172.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.516 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 34.8 mt-10 -124.08 108.76 12.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -172.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 6.3 m -93.43 117.75 30.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . 0.588 ' HB2' HG13 ' C' ' 69' ' ' VAL . 47.1 mt-30 -100.39 171.42 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.463 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.2 144.4 89.65 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 0.0 110.651 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' C' ' 67' ' ' THR . 27.3 Cg_endo -63.08 151.23 85.83 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.557 2.838 . . . . 0.0 114.072 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -103.4 123.22 46.44 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -104.26 113.95 27.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.777 0.322 . . . . 0.0 111.822 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 13.7 m -113.14 101.1 9.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.88 -108.36 1.84 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.705 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 56.1 m -110.9 6.62 21.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . 0.493 ' HA ' ' OG ' ' C' ' 34' ' ' SER . 74.4 mmtt -99.17 134.35 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.108 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -109.11 150.53 27.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.053 0.454 . . . . 0.0 110.795 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 57.5 m -137.04 126.73 25.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.96 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.625 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -112.05 134.16 55.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.872 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . 0.588 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -115.61 127.32 73.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.365 0.602 . . . . 0.0 110.697 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 40.9 p -115.41 129.62 56.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.534 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.516 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 48.1 tttp -107.09 144.62 33.52 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -120.03 116.54 25.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.027 0.441 . . . . 0.0 110.251 177.681 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -77.76 112.59 14.77 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.984 HG22 ' HH ' ' C' ' 85' ' ' TYR . 9.3 p -119.98 151.71 22.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.342 0.592 . . . . 0.0 110.602 -168.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' MET . . . . . 0.857 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 65.9 mtt -84.04 137.43 33.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.251 -176.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.32 -35.98 60.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.824 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 14.5 t -70.74 -28.31 64.61 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.368 0.267 . . . . 0.0 111.627 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' GLU . . . . . 0.857 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 7.7 mm-40 -71.44 -54.75 9.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.712 0.767 . . . . 0.0 109.137 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -64.95 -38.63 91.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.238 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.86 -18.47 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.41 . . . . 0.0 111.039 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 18.6 t -90.16 -4.48 57.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.546 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.58 25.29 70.47 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.34 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -62.22 138.82 58.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.116 0.484 . . . . 0.0 111.145 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.17 149.68 24.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.265 -172.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' TYR . . . . . 0.984 ' HH ' HG22 ' C' ' 74' ' ' VAL . 16.4 m-85 -132.7 131.05 40.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.198 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . 0.535 HG11 ' HE2' ' C' ' 99' ' ' LYS . 25.3 t -119.87 130.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' CYS . . . . . 0.5 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 34.4 t -108.6 120.48 42.56 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.654 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 5.8 mp -116.23 147.52 41.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.63 0.581 . . . . 0.0 110.166 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' VAL . . . . . 0.589 HG23 HG22 ' C' ' 31' ' ' ILE . 12.3 t -134.0 127.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.54 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.06 144.94 51.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.082 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . 0.504 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 27.1 t70 -148.17 156.7 42.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.339 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 37.9 t -65.37 -21.68 66.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -91.9 -11.55 35.99 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 122.192 -0.318 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.504 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 40.8 mt -84.12 146.57 48.69 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.668 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 1.7 Cg_endo -84.34 -29.26 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.512 2.808 . . . . 0.0 111.651 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 27.1 p -147.19 151.62 41.23 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.903 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.42 148.05 47.86 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.532 1.488 . . . . 0.0 110.651 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 27.6 m -108.57 141.1 24.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.654 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 13.7 ptmm? -142.79 153.51 43.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.32 22.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 33.5 t -121.91 149.74 42.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.409 0.624 . . . . 0.0 111.888 -173.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.484 ' HB ' ' HG ' ' C' ' 11' ' ' LEU . 4.8 tp -124.03 145.64 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.413 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -130.86 162.68 29.08 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -80.14 108.5 13.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.338 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.156 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.631 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 121.021 0.439 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.99 73.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -58.78 -58.27 9.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.622 0.249 . . . . 0.0 111.175 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -96.63 -52.27 3.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.276 0.56 . . . . 0.0 110.197 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' THR . . . . . 0.408 HG23 ' O ' ' C' ' 5' ' ' THR . 6.0 t -107.21 94.91 5.35 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.693 1.235 . . . . 0.0 111.294 -177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -96.9 113.15 24.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.624 -1.625 . . . . 0.0 106.863 165.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.3 122.39 50.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.105 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 19.5 m -117.82 114.58 23.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.249 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.82 117.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.19 0.519 . . . . 0.0 110.661 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m -123.15 130.92 53.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . 0.519 HD11 ' HB ' ' C' ' 102' ' ' ILE . 46.8 mt -99.0 130.07 45.32 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 tp -111.47 113.8 26.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -83.23 147.59 53.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -34.23 103.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 125.08 3.854 . . . . 0.0 114.533 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -79.45 109.91 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.117 2.545 . . . . 0.0 111.085 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -87.55 -27.49 22.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.908 0.385 . . . . 0.0 110.674 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -99.63 79.91 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.093 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' GLU . . . . . 0.419 ' HG3' ' H ' ' C' ' 20' ' ' TRP . 11.0 pt-20 -160.18 -170.84 2.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.396 171.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 8.2 tp -62.61 -34.08 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.737 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' TRP . . . . . 0.419 ' H ' ' HG3' ' C' ' 18' ' ' GLU . 50.1 m95 -93.55 114.35 26.68 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 16.4 m -83.4 125.6 31.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.19 0.519 . . . . 0.0 110.483 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -81.35 89.38 6.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.311 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -74.84 -14.31 60.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.393 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 7.6 p -120.5 -178.77 3.78 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.373 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . 0.996 ' HB1' ' HA ' ' C' ' 76' ' ' ALA . . . -95.22 24.71 4.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.249 -176.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t -59.78 126.18 26.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.978 0.894 . . . . 0.0 111.907 -168.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.44 153.96 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.699 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.93 134.38 63.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.216 0.531 . . . . 0.0 111.554 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' CYS . . . . . 0.526 ' HB2' ' CH2' ' C' ' 43' ' ' TRP . 35.7 t -108.88 112.85 25.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.29 115.89 31.0 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' ILE . . . . . 0.647 HG23 HG21 ' C' ' 89' ' ' VAL . 0.2 OUTLIER -126.25 128.65 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 53.8 t -114.69 131.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.744 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' TYR . . . . . 0.525 ' HH ' HD11 ' C' ' 31' ' ' ILE . 0.1 OUTLIER -161.13 163.63 31.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.418 -178.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -142.34 150.94 41.42 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 37.6 t70 78.67 10.99 1.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.811 0.695 . . . . 0.0 111.6 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 17.4 mt -97.97 164.66 12.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.003 0.906 . . . . 0.0 112.654 -172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -94.36 170.84 9.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.83 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.14 114.92 2.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.72 1.724 . . . . 0.0 108.257 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' ILE . . . . . 0.637 HG23 HG11 ' C' ' 89' ' ' VAL . 4.7 mp -70.12 141.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.177 -2.738 . . . . 0.0 113.555 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -103.43 124.05 48.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -108.73 141.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -173.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.411 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.5 t80 -132.5 143.6 49.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' TRP . . . . . 0.606 ' HB2' ' HD3' ' C' ' 50' ' ' ARG . 58.0 m95 -130.45 137.85 50.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -125.9 130.07 50.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.792 0.269 . . . . 0.0 111.191 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 27.6 t -121.66 113.03 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 56.89 36.17 27.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.14 0.495 . . . . 0.0 110.979 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.49 15.1 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.818 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.54 133.96 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.61 138.04 58.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' ARG . . . . . 0.606 ' HD3' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -89.92 156.14 18.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.346 -172.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -69.79 156.08 39.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.077 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -53.14 166.85 0.21 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.776 0.798 . . . . 0.0 112.321 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.15 7.31 12.71 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -160.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' VAL . . . . . 0.428 ' HA ' HD21 ' C' ' 72' ' ' LEU . 23.8 t -84.61 129.21 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.044 -1.578 . . . . 0.0 107.874 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 41.1 mt-10 -128.71 108.9 10.85 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 7.0 p -92.11 123.12 35.22 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -89.04 144.43 26.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' ASN . . . . . 0.405 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.1 t30 -58.37 137.4 85.29 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.774 -175.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' PRO . . . . . 0.442 ' HB3' HD12 ' C' ' 68' ' ' ILE . 31.1 Cg_exo -48.09 134.88 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.781 2.987 . . . . 0.0 112.849 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -121.55 124.32 44.1 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -87.73 109.03 19.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.032 0.444 . . . . 0.0 110.395 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 12.3 m -96.78 102.64 14.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.984 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.28 -109.45 2.91 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.181 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 27.6 t -110.93 6.89 21.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.232 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -118.29 158.09 25.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.185 0.517 . . . . 0.0 110.91 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -101.14 146.79 27.02 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -131.58 119.11 21.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.112 0.482 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ILE . . . . . 0.582 ' O ' HD12 ' C' ' 31' ' ' ILE . 1.6 mp -114.89 133.09 62.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.922 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.31 121.62 61.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 0.0 110.391 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' C' ' 29' ' ' CYS . 40.8 m -108.96 111.12 22.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.695 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' LYS . . . . . 0.518 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 81.8 tttt -105.37 144.56 31.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.978 -174.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' LEU . . . . . 0.428 HD21 ' HA ' ' C' ' 54' ' ' VAL . 0.5 OUTLIER -122.49 119.59 31.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 174.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -91.53 111.17 22.57 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' VAL . . . . . 0.415 HG21 ' CE2' ' C' ' 85' ' ' TYR . 8.3 p -134.33 163.62 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.095 0.474 . . . . 0.0 110.864 -168.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' MET . . . . . 0.74 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 63.2 mtt -74.16 129.1 37.17 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.442 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' ALA . . . . . 0.996 ' HA ' ' HB1' ' C' ' 25' ' ' ALA . . . -56.9 -45.38 82.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.812 -176.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 26.0 t -59.7 -32.72 70.78 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.916 0.486 . . . . 0.0 111.477 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' GLU . . . . . 0.74 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 26.2 mm-40 -67.38 -51.67 49.18 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' TRP . . . . . 0.452 ' CB ' ' HB2' ' C' ' 25' ' ' ALA . 56.3 t-105 -57.84 -44.26 86.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.087 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' ASP . . . . . 0.526 ' HA ' ' HE2' ' C' ' 104' ' ' LYS . 26.7 t70 -70.88 -11.55 61.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 9.9 t -87.71 -3.68 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.5 26.28 68.15 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.487 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -65.58 149.77 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 111.057 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 27.5 mt-10 -71.24 129.08 37.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.115 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' TYR . . . . . 0.529 ' HD1' ' HE3' ' C' ' 43' ' ' TRP . 0.4 OUTLIER -128.9 119.41 24.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 16.7 t -120.48 136.39 57.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' CYS . . . . . 0.424 ' HB3' HD21 ' C' ' 11' ' ' LEU . 10.8 t -111.54 126.38 54.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' LEU . . . . . 0.652 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -119.25 146.02 45.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.882 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' VAL . . . . . 0.647 HG21 HG23 ' C' ' 31' ' ' ILE . 39.2 t -123.54 131.09 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.8 136.56 54.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.976 0.417 . . . . 0.0 111.016 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' ASP . . . . . 0.654 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 15.1 t70 -149.3 145.18 26.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -63.09 -18.46 63.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.119 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -101.53 5.07 41.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.9 pp -99.14 148.42 34.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.05 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.4 -34.74 1.89 Allowed 'Trans proline' 0 N--CA 1.469 0.057 0 C-N-CA 123.83 3.02 . . . . 0.0 112.841 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' THR . . . . . 0.478 ' O ' HD12 ' C' ' 94' ' ' LEU . 20.1 p -144.66 148.7 40.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.37 144.78 91.81 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.325 2.016 . . . . 0.0 111.254 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' VAL . . . . . 0.652 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 44.1 t -94.72 116.66 36.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' LYS . . . . . 0.485 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 18.6 ptpt -127.66 149.18 50.31 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.091 -174.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.401 ' O ' HD13 ' C' ' 11' ' ' LEU . . . -155.76 135.76 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.906 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.4 t -112.8 154.61 25.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.943 0.401 . . . . 0.0 111.179 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.519 ' HB ' HD11 ' C' ' 11' ' ' LEU . 5.7 tp -122.92 144.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.156 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -133.57 150.15 51.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.422 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' LYS . . . . . 0.526 ' HE2' ' HA ' ' C' ' 80' ' ' ASP . 21.6 ttpp -90.65 136.81 32.83 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.576 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tp . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 5.2 m -115.45 111.56 20.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.192 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.642 HG22 HG22 ' C' ' 31' ' ' ILE . 29.1 t -106.43 114.51 45.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.117 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -125.49 123.75 39.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' C' ' 28' ' ' VAL . 44.2 mt -99.24 135.07 41.19 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.66 ' HB3' HG22 ' C' ' 28' ' ' VAL . 3.3 tm? -108.58 125.19 51.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 13' ' ' LYS . . . . . 0.407 ' HB2' ' HD2' ' C' ' 14' ' ' PRO . 62.2 pttt -94.92 153.66 39.88 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.473 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 14' ' ' PRO . . . . . 0.629 ' HD3' HD13 ' C' ' 27' ' ' ILE . 60.0 Cg_endo . . . . . 0 C--O 1.235 0.356 0 C-N-CA 123.046 2.497 . . . . 0.0 112.853 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' THR . . . . . 0.428 HG21 ' HD2' ' C' ' 71' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.083 0 N-CA-C 110.851 -0.055 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 27' ' ' ILE . . . . . 0.629 HD13 ' HD3' ' C' ' 14' ' ' PRO . 20.9 mm -112.75 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 163.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.66 HG22 ' HB3' ' C' ' 12' ' ' LEU . 0.6 OUTLIER -119.13 142.83 32.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.685 -169.154 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 29' ' ' CYS . . . . . 0.488 ' HA ' HD23 ' C' ' 11' ' ' LEU . 41.1 t -115.18 113.48 23.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.306 170.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.23 123.39 46.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' ILE . . . . . 0.642 HG22 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.86 130.54 73.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.932 0.872 . . . . 0.0 111.648 -178.522 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.75 129.38 66.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.497 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.33 161.49 27.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.373 0.42 . . . . 0.0 110.748 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 34' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' C' ' 65' ' ' LYS . 6.0 p -144.04 150.89 38.91 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.3 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' C' ' 34' ' ' SER . 67.1 m-20 75.38 11.04 3.45 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.524 0.515 . . . . 0.0 112.22 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 16.7 mt -91.51 168.14 11.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.554 0.692 . . . . 0.0 111.821 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -96.53 171.81 8.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.151 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -56.94 115.48 2.63 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 123.801 1.763 . . . . 0.0 109.005 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.526 ' CG2' HG13 ' C' ' 89' ' ' VAL . 4.6 mp -74.11 144.46 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 111.247 -2.706 . . . . 0.0 113.069 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 22.4 tptm -106.63 124.34 49.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.802 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.9 139.27 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.559 0.218 . . . . 0.0 110.618 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -135.53 141.1 45.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 111.44 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' TRP . . . . . 0.801 ' HB2' ' HD2' ' C' ' 50' ' ' ARG . 51.9 m95 -129.7 136.78 50.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' GLN . . . . . 0.537 ' OE1' ' HA2' ' C' ' 47' ' ' GLY . 8.3 tt0 -121.47 129.31 52.88 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 21.5 t -120.92 108.06 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 58.03 37.06 26.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 111.09 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' GLY . . . . . 0.537 ' HA2' ' OE1' ' C' ' 44' ' ' GLN . . . 78.13 -6.93 47.69 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.94 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.53 130.98 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.956 0.407 . . . . 0.0 111.172 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.4 136.34 57.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.846 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' ARG . . . . . 0.801 ' HD2' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -91.74 146.9 23.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.917 0.865 . . . . 0.0 112.412 -170.308 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -66.14 161.4 21.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.162 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.603 ' HG2' ' H ' ' C' ' 53' ' ' GLY . 39.4 tttm -53.92 164.33 0.61 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.698 0.761 . . . . 0.0 110.611 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 53' ' ' GLY . . . . . 0.603 ' H ' ' HG2' ' C' ' 52' ' ' LYS . . . 115.8 -13.28 17.55 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -159.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.551 ' HA ' HD22 ' C' ' 72' ' ' LEU . 2.6 p -82.81 129.1 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 112.898 -1.651 . . . . 0.0 107.752 163.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -141.8 114.75 8.63 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.503 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 28.4 m -89.09 126.06 35.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.93 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.541 ' HB2' HG13 ' C' ' 69' ' ' VAL . 52.5 mt-30 -90.99 149.23 21.93 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 58' ' ' ASN . . . . . 0.425 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.3 t30 -56.39 138.73 74.85 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.134 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' C' ' 58' ' ' ASN . 53.6 Cg_exo -47.52 135.84 20.83 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 124.194 3.263 . . . . 0.0 113.616 -174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 60' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' C' ' 67' ' ' THR . 34.4 tt0 . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' LYS . . . . . 0.446 ' HA ' ' HB3' ' C' ' 34' ' ' SER . 35.5 mmtm . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.465 0.65 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 10.2 m -105.6 150.54 25.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.675 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' C' ' 60' ' ' GLU . 66.8 m -134.39 121.62 21.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.275 0.56 . . . . 0.0 110.939 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.497 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.5 mp -112.09 133.47 57.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 69' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -127.75 136.36 60.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.794 0.33 . . . . 0.0 110.779 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.9 p -129.34 125.04 35.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.28 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.428 ' HD2' HG21 ' C' ' 26' ' ' THR . 52.9 mtmt -107.72 139.33 42.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.17 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.566 HD11 ' HG3' ' C' ' 50' ' ' ARG . 0.2 OUTLIER -110.29 127.52 55.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.912 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.1 116.75 29.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' C' ' 85' ' ' TYR . 34.5 m -134.77 163.39 36.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 -169.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 91.1 mmm -81.52 128.67 34.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.172 0.51 . . . . 0.0 110.107 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.91 -48.78 42.27 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.946 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 50.4 m -61.75 -29.54 70.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.457 0.571 . . . . 0.0 111.919 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -52.2 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' TRP . . . . . 0.449 ' HZ3' HG23 ' C' ' 102' ' ' ILE . 66.0 t-105 -56.85 -46.92 81.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.06 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' ASP . . . . . 0.565 ' HA ' ' HD3' ' C' ' 104' ' ' LYS . 22.5 t70 -69.5 -15.05 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.222 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -79.1 -5.4 53.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.3 18.92 65.61 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 8.3 m -65.58 138.55 58.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.436 0.636 . . . . 0.0 111.393 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 84' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.9 mt-10 -74.76 133.52 41.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.541 -172.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' TYR . . . . . 0.576 ' O ' HG22 ' C' ' 102' ' ' ILE . 82.0 m-85 -129.54 115.1 16.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 86' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' C' ' 101' ' ' SER . 0.3 OUTLIER -132.4 140.27 48.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 121.376 0.608 . . . . 0.0 111.298 -176.086 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 7.6 t -106.87 126.74 52.7 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.4 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -117.32 144.35 44.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 89' ' ' VAL . . . . . 0.611 ' HB ' ' CG1' ' C' ' 98' ' ' VAL . 54.6 t -116.76 135.33 57.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' C' ' 40' ' ' LYS . 36.3 tt0 -125.28 130.33 51.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 91' ' ' ASP . . . . . 0.501 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 15.7 t70 -150.67 144.65 25.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.186 0.517 . . . . 0.0 110.046 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.5 t -66.17 -19.27 65.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.859 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' GLU . . . . . 0.431 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 6.6 mm-40 -92.09 -6.67 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 38.7 mt -89.76 145.96 34.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.44 -35.16 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.325 2.683 . . . . 0.0 111.68 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -146.21 154.04 49.45 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.102 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.56 148.81 73.39 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.739 1.626 . . . . 0.0 111.359 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' VAL . . . . . 0.611 ' CG1' ' HB ' ' C' ' 89' ' ' VAL . 10.7 p -110.56 140.01 31.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.566 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 8.6 ptpp? -137.85 151.73 48.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 0.0 111.775 -171.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.85 127.58 4.72 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.434 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' SER . . . . . 0.559 ' HB3' ' HB ' ' C' ' 86' ' ' VAL . 72.2 p -107.48 160.63 15.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.133 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 102' ' ' ILE . . . . . 0.576 HG22 ' O ' ' C' ' 85' ' ' TYR . 3.6 tp -121.77 139.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.077 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -114.84 145.46 42.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.054 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 104' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' C' ' 80' ' ' ASP . 33.9 ttpt -73.61 110.35 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.189 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.143 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 7' ' ' ILE . . . . . 0.712 HG12 HG11 ' C' ' 98' ' ' VAL . 3.3 tp . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 121.169 0.509 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 16.3 m -114.73 106.75 14.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.556 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.05 113.66 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.023 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -112.24 110.2 20.31 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.675 HD21 ' HB ' ' C' ' 102' ' ' ILE . 57.8 tp -99.53 117.5 34.06 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.45 118.45 35.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.162 0.506 . . . . 0.0 110.706 -167.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' LYS . . . . . 0.548 ' HB3' HD11 ' C' ' 102' ' ' ILE . 14.4 ptpt -79.53 147.5 67.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.146 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.462 -0.325 0 C-N-CA 122.477 2.118 . . . . 0.0 111.568 -179.626 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 26' ' ' THR . . . . . 0.787 ' HA ' HG12 ' C' ' 74' ' ' VAL . 5.8 t . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 121.802 0.811 . . . . 0.0 112.283 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' ILE . . . . . 0.526 HG13 HG11 ' C' ' 74' ' ' VAL . 40.1 mt -97.33 154.74 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.704 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.618 HG22 ' HG2' ' C' ' 71' ' ' LYS . 84.1 t -130.61 133.93 62.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.745 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 29' ' ' CYS . . . . . 0.433 ' HB2' ' CZ2' ' C' ' 43' ' ' TRP . 19.3 t -115.78 112.36 21.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -104.97 123.33 47.59 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' ILE . . . . . 0.56 HG12 HG21 ' C' ' 89' ' ' VAL . 0.1 OUTLIER -121.78 136.06 59.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.445 0.64 . . . . 0.0 111.007 -176.069 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 17.9 t -114.94 132.24 64.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.084 -176.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.631 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.88 167.61 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.236 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 34' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 41.8 t -141.01 150.32 42.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' C' ' 34' ' ' SER . 7.2 m-20 76.81 11.59 2.5 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.479 0.487 . . . . 0.0 112.085 170.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -96.35 164.33 12.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.902 0.858 . . . . 0.0 112.351 -175.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' C' ' 38' ' ' ASN . 11.3 tp10 -91.81 174.1 7.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.394 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 1.6 m120 -56.36 114.09 1.85 Allowed 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.131 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.629 HG21 HG13 ' C' ' 89' ' ' VAL . 5.0 mp -73.83 144.57 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 112.448 -2.16 . . . . 0.0 113.266 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.86 122.94 46.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.79 144.12 14.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.0 110.908 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.45 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.5 t80 -135.06 143.85 46.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 43' ' ' TRP . . . . . 0.458 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 51.7 m95 -127.6 139.5 52.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' GLN . . . . . 0.501 ' HG2' ' HB ' ' C' ' 86' ' ' VAL . 30.0 pt20 -132.77 131.02 40.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.628 0.728 . . . . 0.0 111.11 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 0.2 OUTLIER -120.25 122.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.54 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 53.77 34.83 19.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.02 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.65 -16.36 25.96 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.443 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -87.72 134.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.22 139.36 58.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.195 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -89.31 117.23 28.11 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -53.29 158.45 1.63 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.912 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.68 164.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.723 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.18 3.97 20.89 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -155.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.407 ' HA ' HD22 ' C' ' 72' ' ' LEU . 7.6 p -88.23 132.44 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.116 -1.542 . . . . 0.0 108.351 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 86.8 tt0 -125.49 108.86 12.04 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.83 0.348 . . . . 0.0 110.459 -172.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 16.0 p -98.45 122.64 41.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.812 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.692 ' HB2' HG13 ' C' ' 69' ' ' VAL . 48.4 mt-30 -103.06 176.27 5.2 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.236 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.31 150.78 85.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 0.0 110.744 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' PRO . . . . . 0.539 ' HB3' HD11 ' C' ' 68' ' ' ILE . 43.9 Cg_endo -65.48 148.09 87.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.553 2.835 . . . . 0.0 112.989 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 60' ' ' GLU . . . . . 0.582 ' HG3' ' HB ' ' C' ' 67' ' ' THR . 14.4 pt-20 . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 65' ' ' LYS . . . . . 0.464 ' HE2' HG12 ' C' ' 32' ' ' VAL . 46.6 mtpt . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.559 0.695 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -115.59 149.06 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.577 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.582 ' HB ' ' HG3' ' C' ' 60' ' ' GLU . 46.2 m -132.37 122.16 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.397 0.618 . . . . 0.0 110.813 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.631 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -110.06 132.48 58.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.379 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.9 p -108.5 122.47 63.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.552 0.692 . . . . 0.0 110.878 176.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.1 m -120.74 122.19 39.86 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.618 ' HG2' HG22 ' C' ' 28' ' ' VAL . 6.8 mtpm? -106.0 152.54 23.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.952 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' C' ' 72' ' ' LEU . 0.2 OUTLIER -119.84 114.93 22.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.254 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -78.36 112.1 15.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' C' ' 26' ' ' THR . 12.9 p -128.63 153.09 37.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.951 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.643 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 97.0 mmm -72.03 129.47 38.61 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.689 0.757 . . . . 0.0 110.614 -175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.17 -34.11 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.793 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -70.56 -35.27 72.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.283 0.633 . . . . 0.0 111.397 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' GLU . . . . . 0.643 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 59.7 mt-10 -68.58 -52.49 31.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -58.2 -42.47 86.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.801 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.37 -26.03 68.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.325 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 51.0 m -87.05 -2.39 58.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.843 0.354 . . . . 0.0 111.299 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.59 28.79 72.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.521 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.641 HG21 ' HB3' ' C' ' 78' ' ' GLU . 14.6 t -64.88 150.82 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 32.5 mt-10 -80.64 141.86 34.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.069 0.461 . . . . 0.0 111.32 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -137.75 127.86 25.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.754 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' C' ' 99' ' ' LYS . 20.9 t -120.48 138.76 49.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 87' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 29.2 t -111.46 118.5 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.731 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.3 mp -113.28 147.06 38.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.677 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 89' ' ' VAL . . . . . 0.629 HG13 HG21 ' C' ' 39' ' ' ILE . 25.1 t -135.29 125.69 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 122.91 0.484 . . . . 0.0 109.806 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' C' ' 97' ' ' PRO . 12.9 pt-20 -133.64 145.48 50.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 91' ' ' ASP . . . . . 0.554 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 14.5 t70 -136.75 158.48 44.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 34.0 t -52.79 -41.7 64.37 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.386 0.429 . . . . 0.0 110.825 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -86.98 -1.73 58.09 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.554 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 42.8 mt -92.02 128.74 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 109.988 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -35.09 37.03 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 123.051 2.501 . . . . 0.0 112.206 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -147.52 153.67 43.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.944 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 37.6 Cg_endo -68.83 153.39 72.97 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.27 1.98 . . . . 0.0 111.503 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 98' ' ' VAL . . . . . 0.712 HG11 HG12 ' C' ' 7' ' ' ILE . 13.7 p -116.79 146.53 21.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.731 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 14.1 ptmm? -141.03 156.5 46.01 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.304 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.81 140.52 19.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 32.2 t -118.03 153.75 33.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.134 0.492 . . . . 0.0 111.063 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 102' ' ' ILE . . . . . 0.675 ' HB ' HD21 ' C' ' 11' ' ' LEU . 8.0 tp -124.21 149.48 28.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.774 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -142.07 152.96 43.81 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -78.38 108.39 11.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.184 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.854 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.707 -177.827 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 7' ' ' ILE . . . . . 0.421 HG12 HG11 ' C' ' 98' ' ' VAL . 2.1 tp . . . . . 0 N--CA 1.444 -0.74 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.875 ' HB2' HG13 ' C' ' 32' ' ' VAL . 51.0 m -110.31 104.49 13.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.374 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.54 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.27 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 16.0 m -121.01 127.31 51.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' C' ' 87' ' ' CYS . 72.2 mt -99.8 127.23 45.97 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.255 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.06 114.69 28.41 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' LYS . . . . . 0.663 ' HB3' HD11 ' C' ' 102' ' ' ILE . 18.9 ptpt -76.26 154.79 84.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.303 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' PRO . . . . . 0.548 ' HD3' HD13 ' C' ' 27' ' ' ILE . 19.0 Cg_endo . . . . . 0 N--CA 1.464 -0.249 0 C-N-CA 122.4 2.067 . . . . 0.0 111.685 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' THR . . . . . 0.443 ' HA ' HG22 ' C' ' 74' ' ' VAL . 5.9 t . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.543 0.687 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' ILE . . . . . 0.548 HD13 ' HD3' ' C' ' 14' ' ' PRO . 15.8 mm -88.87 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.192 -174.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.41 132.96 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.321 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.05 114.54 21.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.624 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.52 128.54 54.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 31' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' C' ' 8' ' ' SER . 0.0 OUTLIER -126.53 133.51 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.483 0.659 . . . . 0.0 111.373 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.875 HG13 ' HB2' ' C' ' 8' ' ' SER . 2.1 p -129.05 134.73 63.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.516 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.557 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -163.5 168.18 20.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.723 -171.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 34' ' ' SER . . . . . 0.553 ' HB3' ' HD3' ' C' ' 65' ' ' LYS . 18.9 p -141.99 149.88 40.63 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.42 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' C' ' 34' ' ' SER . 4.9 m-20 77.59 11.02 2.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.756 0.66 . . . . 0.0 112.166 171.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -96.18 177.51 5.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.996 0.903 . . . . 0.0 112.793 -170.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 39' ' ' ILE . 20.4 mm-40 -105.8 173.47 6.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.595 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.76 112.73 1.94 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 123.927 1.822 . . . . 0.0 108.773 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.721 HG21 HG13 ' C' ' 89' ' ' VAL . 51.0 mt -87.56 147.3 5.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 110.864 -2.88 . . . . 0.0 114.126 -171.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -100.33 126.49 46.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.156 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.58 137.97 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.694 ' CB ' ' HG ' ' C' ' 88' ' ' LEU . 0.1 OUTLIER -119.31 147.84 43.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.929 -0.123 . . . . 0.0 110.897 -176.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 43' ' ' TRP . . . . . 0.808 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 65.7 m95 -137.18 132.66 34.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -123.27 131.3 53.62 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' VAL . . . . . 0.593 HG21 ' HD2' ' C' ' 50' ' ' ARG . 21.6 t -124.96 118.26 52.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.151 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' ASN . . . . . 0.436 ' H ' ' HG3' ' C' ' 84' ' ' GLU . 29.7 m120 57.99 33.83 23.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 -175.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.7 -1.2 31.28 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.003 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 p -116.62 138.64 46.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.255 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.11 122.21 13.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.263 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' ARG . . . . . 0.593 ' HD2' HG21 ' C' ' 45' ' ' VAL . 7.9 ptm85 -92.86 167.54 11.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.4 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.65 159.47 21.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.991 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' C' ' 52' ' ' LYS . 0.0 OUTLIER -49.63 166.56 0.05 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.107 176.131 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.9 7.7 12.7 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -162.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.56 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.4 p -88.25 126.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' C' ' 70' ' ' SER . 39.9 mt-10 -121.0 109.62 15.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 5.6 p -101.13 116.88 33.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.954 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' C' ' 69' ' ' VAL . 75.1 mt-30 -87.47 150.17 23.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.27 0.557 . . . . 0.0 111.074 -175.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.89 138.18 97.32 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.334 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' PRO . . . . . 0.716 ' HB3' HD11 ' C' ' 68' ' ' ILE . 19.4 Cg_endo -61.68 136.31 61.77 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.525 2.817 . . . . 0.0 113.608 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.541 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 65' ' ' LYS . . . . . 0.553 ' HD3' ' HB3' ' C' ' 34' ' ' SER . 72.3 mmtt . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.165 0.507 . . . . 0.0 111.4 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' SER . . . . . 0.493 ' O ' HG23 ' C' ' 32' ' ' VAL . 9.6 m -115.99 149.13 39.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -130.67 121.46 25.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.984 0.421 . . . . 0.0 110.827 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' C' ' 59' ' ' PRO . 1.5 mp -108.8 137.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' C' ' 57' ' ' GLN . 61.7 t -109.85 129.59 64.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.594 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 43.7 m -124.89 110.33 14.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 0.0 110.137 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -106.64 145.16 32.29 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.6 118.85 27.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.934 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.633 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.605 HG11 ' CE1' ' C' ' 85' ' ' TYR . 24.5 m -136.41 159.66 38.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.699 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.0 mtt -76.74 131.98 39.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.98 -51.6 29.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 10.5 m -59.08 -30.17 67.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' GLU . . . . . 0.574 ' HG3' HG21 ' C' ' 83' ' ' THR . 6.6 tp10 -69.96 -51.18 34.77 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' TRP . . . . . 0.419 ' HE3' ' CE2' ' C' ' 85' ' ' TYR . 50.8 t-105 -56.5 -44.05 80.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.173 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.14 -6.37 42.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.238 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 81' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' C' ' 78' ' ' GLU . 30.5 t -83.82 -7.9 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.335 0.588 . . . . 0.0 109.957 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.22 21.16 68.09 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.058 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.574 HG21 ' HG3' ' C' ' 78' ' ' GLU . 14.9 t -69.88 157.24 37.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.278 0.561 . . . . 0.0 110.324 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' C' ' 46' ' ' ASN . 3.5 pt-20 -81.25 138.97 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.159 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 85' ' ' TYR . . . . . 0.605 ' CE1' HG11 ' C' ' 74' ' ' VAL . 75.8 m-85 -126.21 116.92 22.05 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.0 169.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 86' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 33.3 t -118.57 129.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 87' ' ' CYS . . . . . 0.591 ' HB3' HD21 ' C' ' 11' ' ' LEU . 8.7 t -116.0 124.4 50.42 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.694 ' HG ' ' CB ' ' C' ' 42' ' ' PHE . 1.7 pp -137.39 154.78 49.92 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.327 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 89' ' ' VAL . . . . . 0.721 HG13 HG21 ' C' ' 39' ' ' ILE . 6.3 t -122.13 135.11 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.273 -173.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -131.02 138.35 49.61 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 91' ' ' ASP . . . . . 0.561 ' HB2' HG12 ' C' ' 39' ' ' ILE . 17.3 t70 -146.67 151.52 37.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.676 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -64.45 -20.67 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.162 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -90.84 -8.15 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.44 ' HA ' ' HD3' ' C' ' 95' ' ' PRO . 50.4 mt -94.24 147.77 33.94 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.958 0.408 . . . . 0.0 110.574 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 4.2 Cg_exo -82.12 -30.74 1.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.384 2.722 . . . . 0.0 111.481 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 26.2 p -142.7 154.3 62.59 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.203 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' PRO . . . . . 0.475 ' HB2' HD13 ' C' ' 88' ' ' LEU . 41.4 Cg_endo -68.49 150.34 75.3 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.925 1.75 . . . . 0.0 110.971 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 98' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 47.0 t -109.06 106.14 20.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -176.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' C' ' 88' ' ' LEU . 14.8 ptpt -111.35 149.95 30.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.327 -171.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.6 129.8 12.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.116 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 101' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 42.0 t -110.74 152.76 26.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 111.734 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 102' ' ' ILE . . . . . 0.663 HD11 ' HB3' ' C' ' 13' ' ' LYS . 11.6 tt -131.08 148.27 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.457 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -137.17 158.43 44.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.633 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -64.04 110.4 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.234 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.493 179.34 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 7' ' ' ILE . . . . . 0.579 HG12 HG11 ' C' ' 98' ' ' VAL . 2.8 tp . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.554 0.693 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 37.5 m -126.62 120.51 29.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.851 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.51 119.41 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.136 0.493 . . . . 0.0 110.864 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -110.09 118.03 35.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' C' ' 87' ' ' CYS . 44.1 mt -99.79 121.78 41.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.827 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 57.4 tp -109.97 116.16 31.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' LYS . . . . . 0.478 ' NZ ' ' HB3' ' C' ' 105' ' ' ALA . 22.3 ptmt -77.9 150.3 78.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.658 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.46 -0.49 0 C-N-CA 123.083 2.522 . . . . 0.0 111.642 175.799 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.903 0.859 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 27.6 mt -93.52 153.53 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.759 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.74 133.76 67.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.309 0.576 . . . . 0.0 111.67 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 45.4 t -118.4 112.05 19.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 30' ' ' GLU . . . . . 0.702 ' HG3' HG22 ' C' ' 69' ' ' VAL . 28.2 tt0 -113.29 120.22 40.4 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' ILE . . . . . 0.422 HD12 HG22 ' C' ' 68' ' ' ILE . 0.0 OUTLIER -121.73 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.427 0.632 . . . . 0.0 111.262 -166.31 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 130.35 72.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.761 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.763 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -160.55 164.69 31.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 34' ' ' SER . . . . . 0.414 ' HB2' ' HG2' ' C' ' 65' ' ' LYS . 8.7 t -144.27 147.32 33.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 78.14 9.0 2.27 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.67 0.606 . . . . 0.0 111.297 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 19.1 mt -93.44 157.88 16.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.4 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -83.59 174.11 10.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.219 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -57.19 113.05 1.56 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 123.969 1.842 . . . . 0.0 108.373 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.673 HG23 HG13 ' C' ' 89' ' ' VAL . 5.2 mp -73.57 147.33 9.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 110.941 -2.845 . . . . 0.0 113.144 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.454 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 23.6 ttmm -118.42 136.47 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.966 170.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.88 138.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.066 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.747 ' HB3' HD23 ' C' ' 88' ' ' LEU . 5.3 t80 -119.56 150.35 40.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.427 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 43' ' ' TRP . . . . . 0.769 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 56.9 m95 -132.52 131.89 42.06 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.11 130.72 48.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.224 0.466 . . . . 0.0 111.046 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.15 111.16 34.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.65 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' ASN . . . . . 0.438 HD22 ' HA ' ' C' ' 46' ' ' ASN . 0.7 OUTLIER 58.79 37.29 24.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 110.396 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.51 -9.85 33.21 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.569 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 131.87 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 117.088 0.444 . . . . 0.0 110.348 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.99 137.91 56.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.196 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' ARG . . . . . 0.497 ' HD3' ' N ' ' C' ' 51' ' ' LYS . 1.0 OUTLIER -89.75 136.34 33.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.943 -174.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 51' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' C' ' 50' ' ' ARG . 13.5 mptt -66.93 157.15 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.745 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -45.31 165.79 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.884 0.849 . . . . 0.0 112.987 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.53 7.86 15.3 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -158.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.413 ' HA ' HD22 ' C' ' 72' ' ' LEU . 7.4 p -90.95 134.57 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.268 -1.466 . . . . 0.0 108.076 173.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.66 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 33.6 tt0 -129.03 109.12 10.94 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -98.69 121.68 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -96.83 152.55 18.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 110.097 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.75 133.06 94.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.247 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' PRO . . . . . 0.578 ' HB3' ' CD1' ' C' ' 68' ' ' ILE . 13.2 Cg_endo -59.96 141.85 97.3 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.731 2.954 . . . . 0.0 113.488 -171.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 N--CA 1.45 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.827 174.651 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 65' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' C' ' 34' ' ' SER . 53.6 mttp . . . . . 0 C--O 1.224 -0.245 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 6.0 m -118.95 150.77 39.35 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 94.1 m -131.04 120.05 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.896 0.379 . . . . 0.0 110.983 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.763 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.46 125.31 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 69' ' ' VAL . . . . . 0.702 HG22 ' HG3' ' C' ' 30' ' ' GLU . 47.0 t -106.01 122.49 59.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 36.2 m -120.11 130.35 54.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 110.803 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' C' ' 55' ' ' GLU . 59.2 mttp -105.73 147.88 28.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.657 HD12 HG12 ' C' ' 74' ' ' VAL . 0.2 OUTLIER -125.5 114.6 19.0 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -93.89 112.67 24.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.657 HG12 HD12 ' C' ' 72' ' ' LEU . 4.5 m -122.01 168.54 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.353 -170.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.541 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 81.0 mtp -73.43 132.08 42.56 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.531 0.681 . . . . 0.0 109.458 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.43 -31.34 61.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.407 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -72.43 -31.66 65.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.769 0.828 . . . . 0.0 111.16 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' GLU . . . . . 0.541 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 69.3 mt-10 -65.56 -52.24 53.83 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.526 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.75 -18.82 65.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.244 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -87.06 -5.57 59.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.301 0.572 . . . . 0.0 109.801 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.29 28.89 72.19 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.345 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 152.58 43.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.064 0.459 . . . . 0.0 110.33 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.87 135.1 41.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.757 -173.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -131.6 127.08 36.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 41.0 t -120.55 136.4 57.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 87' ' ' CYS . . . . . 0.579 ' HB3' HD21 ' C' ' 11' ' ' LEU . 12.4 t -115.65 130.48 56.88 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' C' ' 42' ' ' PHE . 0.0 OUTLIER -146.85 147.41 30.81 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.636 -167.032 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 89' ' ' VAL . . . . . 0.673 HG13 HG23 ' C' ' 39' ' ' ILE . 55.6 t -115.5 137.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 122.924 0.489 . . . . 0.0 111.193 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.497 ' HA ' HD21 ' C' ' 94' ' ' LEU . 4.9 pt-20 -129.71 133.12 46.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 91' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 17.0 t70 -148.32 149.42 31.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.981 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 17.2 m -47.0 -47.32 22.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.203 0.525 . . . . 0.0 111.532 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' GLU . . . . . 0.485 ' HB3' ' OD2' ' C' ' 91' ' ' ASP . 11.2 tp10 -83.85 -5.26 59.17 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.308 -167.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.572 ' O ' HD12 ' C' ' 94' ' ' LEU . 2.2 pp -92.97 150.55 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.133 -0.979 . . . . 0.0 111.265 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 -35.41 1.25 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.674 2.916 . . . . 0.0 112.44 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 5.5 p -147.78 151.19 38.19 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.26 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' PRO . . . . . 0.533 ' HB2' HD11 ' C' ' 88' ' ' LEU . 30.5 Cg_endo -61.78 144.69 97.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.579 2.186 . . . . 0.0 111.498 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 98' ' ' VAL . . . . . 0.579 HG11 HG12 ' C' ' 7' ' ' ILE . 41.8 t -107.07 102.5 14.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' C' ' 88' ' ' LEU . 10.6 ptpp? -108.36 151.29 26.22 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.833 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.76 127.63 9.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 29.0 t -111.4 157.5 20.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.464 0.65 . . . . 0.0 111.393 -172.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 102' ' ' ILE . . . . . 0.484 ' HB ' HD13 ' C' ' 11' ' ' LEU . 5.5 tp -122.08 149.26 25.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.969 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 103' ' ' ARG . . . . . 0.46 ' HD3' ' N ' ' C' ' 103' ' ' ARG . 0.0 OUTLIER -131.98 151.2 51.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -76.0 138.89 41.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.18 0.514 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' ALA . . . . . 0.478 ' HB3' ' NZ ' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.246 0.892 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 7' ' ' ILE . . . . . 0.834 HG12 HG21 ' C' ' 98' ' ' VAL . 2.8 tp . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 121.759 0.79 . . . . 0.0 108.892 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.407 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 49.2 m -120.84 116.04 24.41 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.114 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 31' ' ' ILE . 43.8 t -103.73 114.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.957 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 4.0 m -105.84 109.3 21.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.64 HD21 ' HB ' ' C' ' 102' ' ' ILE . 55.6 tp -103.02 117.13 33.9 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.745 -174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 65.6 tp -113.84 123.69 50.41 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.111 0.481 . . . . 0.0 110.43 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' LYS . . . . . 0.549 ' HB3' HD11 ' C' ' 102' ' ' ILE . 21.6 pttp -86.52 152.87 55.35 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.908 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo . . . . . 0 N--CA 1.461 -0.408 0 C-N-CA 122.332 2.021 . . . . 0.0 111.508 -178.884 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 26' ' ' THR . . . . . 0.718 HG22 ' HA ' ' C' ' 73' ' ' LYS . 68.0 p . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.247 0.546 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 13.6 mm -89.4 152.3 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.664 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.649 HG22 ' HG2' ' C' ' 71' ' ' LYS . 77.5 t -133.72 132.95 57.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.745 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 35.8 t -120.42 114.2 21.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.51 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -106.96 127.85 53.81 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' ILE . . . . . 0.624 HG21 HG21 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.46 133.33 69.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.683 -177.114 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 47.6 t -112.34 130.08 66.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.761 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.727 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.25 164.9 27.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.113 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 34' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 47.4 t -139.2 150.09 45.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.985 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' C' ' 34' ' ' SER . 1.6 m-20 75.78 12.25 3.02 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.515 0.509 . . . . 0.0 112.322 172.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.03 159.77 14.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.714 0.769 . . . . 0.0 111.525 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' C' ' 38' ' ' ASN . 22.0 tt0 -92.72 173.17 7.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.568 174.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.401 ' H ' ' HG2' ' C' ' 37' ' ' GLU . 3.7 p-10 -55.46 115.65 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.849 1.785 . . . . 0.0 109.176 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.623 ' CG2' HG13 ' C' ' 89' ' ' VAL . 5.0 mp -76.41 146.37 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.18 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.492 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 55.0 tptt -104.4 127.63 52.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.732 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.11 140.04 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.6 t80 -133.17 144.36 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 111.559 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 43' ' ' TRP . . . . . 0.596 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 69.1 m95 -127.09 140.7 52.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' GLN . . . . . 0.408 ' HB3' HG13 ' C' ' 86' ' ' VAL . 35.0 tt0 -128.09 131.05 49.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 111.195 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 45' ' ' VAL . . . . . 0.786 HG21 ' HE ' ' C' ' 50' ' ' ARG . 21.2 t -116.99 116.01 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.484 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.58 36.62 27.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.213 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.07 -15.64 26.41 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.754 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.56 137.28 25.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.626 -0.338 . . . . 0.0 110.608 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.46 136.51 57.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' ARG . . . . . 0.786 ' HE ' HG21 ' C' ' 45' ' ' VAL . 17.7 tpp180 -91.74 122.15 34.03 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.991 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.88 162.42 5.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.655 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -42.72 164.52 0.01 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.283 1.04 . . . . 0.0 113.613 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.37 -1.03 23.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 -155.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.405 ' HA ' HD22 ' C' ' 72' ' ' LEU . 6.7 p -88.79 131.98 34.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 113.205 -1.497 . . . . 0.0 108.281 174.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' C' ' 71' ' ' LYS . 45.7 mt-10 -126.25 109.24 12.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.0 110.626 -172.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 15.9 m -95.08 117.24 29.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.519 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.79 165.95 11.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.849 0.357 . . . . 0.0 110.438 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' C' ' 59' ' ' PRO . 12.3 t30 -69.18 134.47 89.35 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.899 0.857 . . . . 0.0 112.456 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 59' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' C' ' 67' ' ' THR . 23.5 Cg_exo -55.19 134.8 65.88 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 124.173 3.249 . . . . 0.0 112.586 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 . . . . . 0 N--CA 1.451 -0.417 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.421 175.533 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -113.68 154.03 27.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.994 -0.441 . . . . 0.0 110.962 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 85.4 m -136.45 123.46 21.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.407 . . . . 0.0 111.166 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.727 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.6 mp -108.7 132.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.3 122.1 64.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.006 0.431 . . . . 0.0 110.489 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 27.4 t -118.17 122.78 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.628 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.649 ' HG2' HG22 ' C' ' 28' ' ' VAL . 32.1 mtpt -106.17 154.51 20.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.818 0.342 . . . . 0.0 110.426 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.457 ' HG ' ' CE1' ' C' ' 85' ' ' TYR . 0.2 OUTLIER -119.97 117.73 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 73' ' ' LYS . . . . . 0.718 ' HA ' HG22 ' C' ' 26' ' ' THR . 71.1 tttt -85.07 112.26 20.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' C' ' 26' ' ' THR . 12.5 p -133.62 155.99 40.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -166.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.9 mtm -80.24 130.37 35.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.861 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.04 -53.07 17.52 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.442 0.464 . . . . 0.0 111.762 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 41.3 t -57.72 -32.87 67.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.909 0.484 . . . . 0.0 112.066 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' GLU . . . . . 0.618 ' HG3' HG21 ' C' ' 83' ' ' THR . 3.8 tp10 -66.11 -54.73 21.98 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 79' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' C' ' 104' ' ' LYS . 62.1 t-105 -59.31 -48.88 79.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.863 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' ASP . . . . . 0.484 ' HA ' ' HG3' ' C' ' 104' ' ' LYS . 5.5 t70 -70.27 -6.49 35.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.901 -174.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -81.23 -5.78 58.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 109.883 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' C' ' 104' ' ' LYS . . . 82.83 20.01 62.23 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.618 HG21 ' HG3' ' C' ' 78' ' ' GLU . 0.6 OUTLIER -63.47 145.87 54.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.231 -177.517 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 84' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 33.8 mt-10 -81.58 135.61 35.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 111.767 -176.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' TYR . . . . . 0.484 ' O ' HG22 ' C' ' 102' ' ' ILE . 1.8 m-85 -134.13 124.75 26.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.956 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 86' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 0.2 OUTLIER -133.26 142.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 111.424 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 87' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 18.9 t -112.37 124.53 52.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.412 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.901 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.5 mp -114.73 147.6 39.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 89' ' ' VAL . . . . . 0.624 HG21 HG21 ' C' ' 31' ' ' ILE . 11.4 t -126.44 131.62 71.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.234 0.613 . . . . 0.0 109.958 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 8.3 pt-20 -136.09 134.95 38.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.175 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 91' ' ' ASP . . . . . 0.523 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 7.9 t70 -147.0 151.83 37.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.142 0.496 . . . . 0.0 110.571 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 66.4 m -68.35 -8.13 37.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.636 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 58.0 mm-40 -99.99 -4.57 29.77 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 111.163 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.571 ' C ' HD12 ' C' ' 94' ' ' LEU . 2.4 pp -108.09 158.51 33.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.962 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' C' ' 96' ' ' THR . 5.3 Cg_endo -91.03 -34.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.831 3.687 . . . . 0.0 112.784 -173.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.546 ' H ' ' HD2' ' C' ' 95' ' ' PRO . 33.2 p -141.38 145.84 39.79 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.53 148.47 66.66 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.954 1.769 . . . . 0.0 111.142 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' VAL . . . . . 0.834 HG21 HG12 ' C' ' 7' ' ' ILE . 40.3 t -110.61 139.11 35.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.901 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 24.9 pttm -144.15 157.53 44.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.467 0.651 . . . . 0.0 112.593 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.06 137.02 11.46 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.862 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 101' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 75.2 p -114.65 149.94 35.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.994 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 102' ' ' ILE . . . . . 0.64 ' HB ' HD21 ' C' ' 11' ' ' LEU . 3.9 tp -122.71 153.2 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 103' ' ' ARG . . . . . 0.454 ' N ' HG13 ' C' ' 102' ' ' ILE . 12.8 ptp180 -125.14 156.67 37.98 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 104' ' ' LYS . . . . . 0.546 ' HB3' ' HA2' ' C' ' 82' ' ' GLY . 8.1 tmtm? -78.84 122.88 26.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.998 0.428 . . . . 0.0 110.968 -173.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 105' ' ' ALA . . . . . 0.473 ' HB3' ' HE2' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 172.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 tp . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.305 0.574 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 26.8 t -120.87 121.1 37.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.441 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.812 HG22 HG22 ' C' ' 31' ' ' ILE . 41.2 t -119.0 123.72 71.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.499 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -146.89 146.66 30.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.473 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.2 mm? -97.1 145.08 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.323 0.582 . . . . 0.0 111.104 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 63.0 tp -115.24 117.59 30.9 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 13' ' ' LYS . . . . . 0.431 ' HB3' HD11 ' C' ' 102' ' ' ILE . 43.3 pttt -91.12 155.31 44.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.797 0.332 . . . . 0.0 110.475 -177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 14' ' ' PRO . . . . . 0.607 ' HD3' HD13 ' C' ' 27' ' ' ILE . 74.5 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 C-N-CA 122.805 2.337 . . . . 0.0 111.161 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.667 0.27 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 27' ' ' ILE . . . . . 0.607 HD13 ' HD3' ' C' ' 14' ' ' PRO . 22.8 mm -117.37 117.89 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 79.3 t -112.64 134.78 54.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.103 -170.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' CYS . . . . . 0.402 ' HB2' ' CH2' ' C' ' 43' ' ' TRP . 52.3 t -111.62 114.45 27.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.108 171.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -96.15 125.42 40.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' ILE . . . . . 0.812 HG22 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.59 124.59 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.985 0.898 . . . . 0.0 111.48 176.361 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -114.18 128.85 70.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.699 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.553 ' CE2' HD13 ' C' ' 68' ' ' ILE . 49.0 p90 -147.41 165.11 31.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.421 0.629 . . . . 0.0 111.732 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 12.7 t -143.77 143.67 31.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.873 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 79.62 9.56 1.53 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.605 0.565 . . . . 0.0 112.298 171.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.25 160.58 14.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 0.0 112.217 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' GLU . . . . . 0.59 ' O ' HG13 ' C' ' 39' ' ' ILE . 6.2 tp10 -99.74 172.96 6.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.496 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.45 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 2.9 m120 -55.03 110.81 0.72 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 123.604 1.669 . . . . 0.0 109.109 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.59 HG13 ' O ' ' C' ' 37' ' ' GLU . 17.3 mt -77.3 142.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.165 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 40' ' ' LYS . . . . . 0.662 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 29.2 tptp -105.42 123.68 48.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.823 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.15 139.03 21.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.282 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.458 ' CE1' ' HG2' ' C' ' 49' ' ' GLU . 47.5 t80 -133.24 139.83 47.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.048 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 43' ' ' TRP . . . . . 0.402 ' CH2' ' HB2' ' C' ' 29' ' ' CYS . 71.4 m95 -125.37 137.48 54.03 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -126.94 129.66 48.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.933 0.333 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 25.0 t -120.83 116.72 50.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.323 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' ASN . . . . . 0.528 ' HA ' ' OE1' ' C' ' 84' ' ' GLU . 3.2 m120 54.53 37.17 27.42 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.123 0.487 . . . . 0.0 111.808 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.04 -16.3 38.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.277 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' VAL . . . . . 0.411 HG12 ' O ' ' C' ' 45' ' ' VAL . 15.0 p -104.64 142.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.624 0.712 . . . . 0.0 110.721 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 49' ' ' GLU . . . . . 0.458 ' HG2' ' CE1' ' C' ' 42' ' ' PHE . 41.5 mt-10 -60.4 138.17 58.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.407 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 50' ' ' ARG . . . . . 0.482 ' HB2' HG23 ' C' ' 45' ' ' VAL . 13.2 tpp180 -91.29 124.27 35.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.362 0.601 . . . . 0.0 110.077 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -59.76 162.71 5.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.738 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -41.77 163.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.05 0.929 . . . . 0.0 112.898 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.68 -0.48 23.23 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -158.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.555 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.5 p -89.74 129.68 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 113.637 -1.281 . . . . 0.0 108.133 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.602 ' HB3' ' HG3' ' C' ' 71' ' ' LYS . 31.0 tt0 -141.88 110.29 6.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.082 0.468 . . . . 0.0 110.179 -169.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -94.81 134.22 37.67 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.95 149.39 22.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -58.26 145.78 73.2 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.169 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' PRO . . . . . 0.493 ' HB3' HD11 ' C' ' 68' ' ' ILE . 19.1 Cg_endo -57.74 136.64 76.77 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.728 2.952 . . . . 0.0 113.474 -174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.808 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt . . . . . 0 C--O 1.233 0.184 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 8.8 m -102.09 146.51 27.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.037 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -133.31 119.72 20.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.106 0.479 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.553 HD13 ' CE2' ' C' ' 33' ' ' TYR . 1.7 mp -115.13 127.14 72.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.172 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -105.17 121.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 38.9 m -111.79 113.02 25.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.602 ' HG3' ' HB3' ' C' ' 55' ' ' GLU . 13.0 ptmt -106.17 139.82 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.156 0.503 . . . . 0.0 110.241 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -113.5 127.13 55.98 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.921 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -87.91 116.95 26.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.427 HG12 HD12 ' C' ' 72' ' ' LEU . 21.3 m -130.52 157.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.621 -171.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' C' ' 78' ' ' GLU . 55.2 mtt -83.1 135.49 34.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.216 0.323 . . . . 0.0 110.57 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -47.59 -54.91 10.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 77' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' C' ' 81' ' ' SER . 5.3 m -57.09 -29.38 63.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.718 0.407 . . . . 0.0 112.093 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' C' ' 75' ' ' MET . 5.5 mm-40 -65.37 -54.12 33.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -58.78 -44.8 90.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.764 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.54 -19.82 64.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.043 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' C' ' 77' ' ' SER . 6.6 t -80.89 -4.98 56.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.14 26.71 70.03 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.024 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' THR . . . . . 0.451 HG23 ' CE2' ' C' ' 85' ' ' TYR . 12.8 t -64.83 144.99 56.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.367 0.604 . . . . 0.0 110.377 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' C' ' 46' ' ' ASN . 12.7 mt-10 -74.84 133.7 41.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.323 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 85' ' ' TYR . . . . . 0.664 ' HB2' ' CG2' ' C' ' 102' ' ' ILE . 83.5 m-85 -126.24 118.08 24.4 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.62 133.3 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 32.5 t -108.72 116.24 31.62 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.858 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.8 mp -110.56 145.1 38.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.069 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 89' ' ' VAL . . . . . 0.612 HG21 HG21 ' C' ' 31' ' ' ILE . 40.8 t -125.65 131.29 72.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 123.38 0.672 . . . . 0.0 109.469 176.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 9.7 pt-20 -131.17 137.13 48.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.924 0.393 . . . . 0.0 110.28 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 91' ' ' ASP . . . . . 0.505 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 14.6 t0 -149.89 154.23 38.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.535 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.4 m -67.76 -7.72 29.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.634 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -100.5 -9.3 22.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.583 ' O ' HD12 ' C' ' 94' ' ' LEU . 2.4 pp -97.75 149.22 35.5 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.627 -175.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.27 -33.19 1.47 Allowed 'Trans proline' 0 C--N 1.334 -0.193 0 C-N-CA 123.941 3.094 . . . . 0.0 112.88 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.454 ' O ' HD13 ' C' ' 94' ' ' LEU . 4.7 p -144.85 152.81 53.02 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.437 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.46 139.94 55.77 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.007 1.804 . . . . 0.0 111.283 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 98' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 27.4 t -102.05 124.36 55.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.858 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 22.6 pttp -134.39 156.55 48.33 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.24 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.13 138.1 17.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.255 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t -117.45 151.49 36.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.115 0.483 . . . . 0.0 111.718 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' ILE . . . . . 0.664 ' CG2' ' HB2' ' C' ' 85' ' ' TYR . 3.6 tp -123.95 143.92 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.652 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -133.26 157.11 46.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.3 105.63 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.078 0.861 . . . . 0.0 109.203 -174.92 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 7' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 1.7 tp . . . . . 0 N--CA 1.441 -0.909 0 CA-C-O 121.698 0.761 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 26.9 t -131.73 134.42 45.86 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.414 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -119.29 123.37 71.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.042 0.449 . . . . 0.0 110.236 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 11.7 m -117.89 123.33 45.59 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.554 ' HB3' HD12 ' C' ' 102' ' ' ILE . 91.1 mt -99.76 126.18 45.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.473 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 12' ' ' LEU . . . . . 0.519 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 49.6 tp -104.42 114.93 29.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 13' ' ' LYS . . . . . 0.825 ' HB3' HD11 ' C' ' 102' ' ' ILE . 9.6 ptpp? -91.37 150.77 41.94 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.455 -0.771 0 C-N-CA 121.934 1.756 . . . . 0.0 110.632 175.515 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 121.819 0.818 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.21 148.59 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.586 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 45.6 t -128.47 131.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.338 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -114.99 111.68 21.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.72 121.93 43.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' ILE . . . . . 0.592 HD12 ' O ' ' C' ' 68' ' ' ILE . 0.1 OUTLIER -124.68 130.79 73.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.849 0.833 . . . . 0.0 111.227 -176.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' C' ' 7' ' ' ILE . 60.2 t -110.6 131.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.496 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.502 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -164.67 161.92 21.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.403 0.439 . . . . 0.0 110.529 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 34' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 11.6 t -142.59 155.34 44.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' C' ' 34' ' ' SER . 0.9 OUTLIER 81.6 9.96 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.814 0.697 . . . . 0.0 111.832 177.412 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 36' ' ' LEU . . . . . 0.422 ' HB2' HD11 ' C' ' 39' ' ' ILE . 22.8 mt -105.22 142.9 34.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.456 0.645 . . . . 0.0 112.105 -172.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' GLU . . . . . 0.562 ' O ' HG13 ' C' ' 39' ' ' ILE . 29.8 mm-40 -95.95 179.11 5.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.585 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.26 112.36 0.96 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 124.053 1.882 . . . . 0.0 109.654 -156.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.562 HG13 ' O ' ' C' ' 37' ' ' GLU . 11.1 mt -83.17 146.83 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 110.15 -3.205 . . . . 0.0 112.584 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -112.37 134.68 53.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.634 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.0 131.43 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.445 ' HE1' ' HG2' ' C' ' 49' ' ' GLU . 53.2 t80 -122.66 142.17 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.136 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 43' ' ' TRP . . . . . 0.549 ' CE2' HD23 ' C' ' 72' ' ' LEU . 50.3 m95 -132.02 137.55 47.89 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -124.84 131.24 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.155 -0.341 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' C' ' 50' ' ' ARG . 60.6 t -123.03 117.26 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 55.69 35.89 26.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.62 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.21 -15.85 36.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.331 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.16 145.19 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.492 0.646 . . . . 0.0 111.645 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' GLU . . . . . 0.445 ' HG2' ' HE1' ' C' ' 42' ' ' PHE . 47.8 mt-10 -61.14 127.54 32.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.646 172.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' ARG . . . . . 0.569 ' HD3' HD11 ' C' ' 72' ' ' LEU . 5.4 ptm180 -92.15 166.13 12.8 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.373 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 51' ' ' LYS . . . . . 0.484 ' HA ' ' HD2' ' C' ' 51' ' ' LYS . 31.7 tptt -75.67 163.01 27.74 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.473 ' HG3' ' H ' ' C' ' 53' ' ' GLY . 22.4 tptp -45.51 164.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.84 0.828 . . . . 0.0 111.914 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' C' ' 52' ' ' LYS . . . 115.36 -9.17 20.17 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -161.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.82 HG22 HD21 ' C' ' 72' ' ' LEU . 48.8 t -77.27 118.73 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 113.339 -1.431 . . . . 0.0 107.794 165.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -133.47 144.29 49.36 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.19 -170.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -130.25 130.09 44.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -87.57 158.14 18.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.453 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.05 150.28 51.68 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.482 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' PRO . . . . . 0.523 ' HB3' HD11 ' C' ' 68' ' ' ILE . 37.4 Cg_endo -63.12 139.74 74.48 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.147 2.565 . . . . 0.0 113.133 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.326 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -113.68 152.73 30.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.427 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 64.4 m -135.31 120.44 18.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.377 0.608 . . . . 0.0 111.009 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.592 ' O ' HD12 ' C' ' 31' ' ' ILE . 1.6 mp -110.81 130.94 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.888 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.6 122.54 60.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.394 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -111.3 122.82 48.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -106.86 143.76 34.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.82 HD21 HG22 ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.71 114.57 19.48 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.032 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -84.44 114.59 22.02 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.523 HG11 ' CE1' ' C' ' 85' ' ' TYR . 16.4 m -133.19 161.61 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.719 -173.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.8 mtt -77.75 128.71 34.48 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.539 0.685 . . . . 0.0 109.589 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.96 87.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.078 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -61.9 -30.5 70.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.527 0.331 . . . . 0.0 111.435 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.32 -51.66 42.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' TRP . . . . . 0.445 ' HZ3' HG23 ' C' ' 102' ' ' ILE . 63.4 t-105 -57.62 -44.15 85.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.766 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.1 -17.01 64.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.347 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -81.73 -4.71 57.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.905 0.383 . . . . 0.0 110.772 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.84 21.72 65.4 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 41.5 m -66.22 143.41 57.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.874 -0.663 . . . . 0.0 112.01 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -71.16 131.81 44.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.824 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' TYR . . . . . 0.523 ' CE1' HG11 ' C' ' 74' ' ' VAL . 67.3 m-85 -130.53 116.21 17.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 169.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 86' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 11.3 t -120.43 135.93 59.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.09 127.66 54.33 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.559 HD13 ' O ' ' C' ' 98' ' ' VAL . 1.9 mm? -123.13 144.84 49.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.823 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 89' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' C' ' 98' ' ' VAL . 69.7 t -122.89 132.78 70.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.115 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -127.85 133.82 49.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.523 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' ASP . . . . . 0.655 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 28.4 t70 -153.16 150.44 29.07 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.253 0.549 . . . . 0.0 110.575 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 21.9 t -66.24 -15.17 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.752 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -95.62 -7.65 37.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.243 0.474 . . . . 0.0 112.156 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.5 pp -92.62 149.39 37.96 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.108 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.36 -35.17 0.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.86 3.04 . . . . 0.0 112.453 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.433 ' O ' HD13 ' C' ' 94' ' ' LEU . 16.0 p -142.6 149.32 50.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.256 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 97' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' C' ' 88' ' ' LEU . 52.0 Cg_endo -66.24 143.34 70.43 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.308 2.005 . . . . 0.0 111.258 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 98' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' C' ' 89' ' ' VAL . 47.7 t -91.39 106.54 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.406 ' HB3' HD11 ' C' ' 88' ' ' LEU . 11.1 ptpp? -107.84 142.81 37.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.422 -174.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.65 120.14 5.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 39.4 t -105.51 156.37 18.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.047 0.451 . . . . 0.0 110.69 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 102' ' ' ILE . . . . . 0.825 HD11 ' HB3' ' C' ' 13' ' ' LYS . 14.0 tt -123.83 147.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.008 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -133.68 144.51 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.293 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -85.19 143.61 28.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.96 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.702 173.197 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 7' ' ' ILE . . . . . 0.533 HG12 HG11 ' C' ' 98' ' ' VAL . 3.7 tp . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 13.7 m -116.33 114.95 25.03 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.922 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 t -114.27 115.01 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -131.88 132.53 43.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.075 0.464 . . . . 0.0 109.88 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.66 HD13 ' HB ' ' C' ' 102' ' ' ILE . 17.5 mt -99.5 136.56 39.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.293 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 61.6 tp -110.86 115.19 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -77.24 150.43 80.33 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.975 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' PRO . . . . . 0.503 ' HD3' HG12 ' C' ' 27' ' ' ILE . 82.6 Cg_exo . . . . . 0 CA--C 1.542 0.91 0 C-N-CA 122.924 2.416 . . . . 0.0 113.39 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 26' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' C' ' 72' ' ' LEU . 10.1 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' ILE . . . . . 0.809 HG13 HG11 ' C' ' 74' ' ' VAL . 60.6 mt -120.19 152.36 23.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.08 135.55 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.911 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 51.3 t -107.82 117.71 34.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -105.12 118.39 36.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.57 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' ILE . . . . . 0.523 HG21 HG11 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -120.01 130.86 73.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.677 0.751 . . . . 0.0 111.309 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 21.7 t -117.72 132.59 67.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.254 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.957 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -151.79 170.03 20.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 34' ' ' SER . . . . . 0.504 ' HB2' ' HG2' ' C' ' 65' ' ' LYS . 32.2 t -124.09 141.48 52.01 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.396 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 t0 71.01 11.11 7.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.184 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mt -111.69 129.64 56.04 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.28 -0.888 . . . . 0.0 110.708 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.33 91.28 2.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.705 160.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' ASN . . . . . 0.636 ' O ' ' HA ' ' C' ' 91' ' ' ASP . 0.5 OUTLIER -147.29 106.38 3.87 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 136.477 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.441 HD12 ' CZ ' ' C' ' 33' ' ' TYR . 5.5 mm -115.28 112.53 40.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.977 -1.089 . . . . 0.0 113.721 -169.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -108.16 123.57 48.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.138 172.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.67 142.78 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.3 t80 -129.88 143.55 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 43' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -128.94 137.94 51.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 44' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' C' ' 86' ' ' VAL . 4.4 pt20 -131.23 131.45 43.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.229 0.538 . . . . 0.0 111.409 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 45' ' ' VAL . . . . . 0.634 HG23 ' HB2' ' C' ' 50' ' ' ARG . 13.8 t -104.08 109.14 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.858 177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.31 42.26 31.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.635 0.731 . . . . 0.0 110.693 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.62 -16.98 16.51 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.922 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' VAL . . . . . 0.563 HG12 ' O ' ' C' ' 45' ' ' VAL . 10.0 p -97.85 138.58 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 118.297 1.049 . . . . 0.0 110.521 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -57.72 139.44 53.84 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.379 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' ARG . . . . . 0.634 ' HB2' HG23 ' C' ' 45' ' ' VAL . 16.2 tpt180 -90.98 124.13 34.99 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.845 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' LYS . . . . . 0.636 ' H ' ' HD2' ' C' ' 51' ' ' LYS . 3.1 mptp? -70.45 161.31 30.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.966 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' C' ' 52' ' ' LYS . 45.5 mmtm -42.19 162.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.484 1.135 . . . . 0.0 114.011 -170.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -158.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.54 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.3 p -87.77 128.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 113.707 -1.246 . . . . 0.0 109.095 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -140.02 110.29 6.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.054 0.454 . . . . 0.0 110.17 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -89.22 130.95 35.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.615 ' HB2' HG13 ' C' ' 69' ' ' VAL . 96.6 mt-30 -105.31 172.57 6.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -175.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -76.92 153.19 82.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.827 0.346 . . . . 0.0 110.293 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' C' ' 67' ' ' THR . 60.6 Cg_endo -70.21 149.43 64.01 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.537 2.825 . . . . 0.0 113.424 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 170.207 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 65' ' ' LYS . . . . . 0.504 ' HG2' ' HB2' ' C' ' 34' ' ' SER . 84.3 mttt . . . . . 0 C--O 1.225 -0.221 0 CA-C-O 120.844 0.354 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.8 m -118.2 148.21 42.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 93.9 m -132.71 121.07 22.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.957 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.62 127.89 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.889 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 69' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' C' ' 57' ' ' GLN . 0.7 OUTLIER -111.46 122.87 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.726 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -111.28 125.43 53.82 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.706 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.22 138.52 43.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.558 HD11 ' HG2' ' C' ' 50' ' ' ARG . 0.2 OUTLIER -120.07 122.1 40.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.153 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -77.87 121.0 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.809 HG11 HG13 ' C' ' 27' ' ' ILE . 9.9 p -143.37 148.94 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.716 -170.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -89.81 140.1 29.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.874 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -43.99 -55.39 4.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -57.03 -33.86 67.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.557 0.617 . . . . 0.0 112.285 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -63.94 -53.76 45.24 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 176.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -58.09 -44.03 87.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.768 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 80' ' ' ASP . . . . . 0.547 ' HA ' ' HD2' ' C' ' 104' ' ' LYS . 24.5 t70 -70.25 -17.24 63.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.323 -176.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 66.3 m -86.38 -3.01 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.68 28.87 70.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.184 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.8 t -64.71 143.18 58.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.041 0.448 . . . . 0.0 109.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 84' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.8 mt-10 -75.49 130.1 38.34 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -128.05 120.79 28.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.325 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' C' ' 101' ' ' SER . 26.7 t -120.25 135.76 59.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 87' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 19.5 p -115.39 129.2 56.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.637 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.9 mp -120.24 148.61 43.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.287 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 89' ' ' VAL . . . . . 0.523 HG11 HG21 ' C' ' 31' ' ' ILE . 5.9 p -143.72 127.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.354 0.597 . . . . 0.0 111.448 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -110.77 153.39 25.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.053 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 11.3 t70 -142.69 148.03 36.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -62.31 -21.31 65.16 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -97.2 0.09 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.55 ' C ' HD12 ' C' ' 94' ' ' LEU . 2.6 pp -103.86 158.64 31.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' C' ' 96' ' ' THR . 1.8 Cg_endo -88.21 -35.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.874 3.049 . . . . 0.0 113.294 -168.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.423 ' O ' HD13 ' C' ' 94' ' ' LEU . 16.7 p -147.28 153.64 44.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.43 151.99 79.71 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.294 1.996 . . . . 0.0 112.112 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 19.2 m -122.19 147.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' C' ' 87' ' ' CYS . 0.4 OUTLIER -135.08 161.48 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.181 0.515 . . . . 0.0 112.367 -169.692 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.18 140.99 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 101' ' ' SER . . . . . 0.46 ' HB2' HG22 ' C' ' 86' ' ' VAL . 39.7 t -120.56 149.14 42.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.989 0.358 . . . . 0.0 110.708 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 102' ' ' ILE . . . . . 0.66 ' HB ' HD13 ' C' ' 11' ' ' LEU . 2.9 tp -125.03 142.12 42.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.181 0.515 . . . . 0.0 110.879 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -123.69 153.91 40.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 104' ' ' LYS . . . . . 0.547 ' HD2' ' HA ' ' C' ' 80' ' ' ASP . 76.0 tttt -64.39 107.04 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.454 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.407 -176.869 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 7' ' ' ILE . . . . . 0.601 HG12 HG11 ' C' ' 98' ' ' VAL . 3.3 tp . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.949 0.404 . . . . 0.0 110.656 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 47.2 t -120.47 125.06 46.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 9' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' C' ' 31' ' ' ILE . 3.0 p -128.57 125.32 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.108 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -148.28 148.61 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.053 -0.404 . . . . 0.0 110.539 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.507 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.5 mm? -96.11 146.7 24.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.905 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -115.3 115.38 26.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.712 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -78.1 154.58 80.02 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.203 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.46 -0.486 0 C-N-CA 122.721 2.281 . . . . 0.0 111.579 175.628 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 26' ' ' THR . . . . . 0.498 ' HA ' HG12 ' C' ' 74' ' ' VAL . 3.4 t . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 122.226 1.012 . . . . 0.0 112.302 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mt -102.32 155.52 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.541 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' VAL . . . . . 0.526 HG22 ' HG3' ' C' ' 71' ' ' LYS . 56.0 t -127.95 135.17 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.943 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -111.16 127.03 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 124.62 52.28 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' ILE . . . . . 0.619 HG21 HG21 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.97 131.13 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.651 179.249 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.24 129.7 66.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.748 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.634 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -165.54 160.62 17.88 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 34' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' C' ' 65' ' ' LYS . 14.7 m -144.2 153.94 42.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.792 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' C' ' 34' ' ' SER . 1.1 m-20 78.8 9.22 1.91 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.454 0.472 . . . . 0.0 112.056 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.23 163.99 13.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.624 0.726 . . . . 0.0 112.059 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -83.0 173.82 11.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.291 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -57.62 114.5 2.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.535 1.636 . . . . 0.0 107.784 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.595 ' CG2' HG13 ' C' ' 89' ' ' VAL . 4.6 mp -74.55 146.06 10.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 111.559 -2.564 . . . . 0.0 112.506 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.87 172.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.19 140.1 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -134.36 137.81 44.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.939 0.399 . . . . 0.0 110.94 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' TRP . . . . . 0.535 ' HE3' ' HD2' ' C' ' 85' ' ' TYR . 55.2 m95 -125.77 133.94 51.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -124.8 130.22 51.97 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' C' ' 50' ' ' ARG . 23.5 t -118.31 111.78 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.939 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.18 37.24 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.875 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.76 -14.3 25.91 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.1 134.16 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.22 138.52 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.102 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' ARG . . . . . 0.498 ' HB2' HG23 ' C' ' 45' ' ' VAL . 15.8 tpp180 -90.96 127.11 36.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.479 0.657 . . . . 0.0 110.879 -173.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -57.67 160.4 4.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.844 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -40.65 163.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.301 1.048 . . . . 0.0 113.307 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 53' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' C' ' 73' ' ' LYS . . . 114.51 -0.47 23.46 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -163.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.469 ' HA ' HD22 ' C' ' 72' ' ' LEU . 5.4 p -87.29 127.25 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.314 172.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 34.8 mt-10 -124.08 108.76 12.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -172.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 6.3 m -93.43 117.75 30.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' GLN . . . . . 0.635 ' HB2' HG13 ' C' ' 69' ' ' VAL . 53.4 mt-30 -100.39 171.42 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.463 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.2 144.4 89.65 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 0.0 110.651 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 59' ' ' PRO . . . . . 0.463 ' HB3' ' CD1' ' C' ' 68' ' ' ILE . 27.3 Cg_endo -63.08 151.23 85.83 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.557 2.838 . . . . 0.0 114.072 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.072 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 65' ' ' LYS . . . . . 0.502 ' HA ' ' OG ' ' C' ' 34' ' ' SER . 74.4 mmtt . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -109.11 150.53 27.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.053 0.454 . . . . 0.0 110.795 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 57.5 m -137.04 126.73 25.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.96 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -112.05 134.16 55.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.872 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 69' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -115.61 127.32 73.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.365 0.602 . . . . 0.0 110.697 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 40.9 p -115.41 129.62 56.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.534 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 48.1 tttp -107.09 144.62 33.52 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -120.03 116.54 25.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.027 0.441 . . . . 0.0 110.251 177.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 73' ' ' LYS . . . . . 0.407 ' HD3' ' HA2' ' C' ' 53' ' ' GLY . 26.5 mtpp -77.76 112.59 14.77 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.543 HG23 ' OH ' ' C' ' 85' ' ' TYR . 9.3 p -119.98 151.71 22.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.342 0.592 . . . . 0.0 110.602 -168.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.891 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 65.9 mtt -84.04 137.43 33.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.251 -176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.32 -35.98 60.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.824 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 14.5 t -70.74 -28.31 64.61 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.368 0.267 . . . . 0.0 111.627 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' GLU . . . . . 0.891 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 7.7 mm-40 -71.44 -54.75 9.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.712 0.767 . . . . 0.0 109.137 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -64.95 -38.63 91.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.238 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.86 -18.47 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.41 . . . . 0.0 111.039 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 18.6 t -90.16 -4.48 57.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.546 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.58 25.29 70.47 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.34 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -62.22 138.82 58.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.116 0.484 . . . . 0.0 111.145 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.17 149.68 24.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.265 -172.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 85' ' ' TYR . . . . . 0.543 ' OH ' HG23 ' C' ' 74' ' ' VAL . 16.4 m-85 -132.7 131.05 40.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.198 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 86' ' ' VAL . . . . . 0.558 HG11 ' HE2' ' C' ' 99' ' ' LYS . 25.3 t -119.87 130.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 87' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 34.4 t -108.6 120.48 42.56 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.675 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 5.8 mp -116.23 147.52 41.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.63 0.581 . . . . 0.0 110.166 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 89' ' ' VAL . . . . . 0.619 HG21 HG21 ' C' ' 31' ' ' ILE . 12.3 t -134.0 127.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.54 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.06 144.94 51.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.082 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' ASP . . . . . 0.521 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 27.1 t70 -148.17 156.7 42.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.339 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 37.9 t -65.37 -21.68 66.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -91.9 -11.55 35.99 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 122.192 -0.318 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 40.8 mt -84.12 146.57 48.69 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.668 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 95' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 1.7 Cg_endo -84.34 -29.26 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.512 2.808 . . . . 0.0 111.651 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 27.1 p -147.19 151.62 41.23 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.903 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.42 148.05 47.86 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.532 1.488 . . . . 0.0 110.651 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' VAL . . . . . 0.601 HG11 HG12 ' C' ' 7' ' ' ILE . 27.6 m -108.57 141.1 24.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.675 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 13.7 ptmm? -142.79 153.51 43.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.32 22.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 101' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' C' ' 85' ' ' TYR . 33.5 t -121.91 149.74 42.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.409 0.624 . . . . 0.0 111.888 -173.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 102' ' ' ILE . . . . . 0.507 ' HB ' ' HG ' ' C' ' 11' ' ' LEU . 4.8 tp -124.03 145.64 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.413 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -130.86 162.68 29.08 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -80.14 108.5 13.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.338 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.156 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.631 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 8' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 19.5 m -117.82 114.58 23.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.249 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.82 117.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.19 0.519 . . . . 0.0 110.661 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m -123.15 130.92 53.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' C' ' 102' ' ' ILE . 46.8 mt -99.0 130.07 45.32 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 tp -111.47 113.8 26.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' LYS . . . . . 0.402 ' HB3' HD11 ' C' ' 102' ' ' ILE . 25.1 pttm -83.23 147.59 53.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo . . . . . 0 C--N 1.349 0.594 0 C-N-CA 125.08 3.854 . . . . 0.0 114.533 -172.227 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 121.978 0.894 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.44 153.96 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.699 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.93 134.38 63.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.216 0.531 . . . . 0.0 111.554 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' CYS . . . . . 0.546 ' HB2' ' CH2' ' C' ' 43' ' ' TRP . 35.7 t -108.88 112.85 25.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.29 115.89 31.0 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' ILE . . . . . 0.683 HG21 HG21 ' C' ' 89' ' ' VAL . 0.2 OUTLIER -126.25 128.65 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 32' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 53.8 t -114.69 131.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.744 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 33' ' ' TYR . . . . . 0.499 ' OH ' ' HB ' ' C' ' 68' ' ' ILE . 0.1 OUTLIER -161.13 163.63 31.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.418 -178.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -142.34 150.94 41.42 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 37.6 t70 78.67 10.99 1.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.811 0.695 . . . . 0.0 111.6 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 17.4 mt -97.97 164.66 12.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.003 0.906 . . . . 0.0 112.654 -172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -94.36 170.84 9.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.83 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.14 114.92 2.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.72 1.724 . . . . 0.0 108.257 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 39' ' ' ILE . . . . . 0.62 HG21 HG13 ' C' ' 89' ' ' VAL . 4.7 mp -70.12 141.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.177 -2.738 . . . . 0.0 113.555 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -103.43 124.05 48.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -108.73 141.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -173.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.5 t80 -132.5 143.6 49.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 43' ' ' TRP . . . . . 0.604 ' HB2' ' HD3' ' C' ' 50' ' ' ARG . 58.0 m95 -130.45 137.85 50.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -125.9 130.07 50.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.792 0.269 . . . . 0.0 111.191 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 45' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 27.6 t -121.66 113.03 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 56.89 36.17 27.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.14 0.495 . . . . 0.0 110.979 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.49 15.1 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.818 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.54 133.96 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.61 138.04 58.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' ARG . . . . . 0.604 ' HD3' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -89.92 156.14 18.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.346 -172.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -69.79 156.08 39.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.077 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -53.14 166.85 0.21 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.776 0.798 . . . . 0.0 112.321 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.15 7.31 12.71 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -160.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' VAL . . . . . 0.571 HG22 HD21 ' C' ' 72' ' ' LEU . 23.8 t -84.61 129.21 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.044 -1.578 . . . . 0.0 107.874 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 55' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 41.1 mt-10 -128.71 108.9 10.85 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 7.0 p -92.11 123.12 35.22 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -89.04 144.43 26.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' ASN . . . . . 0.403 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.1 t30 -58.37 137.4 85.29 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.774 -175.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 59' ' ' PRO . . . . . 0.409 ' HB3' HD11 ' C' ' 68' ' ' ILE . 31.1 Cg_exo -48.09 134.88 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.781 2.987 . . . . 0.0 112.849 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 N--CA 1.446 -0.625 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.183 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 121.185 0.517 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -101.14 146.79 27.02 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -131.58 119.11 21.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.112 0.482 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ILE . . . . . 0.587 ' O ' HD12 ' C' ' 31' ' ' ILE . 1.6 mp -114.89 133.09 62.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.922 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.31 121.62 61.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 0.0 110.391 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 70' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' C' ' 29' ' ' CYS . 40.8 m -108.96 111.12 22.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.695 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 81.8 tttt -105.37 144.56 31.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.978 -174.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' LEU . . . . . 0.571 HD21 HG22 ' C' ' 54' ' ' VAL . 0.5 OUTLIER -122.49 119.59 31.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 174.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -91.53 111.17 22.57 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 74' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' C' ' 85' ' ' TYR . 8.3 p -134.33 163.62 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.095 0.474 . . . . 0.0 110.864 -168.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 75' ' ' MET . . . . . 0.773 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 63.2 mtt -74.16 129.1 37.17 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.442 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.38 82.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.812 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 26.0 t -59.7 -32.72 70.78 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.916 0.486 . . . . 0.0 111.477 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' GLU . . . . . 0.773 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 26.2 mm-40 -67.38 -51.67 49.18 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -57.84 -44.26 86.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.087 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 80' ' ' ASP . . . . . 0.547 ' HA ' ' HE2' ' C' ' 104' ' ' LYS . 26.7 t70 -70.88 -11.55 61.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 9.9 t -87.71 -3.68 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.5 26.28 68.15 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.487 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -65.58 149.77 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 111.057 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 27.5 mt-10 -71.24 129.08 37.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.115 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 85' ' ' TYR . . . . . 0.523 ' HD1' ' HE3' ' C' ' 43' ' ' TRP . 0.4 OUTLIER -128.9 119.41 24.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 86' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 16.7 t -120.48 136.39 57.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 87' ' ' CYS . . . . . 0.447 ' HB3' HD21 ' C' ' 11' ' ' LEU . 10.8 t -111.54 126.38 54.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 88' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -119.25 146.02 45.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.882 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 89' ' ' VAL . . . . . 0.683 HG21 HG21 ' C' ' 31' ' ' ILE . 39.2 t -123.54 131.09 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.8 136.56 54.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.976 0.417 . . . . 0.0 111.016 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 15.1 t70 -149.3 145.18 26.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -63.09 -18.46 63.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.119 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -101.53 5.07 41.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.9 pp -99.14 148.42 34.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.05 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.4 -34.74 1.89 Allowed 'Trans proline' 0 N--CA 1.469 0.057 0 C-N-CA 123.83 3.02 . . . . 0.0 112.841 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' THR . . . . . 0.505 ' O ' HD13 ' C' ' 94' ' ' LEU . 20.1 p -144.66 148.7 40.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.37 144.78 91.81 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.325 2.016 . . . . 0.0 111.254 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 44.1 t -94.72 116.66 36.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 99' ' ' LYS . . . . . 0.512 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 18.6 ptpt -127.66 149.18 50.31 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.091 -174.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.407 ' O ' HD11 ' C' ' 11' ' ' LEU . . . -155.76 135.76 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.906 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.4 t -112.8 154.61 25.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.943 0.401 . . . . 0.0 111.179 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' ILE . . . . . 0.559 ' HB ' HD13 ' C' ' 11' ' ' LEU . 5.7 tp -122.92 144.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.156 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -133.57 150.15 51.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.422 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 104' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' C' ' 80' ' ' ASP . 21.6 ttpp -90.65 136.81 32.83 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.576 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.738 0.304 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.33 -173.36 54.87 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.489 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 64.14 57.39 1.27 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.571 0.748 . . . . 0.0 111.218 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -79.64 -25.35 41.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -103.66 90.12 3.56 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.851 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.545 ' HB2' ' HE3' ' C' ' 65' ' ' LYS . 4.4 m-20 -93.38 113.17 25.27 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 162.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tp -122.18 109.83 25.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.042 172.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 5.2 m -115.45 111.56 20.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.192 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.642 HG22 HG22 ' C' ' 31' ' ' ILE . 29.1 t -106.43 114.51 45.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.117 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -125.49 123.75 39.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' C' ' 28' ' ' VAL . 44.2 mt -99.24 135.07 41.19 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.66 ' HB3' HG22 ' C' ' 28' ' ' VAL . 3.3 tm? -108.58 125.19 51.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.407 ' HB2' ' HD2' ' C' ' 14' ' ' PRO . 62.2 pttt -94.92 153.66 39.88 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.473 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' PRO . . . . . 0.629 ' HD3' HD13 ' C' ' 27' ' ' ILE . 60.0 Cg_endo -72.56 140.68 33.31 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.046 2.497 . . . . 0.0 112.853 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.68 153.21 76.62 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.792 2.328 . . . . 0.0 111.498 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -113.65 -179.65 3.7 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.308 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.79 -77.48 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.799 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -144.4 -84.19 0.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.741 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 47.3 mt -97.18 -41.9 11.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.328 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -87.96 156.0 19.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.229 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' C' ' 22' ' ' GLN . 28.2 p -104.38 112.71 25.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.881 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' C' ' 21' ' ' THR . 14.4 mm-40 -166.66 78.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.31 . . . . 0.0 111.069 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -169.73 138.75 1.88 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.716 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 4.9 t -110.65 130.69 55.5 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.359 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.456 ' O ' HG23 ' C' ' 26' ' ' THR . . . -128.43 -54.05 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.41 170.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 26' ' ' THR . . . . . 0.456 HG23 ' O ' ' C' ' 25' ' ' ALA . 0.6 OUTLIER -166.48 145.2 5.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 177.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ILE . . . . . 0.629 HD13 ' HD3' ' C' ' 14' ' ' PRO . 20.9 mm -112.75 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 163.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.66 HG22 ' HB3' ' C' ' 12' ' ' LEU . 0.6 OUTLIER -119.13 142.83 32.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.685 -169.154 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 29' ' ' CYS . . . . . 0.488 ' HA ' HD23 ' C' ' 11' ' ' LEU . 41.1 t -115.18 113.48 23.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.306 170.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.23 123.39 46.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ILE . . . . . 0.642 HG22 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.86 130.54 73.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.932 0.872 . . . . 0.0 111.648 -178.522 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.75 129.38 66.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.497 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.33 161.49 27.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.373 0.42 . . . . 0.0 110.748 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 34' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' C' ' 65' ' ' LYS . 6.0 p -144.04 150.89 38.91 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.3 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' C' ' 34' ' ' SER . 67.1 m-20 75.38 11.04 3.45 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.524 0.515 . . . . 0.0 112.22 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 16.7 mt -91.51 168.14 11.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.554 0.692 . . . . 0.0 111.821 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -96.53 171.81 8.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.151 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -56.94 115.48 2.63 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 123.801 1.763 . . . . 0.0 109.005 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.526 ' CG2' HG13 ' C' ' 89' ' ' VAL . 4.6 mp -74.11 144.46 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 111.247 -2.706 . . . . 0.0 113.069 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 22.4 tptm -106.63 124.34 49.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.802 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.9 139.27 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.559 0.218 . . . . 0.0 110.618 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -135.53 141.1 45.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 111.44 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' TRP . . . . . 0.801 ' HB2' ' HD2' ' C' ' 50' ' ' ARG . 51.9 m95 -129.7 136.78 50.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' GLN . . . . . 0.537 ' OE1' ' HA2' ' C' ' 47' ' ' GLY . 8.3 tt0 -121.47 129.31 52.88 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 21.5 t -120.92 108.06 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 58.03 37.06 26.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 111.09 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' GLY . . . . . 0.537 ' HA2' ' OE1' ' C' ' 44' ' ' GLN . . . 78.13 -6.93 47.69 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.94 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.53 130.98 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.956 0.407 . . . . 0.0 111.172 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.4 136.34 57.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.846 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' ARG . . . . . 0.801 ' HD2' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -91.74 146.9 23.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.917 0.865 . . . . 0.0 112.412 -170.308 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -66.14 161.4 21.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.162 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.603 ' HG2' ' H ' ' C' ' 53' ' ' GLY . 39.4 tttm -53.92 164.33 0.61 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.698 0.761 . . . . 0.0 110.611 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' GLY . . . . . 0.603 ' H ' ' HG2' ' C' ' 52' ' ' LYS . . . 115.8 -13.28 17.55 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -159.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.551 ' HA ' HD22 ' C' ' 72' ' ' LEU . 2.6 p -82.81 129.1 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 112.898 -1.651 . . . . 0.0 107.752 163.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -141.8 114.75 8.63 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.503 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 28.4 m -89.09 126.06 35.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.93 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.541 ' HB2' HG13 ' C' ' 69' ' ' VAL . 52.5 mt-30 -90.99 149.23 21.93 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' ASN . . . . . 0.425 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.3 t30 -56.39 138.73 74.85 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.134 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' C' ' 58' ' ' ASN . 53.6 Cg_exo -47.52 135.84 20.83 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 124.194 3.263 . . . . 0.0 113.616 -174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' C' ' 67' ' ' THR . 34.4 tt0 -102.38 141.31 35.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -122.15 113.06 18.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.218 0.532 . . . . 0.0 111.381 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 46.0 m -126.44 106.95 9.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.878 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.84 -114.45 5.06 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.444 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 19.0 m -111.35 1.29 16.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.321 0.581 . . . . 0.0 109.641 173.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' LYS . . . . . 0.545 ' HE3' ' HB2' ' C' ' 6' ' ' ASP . 35.5 mmtm -97.4 138.92 34.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.13 -175.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 10.2 m -105.6 150.54 25.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.675 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' C' ' 60' ' ' GLU . 66.8 m -134.39 121.62 21.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.275 0.56 . . . . 0.0 110.939 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.497 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.5 mp -112.09 133.47 57.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 69' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -127.75 136.36 60.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.794 0.33 . . . . 0.0 110.779 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.9 p -129.34 125.04 35.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.28 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.428 ' HD2' HG21 ' C' ' 26' ' ' THR . 52.9 mtmt -107.72 139.33 42.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.17 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.566 HD11 ' HG3' ' C' ' 50' ' ' ARG . 0.2 OUTLIER -110.29 127.52 55.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.912 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.1 116.75 29.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' C' ' 85' ' ' TYR . 34.5 m -134.77 163.39 36.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 -169.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 91.1 mmm -81.52 128.67 34.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.172 0.51 . . . . 0.0 110.107 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.91 -48.78 42.27 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.946 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 50.4 m -61.75 -29.54 70.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.457 0.571 . . . . 0.0 111.919 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -52.2 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' TRP . . . . . 0.449 ' HZ3' HG23 ' C' ' 102' ' ' ILE . 66.0 t-105 -56.85 -46.92 81.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.06 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' ASP . . . . . 0.565 ' HA ' ' HD3' ' C' ' 104' ' ' LYS . 22.5 t70 -69.5 -15.05 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.222 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -79.1 -5.4 53.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.3 18.92 65.61 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 8.3 m -65.58 138.55 58.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.436 0.636 . . . . 0.0 111.393 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 84' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.9 mt-10 -74.76 133.52 41.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.541 -172.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' TYR . . . . . 0.576 ' O ' HG22 ' C' ' 102' ' ' ILE . 82.0 m-85 -129.54 115.1 16.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 86' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' C' ' 101' ' ' SER . 0.3 OUTLIER -132.4 140.27 48.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 121.376 0.608 . . . . 0.0 111.298 -176.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 7.6 t -106.87 126.74 52.7 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.4 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -117.32 144.35 44.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 89' ' ' VAL . . . . . 0.611 ' HB ' ' CG1' ' C' ' 98' ' ' VAL . 54.6 t -116.76 135.33 57.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' C' ' 40' ' ' LYS . 36.3 tt0 -125.28 130.33 51.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' ASP . . . . . 0.501 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 15.7 t70 -150.67 144.65 25.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.186 0.517 . . . . 0.0 110.046 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.5 t -66.17 -19.27 65.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.859 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' GLU . . . . . 0.431 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 6.6 mm-40 -92.09 -6.67 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 38.7 mt -89.76 145.96 34.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.44 -35.16 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.325 2.683 . . . . 0.0 111.68 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -146.21 154.04 49.45 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.102 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.56 148.81 73.39 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.739 1.626 . . . . 0.0 111.359 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' VAL . . . . . 0.611 ' CG1' ' HB ' ' C' ' 89' ' ' VAL . 10.7 p -110.56 140.01 31.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.566 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 8.6 ptpp? -137.85 151.73 48.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 0.0 111.775 -171.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.85 127.58 4.72 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.434 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' SER . . . . . 0.559 ' HB3' ' HB ' ' C' ' 86' ' ' VAL . 72.2 p -107.48 160.63 15.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.133 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' ILE . . . . . 0.576 HG22 ' O ' ' C' ' 85' ' ' TYR . 3.6 tp -121.77 139.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.077 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -114.84 145.46 42.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.054 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 104' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' C' ' 80' ' ' ASP . 33.9 ttpt -73.61 110.35 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.189 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.143 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.03 167.49 22.87 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.944 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' C' ' 3' ' ' ARG . 39.9 ttm180 -107.72 124.91 50.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 69.61 -67.21 0.23 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.849 0.718 . . . . 0.0 109.879 -173.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' THR . . . . . 0.476 HG23 ' O ' ' C' ' 5' ' ' THR . 7.7 t -91.3 90.72 7.86 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.796 1.284 . . . . 0.0 109.943 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.05 115.28 29.38 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' ILE . . . . . 0.712 HG12 HG11 ' C' ' 98' ' ' VAL . 3.3 tp -126.37 122.1 60.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.8 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 16.3 m -114.73 106.75 14.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.556 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.05 113.66 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.023 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -112.24 110.2 20.31 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.675 HD21 ' HB ' ' C' ' 102' ' ' ILE . 57.8 tp -99.53 117.5 34.06 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.45 118.45 35.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.162 0.506 . . . . 0.0 110.706 -167.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.548 ' HB3' HD11 ' C' ' 102' ' ' ILE . 14.4 ptpt -79.53 147.5 67.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.146 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 14' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' C' ' 15' ' ' PRO . 18.2 Cg_endo -62.0 123.87 13.38 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.477 2.118 . . . . 0.0 111.568 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' C' ' 14' ' ' PRO . 11.5 Cg_exo -71.03 69.02 2.38 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.336 2.691 . . . . 0.0 113.0 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 72.66 153.39 0.13 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.391 0.677 . . . . 0.0 111.845 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.45 -14.31 20.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.146 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 62.44 -165.97 0.23 Allowed 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.703 0.627 . . . . 0.0 111.402 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 48.5 mm -79.38 -43.55 23.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -109.99 114.17 27.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.94 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 4.2 t -75.94 133.81 40.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -67.26 -27.46 67.22 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.702 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -166.35 -63.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 8.7 t -164.7 -178.58 5.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.353 0.597 . . . . 0.0 110.984 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.22 28.2 0.19 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.056 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' THR . . . . . 0.787 ' HA ' HG12 ' C' ' 74' ' ' VAL . 5.8 t -57.46 130.33 45.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.802 0.811 . . . . 0.0 112.283 -166.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 27' ' ' ILE . . . . . 0.526 HG13 HG11 ' C' ' 74' ' ' VAL . 40.1 mt -97.33 154.74 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.704 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.618 HG22 ' HG2' ' C' ' 71' ' ' LYS . 84.1 t -130.61 133.93 62.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.745 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 29' ' ' CYS . . . . . 0.433 ' HB2' ' CZ2' ' C' ' 43' ' ' TRP . 19.3 t -115.78 112.36 21.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -104.97 123.33 47.59 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' ILE . . . . . 0.56 HG12 HG21 ' C' ' 89' ' ' VAL . 0.1 OUTLIER -121.78 136.06 59.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.445 0.64 . . . . 0.0 111.007 -176.069 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 17.9 t -114.94 132.24 64.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.084 -176.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.631 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.88 167.61 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.236 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 34' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 41.8 t -141.01 150.32 42.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' C' ' 34' ' ' SER . 7.2 m-20 76.81 11.59 2.5 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.479 0.487 . . . . 0.0 112.085 170.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -96.35 164.33 12.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.902 0.858 . . . . 0.0 112.351 -175.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' C' ' 38' ' ' ASN . 11.3 tp10 -91.81 174.1 7.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.394 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 1.6 m120 -56.36 114.09 1.85 Allowed 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.131 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.629 HG21 HG13 ' C' ' 89' ' ' VAL . 5.0 mp -73.83 144.57 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 112.448 -2.16 . . . . 0.0 113.266 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.86 122.94 46.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.79 144.12 14.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.0 110.908 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.45 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.5 t80 -135.06 143.85 46.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 43' ' ' TRP . . . . . 0.458 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 51.7 m95 -127.6 139.5 52.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' GLN . . . . . 0.501 ' HG2' ' HB ' ' C' ' 86' ' ' VAL . 30.0 pt20 -132.77 131.02 40.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.628 0.728 . . . . 0.0 111.11 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 0.2 OUTLIER -120.25 122.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.54 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 53.77 34.83 19.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.02 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.65 -16.36 25.96 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.443 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -87.72 134.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.22 139.36 58.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.195 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -89.31 117.23 28.11 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -53.29 158.45 1.63 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.912 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.68 164.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.723 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.18 3.97 20.89 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -155.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.407 ' HA ' HD22 ' C' ' 72' ' ' LEU . 7.6 p -88.23 132.44 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.116 -1.542 . . . . 0.0 108.351 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 86.8 tt0 -125.49 108.86 12.04 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.83 0.348 . . . . 0.0 110.459 -172.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 16.0 p -98.45 122.64 41.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.812 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.692 ' HB2' HG13 ' C' ' 69' ' ' VAL . 48.4 mt-30 -103.06 176.27 5.2 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.236 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.31 150.78 85.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 0.0 110.744 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' PRO . . . . . 0.539 ' HB3' HD11 ' C' ' 68' ' ' ILE . 43.9 Cg_endo -65.48 148.09 87.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.553 2.835 . . . . 0.0 112.989 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 60' ' ' GLU . . . . . 0.582 ' HG3' ' HB ' ' C' ' 67' ' ' THR . 14.4 pt-20 -117.57 149.53 40.5 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -110.58 127.58 55.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.261 0.553 . . . . 0.0 112.301 -170.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 55.4 p -128.17 101.64 6.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.148 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.03 -130.16 47.2 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.489 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -84.45 -6.44 59.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.846 0.355 . . . . 0.0 110.706 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 65' ' ' LYS . . . . . 0.464 ' HE2' HG12 ' C' ' 32' ' ' VAL . 46.6 mtpt -97.12 153.17 18.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.559 0.695 . . . . 0.0 111.12 -175.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -115.59 149.06 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.577 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.582 ' HB ' ' HG3' ' C' ' 60' ' ' GLU . 46.2 m -132.37 122.16 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.397 0.618 . . . . 0.0 110.813 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.631 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -110.06 132.48 58.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.379 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.9 p -108.5 122.47 63.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.552 0.692 . . . . 0.0 110.878 176.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.1 m -120.74 122.19 39.86 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.618 ' HG2' HG22 ' C' ' 28' ' ' VAL . 6.8 mtpm? -106.0 152.54 23.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.952 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' C' ' 72' ' ' LEU . 0.2 OUTLIER -119.84 114.93 22.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.254 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -78.36 112.1 15.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' C' ' 26' ' ' THR . 12.9 p -128.63 153.09 37.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.951 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.643 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 97.0 mmm -72.03 129.47 38.61 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.689 0.757 . . . . 0.0 110.614 -175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.17 -34.11 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.793 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -70.56 -35.27 72.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.283 0.633 . . . . 0.0 111.397 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' GLU . . . . . 0.643 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 59.7 mt-10 -68.58 -52.49 31.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -58.2 -42.47 86.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.801 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.37 -26.03 68.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.325 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 51.0 m -87.05 -2.39 58.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.843 0.354 . . . . 0.0 111.299 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.59 28.79 72.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.521 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.641 HG21 ' HB3' ' C' ' 78' ' ' GLU . 14.6 t -64.88 150.82 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 32.5 mt-10 -80.64 141.86 34.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.069 0.461 . . . . 0.0 111.32 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -137.75 127.86 25.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.754 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' C' ' 99' ' ' LYS . 20.9 t -120.48 138.76 49.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 87' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 29.2 t -111.46 118.5 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.731 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.3 mp -113.28 147.06 38.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.677 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 89' ' ' VAL . . . . . 0.629 HG13 HG21 ' C' ' 39' ' ' ILE . 25.1 t -135.29 125.69 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 122.91 0.484 . . . . 0.0 109.806 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' C' ' 97' ' ' PRO . 12.9 pt-20 -133.64 145.48 50.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' ASP . . . . . 0.554 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 14.5 t70 -136.75 158.48 44.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 34.0 t -52.79 -41.7 64.37 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.386 0.429 . . . . 0.0 110.825 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -86.98 -1.73 58.09 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.554 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 42.8 mt -92.02 128.74 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 109.988 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -35.09 37.03 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 123.051 2.501 . . . . 0.0 112.206 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -147.52 153.67 43.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.944 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 37.6 Cg_endo -68.83 153.39 72.97 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.27 1.98 . . . . 0.0 111.503 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 98' ' ' VAL . . . . . 0.712 HG11 HG12 ' C' ' 7' ' ' ILE . 13.7 p -116.79 146.53 21.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.731 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 14.1 ptmm? -141.03 156.5 46.01 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.304 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.81 140.52 19.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 32.2 t -118.03 153.75 33.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.134 0.492 . . . . 0.0 111.063 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' ILE . . . . . 0.675 ' HB ' HD21 ' C' ' 11' ' ' LEU . 8.0 tp -124.21 149.48 28.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.774 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -142.07 152.96 43.81 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -78.38 108.39 11.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.184 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.854 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.707 -177.827 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.81 56.08 4.26 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.327 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? 53.77 65.67 1.45 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -90.48 130.77 36.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.591 -172.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -72.72 96.6 2.05 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 122.244 1.021 . . . . 0.0 112.391 -175.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -96.97 112.65 24.31 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 161.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' ILE . . . . . 0.421 HG12 HG11 ' C' ' 98' ' ' VAL . 2.1 tp -125.21 110.75 25.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.673 169.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.875 ' HB2' HG13 ' C' ' 32' ' ' VAL . 51.0 m -110.31 104.49 13.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.374 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.54 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.27 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 16.0 m -121.01 127.31 51.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' C' ' 87' ' ' CYS . 72.2 mt -99.8 127.23 45.97 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.255 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.06 114.69 28.41 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.663 ' HB3' HD11 ' C' ' 102' ' ' ILE . 18.9 ptpt -76.26 154.79 84.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.303 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' PRO . . . . . 0.548 ' HD3' HD13 ' C' ' 27' ' ' ILE . 19.0 Cg_endo -59.97 122.83 12.02 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.4 2.067 . . . . 0.0 111.685 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' C' ' 14' ' ' PRO . 17.2 Cg_endo -57.76 140.48 93.76 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.892 2.395 . . . . 0.0 111.997 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -109.87 88.74 2.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.6 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' GLU . . . . . 0.615 ' HG3' ' HB2' ' C' ' 20' ' ' TRP . 0.4 OUTLIER -104.87 157.84 16.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -119.86 -19.86 7.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.345 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 76.1 mt -80.72 -36.14 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.148 0.499 . . . . 0.0 110.223 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.615 ' HB2' ' HG3' ' C' ' 17' ' ' GLU . 84.4 m95 -111.98 172.35 6.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.265 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 41.6 m -146.98 115.07 6.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.079 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -85.38 -167.64 1.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.76 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -61.77 -63.21 1.34 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.671 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -165.61 -176.4 3.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.853 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' C' ' 76' ' ' ALA . . . -71.47 26.62 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.032 0.933 . . . . 0.0 112.751 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 26' ' ' THR . . . . . 0.443 ' HA ' HG22 ' C' ' 74' ' ' VAL . 5.9 t -59.3 129.4 41.87 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.543 0.687 . . . . 0.0 111.518 -171.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 27' ' ' ILE . . . . . 0.548 HD13 ' HD3' ' C' ' 14' ' ' PRO . 15.8 mm -88.87 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.192 -174.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.41 132.96 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.321 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.05 114.54 21.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.624 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.52 128.54 54.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' C' ' 8' ' ' SER . 0.0 OUTLIER -126.53 133.51 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.483 0.659 . . . . 0.0 111.373 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.875 HG13 ' HB2' ' C' ' 8' ' ' SER . 2.1 p -129.05 134.73 63.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.516 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.557 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -163.5 168.18 20.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.723 -171.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 34' ' ' SER . . . . . 0.553 ' HB3' ' HD3' ' C' ' 65' ' ' LYS . 18.9 p -141.99 149.88 40.63 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.42 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' C' ' 34' ' ' SER . 4.9 m-20 77.59 11.02 2.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.756 0.66 . . . . 0.0 112.166 171.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -96.18 177.51 5.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.996 0.903 . . . . 0.0 112.793 -170.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 37' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 39' ' ' ILE . 20.4 mm-40 -105.8 173.47 6.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.595 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.76 112.73 1.94 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 123.927 1.822 . . . . 0.0 108.773 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.721 HG21 HG13 ' C' ' 89' ' ' VAL . 51.0 mt -87.56 147.3 5.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 110.864 -2.88 . . . . 0.0 114.126 -171.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -100.33 126.49 46.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.156 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.58 137.97 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.694 ' CB ' ' HG ' ' C' ' 88' ' ' LEU . 0.1 OUTLIER -119.31 147.84 43.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.929 -0.123 . . . . 0.0 110.897 -176.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 43' ' ' TRP . . . . . 0.808 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 65.7 m95 -137.18 132.66 34.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 20.8 mm-40 -123.27 131.3 53.62 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' VAL . . . . . 0.593 HG21 ' HD2' ' C' ' 50' ' ' ARG . 21.6 t -124.96 118.26 52.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.151 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' ASN . . . . . 0.436 ' H ' ' HG3' ' C' ' 84' ' ' GLU . 29.7 m120 57.99 33.83 23.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 -175.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.7 -1.2 31.28 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.003 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 p -116.62 138.64 46.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.255 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.11 122.21 13.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.263 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' ARG . . . . . 0.593 ' HD2' HG21 ' C' ' 45' ' ' VAL . 7.9 ptm85 -92.86 167.54 11.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.4 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.65 159.47 21.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.991 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' C' ' 52' ' ' LYS . 0.0 OUTLIER -49.63 166.56 0.05 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.107 176.131 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.9 7.7 12.7 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -162.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.56 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.4 p -88.25 126.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' C' ' 70' ' ' SER . 39.9 mt-10 -121.0 109.62 15.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 5.6 p -101.13 116.88 33.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.954 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' C' ' 69' ' ' VAL . 75.1 mt-30 -87.47 150.17 23.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.27 0.557 . . . . 0.0 111.074 -175.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.89 138.18 97.32 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.334 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' PRO . . . . . 0.716 ' HB3' HD11 ' C' ' 68' ' ' ILE . 19.4 Cg_endo -61.68 136.31 61.77 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.525 2.817 . . . . 0.0 113.608 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -121.27 129.84 53.36 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -86.21 139.99 30.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.056 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 45.8 t -140.04 103.81 4.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.052 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.1 -105.67 1.69 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.506 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 9.5 t -112.66 2.74 16.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 109.945 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' LYS . . . . . 0.553 ' HD3' ' HB3' ' C' ' 34' ' ' SER . 72.3 mmtt -119.4 162.4 18.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.165 0.507 . . . . 0.0 111.4 -173.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 66' ' ' SER . . . . . 0.493 ' O ' HG23 ' C' ' 32' ' ' VAL . 9.6 m -115.99 149.13 39.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -130.67 121.46 25.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.984 0.421 . . . . 0.0 110.827 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' C' ' 59' ' ' PRO . 1.5 mp -108.8 137.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' C' ' 57' ' ' GLN . 61.7 t -109.85 129.59 64.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.594 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 43.7 m -124.89 110.33 14.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 0.0 110.137 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -106.64 145.16 32.29 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.6 118.85 27.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.934 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.633 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.605 HG11 ' CE1' ' C' ' 85' ' ' TYR . 24.5 m -136.41 159.66 38.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.699 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.0 mtt -76.74 131.98 39.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' ALA . . . . . 0.536 ' HA ' ' CB ' ' C' ' 25' ' ' ALA . . . -48.98 -51.6 29.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 10.5 m -59.08 -30.17 67.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' GLU . . . . . 0.574 ' HG3' HG21 ' C' ' 83' ' ' THR . 6.6 tp10 -69.96 -51.18 34.77 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' TRP . . . . . 0.419 ' HE3' ' CE2' ' C' ' 85' ' ' TYR . 50.8 t-105 -56.5 -44.05 80.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.173 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.14 -6.37 42.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.238 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 81' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' C' ' 78' ' ' GLU . 30.5 t -83.82 -7.9 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.335 0.588 . . . . 0.0 109.957 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.22 21.16 68.09 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.058 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.574 HG21 ' HG3' ' C' ' 78' ' ' GLU . 14.9 t -69.88 157.24 37.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.278 0.561 . . . . 0.0 110.324 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' C' ' 46' ' ' ASN . 3.5 pt-20 -81.25 138.97 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.159 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 85' ' ' TYR . . . . . 0.605 ' CE1' HG11 ' C' ' 74' ' ' VAL . 75.8 m-85 -126.21 116.92 22.05 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.0 169.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 86' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 33.3 t -118.57 129.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 87' ' ' CYS . . . . . 0.591 ' HB3' HD21 ' C' ' 11' ' ' LEU . 8.7 t -116.0 124.4 50.42 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.694 ' HG ' ' CB ' ' C' ' 42' ' ' PHE . 1.7 pp -137.39 154.78 49.92 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.327 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 89' ' ' VAL . . . . . 0.721 HG13 HG21 ' C' ' 39' ' ' ILE . 6.3 t -122.13 135.11 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.273 -173.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -131.02 138.35 49.61 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' ASP . . . . . 0.561 ' HB2' HG12 ' C' ' 39' ' ' ILE . 17.3 t70 -146.67 151.52 37.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.676 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -64.45 -20.67 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.162 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -90.84 -8.15 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.44 ' HA ' ' HD3' ' C' ' 95' ' ' PRO . 50.4 mt -94.24 147.77 33.94 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.958 0.408 . . . . 0.0 110.574 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 4.2 Cg_exo -82.12 -30.74 1.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.384 2.722 . . . . 0.0 111.481 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 26.2 p -142.7 154.3 62.59 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.203 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' PRO . . . . . 0.475 ' HB2' HD13 ' C' ' 88' ' ' LEU . 41.4 Cg_endo -68.49 150.34 75.3 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.925 1.75 . . . . 0.0 110.971 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 98' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 47.0 t -109.06 106.14 20.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -176.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' C' ' 88' ' ' LEU . 14.8 ptpt -111.35 149.95 30.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.327 -171.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.6 129.8 12.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.116 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 42.0 t -110.74 152.76 26.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 111.734 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 102' ' ' ILE . . . . . 0.663 HD11 ' HB3' ' C' ' 13' ' ' LYS . 11.6 tt -131.08 148.27 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.457 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -137.17 158.43 44.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.633 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -64.04 110.4 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.234 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.493 179.34 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.975 0.417 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.63 22.64 12.11 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -170.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' C' ' 3' ' ' ARG . 10.1 tpt180 -83.82 -52.56 6.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.912 -0.644 . . . . 0.0 110.893 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -179.41 -71.65 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' THR . . . . . 0.453 HG23 ' O ' ' C' ' 5' ' ' THR . 9.0 t -96.09 91.16 5.81 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 123.052 1.406 . . . . 0.0 109.883 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -101.51 111.79 24.13 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.608 -1.633 . . . . 0.0 106.785 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' ILE . . . . . 0.579 HG12 HG11 ' C' ' 98' ' ' VAL . 2.8 tp -121.48 119.34 58.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.264 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 37.5 m -126.62 120.51 29.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.851 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.51 119.41 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.136 0.493 . . . . 0.0 110.864 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -110.09 118.03 35.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' C' ' 87' ' ' CYS . 44.1 mt -99.79 121.78 41.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.827 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 57.4 tp -109.97 116.16 31.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.478 ' NZ ' ' HB3' ' C' ' 105' ' ' ALA . 22.3 ptmt -77.9 150.3 78.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.658 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.77 136.8 17.28 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.083 2.522 . . . . 0.0 111.642 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.678 ' HB2' ' HG3' ' C' ' 17' ' ' GLU . 86.7 Cg_endo -80.52 165.3 20.7 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.75 2.3 . . . . 0.0 112.169 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -108.83 37.85 2.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' GLU . . . . . 0.678 ' HG3' ' HB2' ' C' ' 15' ' ' PRO . 40.3 mt-10 -78.85 104.02 9.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.826 -175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.42 3.26 21.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.776 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' ILE . . . . . 0.575 HG22 ' HB3' ' C' ' 17' ' ' GLU . 7.0 tp -66.26 -29.82 47.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.268 0.556 . . . . 0.0 109.726 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.447 ' CD1' ' HB2' ' C' ' 17' ' ' GLU . 45.5 m95 -83.6 113.22 20.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 12.5 p -76.38 113.3 13.81 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.57 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 66.68 94.03 0.07 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.998 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -138.42 175.96 9.11 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 11.8 p -121.84 159.55 26.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.196 0.522 . . . . 0.0 111.64 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.582 ' HB2' ' HA ' ' C' ' 76' ' ' ALA . . . -78.1 26.71 0.2 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.258 -176.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t -60.59 124.76 21.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.903 0.859 . . . . 0.0 111.62 -171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 27.6 mt -93.52 153.53 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.759 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.74 133.76 67.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.309 0.576 . . . . 0.0 111.67 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 45.4 t -118.4 112.05 19.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 30' ' ' GLU . . . . . 0.702 ' HG3' HG22 ' C' ' 69' ' ' VAL . 28.2 tt0 -113.29 120.22 40.4 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' ILE . . . . . 0.422 HD12 HG22 ' C' ' 68' ' ' ILE . 0.0 OUTLIER -121.73 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.427 0.632 . . . . 0.0 111.262 -166.31 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 130.35 72.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.761 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.763 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -160.55 164.69 31.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 34' ' ' SER . . . . . 0.414 ' HB2' ' HG2' ' C' ' 65' ' ' LYS . 8.7 t -144.27 147.32 33.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 78.14 9.0 2.27 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.67 0.606 . . . . 0.0 111.297 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 19.1 mt -93.44 157.88 16.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.4 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -83.59 174.11 10.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.219 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -57.19 113.05 1.56 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 123.969 1.842 . . . . 0.0 108.373 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.673 HG23 HG13 ' C' ' 89' ' ' VAL . 5.2 mp -73.57 147.33 9.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 110.941 -2.845 . . . . 0.0 113.144 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.454 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 23.6 ttmm -118.42 136.47 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.966 170.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.88 138.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.066 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.747 ' HB3' HD23 ' C' ' 88' ' ' LEU . 5.3 t80 -119.56 150.35 40.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.427 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 43' ' ' TRP . . . . . 0.769 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 56.9 m95 -132.52 131.89 42.06 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.11 130.72 48.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.224 0.466 . . . . 0.0 111.046 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.15 111.16 34.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.65 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' ASN . . . . . 0.438 HD22 ' HA ' ' C' ' 46' ' ' ASN . 0.7 OUTLIER 58.79 37.29 24.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 110.396 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.51 -9.85 33.21 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.569 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 131.87 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 117.088 0.444 . . . . 0.0 110.348 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.99 137.91 56.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.196 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' ARG . . . . . 0.497 ' HD3' ' N ' ' C' ' 51' ' ' LYS . 1.0 OUTLIER -89.75 136.34 33.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.943 -174.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 51' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' C' ' 50' ' ' ARG . 13.5 mptt -66.93 157.15 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.745 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -45.31 165.79 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.884 0.849 . . . . 0.0 112.987 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.53 7.86 15.3 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -158.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.413 ' HA ' HD22 ' C' ' 72' ' ' LEU . 7.4 p -90.95 134.57 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.268 -1.466 . . . . 0.0 108.076 173.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.66 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 33.6 tt0 -129.03 109.12 10.94 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -98.69 121.68 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -96.83 152.55 18.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 110.097 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.75 133.06 94.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.247 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 59' ' ' PRO . . . . . 0.578 ' HB3' ' CD1' ' C' ' 68' ' ' ILE . 13.2 Cg_endo -59.96 141.85 97.3 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.731 2.954 . . . . 0.0 113.488 -171.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -152.92 105.68 2.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.827 174.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' TRP . . . . . 0.641 ' HB3' ' O ' ' C' ' 65' ' ' LYS . 31.3 t-105 -141.98 163.72 32.12 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 166.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 39.1 m -53.86 142.84 22.91 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 168.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -49.86 -13.77 0.63 Allowed Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.567 1.387 . . . . 0.0 116.567 -168.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -76.29 -23.89 54.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.025 0.912 . . . . 0.0 111.744 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' LYS . . . . . 0.641 ' O ' ' HB3' ' C' ' 61' ' ' TRP . 53.6 mttp -145.93 165.84 27.78 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 6.0 m -118.95 150.77 39.35 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 94.1 m -131.04 120.05 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.896 0.379 . . . . 0.0 110.983 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.763 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.46 125.31 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 69' ' ' VAL . . . . . 0.702 HG22 ' HG3' ' C' ' 30' ' ' GLU . 47.0 t -106.01 122.49 59.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 36.2 m -120.11 130.35 54.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 110.803 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' C' ' 55' ' ' GLU . 59.2 mttp -105.73 147.88 28.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.657 HD12 HG12 ' C' ' 74' ' ' VAL . 0.2 OUTLIER -125.5 114.6 19.0 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -93.89 112.67 24.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.657 HG12 HD12 ' C' ' 72' ' ' LEU . 4.5 m -122.01 168.54 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.353 -170.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.541 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 81.0 mtp -73.43 132.08 42.56 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.531 0.681 . . . . 0.0 109.458 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' ALA . . . . . 0.582 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . . . -55.43 -31.34 61.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.407 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -72.43 -31.66 65.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.769 0.828 . . . . 0.0 111.16 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' GLU . . . . . 0.541 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 69.3 mt-10 -65.56 -52.24 53.83 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.526 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.75 -18.82 65.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.244 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -87.06 -5.57 59.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.301 0.572 . . . . 0.0 109.801 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.29 28.89 72.19 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.345 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 152.58 43.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.064 0.459 . . . . 0.0 110.33 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.87 135.1 41.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.757 -173.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -131.6 127.08 36.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 41.0 t -120.55 136.4 57.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 87' ' ' CYS . . . . . 0.579 ' HB3' HD21 ' C' ' 11' ' ' LEU . 12.4 t -115.65 130.48 56.88 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' C' ' 42' ' ' PHE . 0.0 OUTLIER -146.85 147.41 30.81 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.636 -167.032 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 89' ' ' VAL . . . . . 0.673 HG13 HG23 ' C' ' 39' ' ' ILE . 55.6 t -115.5 137.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 122.924 0.489 . . . . 0.0 111.193 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.497 ' HA ' HD21 ' C' ' 94' ' ' LEU . 4.9 pt-20 -129.71 133.12 46.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 91' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 17.0 t70 -148.32 149.42 31.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.981 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 17.2 m -47.0 -47.32 22.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.203 0.525 . . . . 0.0 111.532 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' GLU . . . . . 0.485 ' HB3' ' OD2' ' C' ' 91' ' ' ASP . 11.2 tp10 -83.85 -5.26 59.17 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.308 -167.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.572 ' O ' HD12 ' C' ' 94' ' ' LEU . 2.2 pp -92.97 150.55 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.133 -0.979 . . . . 0.0 111.265 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 -35.41 1.25 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.674 2.916 . . . . 0.0 112.44 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 5.5 p -147.78 151.19 38.19 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.26 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' PRO . . . . . 0.533 ' HB2' HD11 ' C' ' 88' ' ' LEU . 30.5 Cg_endo -61.78 144.69 97.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.579 2.186 . . . . 0.0 111.498 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 98' ' ' VAL . . . . . 0.579 HG11 HG12 ' C' ' 7' ' ' ILE . 41.8 t -107.07 102.5 14.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' C' ' 88' ' ' LEU . 10.6 ptpp? -108.36 151.29 26.22 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.833 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.76 127.63 9.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 29.0 t -111.4 157.5 20.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.464 0.65 . . . . 0.0 111.393 -172.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 102' ' ' ILE . . . . . 0.484 ' HB ' HD13 ' C' ' 11' ' ' LEU . 5.5 tp -122.08 149.26 25.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.969 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 103' ' ' ARG . . . . . 0.46 ' HD3' ' N ' ' C' ' 103' ' ' ARG . 0.0 OUTLIER -131.98 151.2 51.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -76.0 138.89 41.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.18 0.514 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ALA . . . . . 0.478 ' HB3' ' NZ ' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.246 0.892 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.888 0.375 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.54 168.1 31.68 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.887 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' ARG . . . . . 0.511 ' HD2' ' H ' ' C' ' 3' ' ' ARG . 0.0 OUTLIER -124.74 36.76 4.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.592 0.71 . . . . 0.0 109.855 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.416 ' HB2' ' OD1' ' C' ' 35' ' ' ASP . 5.4 pm0 -64.27 -28.46 69.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.476 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 8.4 m -84.91 89.55 7.6 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.598 1.19 . . . . 0.0 111.232 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' C' ' 33' ' ' TYR . 8.4 m-20 -117.83 115.98 26.06 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.158 -1.837 . . . . 0.0 106.286 161.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' ILE . . . . . 0.834 HG12 HG21 ' C' ' 98' ' ' VAL . 2.8 tp -114.0 108.08 24.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-O 121.759 0.79 . . . . 0.0 108.892 169.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.407 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 49.2 m -120.84 116.04 24.41 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.114 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 31' ' ' ILE . 43.8 t -103.73 114.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.957 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 4.0 m -105.84 109.3 21.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.64 HD21 ' HB ' ' C' ' 102' ' ' ILE . 55.6 tp -103.02 117.13 33.9 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.745 -174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 65.6 tp -113.84 123.69 50.41 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.111 0.481 . . . . 0.0 110.43 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.549 ' HB3' HD11 ' C' ' 102' ' ' ILE . 21.6 pttp -86.52 152.87 55.35 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.908 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 14' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' C' ' 15' ' ' PRO . 25.4 Cg_endo -64.78 122.22 9.99 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.332 2.021 . . . . 0.0 111.508 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 14' ' ' PRO . 43.1 Cg_exo -56.51 121.79 10.65 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.008 2.472 . . . . 0.0 112.169 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -79.26 82.59 5.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.784 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.42 113.6 24.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.558 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 62.85 -165.35 0.24 Allowed 'General case' 0 C--O 1.233 0.204 0 O-C-N 123.933 0.77 . . . . 0.0 110.921 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 57.6 mt -83.35 -41.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.287 0.565 . . . . 0.0 110.301 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -91.11 126.32 36.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.404 -173.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 12.4 p -77.63 114.2 16.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.892 172.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -77.49 -24.7 50.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.146 0.498 . . . . 0.0 110.241 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' GLN . . . . . 0.422 ' HB3' ' H ' ' C' ' 24' ' ' THR . 64.9 mt-30 -129.77 -157.34 0.81 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.619 175.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 24' ' ' THR . . . . . 0.422 ' H ' ' HB3' ' C' ' 23' ' ' GLN . 11.3 p -93.56 175.84 6.59 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.481 0.657 . . . . 0.0 111.613 -174.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.36 26.37 3.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.919 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' THR . . . . . 0.718 HG22 ' HA ' ' C' ' 73' ' ' LYS . 68.0 p -59.13 132.12 53.08 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.247 0.546 . . . . 0.0 112.131 -168.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 13.6 mm -89.4 152.3 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.664 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.649 HG22 ' HG2' ' C' ' 71' ' ' LYS . 77.5 t -133.72 132.95 57.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.745 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 35.8 t -120.42 114.2 21.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.51 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -106.96 127.85 53.81 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' ILE . . . . . 0.624 HG21 HG21 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.46 133.33 69.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.683 -177.114 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 47.6 t -112.34 130.08 66.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.761 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.727 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.25 164.9 27.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.113 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 34' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 47.4 t -139.2 150.09 45.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.985 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' C' ' 34' ' ' SER . 1.6 m-20 75.78 12.25 3.02 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.515 0.509 . . . . 0.0 112.322 172.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.03 159.77 14.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.714 0.769 . . . . 0.0 111.525 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' C' ' 38' ' ' ASN . 22.0 tt0 -92.72 173.17 7.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.568 174.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.401 ' H ' ' HG2' ' C' ' 37' ' ' GLU . 3.7 p-10 -55.46 115.65 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.849 1.785 . . . . 0.0 109.176 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.623 ' CG2' HG13 ' C' ' 89' ' ' VAL . 5.0 mp -76.41 146.37 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.18 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.492 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 55.0 tptt -104.4 127.63 52.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.732 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.11 140.04 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.6 t80 -133.17 144.36 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 111.559 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 43' ' ' TRP . . . . . 0.596 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 69.1 m95 -127.09 140.7 52.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' GLN . . . . . 0.408 ' HB3' HG13 ' C' ' 86' ' ' VAL . 35.0 tt0 -128.09 131.05 49.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 111.195 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' VAL . . . . . 0.786 HG21 ' HE ' ' C' ' 50' ' ' ARG . 21.2 t -116.99 116.01 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.484 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.58 36.62 27.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.213 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.07 -15.64 26.41 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.754 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.56 137.28 25.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.626 -0.338 . . . . 0.0 110.608 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.46 136.51 57.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' ARG . . . . . 0.786 ' HE ' HG21 ' C' ' 45' ' ' VAL . 17.7 tpp180 -91.74 122.15 34.03 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.991 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.88 162.42 5.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.655 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -42.72 164.52 0.01 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.283 1.04 . . . . 0.0 113.613 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.37 -1.03 23.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 -155.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.405 ' HA ' HD22 ' C' ' 72' ' ' LEU . 6.7 p -88.79 131.98 34.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 113.205 -1.497 . . . . 0.0 108.281 174.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' C' ' 71' ' ' LYS . 45.7 mt-10 -126.25 109.24 12.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.0 110.626 -172.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 15.9 m -95.08 117.24 29.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.519 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.79 165.95 11.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.849 0.357 . . . . 0.0 110.438 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' ASN . . . . . 0.427 ' HA ' ' HD3' ' C' ' 59' ' ' PRO . 12.3 t30 -69.18 134.47 89.35 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.899 0.857 . . . . 0.0 112.456 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' C' ' 67' ' ' THR . 23.5 Cg_exo -55.19 134.8 65.88 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 124.173 3.249 . . . . 0.0 112.586 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -153.46 107.45 3.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.421 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' TRP . . . . . 0.603 ' HB3' ' O ' ' C' ' 65' ' ' LYS . 65.0 t-105 -140.63 163.92 31.57 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 166.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 62' ' ' SER . . . . . 0.403 ' O ' ' N ' ' C' ' 64' ' ' SER . 48.4 m -48.19 141.74 6.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 166.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.16 33.69 0.19 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 115.575 0.99 . . . . 0.0 115.575 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' SER . . . . . 0.403 ' N ' ' O ' ' C' ' 62' ' ' SER . 37.1 m -112.82 -26.29 8.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 117.424 0.612 . . . . 0.0 109.725 171.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' LYS . . . . . 0.603 ' O ' ' HB3' ' C' ' 61' ' ' TRP . 12.6 mtpp -141.58 164.87 29.05 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -113.68 154.03 27.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.994 -0.441 . . . . 0.0 110.962 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 85.4 m -136.45 123.46 21.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.407 . . . . 0.0 111.166 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.727 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.6 mp -108.7 132.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.3 122.1 64.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.006 0.431 . . . . 0.0 110.489 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 27.4 t -118.17 122.78 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.628 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.649 ' HG2' HG22 ' C' ' 28' ' ' VAL . 32.1 mtpt -106.17 154.51 20.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.818 0.342 . . . . 0.0 110.426 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.457 ' HG ' ' CE1' ' C' ' 85' ' ' TYR . 0.2 OUTLIER -119.97 117.73 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 73' ' ' LYS . . . . . 0.718 ' HA ' HG22 ' C' ' 26' ' ' THR . 71.1 tttt -85.07 112.26 20.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' C' ' 26' ' ' THR . 12.5 p -133.62 155.99 40.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -166.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.9 mtm -80.24 130.37 35.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.861 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.04 -53.07 17.52 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.442 0.464 . . . . 0.0 111.762 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 41.3 t -57.72 -32.87 67.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.909 0.484 . . . . 0.0 112.066 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' GLU . . . . . 0.618 ' HG3' HG21 ' C' ' 83' ' ' THR . 3.8 tp10 -66.11 -54.73 21.98 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 79' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' C' ' 104' ' ' LYS . 62.1 t-105 -59.31 -48.88 79.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.863 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' ASP . . . . . 0.484 ' HA ' ' HG3' ' C' ' 104' ' ' LYS . 5.5 t70 -70.27 -6.49 35.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.901 -174.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -81.23 -5.78 58.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 109.883 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' C' ' 104' ' ' LYS . . . 82.83 20.01 62.23 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.618 HG21 ' HG3' ' C' ' 78' ' ' GLU . 0.6 OUTLIER -63.47 145.87 54.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.231 -177.517 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 84' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 33.8 mt-10 -81.58 135.61 35.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 111.767 -176.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' TYR . . . . . 0.484 ' O ' HG22 ' C' ' 102' ' ' ILE . 1.8 m-85 -134.13 124.75 26.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.956 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 86' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 0.2 OUTLIER -133.26 142.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 111.424 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 87' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 18.9 t -112.37 124.53 52.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.412 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.901 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.5 mp -114.73 147.6 39.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 89' ' ' VAL . . . . . 0.624 HG21 HG21 ' C' ' 31' ' ' ILE . 11.4 t -126.44 131.62 71.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.234 0.613 . . . . 0.0 109.958 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 8.3 pt-20 -136.09 134.95 38.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.175 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 91' ' ' ASP . . . . . 0.523 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 7.9 t70 -147.0 151.83 37.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.142 0.496 . . . . 0.0 110.571 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 66.4 m -68.35 -8.13 37.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.636 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 58.0 mm-40 -99.99 -4.57 29.77 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 111.163 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.571 ' C ' HD12 ' C' ' 94' ' ' LEU . 2.4 pp -108.09 158.51 33.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.962 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' C' ' 96' ' ' THR . 5.3 Cg_endo -91.03 -34.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.831 3.687 . . . . 0.0 112.784 -173.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.546 ' H ' ' HD2' ' C' ' 95' ' ' PRO . 33.2 p -141.38 145.84 39.79 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.53 148.47 66.66 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.954 1.769 . . . . 0.0 111.142 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' VAL . . . . . 0.834 HG21 HG12 ' C' ' 7' ' ' ILE . 40.3 t -110.61 139.11 35.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.901 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 24.9 pttm -144.15 157.53 44.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.467 0.651 . . . . 0.0 112.593 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.06 137.02 11.46 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.862 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 75.2 p -114.65 149.94 35.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.994 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 102' ' ' ILE . . . . . 0.64 ' HB ' HD21 ' C' ' 11' ' ' LEU . 3.9 tp -122.71 153.2 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 103' ' ' ARG . . . . . 0.454 ' N ' HG13 ' C' ' 102' ' ' ILE . 12.8 ptp180 -125.14 156.67 37.98 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 104' ' ' LYS . . . . . 0.546 ' HB3' ' HA2' ' C' ' 82' ' ' GLY . 8.1 tmtm? -78.84 122.88 26.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.998 0.428 . . . . 0.0 110.968 -173.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ALA . . . . . 0.473 ' HB3' ' HE2' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 172.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.27 50.77 48.57 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.849 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -110.93 156.08 21.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 61.65 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.676 0.61 . . . . 0.0 110.895 -174.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' THR . . . . . 0.417 HG23 HD21 ' C' ' 36' ' ' LEU . 10.6 m -116.13 95.67 5.2 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.029 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' C' ' 33' ' ' TYR . 30.3 t70 -112.63 120.54 41.9 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.325 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 tp -142.48 129.34 18.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.101 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 26.8 t -120.87 121.1 37.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.441 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.812 HG22 HG22 ' C' ' 31' ' ' ILE . 41.2 t -119.0 123.72 71.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.499 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -146.89 146.66 30.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.473 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.2 mm? -97.1 145.08 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.323 0.582 . . . . 0.0 111.104 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 63.0 tp -115.24 117.59 30.9 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.431 ' HB3' HD11 ' C' ' 102' ' ' ILE . 43.3 pttt -91.12 155.31 44.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.797 0.332 . . . . 0.0 110.475 -177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 14' ' ' PRO . . . . . 0.607 ' HD3' HD13 ' C' ' 27' ' ' ILE . 74.5 Cg_endo -79.97 132.46 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.805 2.337 . . . . 0.0 111.161 176.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' C' ' 14' ' ' PRO . 7.4 Cg_exo -73.4 177.62 7.69 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.868 2.378 . . . . 0.0 112.114 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' C' ' 21' ' ' THR . 46.4 m-85 65.48 46.69 2.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.397 0.618 . . . . 0.0 111.564 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 17' ' ' GLU . . . . . 0.907 ' HG2' ' HE1' ' C' ' 79' ' ' TRP . 0.0 OUTLIER -127.06 -12.34 5.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.961 171.036 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.82 -79.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.101 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 64.0 mt -101.97 -56.4 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.304 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -102.26 134.75 45.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.644 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' C' ' 16' ' ' PHE . 11.6 p -99.89 153.95 18.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.034 0.445 . . . . 0.0 112.096 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -150.16 50.14 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.556 0.693 . . . . 0.0 109.63 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' GLN . . . . . 0.425 ' HB3' ' H ' ' C' ' 24' ' ' THR . 74.1 mt-30 57.22 -148.83 0.48 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.312 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' THR . . . . . 0.641 ' HB ' ' CA ' ' C' ' 76' ' ' ALA . 8.8 t -116.95 147.9 41.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.435 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.42 -53.32 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.835 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -169.78 160.33 8.56 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.667 0.27 . . . . 0.0 111.669 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' ILE . . . . . 0.607 HD13 ' HD3' ' C' ' 14' ' ' PRO . 22.8 mm -117.37 117.89 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 79.3 t -112.64 134.78 54.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.103 -170.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' CYS . . . . . 0.402 ' HB2' ' CH2' ' C' ' 43' ' ' TRP . 52.3 t -111.62 114.45 27.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.108 171.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -96.15 125.42 40.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' ILE . . . . . 0.812 HG22 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.59 124.59 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.985 0.898 . . . . 0.0 111.48 176.361 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -114.18 128.85 70.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.699 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.553 ' CE2' HD13 ' C' ' 68' ' ' ILE . 49.0 p90 -147.41 165.11 31.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.421 0.629 . . . . 0.0 111.732 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 12.7 t -143.77 143.67 31.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.873 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 79.62 9.56 1.53 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.605 0.565 . . . . 0.0 112.298 171.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.417 HD21 HG23 ' C' ' 5' ' ' THR . 21.2 mt -93.25 160.58 14.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 0.0 112.217 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' GLU . . . . . 0.59 ' O ' HG13 ' C' ' 39' ' ' ILE . 6.2 tp10 -99.74 172.96 6.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.496 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.45 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 2.9 m120 -55.03 110.81 0.72 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 123.604 1.669 . . . . 0.0 109.109 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.59 HG13 ' O ' ' C' ' 37' ' ' GLU . 17.3 mt -77.3 142.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.165 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 40' ' ' LYS . . . . . 0.662 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 29.2 tptp -105.42 123.68 48.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.823 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.15 139.03 21.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.282 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.458 ' CE1' ' HG2' ' C' ' 49' ' ' GLU . 47.5 t80 -133.24 139.83 47.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.048 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' TRP . . . . . 0.402 ' CH2' ' HB2' ' C' ' 29' ' ' CYS . 71.4 m95 -125.37 137.48 54.03 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -126.94 129.66 48.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.933 0.333 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 25.0 t -120.83 116.72 50.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.323 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' ASN . . . . . 0.528 ' HA ' ' OE1' ' C' ' 84' ' ' GLU . 3.2 m120 54.53 37.17 27.42 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.123 0.487 . . . . 0.0 111.808 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.04 -16.3 38.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.277 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' VAL . . . . . 0.411 HG12 ' O ' ' C' ' 45' ' ' VAL . 15.0 p -104.64 142.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.624 0.712 . . . . 0.0 110.721 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 49' ' ' GLU . . . . . 0.458 ' HG2' ' CE1' ' C' ' 42' ' ' PHE . 41.5 mt-10 -60.4 138.17 58.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.407 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 50' ' ' ARG . . . . . 0.482 ' HB2' HG23 ' C' ' 45' ' ' VAL . 13.2 tpp180 -91.29 124.27 35.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.362 0.601 . . . . 0.0 110.077 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -59.76 162.71 5.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.738 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -41.77 163.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.05 0.929 . . . . 0.0 112.898 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.68 -0.48 23.23 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -158.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.555 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.5 p -89.74 129.68 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 113.637 -1.281 . . . . 0.0 108.133 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.602 ' HB3' ' HG3' ' C' ' 71' ' ' LYS . 31.0 tt0 -141.88 110.29 6.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.082 0.468 . . . . 0.0 110.179 -169.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -94.81 134.22 37.67 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.95 149.39 22.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -58.26 145.78 73.2 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.169 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' PRO . . . . . 0.493 ' HB3' HD11 ' C' ' 68' ' ' ILE . 19.1 Cg_endo -57.74 136.64 76.77 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.728 2.952 . . . . 0.0 113.474 -174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -107.54 129.28 54.99 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -108.09 120.65 42.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.924 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 22.7 t -124.47 102.31 7.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.363 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.87 -113.34 5.68 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.388 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 78.3 p -110.69 5.45 20.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.078 0.466 . . . . 0.0 110.594 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -98.53 130.84 45.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.847 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 8.8 m -102.09 146.51 27.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.037 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -133.31 119.72 20.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.106 0.479 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.553 HD13 ' CE2' ' C' ' 33' ' ' TYR . 1.7 mp -115.13 127.14 72.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.172 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -105.17 121.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 38.9 m -111.79 113.02 25.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.602 ' HG3' ' HB3' ' C' ' 55' ' ' GLU . 13.0 ptmt -106.17 139.82 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.156 0.503 . . . . 0.0 110.241 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -113.5 127.13 55.98 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.921 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -87.91 116.95 26.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.427 HG12 HD12 ' C' ' 72' ' ' LEU . 21.3 m -130.52 157.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.621 -171.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' C' ' 78' ' ' GLU . 55.2 mtt -83.1 135.49 34.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.216 0.323 . . . . 0.0 110.57 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 76' ' ' ALA . . . . . 0.641 ' CA ' ' HB ' ' C' ' 24' ' ' THR . . . -47.59 -54.91 10.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 77' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' C' ' 81' ' ' SER . 5.3 m -57.09 -29.38 63.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.718 0.407 . . . . 0.0 112.093 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' C' ' 75' ' ' MET . 5.5 mm-40 -65.37 -54.12 33.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 79' ' ' TRP . . . . . 0.907 ' HE1' ' HG2' ' C' ' 17' ' ' GLU . 53.2 t-105 -58.78 -44.8 90.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.764 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.54 -19.82 64.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.043 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' C' ' 77' ' ' SER . 6.6 t -80.89 -4.98 56.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.14 26.71 70.03 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.024 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' THR . . . . . 0.451 HG23 ' CE2' ' C' ' 85' ' ' TYR . 12.8 t -64.83 144.99 56.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.367 0.604 . . . . 0.0 110.377 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' C' ' 46' ' ' ASN . 12.7 mt-10 -74.84 133.7 41.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.323 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' TYR . . . . . 0.664 ' HB2' ' CG2' ' C' ' 102' ' ' ILE . 83.5 m-85 -126.24 118.08 24.4 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.62 133.3 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 32.5 t -108.72 116.24 31.62 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.858 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.8 mp -110.56 145.1 38.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.069 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 89' ' ' VAL . . . . . 0.612 HG21 HG21 ' C' ' 31' ' ' ILE . 40.8 t -125.65 131.29 72.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 123.38 0.672 . . . . 0.0 109.469 176.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 9.7 pt-20 -131.17 137.13 48.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.924 0.393 . . . . 0.0 110.28 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 91' ' ' ASP . . . . . 0.505 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 14.6 t0 -149.89 154.23 38.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.535 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.4 m -67.76 -7.72 29.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.634 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -100.5 -9.3 22.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.583 ' O ' HD12 ' C' ' 94' ' ' LEU . 2.4 pp -97.75 149.22 35.5 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.627 -175.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.27 -33.19 1.47 Allowed 'Trans proline' 0 C--N 1.334 -0.193 0 C-N-CA 123.941 3.094 . . . . 0.0 112.88 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.454 ' O ' HD13 ' C' ' 94' ' ' LEU . 4.7 p -144.85 152.81 53.02 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.437 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.46 139.94 55.77 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.007 1.804 . . . . 0.0 111.283 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 27.4 t -102.05 124.36 55.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.858 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 22.6 pttp -134.39 156.55 48.33 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.24 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.13 138.1 17.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.255 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t -117.45 151.49 36.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.115 0.483 . . . . 0.0 111.718 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' ILE . . . . . 0.664 ' CG2' ' HB2' ' C' ' 85' ' ' TYR . 3.6 tp -123.95 143.92 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.652 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -133.26 157.11 46.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' C' ' 17' ' ' GLU . 81.8 tttt -68.3 105.63 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.078 0.861 . . . . 0.0 109.203 -174.92 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.112 0.482 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.66 -115.89 2.38 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.453 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -84.22 67.75 9.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.377 0.608 . . . . 0.0 110.564 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -92.62 -27.34 17.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.141 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 8.3 m -115.65 91.24 3.54 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.283 -173.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ASP . . . . . 0.705 ' O ' ' HA ' ' C' ' 33' ' ' TYR . 1.6 m-20 -96.41 112.86 24.46 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 165.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 7' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 1.7 tp -115.1 108.24 24.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.184 165.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 26.9 t -131.73 134.42 45.86 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.414 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -119.29 123.37 71.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.042 0.449 . . . . 0.0 110.236 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 11.7 m -117.89 123.33 45.59 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.554 ' HB3' HD12 ' C' ' 102' ' ' ILE . 91.1 mt -99.76 126.18 45.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.473 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 12' ' ' LEU . . . . . 0.519 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 49.6 tp -104.42 114.93 29.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.825 ' HB3' HD11 ' C' ' 102' ' ' ILE . 9.6 ptpp? -91.37 150.77 41.94 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 14' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' C' ' 15' ' ' PRO . 37.0 Cg_endo -70.55 119.37 6.29 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.934 1.756 . . . . 0.0 110.632 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' C' ' 14' ' ' PRO . 8.6 Cg_exo -72.11 52.34 1.84 Allowed 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.45 2.767 . . . . 0.0 112.383 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' C' ' 20' ' ' TRP . 59.9 t80 -60.97 -56.98 14.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.686 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 66.1 -65.87 0.18 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.67 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -177.27 -43.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.579 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 tp -101.16 -16.47 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.154 -173.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.475 ' O ' ' HA ' ' C' ' 16' ' ' PHE . 97.5 m95 -93.8 114.6 26.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 111.316 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 48.6 m -122.68 114.03 20.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.621 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -110.96 72.42 0.78 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 68.41 -68.13 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.041 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 13.8 p -137.81 170.38 16.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.557 0.694 . . . . 0.0 111.433 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' C' ' 76' ' ' ALA . . . -85.51 27.35 0.84 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.659 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 8.4 t -59.0 130.0 44.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.819 0.818 . . . . 0.0 111.607 -168.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.21 148.59 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.586 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 45.6 t -128.47 131.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.338 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -114.99 111.68 21.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.72 121.93 43.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' ILE . . . . . 0.592 HD12 ' O ' ' C' ' 68' ' ' ILE . 0.1 OUTLIER -124.68 130.79 73.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.849 0.833 . . . . 0.0 111.227 -176.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' C' ' 7' ' ' ILE . 60.2 t -110.6 131.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.496 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' C' ' 6' ' ' ASP . 0.1 OUTLIER -164.67 161.92 21.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.403 0.439 . . . . 0.0 110.529 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 34' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 11.6 t -142.59 155.34 44.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' C' ' 34' ' ' SER . 0.9 OUTLIER 81.6 9.96 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.814 0.697 . . . . 0.0 111.832 177.412 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 36' ' ' LEU . . . . . 0.422 ' HB2' HD11 ' C' ' 39' ' ' ILE . 22.8 mt -105.22 142.9 34.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.456 0.645 . . . . 0.0 112.105 -172.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' GLU . . . . . 0.562 ' O ' HG13 ' C' ' 39' ' ' ILE . 29.8 mm-40 -95.95 179.11 5.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.585 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -54.26 112.36 0.96 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 124.053 1.882 . . . . 0.0 109.654 -156.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.562 HG13 ' O ' ' C' ' 37' ' ' GLU . 11.1 mt -83.17 146.83 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 110.15 -3.205 . . . . 0.0 112.584 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -112.37 134.68 53.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.634 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.0 131.43 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.445 ' HE1' ' HG2' ' C' ' 49' ' ' GLU . 53.2 t80 -122.66 142.17 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.136 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 43' ' ' TRP . . . . . 0.549 ' CE2' HD23 ' C' ' 72' ' ' LEU . 50.3 m95 -132.02 137.55 47.89 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -124.84 131.24 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.155 -0.341 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' C' ' 50' ' ' ARG . 60.6 t -123.03 117.26 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 55.69 35.89 26.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.62 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.21 -15.85 36.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.331 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.16 145.19 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.492 0.646 . . . . 0.0 111.645 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' GLU . . . . . 0.445 ' HG2' ' HE1' ' C' ' 42' ' ' PHE . 47.8 mt-10 -61.14 127.54 32.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.646 172.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' ARG . . . . . 0.569 ' HD3' HD11 ' C' ' 72' ' ' LEU . 5.4 ptm180 -92.15 166.13 12.8 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.373 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 51' ' ' LYS . . . . . 0.484 ' HA ' ' HD2' ' C' ' 51' ' ' LYS . 31.7 tptt -75.67 163.01 27.74 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.473 ' HG3' ' H ' ' C' ' 53' ' ' GLY . 22.4 tptp -45.51 164.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.84 0.828 . . . . 0.0 111.914 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' C' ' 52' ' ' LYS . . . 115.36 -9.17 20.17 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -161.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.82 HG22 HD21 ' C' ' 72' ' ' LEU . 48.8 t -77.27 118.73 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 113.339 -1.431 . . . . 0.0 107.794 165.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -133.47 144.29 49.36 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.19 -170.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -130.25 130.09 44.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -87.57 158.14 18.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.453 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.05 150.28 51.68 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.482 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' PRO . . . . . 0.523 ' HB3' HD11 ' C' ' 68' ' ' ILE . 37.4 Cg_endo -63.12 139.74 74.48 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.147 2.565 . . . . 0.0 113.133 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -114.09 149.07 36.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -111.69 132.31 54.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.101 0.477 . . . . 0.0 111.548 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 27.7 m -135.37 103.77 5.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.698 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.25 -110.74 3.44 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 42.3 m -111.01 6.49 21.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 109.803 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -106.21 160.2 15.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.146 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -113.68 152.73 30.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.427 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 64.4 m -135.31 120.44 18.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.377 0.608 . . . . 0.0 111.009 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.592 ' O ' HD12 ' C' ' 31' ' ' ILE . 1.6 mp -110.81 130.94 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.888 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.6 122.54 60.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.394 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -111.3 122.82 48.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -106.86 143.76 34.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.82 HD21 HG22 ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.71 114.57 19.48 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.032 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -84.44 114.59 22.02 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.523 HG11 ' CE1' ' C' ' 85' ' ' TYR . 16.4 m -133.19 161.61 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.719 -173.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.8 mtt -77.75 128.71 34.48 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.539 0.685 . . . . 0.0 109.589 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 76' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' C' ' 25' ' ' ALA . . . -58.21 -42.96 87.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.078 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -61.9 -30.5 70.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.527 0.331 . . . . 0.0 111.435 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.32 -51.66 42.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' TRP . . . . . 0.445 ' HZ3' HG23 ' C' ' 102' ' ' ILE . 63.4 t-105 -57.62 -44.15 85.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.766 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.1 -17.01 64.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.347 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -81.73 -4.71 57.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.905 0.383 . . . . 0.0 110.772 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.84 21.72 65.4 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 41.5 m -66.22 143.41 57.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.874 -0.663 . . . . 0.0 112.01 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -71.16 131.81 44.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.824 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' TYR . . . . . 0.523 ' CE1' HG11 ' C' ' 74' ' ' VAL . 67.3 m-85 -130.53 116.21 17.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 169.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 86' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 11.3 t -120.43 135.93 59.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.09 127.66 54.33 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.559 HD13 ' O ' ' C' ' 98' ' ' VAL . 1.9 mm? -123.13 144.84 49.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.823 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 89' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' C' ' 98' ' ' VAL . 69.7 t -122.89 132.78 70.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.115 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -127.85 133.82 49.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.523 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' ASP . . . . . 0.655 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 28.4 t70 -153.16 150.44 29.07 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.253 0.549 . . . . 0.0 110.575 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 21.9 t -66.24 -15.17 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.752 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -95.62 -7.65 37.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.243 0.474 . . . . 0.0 112.156 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.5 pp -92.62 149.39 37.96 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.108 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.36 -35.17 0.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.86 3.04 . . . . 0.0 112.453 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.433 ' O ' HD13 ' C' ' 94' ' ' LEU . 16.0 p -142.6 149.32 50.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.256 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 97' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' C' ' 88' ' ' LEU . 52.0 Cg_endo -66.24 143.34 70.43 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.308 2.005 . . . . 0.0 111.258 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 98' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' C' ' 89' ' ' VAL . 47.7 t -91.39 106.54 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.406 ' HB3' HD11 ' C' ' 88' ' ' LEU . 11.1 ptpp? -107.84 142.81 37.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.422 -174.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.65 120.14 5.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 39.4 t -105.51 156.37 18.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.047 0.451 . . . . 0.0 110.69 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 102' ' ' ILE . . . . . 0.825 HD11 ' HB3' ' C' ' 13' ' ' LYS . 14.0 tt -123.83 147.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.008 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -133.68 144.51 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.293 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -85.19 143.61 28.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.96 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.702 173.197 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptp . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.761 0.315 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.77 -166.37 33.14 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.778 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' C' ' 3' ' ' ARG . 4.8 mmp_? 53.76 69.5 0.7 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.335 0.254 . . . . 0.0 110.441 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -50.21 110.0 0.36 Allowed 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.635 0.585 . . . . 0.0 111.491 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' THR . . . . . 0.452 HG23 ' O ' ' C' ' 5' ' ' THR . 5.8 t -88.73 91.32 8.77 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 122.98 1.371 . . . . 0.0 110.557 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -99.72 115.92 30.6 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.809 -1.541 . . . . 0.0 107.519 168.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' ILE . . . . . 0.533 HG12 HG11 ' C' ' 98' ' ' VAL . 3.7 tp -129.33 115.18 34.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 112.595 -2.093 . . . . 0.0 109.094 172.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 13.7 m -116.33 114.95 25.03 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.922 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 t -114.27 115.01 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -131.88 132.53 43.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.075 0.464 . . . . 0.0 109.88 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.66 HD13 ' HB ' ' C' ' 102' ' ' ILE . 17.5 mt -99.5 136.56 39.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.293 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 61.6 tp -110.86 115.19 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -77.24 150.43 80.33 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.975 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' PRO . . . . . 0.535 ' HB2' ' HD3' ' C' ' 15' ' ' PRO . 82.6 Cg_exo -41.75 -52.62 3.78 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.924 2.416 . . . . 0.0 113.39 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 15' ' ' PRO . . . . . 0.535 ' HD3' ' HB2' ' C' ' 14' ' ' PRO . 55.0 Cg_endo -71.72 94.3 0.7 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.436 1.424 . . . . 0.0 111.959 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -53.7 -36.41 62.2 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.109 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' GLU . . . . . 0.479 ' HG3' HG22 ' C' ' 19' ' ' ILE . 9.0 tp10 -117.71 136.68 53.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -70.26 -7.68 44.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -169.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' ILE . . . . . 0.479 HG22 ' HG3' ' C' ' 17' ' ' GLU . 10.7 tp -83.71 -17.78 10.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.86 0.362 . . . . 0.0 111.092 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -107.69 114.09 27.82 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 34.1 m -103.61 113.26 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -127.62 164.2 22.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.249 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -58.26 132.58 54.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.149 0.499 . . . . 0.0 109.887 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' THR . . . . . 1.041 ' HB ' ' HA ' ' C' ' 76' ' ' ALA . 58.6 m -93.58 132.35 37.98 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.165 -168.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.07 -18.04 5.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.556 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 26' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' C' ' 72' ' ' LEU . 10.1 t -161.41 144.33 12.39 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -175.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 27' ' ' ILE . . . . . 0.809 HG13 HG11 ' C' ' 74' ' ' VAL . 60.6 mt -120.19 152.36 23.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.08 135.55 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.911 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 51.3 t -107.82 117.71 34.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -105.12 118.39 36.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.57 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' ILE . . . . . 0.523 HG21 HG11 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -120.01 130.86 73.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.677 0.751 . . . . 0.0 111.309 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 21.7 t -117.72 132.59 67.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.254 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.957 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -151.79 170.03 20.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 34' ' ' SER . . . . . 0.504 ' HB2' ' HG2' ' C' ' 65' ' ' LYS . 32.2 t -124.09 141.48 52.01 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.396 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 t0 71.01 11.11 7.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.184 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mt -111.69 129.64 56.04 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.28 -0.888 . . . . 0.0 110.708 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.33 91.28 2.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.705 160.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' ASN . . . . . 0.636 ' O ' ' HA ' ' C' ' 91' ' ' ASP . 0.5 OUTLIER -147.29 106.38 3.87 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 136.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.441 HD12 ' CZ ' ' C' ' 33' ' ' TYR . 5.5 mm -115.28 112.53 40.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.977 -1.089 . . . . 0.0 113.721 -169.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -108.16 123.57 48.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.138 172.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.67 142.78 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.3 t80 -129.88 143.55 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 43' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -128.94 137.94 51.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 44' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' C' ' 86' ' ' VAL . 4.4 pt20 -131.23 131.45 43.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.229 0.538 . . . . 0.0 111.409 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' VAL . . . . . 0.634 HG23 ' HB2' ' C' ' 50' ' ' ARG . 13.8 t -104.08 109.14 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.858 177.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.31 42.26 31.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.635 0.731 . . . . 0.0 110.693 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.62 -16.98 16.51 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.922 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' VAL . . . . . 0.563 HG12 ' O ' ' C' ' 45' ' ' VAL . 10.0 p -97.85 138.58 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 118.297 1.049 . . . . 0.0 110.521 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -57.72 139.44 53.84 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.379 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' ARG . . . . . 0.634 ' HB2' HG23 ' C' ' 45' ' ' VAL . 16.2 tpt180 -90.98 124.13 34.99 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.845 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' LYS . . . . . 0.636 ' H ' ' HD2' ' C' ' 51' ' ' LYS . 3.1 mptp? -70.45 161.31 30.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.966 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' C' ' 52' ' ' LYS . 45.5 mmtm -42.19 162.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.484 1.135 . . . . 0.0 114.011 -170.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -158.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.54 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.3 p -87.77 128.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 113.707 -1.246 . . . . 0.0 109.095 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -140.02 110.29 6.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.054 0.454 . . . . 0.0 110.17 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -89.22 130.95 35.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.615 ' HB2' HG13 ' C' ' 69' ' ' VAL . 96.6 mt-30 -105.31 172.57 6.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -175.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -76.92 153.19 82.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.827 0.346 . . . . 0.0 110.293 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' C' ' 67' ' ' THR . 60.6 Cg_endo -70.21 149.43 64.01 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.537 2.825 . . . . 0.0 113.424 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -154.25 106.64 2.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 170.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' TRP . . . . . 0.637 ' HB3' ' O ' ' C' ' 65' ' ' LYS . 26.8 t-105 -140.89 165.83 26.44 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 165.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 10.7 t -52.72 155.34 2.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 168.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.36 0.44 1.37 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 115.611 1.005 . . . . 0.0 115.611 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 5.3 p -89.28 -25.8 21.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.759 0.78 . . . . 0.0 111.705 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' LYS . . . . . 0.637 ' O ' ' HB3' ' C' ' 61' ' ' TRP . 84.3 mttt -145.47 167.62 22.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.844 0.354 . . . . 0.0 110.57 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.8 m -118.2 148.21 42.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 93.9 m -132.71 121.07 22.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.957 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.62 127.89 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.889 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 69' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' C' ' 57' ' ' GLN . 0.7 OUTLIER -111.46 122.87 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.726 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -111.28 125.43 53.82 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.706 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.22 138.52 43.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.558 HD11 ' HG2' ' C' ' 50' ' ' ARG . 0.2 OUTLIER -120.07 122.1 40.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.153 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -77.87 121.0 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.809 HG11 HG13 ' C' ' 27' ' ' ILE . 9.9 p -143.37 148.94 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.716 -170.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -89.81 140.1 29.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.874 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 76' ' ' ALA . . . . . 1.041 ' HA ' ' HB ' ' C' ' 24' ' ' THR . . . -43.99 -55.39 4.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -57.03 -33.86 67.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.557 0.617 . . . . 0.0 112.285 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -63.94 -53.76 45.24 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 176.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -58.09 -44.03 87.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.768 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 80' ' ' ASP . . . . . 0.547 ' HA ' ' HD2' ' C' ' 104' ' ' LYS . 24.5 t70 -70.25 -17.24 63.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.323 -176.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 66.3 m -86.38 -3.01 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.68 28.87 70.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.184 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.8 t -64.71 143.18 58.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.041 0.448 . . . . 0.0 109.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 84' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.8 mt-10 -75.49 130.1 38.34 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -128.05 120.79 28.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.325 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' C' ' 101' ' ' SER . 26.7 t -120.25 135.76 59.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 87' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 19.5 p -115.39 129.2 56.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.637 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.9 mp -120.24 148.61 43.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.287 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 89' ' ' VAL . . . . . 0.523 HG11 HG21 ' C' ' 31' ' ' ILE . 5.9 p -143.72 127.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.354 0.597 . . . . 0.0 111.448 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -110.77 153.39 25.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.053 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 11.3 t70 -142.69 148.03 36.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -62.31 -21.31 65.16 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -97.2 0.09 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.55 ' C ' HD12 ' C' ' 94' ' ' LEU . 2.6 pp -103.86 158.64 31.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' C' ' 96' ' ' THR . 1.8 Cg_endo -88.21 -35.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.874 3.049 . . . . 0.0 113.294 -168.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.423 ' O ' HD13 ' C' ' 94' ' ' LEU . 16.7 p -147.28 153.64 44.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.43 151.99 79.71 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.294 1.996 . . . . 0.0 112.112 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 19.2 m -122.19 147.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' C' ' 87' ' ' CYS . 0.4 OUTLIER -135.08 161.48 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.181 0.515 . . . . 0.0 112.367 -169.692 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.18 140.99 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 101' ' ' SER . . . . . 0.46 ' HB2' HG22 ' C' ' 86' ' ' VAL . 39.7 t -120.56 149.14 42.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.989 0.358 . . . . 0.0 110.708 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 102' ' ' ILE . . . . . 0.66 ' HB ' HD13 ' C' ' 11' ' ' LEU . 2.9 tp -125.03 142.12 42.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.181 0.515 . . . . 0.0 110.879 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -123.69 153.91 40.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 104' ' ' LYS . . . . . 0.547 ' HD2' ' HA ' ' C' ' 80' ' ' ASP . 76.0 tttt -64.39 107.04 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.454 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.407 -176.869 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.737 0.303 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.01 170.46 14.22 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -140.93 -80.64 0.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.045 0.423 . . . . 0.0 110.023 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -100.89 -16.31 17.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.332 0.587 . . . . 0.0 109.94 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -93.0 151.12 20.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.339 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -111.05 122.34 47.65 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.645 0.736 . . . . 0.0 109.191 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' ILE . . . . . 0.601 HG12 HG11 ' C' ' 98' ' ' VAL . 3.3 tp -134.69 124.11 43.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.656 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 47.2 t -120.47 125.06 46.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' C' ' 31' ' ' ILE . 3.0 p -128.57 125.32 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.108 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -148.28 148.61 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.053 -0.404 . . . . 0.0 110.539 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.507 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.5 mm? -96.11 146.7 24.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.905 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -115.3 115.38 26.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.712 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -78.1 154.58 80.02 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.203 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' PRO . . . . . 0.434 ' HG3' ' O ' ' C' ' 25' ' ' ALA . 73.8 Cg_endo -75.68 118.42 5.09 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.721 2.281 . . . . 0.0 111.579 175.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.03 144.75 71.06 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.611 2.207 . . . . 0.0 111.521 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -79.45 74.8 6.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -78.65 101.91 7.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.618 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 67.16 -179.04 0.21 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.263 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 8.3 tp -101.06 -21.58 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.561 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -98.42 121.88 40.91 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 5.3 t -155.35 135.64 13.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.975 0.417 . . . . 0.0 111.02 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -110.11 15.25 22.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.936 0.874 . . . . 0.0 109.136 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -111.27 167.55 10.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.547 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 17.1 p -96.49 171.79 8.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.536 0.684 . . . . 0.0 111.258 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' C' ' 14' ' ' PRO . . . -78.08 30.31 0.17 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.927 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 26' ' ' THR . . . . . 0.498 ' HA ' HG12 ' C' ' 74' ' ' VAL . 3.4 t -55.46 129.09 37.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.226 1.012 . . . . 0.0 112.302 -164.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mt -102.32 155.52 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.541 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' VAL . . . . . 0.526 HG22 ' HG3' ' C' ' 71' ' ' LYS . 56.0 t -127.95 135.17 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.943 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -111.16 127.03 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 124.62 52.28 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' ILE . . . . . 0.619 HG21 HG21 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.97 131.13 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.651 179.249 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.24 129.7 66.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.748 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.634 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -165.54 160.62 17.88 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 34' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' C' ' 65' ' ' LYS . 14.7 m -144.2 153.94 42.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.792 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' C' ' 34' ' ' SER . 1.1 m-20 78.8 9.22 1.91 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.454 0.472 . . . . 0.0 112.056 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.23 163.99 13.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.624 0.726 . . . . 0.0 112.059 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -83.0 173.82 11.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.291 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -57.62 114.5 2.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.535 1.636 . . . . 0.0 107.784 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.595 ' CG2' HG13 ' C' ' 89' ' ' VAL . 4.6 mp -74.55 146.06 10.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 111.559 -2.564 . . . . 0.0 112.506 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.87 172.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.19 140.1 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -134.36 137.81 44.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.939 0.399 . . . . 0.0 110.94 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' TRP . . . . . 0.535 ' HE3' ' HD2' ' C' ' 85' ' ' TYR . 55.2 m95 -125.77 133.94 51.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -124.8 130.22 51.97 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' C' ' 50' ' ' ARG . 23.5 t -118.31 111.78 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.939 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.18 37.24 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.875 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.76 -14.3 25.91 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.1 134.16 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.22 138.52 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.102 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' ARG . . . . . 0.498 ' HB2' HG23 ' C' ' 45' ' ' VAL . 15.8 tpp180 -90.96 127.11 36.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.479 0.657 . . . . 0.0 110.879 -173.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -57.67 160.4 4.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.844 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -40.65 163.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.301 1.048 . . . . 0.0 113.307 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 53' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' C' ' 73' ' ' LYS . . . 114.51 -0.47 23.46 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -163.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.469 ' HA ' HD22 ' C' ' 72' ' ' LEU . 5.4 p -87.29 127.25 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.314 172.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 34.8 mt-10 -124.08 108.76 12.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -172.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 6.3 m -93.43 117.75 30.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' GLN . . . . . 0.635 ' HB2' HG13 ' C' ' 69' ' ' VAL . 53.4 mt-30 -100.39 171.42 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.463 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.2 144.4 89.65 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 0.0 110.651 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 59' ' ' PRO . . . . . 0.463 ' HB3' ' CD1' ' C' ' 68' ' ' ILE . 27.3 Cg_endo -63.08 151.23 85.83 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.557 2.838 . . . . 0.0 114.072 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -103.4 123.22 46.44 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -104.26 113.95 27.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.777 0.322 . . . . 0.0 111.822 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 13.7 m -113.14 101.1 9.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.88 -108.36 1.84 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.705 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 56.1 m -110.9 6.62 21.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' LYS . . . . . 0.502 ' HA ' ' OG ' ' C' ' 34' ' ' SER . 74.4 mmtt -99.17 134.35 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.108 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -109.11 150.53 27.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.053 0.454 . . . . 0.0 110.795 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 57.5 m -137.04 126.73 25.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.96 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -112.05 134.16 55.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.872 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 69' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -115.61 127.32 73.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.365 0.602 . . . . 0.0 110.697 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 40.9 p -115.41 129.62 56.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.534 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 48.1 tttp -107.09 144.62 33.52 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -120.03 116.54 25.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.027 0.441 . . . . 0.0 110.251 177.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 73' ' ' LYS . . . . . 0.407 ' HD3' ' HA2' ' C' ' 53' ' ' GLY . 26.5 mtpp -77.76 112.59 14.77 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.543 HG23 ' OH ' ' C' ' 85' ' ' TYR . 9.3 p -119.98 151.71 22.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.342 0.592 . . . . 0.0 110.602 -168.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.891 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 65.9 mtt -84.04 137.43 33.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.251 -176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.32 -35.98 60.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.824 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 14.5 t -70.74 -28.31 64.61 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.368 0.267 . . . . 0.0 111.627 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' GLU . . . . . 0.891 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 7.7 mm-40 -71.44 -54.75 9.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.712 0.767 . . . . 0.0 109.137 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -64.95 -38.63 91.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.238 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.86 -18.47 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.41 . . . . 0.0 111.039 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 18.6 t -90.16 -4.48 57.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.546 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.58 25.29 70.47 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.34 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -62.22 138.82 58.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.116 0.484 . . . . 0.0 111.145 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.17 149.68 24.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.265 -172.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 85' ' ' TYR . . . . . 0.543 ' OH ' HG23 ' C' ' 74' ' ' VAL . 16.4 m-85 -132.7 131.05 40.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.198 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 86' ' ' VAL . . . . . 0.558 HG11 ' HE2' ' C' ' 99' ' ' LYS . 25.3 t -119.87 130.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 34.4 t -108.6 120.48 42.56 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.675 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 5.8 mp -116.23 147.52 41.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.63 0.581 . . . . 0.0 110.166 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 89' ' ' VAL . . . . . 0.619 HG21 HG21 ' C' ' 31' ' ' ILE . 12.3 t -134.0 127.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.54 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.06 144.94 51.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.082 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' ASP . . . . . 0.521 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 27.1 t70 -148.17 156.7 42.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.339 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 37.9 t -65.37 -21.68 66.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -91.9 -11.55 35.99 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 122.192 -0.318 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 40.8 mt -84.12 146.57 48.69 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.668 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 1.7 Cg_endo -84.34 -29.26 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.512 2.808 . . . . 0.0 111.651 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 27.1 p -147.19 151.62 41.23 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.903 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.42 148.05 47.86 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.532 1.488 . . . . 0.0 110.651 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' VAL . . . . . 0.601 HG11 HG12 ' C' ' 7' ' ' ILE . 27.6 m -108.57 141.1 24.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.675 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 13.7 ptmm? -142.79 153.51 43.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.32 22.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' C' ' 85' ' ' TYR . 33.5 t -121.91 149.74 42.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.409 0.624 . . . . 0.0 111.888 -173.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 102' ' ' ILE . . . . . 0.507 ' HB ' ' HG ' ' C' ' 11' ' ' LEU . 4.8 tp -124.03 145.64 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.413 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -130.86 162.68 29.08 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -80.14 108.5 13.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.338 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.156 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.631 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 121.021 0.439 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.99 73.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -58.78 -58.27 9.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.622 0.249 . . . . 0.0 111.175 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -96.63 -52.27 3.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.276 0.56 . . . . 0.0 110.197 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 6.0 t -107.21 94.91 5.35 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.693 1.235 . . . . 0.0 111.294 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -96.9 113.15 24.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.624 -1.625 . . . . 0.0 106.863 165.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.3 122.39 50.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.105 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 8' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 19.5 m -117.82 114.58 23.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.249 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.82 117.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.19 0.519 . . . . 0.0 110.661 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m -123.15 130.92 53.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' C' ' 102' ' ' ILE . 46.8 mt -99.0 130.07 45.32 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 tp -111.47 113.8 26.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' LYS . . . . . 0.402 ' HB3' HD11 ' C' ' 102' ' ' ILE . 25.1 pttm -83.23 147.59 53.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -34.23 103.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 125.08 3.854 . . . . 0.0 114.533 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -79.45 109.91 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.117 2.545 . . . . 0.0 111.085 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -87.55 -27.49 22.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.908 0.385 . . . . 0.0 110.674 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -99.63 79.91 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.093 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' C' ' 20' ' ' TRP . 11.0 pt-20 -160.18 -170.84 2.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.396 171.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 8.2 tp -62.61 -34.08 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.737 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' TRP . . . . . 0.46 ' H ' ' HG3' ' C' ' 18' ' ' GLU . 50.1 m95 -93.55 114.35 26.68 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 16.4 m -83.4 125.6 31.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.19 0.519 . . . . 0.0 110.483 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -81.35 89.38 6.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.311 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -74.84 -14.31 60.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.393 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 7.6 p -120.5 -178.77 3.78 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.373 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.982 ' HB2' ' HA ' ' C' ' 76' ' ' ALA . . . -95.22 24.71 4.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.249 -176.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t -59.78 126.18 26.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.978 0.894 . . . . 0.0 111.907 -168.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.44 153.96 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.699 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.93 134.38 63.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.216 0.531 . . . . 0.0 111.554 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' CYS . . . . . 0.546 ' HB2' ' CH2' ' C' ' 43' ' ' TRP . 35.7 t -108.88 112.85 25.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.29 115.89 31.0 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' ILE . . . . . 0.683 HG21 HG21 ' C' ' 89' ' ' VAL . 0.2 OUTLIER -126.25 128.65 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 53.8 t -114.69 131.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.744 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' TYR . . . . . 0.499 ' OH ' ' HB ' ' C' ' 68' ' ' ILE . 0.1 OUTLIER -161.13 163.63 31.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.418 -178.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -142.34 150.94 41.42 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 37.6 t70 78.67 10.99 1.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.811 0.695 . . . . 0.0 111.6 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 17.4 mt -97.97 164.66 12.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.003 0.906 . . . . 0.0 112.654 -172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -94.36 170.84 9.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.83 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.14 114.92 2.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.72 1.724 . . . . 0.0 108.257 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 39' ' ' ILE . . . . . 0.62 HG21 HG13 ' C' ' 89' ' ' VAL . 4.7 mp -70.12 141.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.177 -2.738 . . . . 0.0 113.555 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -103.43 124.05 48.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -108.73 141.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -173.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.5 t80 -132.5 143.6 49.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 43' ' ' TRP . . . . . 0.604 ' HB2' ' HD3' ' C' ' 50' ' ' ARG . 58.0 m95 -130.45 137.85 50.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -125.9 130.07 50.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.792 0.269 . . . . 0.0 111.191 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 45' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 27.6 t -121.66 113.03 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 56.89 36.17 27.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.14 0.495 . . . . 0.0 110.979 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.49 15.1 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.818 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.54 133.96 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.61 138.04 58.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' ARG . . . . . 0.604 ' HD3' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -89.92 156.14 18.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.346 -172.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -69.79 156.08 39.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.077 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -53.14 166.85 0.21 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.776 0.798 . . . . 0.0 112.321 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.15 7.31 12.71 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -160.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' VAL . . . . . 0.571 HG22 HD21 ' C' ' 72' ' ' LEU . 23.8 t -84.61 129.21 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.044 -1.578 . . . . 0.0 107.874 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 55' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 41.1 mt-10 -128.71 108.9 10.85 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 7.0 p -92.11 123.12 35.22 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -89.04 144.43 26.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' ASN . . . . . 0.403 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.1 t30 -58.37 137.4 85.29 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.774 -175.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' PRO . . . . . 0.409 ' HB3' HD11 ' C' ' 68' ' ' ILE . 31.1 Cg_exo -48.09 134.88 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.781 2.987 . . . . 0.0 112.849 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -121.55 124.32 44.1 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -87.73 109.03 19.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.032 0.444 . . . . 0.0 110.395 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 12.3 m -96.78 102.64 14.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.984 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.28 -109.45 2.91 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.181 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 27.6 t -110.93 6.89 21.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.232 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -118.29 158.09 25.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.185 0.517 . . . . 0.0 110.91 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -101.14 146.79 27.02 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -131.58 119.11 21.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.112 0.482 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ILE . . . . . 0.587 ' O ' HD12 ' C' ' 31' ' ' ILE . 1.6 mp -114.89 133.09 62.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.922 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.31 121.62 61.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 0.0 110.391 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' C' ' 29' ' ' CYS . 40.8 m -108.96 111.12 22.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.695 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 81.8 tttt -105.37 144.56 31.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.978 -174.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' LEU . . . . . 0.571 HD21 HG22 ' C' ' 54' ' ' VAL . 0.5 OUTLIER -122.49 119.59 31.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 174.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -91.53 111.17 22.57 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 74' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' C' ' 85' ' ' TYR . 8.3 p -134.33 163.62 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.095 0.474 . . . . 0.0 110.864 -168.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.773 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 63.2 mtt -74.16 129.1 37.17 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.442 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' ALA . . . . . 0.982 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . . . -56.9 -45.38 82.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.812 -176.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 26.0 t -59.7 -32.72 70.78 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.916 0.486 . . . . 0.0 111.477 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' GLU . . . . . 0.773 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 26.2 mm-40 -67.38 -51.67 49.18 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' TRP . . . . . 0.45 ' CB ' ' HB1' ' C' ' 25' ' ' ALA . 56.3 t-105 -57.84 -44.26 86.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.087 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' ASP . . . . . 0.547 ' HA ' ' HE2' ' C' ' 104' ' ' LYS . 26.7 t70 -70.88 -11.55 61.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 9.9 t -87.71 -3.68 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.5 26.28 68.15 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.487 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -65.58 149.77 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 111.057 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 27.5 mt-10 -71.24 129.08 37.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.115 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 85' ' ' TYR . . . . . 0.523 ' HD1' ' HE3' ' C' ' 43' ' ' TRP . 0.4 OUTLIER -128.9 119.41 24.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 86' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 16.7 t -120.48 136.39 57.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 87' ' ' CYS . . . . . 0.447 ' HB3' HD21 ' C' ' 11' ' ' LEU . 10.8 t -111.54 126.38 54.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 88' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -119.25 146.02 45.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.882 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 89' ' ' VAL . . . . . 0.683 HG21 HG21 ' C' ' 31' ' ' ILE . 39.2 t -123.54 131.09 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.8 136.56 54.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.976 0.417 . . . . 0.0 111.016 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 15.1 t70 -149.3 145.18 26.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -63.09 -18.46 63.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.119 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -101.53 5.07 41.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.9 pp -99.14 148.42 34.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.05 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.4 -34.74 1.89 Allowed 'Trans proline' 0 N--CA 1.469 0.057 0 C-N-CA 123.83 3.02 . . . . 0.0 112.841 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' THR . . . . . 0.505 ' O ' HD13 ' C' ' 94' ' ' LEU . 20.1 p -144.66 148.7 40.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.37 144.78 91.81 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.325 2.016 . . . . 0.0 111.254 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 44.1 t -94.72 116.66 36.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 99' ' ' LYS . . . . . 0.512 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 18.6 ptpt -127.66 149.18 50.31 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.091 -174.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.407 ' O ' HD11 ' C' ' 11' ' ' LEU . . . -155.76 135.76 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.906 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.4 t -112.8 154.61 25.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.943 0.401 . . . . 0.0 111.179 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' ILE . . . . . 0.559 ' HB ' HD13 ' C' ' 11' ' ' LEU . 5.7 tp -122.92 144.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.156 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -133.57 150.15 51.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.422 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' C' ' 80' ' ' ASP . 21.6 ttpp -90.65 136.81 32.83 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.576 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tp . . . . . 0 N--CA 1.443 -0.802 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 5.2 m -115.45 111.56 20.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.192 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.642 HG22 HG22 ' C' ' 31' ' ' ILE . 29.1 t -106.43 114.51 45.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.117 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -125.49 123.75 39.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' C' ' 28' ' ' VAL . 44.2 mt -99.24 135.07 41.19 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.66 ' HB3' HG22 ' C' ' 28' ' ' VAL . 3.3 tm? -108.58 125.19 51.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.407 ' HB2' ' HD2' ' C' ' 14' ' ' PRO . 62.2 pttt -94.92 153.66 39.88 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.473 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . 0.629 ' HD3' HD13 ' C' ' 27' ' ' ILE . 60.0 Cg_endo . . . . . 0 C--O 1.235 0.356 0 C-N-CA 123.046 2.497 . . . . 0.0 112.853 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' THR . . . . . 0.428 HG21 ' HD2' ' C' ' 71' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.083 0 N-CA-C 110.851 -0.055 . . . . 0.0 110.851 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' ILE . . . . . 0.629 HD13 ' HD3' ' C' ' 14' ' ' PRO . 20.9 mm -112.75 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 163.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.66 HG22 ' HB3' ' C' ' 12' ' ' LEU . 0.6 OUTLIER -119.13 142.83 32.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.685 -169.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' CYS . . . . . 0.488 ' HA ' HD23 ' C' ' 11' ' ' LEU . 41.1 t -115.18 113.48 23.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.306 170.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.23 123.39 46.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' ILE . . . . . 0.642 HG22 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.86 130.54 73.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.932 0.872 . . . . 0.0 111.648 -178.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.75 129.38 66.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.497 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.33 161.49 27.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.373 0.42 . . . . 0.0 110.748 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' C' ' 65' ' ' LYS . 6.0 p -144.04 150.89 38.91 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.3 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' C' ' 34' ' ' SER . 67.1 m-20 75.38 11.04 3.45 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.524 0.515 . . . . 0.0 112.22 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 16.7 mt -91.51 168.14 11.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.554 0.692 . . . . 0.0 111.821 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -96.53 171.81 8.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.151 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -56.94 115.48 2.63 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 123.801 1.763 . . . . 0.0 109.005 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.526 ' CG2' HG13 ' C' ' 89' ' ' VAL . 4.6 mp -74.11 144.46 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 111.247 -2.706 . . . . 0.0 113.069 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 22.4 tptm -106.63 124.34 49.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.802 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.9 139.27 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.559 0.218 . . . . 0.0 110.618 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -135.53 141.1 45.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 111.44 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' TRP . . . . . 0.801 ' HB2' ' HD2' ' C' ' 50' ' ' ARG . 51.9 m95 -129.7 136.78 50.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . 0.537 ' OE1' ' HA2' ' C' ' 47' ' ' GLY . 8.3 tt0 -121.47 129.31 52.88 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 21.5 t -120.92 108.06 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 58.03 37.06 26.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 111.09 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . 0.537 ' HA2' ' OE1' ' C' ' 44' ' ' GLN . . . 78.13 -6.93 47.69 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.94 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.53 130.98 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.956 0.407 . . . . 0.0 111.172 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.4 136.34 57.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.846 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' ARG . . . . . 0.801 ' HD2' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -91.74 146.9 23.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.917 0.865 . . . . 0.0 112.412 -170.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -66.14 161.4 21.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.162 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.603 ' HG2' ' H ' ' C' ' 53' ' ' GLY . 39.4 tttm -53.92 164.33 0.61 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.698 0.761 . . . . 0.0 110.611 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . 0.603 ' H ' ' HG2' ' C' ' 52' ' ' LYS . . . 115.8 -13.28 17.55 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -159.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.551 ' HA ' HD22 ' C' ' 72' ' ' LEU . 2.6 p -82.81 129.1 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 112.898 -1.651 . . . . 0.0 107.752 163.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -141.8 114.75 8.63 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.503 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 28.4 m -89.09 126.06 35.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.93 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.541 ' HB2' HG13 ' C' ' 69' ' ' VAL . 48.1 mt-30 -90.99 149.23 21.93 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' ASN . . . . . 0.425 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.3 t30 -56.39 138.73 74.85 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.134 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' C' ' 58' ' ' ASN . 53.6 Cg_exo -47.52 135.84 20.83 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 124.194 3.263 . . . . 0.0 113.616 -174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' C' ' 67' ' ' THR . 34.4 tt0 . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . 0.446 ' HA ' ' HB3' ' C' ' 34' ' ' SER . 35.5 mmtm . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.465 0.65 . . . . 0.0 111.13 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 10.2 m -105.6 150.54 25.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.675 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' C' ' 60' ' ' GLU . 66.8 m -134.39 121.62 21.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.275 0.56 . . . . 0.0 110.939 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.497 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.5 mp -112.09 133.47 57.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -127.75 136.36 60.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.794 0.33 . . . . 0.0 110.779 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.9 p -129.34 125.04 35.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.28 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.428 ' HD2' HG21 ' C' ' 26' ' ' THR . 52.9 mtmt -107.72 139.33 42.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.17 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.566 HD11 ' HG3' ' C' ' 50' ' ' ARG . 0.2 OUTLIER -110.29 127.52 55.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.912 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.1 116.75 29.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' C' ' 85' ' ' TYR . 34.5 m -134.77 163.39 36.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 -169.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 91.1 mmm -81.52 128.67 34.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.172 0.51 . . . . 0.0 110.107 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.91 -48.78 42.27 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.946 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 50.4 m -61.75 -29.54 70.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.457 0.571 . . . . 0.0 111.919 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -52.2 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' TRP . . . . . 0.449 ' HZ3' HG23 ' C' ' 102' ' ' ILE . 66.0 t-105 -56.85 -46.92 81.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.06 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' ASP . . . . . 0.565 ' HA ' ' HD3' ' C' ' 104' ' ' LYS . 22.5 t70 -69.5 -15.05 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.222 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -79.1 -5.4 53.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.3 18.92 65.61 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 8.3 m -65.58 138.55 58.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.436 0.636 . . . . 0.0 111.393 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.9 mt-10 -74.76 133.52 41.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.541 -172.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' TYR . . . . . 0.576 ' O ' HG22 ' C' ' 102' ' ' ILE . 82.0 m-85 -129.54 115.1 16.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' C' ' 101' ' ' SER . 0.3 OUTLIER -132.4 140.27 48.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 121.376 0.608 . . . . 0.0 111.298 -176.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 7.6 t -106.87 126.74 52.7 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.4 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -117.32 144.35 44.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' VAL . . . . . 0.611 ' HB ' ' CG1' ' C' ' 98' ' ' VAL . 54.6 t -116.76 135.33 57.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' C' ' 40' ' ' LYS . 36.3 tt0 -125.28 130.33 51.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . 0.501 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 15.7 t70 -150.67 144.65 25.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.186 0.517 . . . . 0.0 110.046 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.5 t -66.17 -19.27 65.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.859 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . 0.431 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 6.6 mm-40 -92.09 -6.67 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 38.7 mt -89.76 145.96 34.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.44 -35.16 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.325 2.683 . . . . 0.0 111.68 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -146.21 154.04 49.45 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.102 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.56 148.81 73.39 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.739 1.626 . . . . 0.0 111.359 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' VAL . . . . . 0.611 ' CG1' ' HB ' ' C' ' 89' ' ' VAL . 10.7 p -110.56 140.01 31.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.566 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 8.6 ptpp? -137.85 151.73 48.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 0.0 111.775 -171.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.85 127.58 4.72 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.434 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . 0.559 ' HB3' ' HB ' ' C' ' 86' ' ' VAL . 72.2 p -107.48 160.63 15.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.133 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . 0.576 HG22 ' O ' ' C' ' 85' ' ' TYR . 3.6 tp -121.77 139.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.077 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -114.84 145.46 42.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.054 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' C' ' 80' ' ' ASP . 33.9 ttpt -73.61 110.35 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.189 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.143 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' ILE . . . . . 0.712 HG12 HG11 ' C' ' 98' ' ' VAL . 3.3 tp . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 121.169 0.509 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 16.3 m -114.73 106.75 14.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.556 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.05 113.66 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.023 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -112.24 110.2 20.31 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.675 HD21 ' HB ' ' C' ' 102' ' ' ILE . 57.8 tp -99.53 117.5 34.06 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.45 118.45 35.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.162 0.506 . . . . 0.0 110.706 -167.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.548 ' HB3' HD11 ' C' ' 102' ' ' ILE . 14.4 ptpt -79.53 147.5 67.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.146 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 N--CA 1.462 -0.325 0 C-N-CA 122.477 2.118 . . . . 0.0 111.568 -179.626 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' THR . . . . . 0.787 ' HA ' HG12 ' C' ' 74' ' ' VAL . 5.8 t . . . . . 0 CA--C 1.536 0.44 0 CA-C-O 121.802 0.811 . . . . 0.0 112.283 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' ILE . . . . . 0.526 HG13 HG11 ' C' ' 74' ' ' VAL . 40.1 mt -97.33 154.74 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.704 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.618 HG22 ' HG2' ' C' ' 71' ' ' LYS . 84.1 t -130.61 133.93 62.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.745 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' CYS . . . . . 0.433 ' HB2' ' CZ2' ' C' ' 43' ' ' TRP . 19.3 t -115.78 112.36 21.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -104.97 123.33 47.59 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' ILE . . . . . 0.56 HG12 HG21 ' C' ' 89' ' ' VAL . 0.1 OUTLIER -121.78 136.06 59.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.445 0.64 . . . . 0.0 111.007 -176.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 17.9 t -114.94 132.24 64.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.084 -176.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.631 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.88 167.61 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.236 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 41.8 t -141.01 150.32 42.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' C' ' 34' ' ' SER . 7.2 m-20 76.81 11.59 2.5 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.479 0.487 . . . . 0.0 112.085 170.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -96.35 164.33 12.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.902 0.858 . . . . 0.0 112.351 -175.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' C' ' 38' ' ' ASN . 11.3 tp10 -91.81 174.1 7.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.394 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 1.2 m-80 -56.36 114.09 1.85 Allowed 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.131 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.629 HG21 HG13 ' C' ' 89' ' ' VAL . 5.0 mp -73.83 144.57 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 112.448 -2.16 . . . . 0.0 113.266 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.86 122.94 46.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.79 144.12 14.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.0 110.908 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.45 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.5 t80 -135.06 143.85 46.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' TRP . . . . . 0.458 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 51.7 m95 -127.6 139.5 52.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . 0.501 ' HG2' ' HB ' ' C' ' 86' ' ' VAL . 4.0 pt20 -132.77 131.02 40.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.628 0.728 . . . . 0.0 111.11 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 0.2 OUTLIER -120.25 122.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.54 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 53.77 34.83 19.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.02 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.65 -16.36 25.96 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.443 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -87.72 134.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.22 139.36 58.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.195 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -89.31 117.23 28.11 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -53.29 158.45 1.63 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.912 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.68 164.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.723 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.18 3.97 20.89 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -155.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.407 ' HA ' HD22 ' C' ' 72' ' ' LEU . 7.6 p -88.23 132.44 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.116 -1.542 . . . . 0.0 108.351 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 86.8 tt0 -125.49 108.86 12.04 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.83 0.348 . . . . 0.0 110.459 -172.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 16.0 p -98.45 122.64 41.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.812 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.692 ' HB2' HG13 ' C' ' 69' ' ' VAL . 42.5 mt-30 -103.06 176.27 5.2 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.236 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.31 150.78 85.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 0.0 110.744 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' PRO . . . . . 0.539 ' HB3' HD11 ' C' ' 68' ' ' ILE . 43.9 Cg_endo -65.48 148.09 87.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.553 2.835 . . . . 0.0 112.989 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' GLU . . . . . 0.582 ' HG3' ' HB ' ' C' ' 67' ' ' THR . 14.4 pt-20 . . . . . 0 N--CA 1.443 -0.824 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . 0.464 ' HE2' HG12 ' C' ' 32' ' ' VAL . 46.6 mtpt . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.559 0.695 . . . . 0.0 111.12 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -115.59 149.06 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.577 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.582 ' HB ' ' HG3' ' C' ' 60' ' ' GLU . 46.2 m -132.37 122.16 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.397 0.618 . . . . 0.0 110.813 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.631 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -110.06 132.48 58.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.379 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.9 p -108.5 122.47 63.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.552 0.692 . . . . 0.0 110.878 176.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.1 m -120.74 122.19 39.86 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.618 ' HG2' HG22 ' C' ' 28' ' ' VAL . 6.8 mtpm? -106.0 152.54 23.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.952 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' C' ' 72' ' ' LEU . 0.2 OUTLIER -119.84 114.93 22.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -78.36 112.1 15.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' C' ' 26' ' ' THR . 12.9 p -128.63 153.09 37.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.951 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.643 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 97.0 mmm -72.03 129.47 38.61 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.689 0.757 . . . . 0.0 110.614 -175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.17 -34.11 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.793 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -70.56 -35.27 72.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.283 0.633 . . . . 0.0 111.397 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' GLU . . . . . 0.643 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 59.7 mt-10 -68.58 -52.49 31.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -58.2 -42.47 86.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.801 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.37 -26.03 68.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.325 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 51.0 m -87.05 -2.39 58.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.843 0.354 . . . . 0.0 111.299 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.59 28.79 72.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.521 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.641 HG21 ' HB3' ' C' ' 78' ' ' GLU . 14.6 t -64.88 150.82 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 32.5 mt-10 -80.64 141.86 34.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.069 0.461 . . . . 0.0 111.32 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -137.75 127.86 25.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.754 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' C' ' 99' ' ' LYS . 20.9 t -120.48 138.76 49.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 29.2 t -111.46 118.5 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.731 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.3 mp -113.28 147.06 38.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.677 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' VAL . . . . . 0.629 HG13 HG21 ' C' ' 39' ' ' ILE . 25.1 t -135.29 125.69 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 122.91 0.484 . . . . 0.0 109.806 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' C' ' 97' ' ' PRO . 12.9 pt-20 -133.64 145.48 50.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . 0.554 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 14.5 t70 -136.75 158.48 44.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 34.0 t -52.79 -41.7 64.37 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.386 0.429 . . . . 0.0 110.825 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -86.98 -1.73 58.09 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.554 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 42.8 mt -92.02 128.74 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 109.988 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -35.09 37.03 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 123.051 2.501 . . . . 0.0 112.206 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -147.52 153.67 43.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.944 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 37.6 Cg_endo -68.83 153.39 72.97 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.27 1.98 . . . . 0.0 111.503 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' VAL . . . . . 0.712 HG11 HG12 ' C' ' 7' ' ' ILE . 13.7 p -116.79 146.53 21.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.731 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 14.1 ptmm? -141.03 156.5 46.01 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.304 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.81 140.52 19.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 32.2 t -118.03 153.75 33.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.134 0.492 . . . . 0.0 111.063 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . 0.675 ' HB ' HD21 ' C' ' 11' ' ' LEU . 8.0 tp -124.21 149.48 28.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.774 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -142.07 152.96 43.81 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -78.38 108.39 11.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.184 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.854 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.707 -177.827 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' ILE . . . . . 0.421 HG12 HG11 ' C' ' 98' ' ' VAL . 2.1 tp . . . . . 0 N--CA 1.444 -0.74 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.875 ' HB2' HG13 ' C' ' 32' ' ' VAL . 51.0 m -110.31 104.49 13.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.374 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.54 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.27 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 16.0 m -121.01 127.31 51.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' C' ' 87' ' ' CYS . 72.2 mt -99.8 127.23 45.97 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.255 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.06 114.69 28.41 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.663 ' HB3' HD11 ' C' ' 102' ' ' ILE . 18.9 ptpt -76.26 154.79 84.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.303 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . 0.548 ' HD3' HD13 ' C' ' 27' ' ' ILE . 19.0 Cg_endo . . . . . 0 N--CA 1.464 -0.249 0 C-N-CA 122.4 2.067 . . . . 0.0 111.685 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' THR . . . . . 0.443 ' HA ' HG22 ' C' ' 74' ' ' VAL . 5.9 t . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.543 0.687 . . . . 0.0 111.518 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' ILE . . . . . 0.548 HD13 ' HD3' ' C' ' 14' ' ' PRO . 15.8 mm -88.87 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.192 -174.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.41 132.96 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.321 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.05 114.54 21.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.624 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.52 128.54 54.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' C' ' 8' ' ' SER . 0.0 OUTLIER -126.53 133.51 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.483 0.659 . . . . 0.0 111.373 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.875 HG13 ' HB2' ' C' ' 8' ' ' SER . 2.1 p -129.05 134.73 63.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.516 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.557 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -163.5 168.18 20.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.723 -171.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' SER . . . . . 0.553 ' HB3' ' HD3' ' C' ' 65' ' ' LYS . 18.9 p -141.99 149.88 40.63 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.42 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' C' ' 34' ' ' SER . 4.9 m-20 77.59 11.02 2.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.756 0.66 . . . . 0.0 112.166 171.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -96.18 177.51 5.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.996 0.903 . . . . 0.0 112.793 -170.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 39' ' ' ILE . 20.4 mm-40 -105.8 173.47 6.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.595 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.76 112.73 1.94 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 123.927 1.822 . . . . 0.0 108.773 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.721 HG21 HG13 ' C' ' 89' ' ' VAL . 51.0 mt -87.56 147.3 5.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 110.864 -2.88 . . . . 0.0 114.126 -171.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -100.33 126.49 46.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.156 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.58 137.97 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.694 ' CB ' ' HG ' ' C' ' 88' ' ' LEU . 0.1 OUTLIER -119.31 147.84 43.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.929 -0.123 . . . . 0.0 110.897 -176.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' TRP . . . . . 0.808 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 65.7 m95 -137.18 132.66 34.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . 0.793 HE21 ' HA ' ' C' ' 44' ' ' GLN . 0.0 OUTLIER -123.27 131.3 53.62 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 177.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' VAL . . . . . 0.593 HG21 ' HD2' ' C' ' 50' ' ' ARG . 21.6 t -124.96 118.26 52.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.151 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . 0.512 ' ND2' HG12 ' C' ' 45' ' ' VAL . 57.1 m-80 57.99 33.83 23.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 -175.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.7 -1.2 31.28 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.003 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 p -116.62 138.64 46.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.255 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.11 122.21 13.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.263 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' ARG . . . . . 0.593 ' HD2' HG21 ' C' ' 45' ' ' VAL . 7.9 ptm85 -92.86 167.54 11.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.4 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.65 159.47 21.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.991 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' C' ' 52' ' ' LYS . 0.0 OUTLIER -49.63 166.56 0.05 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.107 176.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.9 7.7 12.7 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -162.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.56 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.4 p -88.25 126.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' C' ' 70' ' ' SER . 39.9 mt-10 -121.0 109.62 15.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 5.6 p -101.13 116.88 33.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.954 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' C' ' 69' ' ' VAL . 75.1 mt-30 -87.47 150.17 23.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.27 0.557 . . . . 0.0 111.074 -175.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.89 138.18 97.32 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.334 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' PRO . . . . . 0.716 ' HB3' HD11 ' C' ' 68' ' ' ILE . 19.4 Cg_endo -61.68 136.31 61.77 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.525 2.817 . . . . 0.0 113.608 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 . . . . . 0 C--N 1.324 -0.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.541 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . 0.553 ' HD3' ' HB3' ' C' ' 34' ' ' SER . 72.3 mmtt . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.165 0.507 . . . . 0.0 111.4 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . 0.493 ' O ' HG23 ' C' ' 32' ' ' VAL . 9.6 m -115.99 149.13 39.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -130.67 121.46 25.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.984 0.421 . . . . 0.0 110.827 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' C' ' 59' ' ' PRO . 1.5 mp -108.8 137.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' C' ' 57' ' ' GLN . 61.7 t -109.85 129.59 64.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.594 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 43.7 m -124.89 110.33 14.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 0.0 110.137 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -106.64 145.16 32.29 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.6 118.85 27.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.934 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.633 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.605 HG11 ' CE1' ' C' ' 85' ' ' TYR . 24.5 m -136.41 159.66 38.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.699 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.0 mtt -76.74 131.98 39.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.98 -51.6 29.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 10.5 m -59.08 -30.17 67.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' GLU . . . . . 0.574 ' HG3' HG21 ' C' ' 83' ' ' THR . 6.6 tp10 -69.96 -51.18 34.77 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' TRP . . . . . 0.419 ' HE3' ' CE2' ' C' ' 85' ' ' TYR . 50.8 t-105 -56.5 -44.05 80.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.173 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.14 -6.37 42.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.238 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' C' ' 78' ' ' GLU . 30.5 t -83.82 -7.9 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.335 0.588 . . . . 0.0 109.957 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.22 21.16 68.09 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.058 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.574 HG21 ' HG3' ' C' ' 78' ' ' GLU . 14.9 t -69.88 157.24 37.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.278 0.561 . . . . 0.0 110.324 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' C' ' 46' ' ' ASN . 3.5 pt-20 -81.25 138.97 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.159 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' TYR . . . . . 0.605 ' CE1' HG11 ' C' ' 74' ' ' VAL . 75.8 m-85 -126.21 116.92 22.05 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.0 169.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 33.3 t -118.57 129.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' CYS . . . . . 0.591 ' HB3' HD21 ' C' ' 11' ' ' LEU . 8.7 t -116.0 124.4 50.42 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.694 ' HG ' ' CB ' ' C' ' 42' ' ' PHE . 1.7 pp -137.39 154.78 49.92 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.327 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' VAL . . . . . 0.721 HG13 HG21 ' C' ' 39' ' ' ILE . 6.3 t -122.13 135.11 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.273 -173.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -131.02 138.35 49.61 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . 0.561 ' HB2' HG12 ' C' ' 39' ' ' ILE . 17.3 t70 -146.67 151.52 37.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.676 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -64.45 -20.67 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.162 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -90.84 -8.15 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.44 ' HA ' ' HD3' ' C' ' 95' ' ' PRO . 50.4 mt -94.24 147.77 33.94 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.958 0.408 . . . . 0.0 110.574 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 4.2 Cg_exo -82.12 -30.74 1.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.384 2.722 . . . . 0.0 111.481 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 26.2 p -142.7 154.3 62.59 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.203 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' PRO . . . . . 0.475 ' HB2' HD13 ' C' ' 88' ' ' LEU . 41.4 Cg_endo -68.49 150.34 75.3 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.925 1.75 . . . . 0.0 110.971 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 47.0 t -109.06 106.14 20.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -176.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' C' ' 88' ' ' LEU . 14.8 ptpt -111.35 149.95 30.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.327 -171.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.6 129.8 12.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.116 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 42.0 t -110.74 152.76 26.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 111.734 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . 0.663 HD11 ' HB3' ' C' ' 13' ' ' LYS . 11.6 tt -131.08 148.27 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.457 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -137.17 158.43 44.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.633 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -64.04 110.4 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.234 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.493 179.34 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' ILE . . . . . 0.579 HG12 HG11 ' C' ' 98' ' ' VAL . 2.8 tp . . . . . 0 N--CA 1.448 -0.57 0 CA-C-O 121.554 0.693 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 37.5 m -126.62 120.51 29.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.851 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.51 119.41 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.136 0.493 . . . . 0.0 110.864 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -110.09 118.03 35.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' C' ' 87' ' ' CYS . 44.1 mt -99.79 121.78 41.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.827 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 57.4 tp -109.97 116.16 31.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.478 ' NZ ' ' HB3' ' C' ' 105' ' ' ALA . 22.3 ptmt -77.9 150.3 78.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.658 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 N--CA 1.46 -0.49 0 C-N-CA 123.083 2.522 . . . . 0.0 111.642 175.799 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.903 0.859 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 27.6 mt -93.52 153.53 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.759 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.74 133.76 67.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.309 0.576 . . . . 0.0 111.67 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 45.4 t -118.4 112.05 19.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . 0.702 ' HG3' HG22 ' C' ' 69' ' ' VAL . 28.2 tt0 -113.29 120.22 40.4 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' ILE . . . . . 0.422 HD12 HG22 ' C' ' 68' ' ' ILE . 0.0 OUTLIER -121.73 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.427 0.632 . . . . 0.0 111.262 -166.31 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 130.35 72.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.761 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.763 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -160.55 164.69 31.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' SER . . . . . 0.414 ' HB2' ' HG2' ' C' ' 65' ' ' LYS . 8.7 t -144.27 147.32 33.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 78.14 9.0 2.27 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.67 0.606 . . . . 0.0 111.297 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 19.1 mt -93.44 157.88 16.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.4 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -83.59 174.11 10.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.219 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -57.19 113.05 1.56 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 123.969 1.842 . . . . 0.0 108.373 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.673 HG23 HG13 ' C' ' 89' ' ' VAL . 5.2 mp -73.57 147.33 9.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 110.941 -2.845 . . . . 0.0 113.144 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.454 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 23.6 ttmm -118.42 136.47 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.966 170.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.88 138.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.066 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.747 ' HB3' HD23 ' C' ' 88' ' ' LEU . 5.3 t80 -119.56 150.35 40.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.427 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' TRP . . . . . 0.769 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 56.9 m95 -132.52 131.89 42.06 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.11 130.72 48.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.224 0.466 . . . . 0.0 111.046 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.15 111.16 34.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.65 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . 0.438 HD22 ' HA ' ' C' ' 46' ' ' ASN . 0.7 OUTLIER 58.79 37.29 24.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 110.396 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.51 -9.85 33.21 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.569 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 131.87 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 117.088 0.444 . . . . 0.0 110.348 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.99 137.91 56.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.196 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' ARG . . . . . 0.497 ' HD3' ' N ' ' C' ' 51' ' ' LYS . 1.0 OUTLIER -89.75 136.34 33.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.943 -174.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' C' ' 50' ' ' ARG . 13.5 mptt -66.93 157.15 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.745 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -45.31 165.79 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.884 0.849 . . . . 0.0 112.987 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.53 7.86 15.3 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -158.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.413 ' HA ' HD22 ' C' ' 72' ' ' LEU . 7.4 p -90.95 134.57 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.268 -1.466 . . . . 0.0 108.076 173.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.66 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 33.6 tt0 -129.03 109.12 10.94 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -98.69 121.68 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -96.83 152.55 18.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 110.097 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.75 133.06 94.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.247 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' PRO . . . . . 0.578 ' HB3' ' CD1' ' C' ' 68' ' ' ILE . 13.2 Cg_endo -59.96 141.85 97.3 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.731 2.954 . . . . 0.0 113.488 -171.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 . . . . . 0 N--CA 1.45 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.827 174.651 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' C' ' 34' ' ' SER . 53.6 mttp . . . . . 0 C--O 1.224 -0.245 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 6.0 m -118.95 150.77 39.35 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 94.1 m -131.04 120.05 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.896 0.379 . . . . 0.0 110.983 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.763 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.46 125.31 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' VAL . . . . . 0.702 HG22 ' HG3' ' C' ' 30' ' ' GLU . 47.0 t -106.01 122.49 59.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 36.2 m -120.11 130.35 54.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 110.803 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' C' ' 55' ' ' GLU . 59.2 mttp -105.73 147.88 28.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.657 HD12 HG12 ' C' ' 74' ' ' VAL . 0.2 OUTLIER -125.5 114.6 19.0 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -93.89 112.67 24.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.657 HG12 HD12 ' C' ' 72' ' ' LEU . 4.5 m -122.01 168.54 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.353 -170.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.541 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 81.0 mtp -73.43 132.08 42.56 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.531 0.681 . . . . 0.0 109.458 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.43 -31.34 61.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.407 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -72.43 -31.66 65.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.769 0.828 . . . . 0.0 111.16 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' GLU . . . . . 0.541 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 69.3 mt-10 -65.56 -52.24 53.83 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.526 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.75 -18.82 65.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.244 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -87.06 -5.57 59.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.301 0.572 . . . . 0.0 109.801 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.29 28.89 72.19 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.345 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 152.58 43.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.064 0.459 . . . . 0.0 110.33 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.87 135.1 41.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.757 -173.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -131.6 127.08 36.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 41.0 t -120.55 136.4 57.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' CYS . . . . . 0.579 ' HB3' HD21 ' C' ' 11' ' ' LEU . 12.4 t -115.65 130.48 56.88 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' C' ' 42' ' ' PHE . 0.0 OUTLIER -146.85 147.41 30.81 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.636 -167.032 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' VAL . . . . . 0.673 HG13 HG23 ' C' ' 39' ' ' ILE . 55.6 t -115.5 137.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 122.924 0.489 . . . . 0.0 111.193 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.497 ' HA ' HD21 ' C' ' 94' ' ' LEU . 4.9 pt-20 -129.71 133.12 46.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 17.0 t70 -148.32 149.42 31.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.981 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 17.2 m -47.0 -47.32 22.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.203 0.525 . . . . 0.0 111.532 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . 0.485 ' HB3' ' OD2' ' C' ' 91' ' ' ASP . 11.2 tp10 -83.85 -5.26 59.17 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.308 -167.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.572 ' O ' HD12 ' C' ' 94' ' ' LEU . 2.2 pp -92.97 150.55 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.133 -0.979 . . . . 0.0 111.265 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 -35.41 1.25 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.674 2.916 . . . . 0.0 112.44 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 5.5 p -147.78 151.19 38.19 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.26 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' PRO . . . . . 0.533 ' HB2' HD11 ' C' ' 88' ' ' LEU . 30.5 Cg_endo -61.78 144.69 97.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.579 2.186 . . . . 0.0 111.498 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' VAL . . . . . 0.579 HG11 HG12 ' C' ' 7' ' ' ILE . 41.8 t -107.07 102.5 14.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' C' ' 88' ' ' LEU . 10.6 ptpp? -108.36 151.29 26.22 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.833 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.76 127.63 9.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 29.0 t -111.4 157.5 20.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.464 0.65 . . . . 0.0 111.393 -172.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . 0.484 ' HB ' HD13 ' C' ' 11' ' ' LEU . 5.5 tp -122.08 149.26 25.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.969 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' ARG . . . . . 0.46 ' HD3' ' N ' ' C' ' 103' ' ' ARG . 0.0 OUTLIER -131.98 151.2 51.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -76.0 138.89 41.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.18 0.514 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' ALA . . . . . 0.478 ' HB3' ' NZ ' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.246 0.892 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' ILE . . . . . 0.834 HG12 HG21 ' C' ' 98' ' ' VAL . 2.8 tp . . . . . 0 N--CA 1.438 -1.027 0 CA-C-O 121.759 0.79 . . . . 0.0 108.892 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.407 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 49.2 m -120.84 116.04 24.41 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.114 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 31' ' ' ILE . 43.8 t -103.73 114.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.957 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 4.0 m -105.84 109.3 21.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.64 HD21 ' HB ' ' C' ' 102' ' ' ILE . 55.6 tp -103.02 117.13 33.9 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.745 -174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 65.6 tp -113.84 123.69 50.41 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.111 0.481 . . . . 0.0 110.43 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.549 ' HB3' HD11 ' C' ' 102' ' ' ILE . 21.6 pttp -86.52 152.87 55.35 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.908 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo . . . . . 0 N--CA 1.461 -0.408 0 C-N-CA 122.332 2.021 . . . . 0.0 111.508 -178.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' THR . . . . . 0.718 HG22 ' HA ' ' C' ' 73' ' ' LYS . 68.0 p . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.247 0.546 . . . . 0.0 112.131 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 13.6 mm -89.4 152.3 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.664 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.649 HG22 ' HG2' ' C' ' 71' ' ' LYS . 77.5 t -133.72 132.95 57.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.745 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 35.8 t -120.42 114.2 21.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.51 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -106.96 127.85 53.81 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' ILE . . . . . 0.624 HG21 HG21 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.46 133.33 69.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.683 -177.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 47.6 t -112.34 130.08 66.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.761 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.727 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.25 164.9 27.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.113 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 47.4 t -139.2 150.09 45.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.985 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' C' ' 34' ' ' SER . 1.6 m-20 75.78 12.25 3.02 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.515 0.509 . . . . 0.0 112.322 172.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.03 159.77 14.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.714 0.769 . . . . 0.0 111.525 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' C' ' 38' ' ' ASN . 22.0 tt0 -92.72 173.17 7.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.568 174.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.401 ' H ' ' HG2' ' C' ' 37' ' ' GLU . 5.5 p30 -55.46 115.65 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.849 1.785 . . . . 0.0 109.176 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.623 ' CG2' HG13 ' C' ' 89' ' ' VAL . 5.0 mp -76.41 146.37 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.18 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.492 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 55.0 tptt -104.4 127.63 52.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.732 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.11 140.04 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.6 t80 -133.17 144.36 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 111.559 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' TRP . . . . . 0.596 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 69.1 m95 -127.09 140.7 52.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . 0.408 ' HB3' HG13 ' C' ' 86' ' ' VAL . 35.0 tt0 -128.09 131.05 49.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 111.195 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' VAL . . . . . 0.786 HG21 ' HE ' ' C' ' 50' ' ' ARG . 21.2 t -116.99 116.01 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.484 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.58 36.62 27.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.213 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.07 -15.64 26.41 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.754 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.56 137.28 25.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.626 -0.338 . . . . 0.0 110.608 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.46 136.51 57.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' ARG . . . . . 0.786 ' HE ' HG21 ' C' ' 45' ' ' VAL . 17.7 tpp180 -91.74 122.15 34.03 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.991 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.88 162.42 5.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.655 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -42.72 164.52 0.01 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.283 1.04 . . . . 0.0 113.613 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.37 -1.03 23.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 -155.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.405 ' HA ' HD22 ' C' ' 72' ' ' LEU . 6.7 p -88.79 131.98 34.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 113.205 -1.497 . . . . 0.0 108.281 174.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' C' ' 71' ' ' LYS . 45.7 mt-10 -126.25 109.24 12.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.0 110.626 -172.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 15.9 m -95.08 117.24 29.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.519 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.79 165.95 11.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.849 0.357 . . . . 0.0 110.438 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' ASN . . . . . 0.491 ' ND2' ' HD2' ' C' ' 59' ' ' PRO . 29.3 t-20 -69.18 134.47 89.35 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.899 0.857 . . . . 0.0 112.456 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' C' ' 67' ' ' THR . 23.5 Cg_exo -55.19 134.8 65.88 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 124.173 3.249 . . . . 0.0 112.586 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 . . . . . 0 N--CA 1.451 -0.417 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.421 175.533 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 12.6 mtpp . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -113.68 154.03 27.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.994 -0.441 . . . . 0.0 110.962 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 85.4 m -136.45 123.46 21.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.407 . . . . 0.0 111.166 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.727 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.6 mp -108.7 132.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.3 122.1 64.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.006 0.431 . . . . 0.0 110.489 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 27.4 t -118.17 122.78 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.628 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.649 ' HG2' HG22 ' C' ' 28' ' ' VAL . 32.1 mtpt -106.17 154.51 20.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.818 0.342 . . . . 0.0 110.426 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.457 ' HG ' ' CE1' ' C' ' 85' ' ' TYR . 0.2 OUTLIER -119.97 117.73 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' LYS . . . . . 0.718 ' HA ' HG22 ' C' ' 26' ' ' THR . 71.1 tttt -85.07 112.26 20.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' C' ' 26' ' ' THR . 12.5 p -133.62 155.99 40.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -166.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.9 mtm -80.24 130.37 35.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.861 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.04 -53.07 17.52 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.442 0.464 . . . . 0.0 111.762 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 41.3 t -57.72 -32.87 67.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.909 0.484 . . . . 0.0 112.066 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' GLU . . . . . 0.618 ' HG3' HG21 ' C' ' 83' ' ' THR . 3.8 tp10 -66.11 -54.73 21.98 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' C' ' 104' ' ' LYS . 62.1 t-105 -59.31 -48.88 79.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.863 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' ASP . . . . . 0.484 ' HA ' ' HG3' ' C' ' 104' ' ' LYS . 5.5 t70 -70.27 -6.49 35.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.901 -174.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -81.23 -5.78 58.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 109.883 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' C' ' 104' ' ' LYS . . . 82.83 20.01 62.23 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.618 HG21 ' HG3' ' C' ' 78' ' ' GLU . 0.6 OUTLIER -63.47 145.87 54.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.231 -177.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 33.8 mt-10 -81.58 135.61 35.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 111.767 -176.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' TYR . . . . . 0.484 ' O ' HG22 ' C' ' 102' ' ' ILE . 1.8 m-85 -134.13 124.75 26.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.956 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 0.2 OUTLIER -133.26 142.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 111.424 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 18.9 t -112.37 124.53 52.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.412 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.901 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.5 mp -114.73 147.6 39.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' VAL . . . . . 0.624 HG21 HG21 ' C' ' 31' ' ' ILE . 11.4 t -126.44 131.62 71.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.234 0.613 . . . . 0.0 109.958 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 8.3 pt-20 -136.09 134.95 38.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.175 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . 0.523 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 7.9 t70 -147.0 151.83 37.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.142 0.496 . . . . 0.0 110.571 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 66.4 m -68.35 -8.13 37.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.636 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 58.0 mm-40 -99.99 -4.57 29.77 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 111.163 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.571 ' C ' HD12 ' C' ' 94' ' ' LEU . 2.4 pp -108.09 158.51 33.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.962 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' C' ' 96' ' ' THR . 5.3 Cg_endo -91.03 -34.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.831 3.687 . . . . 0.0 112.784 -173.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.546 ' H ' ' HD2' ' C' ' 95' ' ' PRO . 33.2 p -141.38 145.84 39.79 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.53 148.47 66.66 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.954 1.769 . . . . 0.0 111.142 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' VAL . . . . . 0.834 HG21 HG12 ' C' ' 7' ' ' ILE . 40.3 t -110.61 139.11 35.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.901 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 24.9 pttm -144.15 157.53 44.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.467 0.651 . . . . 0.0 112.593 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.06 137.02 11.46 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.862 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 75.2 p -114.65 149.94 35.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.994 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . 0.64 ' HB ' HD21 ' C' ' 11' ' ' LEU . 3.9 tp -122.71 153.2 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' ARG . . . . . 0.454 ' N ' HG13 ' C' ' 102' ' ' ILE . 12.8 ptp180 -125.14 156.67 37.98 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' LYS . . . . . 0.546 ' HB3' ' HA2' ' C' ' 82' ' ' GLY . 8.1 tmtm? -78.84 122.88 26.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.998 0.428 . . . . 0.0 110.968 -173.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' ALA . . . . . 0.473 ' HB3' ' HE2' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 172.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 tp . . . . . 0 N--CA 1.446 -0.669 0 CA-C-O 121.305 0.574 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 26.8 t -120.87 121.1 37.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.441 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.812 HG22 HG22 ' C' ' 31' ' ' ILE . 41.2 t -119.0 123.72 71.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.499 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -146.89 146.66 30.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.473 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.2 mm? -97.1 145.08 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.323 0.582 . . . . 0.0 111.104 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 63.0 tp -115.24 117.59 30.9 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.431 ' HB3' HD11 ' C' ' 102' ' ' ILE . 43.3 pttt -91.12 155.31 44.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.797 0.332 . . . . 0.0 110.475 -177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . 0.607 ' HD3' HD13 ' C' ' 27' ' ' ILE . 74.5 Cg_endo . . . . . 0 N--CA 1.456 -0.725 0 C-N-CA 122.805 2.337 . . . . 0.0 111.161 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 CA--C 1.536 0.412 0 CA-C-O 120.667 0.27 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' ILE . . . . . 0.607 HD13 ' HD3' ' C' ' 14' ' ' PRO . 22.8 mm -117.37 117.89 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 79.3 t -112.64 134.78 54.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.103 -170.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' CYS . . . . . 0.402 ' HB2' ' CH2' ' C' ' 43' ' ' TRP . 52.3 t -111.62 114.45 27.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.108 171.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -96.15 125.42 40.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' ILE . . . . . 0.812 HG22 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.59 124.59 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.985 0.898 . . . . 0.0 111.48 176.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -114.18 128.85 70.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.699 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.553 ' CE2' HD13 ' C' ' 68' ' ' ILE . 49.0 p90 -147.41 165.11 31.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.421 0.629 . . . . 0.0 111.732 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 12.7 t -143.77 143.67 31.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.873 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 79.62 9.56 1.53 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.605 0.565 . . . . 0.0 112.298 171.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 21.2 mt -93.25 160.58 14.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 0.0 112.217 -175.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' GLU . . . . . 0.59 ' O ' HG13 ' C' ' 39' ' ' ILE . 6.2 tp10 -99.74 172.96 6.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.496 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.45 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 2.7 m-80 -55.03 110.81 0.72 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 123.604 1.669 . . . . 0.0 109.109 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.59 HG13 ' O ' ' C' ' 37' ' ' GLU . 17.3 mt -77.3 142.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.165 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . 0.662 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 29.2 tptp -105.42 123.68 48.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.823 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.15 139.03 21.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.282 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.458 ' CE1' ' HG2' ' C' ' 49' ' ' GLU . 47.5 t80 -133.24 139.83 47.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.048 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' TRP . . . . . 0.402 ' CH2' ' HB2' ' C' ' 29' ' ' CYS . 71.4 m95 -125.37 137.48 54.03 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -126.94 129.66 48.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.933 0.333 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 25.0 t -120.83 116.72 50.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.323 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . 0.528 ' HA ' ' OE1' ' C' ' 84' ' ' GLU . 3.2 m120 54.53 37.17 27.42 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.123 0.487 . . . . 0.0 111.808 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.04 -16.3 38.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.277 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . 0.411 HG12 ' O ' ' C' ' 45' ' ' VAL . 15.0 p -104.64 142.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.624 0.712 . . . . 0.0 110.721 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . 0.458 ' HG2' ' CE1' ' C' ' 42' ' ' PHE . 41.5 mt-10 -60.4 138.17 58.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.407 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' ARG . . . . . 0.482 ' HB2' HG23 ' C' ' 45' ' ' VAL . 13.2 tpp180 -91.29 124.27 35.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.362 0.601 . . . . 0.0 110.077 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -59.76 162.71 5.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.738 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -41.77 163.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.05 0.929 . . . . 0.0 112.898 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.68 -0.48 23.23 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -158.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.555 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.5 p -89.74 129.68 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 113.637 -1.281 . . . . 0.0 108.133 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.602 ' HB3' ' HG3' ' C' ' 71' ' ' LYS . 31.0 tt0 -141.88 110.29 6.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.082 0.468 . . . . 0.0 110.179 -169.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -94.81 134.22 37.67 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.95 149.39 22.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -58.26 145.78 73.2 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.169 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' PRO . . . . . 0.493 ' HB3' HD11 ' C' ' 68' ' ' ILE . 19.1 Cg_endo -57.74 136.64 76.77 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.728 2.952 . . . . 0.0 113.474 -174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 . . . . . 0 C--N 1.324 -0.531 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.808 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt . . . . . 0 C--O 1.233 0.184 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 8.8 m -102.09 146.51 27.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.037 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -133.31 119.72 20.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.106 0.479 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.553 HD13 ' CE2' ' C' ' 33' ' ' TYR . 1.7 mp -115.13 127.14 72.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.172 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -105.17 121.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 38.9 m -111.79 113.02 25.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.602 ' HG3' ' HB3' ' C' ' 55' ' ' GLU . 13.0 ptmt -106.17 139.82 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.156 0.503 . . . . 0.0 110.241 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -113.5 127.13 55.98 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.921 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -87.91 116.95 26.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.427 HG12 HD12 ' C' ' 72' ' ' LEU . 21.3 m -130.52 157.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.621 -171.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' C' ' 78' ' ' GLU . 55.2 mtt -83.1 135.49 34.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.216 0.323 . . . . 0.0 110.57 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -47.59 -54.91 10.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' C' ' 81' ' ' SER . 5.3 m -57.09 -29.38 63.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.718 0.407 . . . . 0.0 112.093 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' C' ' 75' ' ' MET . 5.5 mm-40 -65.37 -54.12 33.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 53.2 t-105 -58.78 -44.8 90.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.764 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.54 -19.82 64.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.043 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' C' ' 77' ' ' SER . 6.6 t -80.89 -4.98 56.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.14 26.71 70.03 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.024 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . 0.451 HG23 ' CE2' ' C' ' 85' ' ' TYR . 12.8 t -64.83 144.99 56.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.367 0.604 . . . . 0.0 110.377 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' C' ' 46' ' ' ASN . 12.7 mt-10 -74.84 133.7 41.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.323 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' TYR . . . . . 0.664 ' HB2' ' CG2' ' C' ' 102' ' ' ILE . 83.5 m-85 -126.24 118.08 24.4 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.62 133.3 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 32.5 t -108.72 116.24 31.62 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.858 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.8 mp -110.56 145.1 38.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.069 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' VAL . . . . . 0.612 HG21 HG21 ' C' ' 31' ' ' ILE . 40.8 t -125.65 131.29 72.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 123.38 0.672 . . . . 0.0 109.469 176.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 9.7 pt-20 -131.17 137.13 48.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.924 0.393 . . . . 0.0 110.28 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . 0.505 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 14.6 t0 -149.89 154.23 38.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.535 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.4 m -67.76 -7.72 29.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.634 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -100.5 -9.3 22.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.583 ' O ' HD12 ' C' ' 94' ' ' LEU . 2.4 pp -97.75 149.22 35.5 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.627 -175.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.27 -33.19 1.47 Allowed 'Trans proline' 0 C--N 1.334 -0.193 0 C-N-CA 123.941 3.094 . . . . 0.0 112.88 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.454 ' O ' HD13 ' C' ' 94' ' ' LEU . 4.7 p -144.85 152.81 53.02 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.437 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.46 139.94 55.77 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.007 1.804 . . . . 0.0 111.283 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 27.4 t -102.05 124.36 55.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.858 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 22.6 pttp -134.39 156.55 48.33 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.24 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.13 138.1 17.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.255 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t -117.45 151.49 36.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.115 0.483 . . . . 0.0 111.718 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . 0.664 ' CG2' ' HB2' ' C' ' 85' ' ' TYR . 3.6 tp -123.95 143.92 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.652 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -133.26 157.11 46.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -68.3 105.63 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.078 0.861 . . . . 0.0 109.203 -174.92 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 1.7 tp . . . . . 0 N--CA 1.441 -0.909 0 CA-C-O 121.698 0.761 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 26.9 t -131.73 134.42 45.86 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.414 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -119.29 123.37 71.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.042 0.449 . . . . 0.0 110.236 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 11.7 m -117.89 123.33 45.59 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.554 ' HB3' HD12 ' C' ' 102' ' ' ILE . 91.1 mt -99.76 126.18 45.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.473 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . 0.519 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 49.6 tp -104.42 114.93 29.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.825 ' HB3' HD11 ' C' ' 102' ' ' ILE . 9.6 ptpp? -91.37 150.77 41.94 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo . . . . . 0 N--CA 1.455 -0.771 0 C-N-CA 121.934 1.756 . . . . 0.0 110.632 175.515 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.534 0.329 0 CA-C-O 121.819 0.818 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.21 148.59 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.586 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 45.6 t -128.47 131.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.338 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -114.99 111.68 21.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.72 121.93 43.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' ILE . . . . . 0.592 HD12 ' O ' ' C' ' 68' ' ' ILE . 0.1 OUTLIER -124.68 130.79 73.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.849 0.833 . . . . 0.0 111.227 -176.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' C' ' 7' ' ' ILE . 60.2 t -110.6 131.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.496 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.502 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -164.67 161.92 21.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.403 0.439 . . . . 0.0 110.529 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 11.6 t -142.59 155.34 44.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' C' ' 34' ' ' SER . 0.9 OUTLIER 81.6 9.96 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.814 0.697 . . . . 0.0 111.832 177.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . 0.422 ' HB2' HD11 ' C' ' 39' ' ' ILE . 22.8 mt -105.22 142.9 34.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.456 0.645 . . . . 0.0 112.105 -172.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' GLU . . . . . 0.562 ' O ' HG13 ' C' ' 39' ' ' ILE . 29.8 mm-40 -95.95 179.11 5.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.585 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.662 HD22 ' N ' ' C' ' 38' ' ' ASN . 0.7 OUTLIER -54.26 112.36 0.96 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 124.053 1.882 . . . . 0.0 109.654 -156.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.562 HG13 ' O ' ' C' ' 37' ' ' GLU . 11.1 mt -83.17 146.83 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 110.15 -3.205 . . . . 0.0 112.584 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -112.37 134.68 53.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.634 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.0 131.43 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.445 ' HE1' ' HG2' ' C' ' 49' ' ' GLU . 53.2 t80 -122.66 142.17 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.136 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' TRP . . . . . 0.549 ' CE2' HD23 ' C' ' 72' ' ' LEU . 50.3 m95 -132.02 137.55 47.89 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -124.84 131.24 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.155 -0.341 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' C' ' 50' ' ' ARG . 60.6 t -123.03 117.26 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 55.69 35.89 26.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.62 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.21 -15.85 36.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.331 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.16 145.19 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.492 0.646 . . . . 0.0 111.645 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . 0.445 ' HG2' ' HE1' ' C' ' 42' ' ' PHE . 47.8 mt-10 -61.14 127.54 32.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.646 172.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' ARG . . . . . 0.569 ' HD3' HD11 ' C' ' 72' ' ' LEU . 5.4 ptm180 -92.15 166.13 12.8 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.373 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' LYS . . . . . 0.484 ' HA ' ' HD2' ' C' ' 51' ' ' LYS . 31.7 tptt -75.67 163.01 27.74 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.473 ' HG3' ' H ' ' C' ' 53' ' ' GLY . 22.4 tptp -45.51 164.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.84 0.828 . . . . 0.0 111.914 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' C' ' 52' ' ' LYS . . . 115.36 -9.17 20.17 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -161.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.82 HG22 HD21 ' C' ' 72' ' ' LEU . 48.8 t -77.27 118.73 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 113.339 -1.431 . . . . 0.0 107.794 165.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -133.47 144.29 49.36 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.19 -170.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -130.25 130.09 44.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.57 158.14 18.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.453 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.05 150.28 51.68 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.482 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' PRO . . . . . 0.523 ' HB3' HD11 ' C' ' 68' ' ' ILE . 37.4 Cg_endo -63.12 139.74 74.48 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.147 2.565 . . . . 0.0 113.133 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 . . . . . 0 C--N 1.323 -0.555 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.326 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 121.278 0.561 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -113.68 152.73 30.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.427 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 64.4 m -135.31 120.44 18.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.377 0.608 . . . . 0.0 111.009 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.592 ' O ' HD12 ' C' ' 31' ' ' ILE . 1.6 mp -110.81 130.94 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.888 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.6 122.54 60.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.394 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -111.3 122.82 48.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -106.86 143.76 34.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.82 HD21 HG22 ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.71 114.57 19.48 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.032 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -84.44 114.59 22.02 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.523 HG11 ' CE1' ' C' ' 85' ' ' TYR . 16.4 m -133.19 161.61 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.719 -173.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.8 mtt -77.75 128.71 34.48 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.539 0.685 . . . . 0.0 109.589 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.96 87.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.078 -174.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -61.9 -30.5 70.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.527 0.331 . . . . 0.0 111.435 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.32 -51.66 42.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' TRP . . . . . 0.445 ' HZ3' HG23 ' C' ' 102' ' ' ILE . 63.4 t-105 -57.62 -44.15 85.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.766 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.1 -17.01 64.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.347 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -81.73 -4.71 57.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.905 0.383 . . . . 0.0 110.772 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.84 21.72 65.4 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 41.5 m -66.22 143.41 57.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.874 -0.663 . . . . 0.0 112.01 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -71.16 131.81 44.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.824 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' TYR . . . . . 0.523 ' CE1' HG11 ' C' ' 74' ' ' VAL . 67.3 m-85 -130.53 116.21 17.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 169.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 11.3 t -120.43 135.93 59.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.09 127.66 54.33 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.559 HD13 ' O ' ' C' ' 98' ' ' VAL . 1.9 mm? -123.13 144.84 49.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.823 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' C' ' 98' ' ' VAL . 69.7 t -122.89 132.78 70.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.115 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -127.85 133.82 49.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.523 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . 0.655 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 28.4 t70 -153.16 150.44 29.07 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.253 0.549 . . . . 0.0 110.575 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 21.9 t -66.24 -15.17 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.752 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -95.62 -7.65 37.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.243 0.474 . . . . 0.0 112.156 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.5 pp -92.62 149.39 37.96 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.108 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.36 -35.17 0.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.86 3.04 . . . . 0.0 112.453 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.433 ' O ' HD13 ' C' ' 94' ' ' LEU . 16.0 p -142.6 149.32 50.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.256 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' C' ' 88' ' ' LEU . 52.0 Cg_endo -66.24 143.34 70.43 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.308 2.005 . . . . 0.0 111.258 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' C' ' 89' ' ' VAL . 47.7 t -91.39 106.54 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.406 ' HB3' HD11 ' C' ' 88' ' ' LEU . 11.1 ptpp? -107.84 142.81 37.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.422 -174.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.65 120.14 5.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 39.4 t -105.51 156.37 18.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.047 0.451 . . . . 0.0 110.69 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . 0.825 HD11 ' HB3' ' C' ' 13' ' ' LYS . 14.0 tt -123.83 147.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.008 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -133.68 144.51 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.293 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -85.19 143.61 28.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.96 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.702 173.197 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' ILE . . . . . 0.533 HG12 HG11 ' C' ' 98' ' ' VAL . 3.7 tp . . . . . 0 N--CA 1.434 -1.234 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 13.7 m -116.33 114.95 25.03 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.922 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 t -114.27 115.01 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -131.88 132.53 43.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.075 0.464 . . . . 0.0 109.88 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.66 HD13 ' HB ' ' C' ' 102' ' ' ILE . 17.5 mt -99.5 136.56 39.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.293 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 61.6 tp -110.86 115.19 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -77.24 150.43 80.33 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.975 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . 0.503 ' HD3' HG12 ' C' ' 27' ' ' ILE . 82.6 Cg_exo . . . . . 0 CA--C 1.542 0.91 0 C-N-CA 122.924 2.416 . . . . 0.0 113.39 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' C' ' 72' ' ' LEU . 10.1 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' ILE . . . . . 0.809 HG13 HG11 ' C' ' 74' ' ' VAL . 60.6 mt -120.19 152.36 23.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.08 135.55 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.911 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 51.3 t -107.82 117.71 34.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -105.12 118.39 36.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.57 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' ILE . . . . . 0.523 HG21 HG11 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -120.01 130.86 73.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.677 0.751 . . . . 0.0 111.309 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 21.7 t -117.72 132.59 67.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.254 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.957 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -151.79 170.03 20.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' SER . . . . . 0.504 ' HB2' ' HG2' ' C' ' 65' ' ' LYS . 32.2 t -124.09 141.48 52.01 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.396 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 t0 71.01 11.11 7.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.184 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mt -111.69 129.64 56.04 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.28 -0.888 . . . . 0.0 110.708 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.33 91.28 2.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.705 160.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . 0.636 ' O ' ' HA ' ' C' ' 91' ' ' ASP . 0.5 OUTLIER -147.29 106.38 3.87 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 136.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.441 HD12 ' CZ ' ' C' ' 33' ' ' TYR . 5.5 mm -115.28 112.53 40.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.977 -1.089 . . . . 0.0 113.721 -169.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -108.16 123.57 48.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.138 172.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.67 142.78 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.3 t80 -129.88 143.55 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -128.94 137.94 51.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' C' ' 86' ' ' VAL . 4.4 pt20 -131.23 131.45 43.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.229 0.538 . . . . 0.0 111.409 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' VAL . . . . . 0.634 HG23 ' HB2' ' C' ' 50' ' ' ARG . 13.8 t -104.08 109.14 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.858 177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.31 42.26 31.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.635 0.731 . . . . 0.0 110.693 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.62 -16.98 16.51 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.922 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . 0.563 HG12 ' O ' ' C' ' 45' ' ' VAL . 10.0 p -97.85 138.58 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 118.297 1.049 . . . . 0.0 110.521 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -57.72 139.44 53.84 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.379 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' ARG . . . . . 0.634 ' HB2' HG23 ' C' ' 45' ' ' VAL . 16.2 tpt180 -90.98 124.13 34.99 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.845 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' LYS . . . . . 0.636 ' HD2' ' H ' ' C' ' 51' ' ' LYS . 3.1 mptp? -70.45 161.31 30.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.966 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' C' ' 52' ' ' LYS . 45.5 mmtm -42.19 162.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.484 1.135 . . . . 0.0 114.011 -170.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -158.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.54 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.3 p -87.77 128.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 113.707 -1.246 . . . . 0.0 109.095 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -140.02 110.29 6.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.054 0.454 . . . . 0.0 110.17 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -89.22 130.95 35.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.615 ' HB2' HG13 ' C' ' 69' ' ' VAL . 23.7 mt-30 -105.31 172.57 6.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -175.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -76.92 153.19 82.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.827 0.346 . . . . 0.0 110.293 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' C' ' 67' ' ' THR . 60.6 Cg_endo -70.21 149.43 64.01 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.537 2.825 . . . . 0.0 113.424 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 170.207 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . 0.504 ' HG2' ' HB2' ' C' ' 34' ' ' SER . 84.3 mttt . . . . . 0 C--O 1.225 -0.221 0 CA-C-O 120.844 0.354 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.8 m -118.2 148.21 42.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 93.9 m -132.71 121.07 22.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.957 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.62 127.89 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.889 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' C' ' 57' ' ' GLN . 0.7 OUTLIER -111.46 122.87 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.726 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -111.28 125.43 53.82 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.706 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.22 138.52 43.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.558 HD11 ' HG2' ' C' ' 50' ' ' ARG . 0.2 OUTLIER -120.07 122.1 40.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -77.87 121.0 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.809 HG11 HG13 ' C' ' 27' ' ' ILE . 9.9 p -143.37 148.94 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.716 -170.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -89.81 140.1 29.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.874 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -43.99 -55.39 4.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -57.03 -33.86 67.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.557 0.617 . . . . 0.0 112.285 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -63.94 -53.76 45.24 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 176.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -58.09 -44.03 87.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.768 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' ASP . . . . . 0.547 ' HA ' ' HD2' ' C' ' 104' ' ' LYS . 24.5 t70 -70.25 -17.24 63.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.323 -176.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 66.3 m -86.38 -3.01 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.68 28.87 70.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.184 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.8 t -64.71 143.18 58.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.041 0.448 . . . . 0.0 109.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.8 mt-10 -75.49 130.1 38.34 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -128.05 120.79 28.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.325 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' C' ' 101' ' ' SER . 26.7 t -120.25 135.76 59.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 19.5 p -115.39 129.2 56.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.637 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.9 mp -120.24 148.61 43.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.287 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' VAL . . . . . 0.523 HG11 HG21 ' C' ' 31' ' ' ILE . 5.9 p -143.72 127.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.354 0.597 . . . . 0.0 111.448 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -110.77 153.39 25.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.053 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 11.3 t70 -142.69 148.03 36.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -62.31 -21.31 65.16 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -97.2 0.09 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.55 ' C ' HD12 ' C' ' 94' ' ' LEU . 2.6 pp -103.86 158.64 31.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' C' ' 96' ' ' THR . 1.8 Cg_endo -88.21 -35.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.874 3.049 . . . . 0.0 113.294 -168.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.423 ' O ' HD13 ' C' ' 94' ' ' LEU . 16.7 p -147.28 153.64 44.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.43 151.99 79.71 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.294 1.996 . . . . 0.0 112.112 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 19.2 m -122.19 147.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' C' ' 87' ' ' CYS . 0.4 OUTLIER -135.08 161.48 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.181 0.515 . . . . 0.0 112.367 -169.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.18 140.99 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . 0.46 ' HB2' HG22 ' C' ' 86' ' ' VAL . 39.7 t -120.56 149.14 42.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.989 0.358 . . . . 0.0 110.708 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . 0.66 ' HB ' HD13 ' C' ' 11' ' ' LEU . 2.9 tp -125.03 142.12 42.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.181 0.515 . . . . 0.0 110.879 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -123.69 153.91 40.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' LYS . . . . . 0.547 ' HD2' ' HA ' ' C' ' 80' ' ' ASP . 76.0 tttt -64.39 107.04 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.454 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.407 -176.869 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' ILE . . . . . 0.601 HG12 HG11 ' C' ' 98' ' ' VAL . 3.3 tp . . . . . 0 N--CA 1.449 -0.482 0 CA-C-O 120.949 0.404 . . . . 0.0 110.656 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 47.2 t -120.47 125.06 46.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' C' ' 31' ' ' ILE . 3.0 p -128.57 125.32 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.108 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -148.28 148.61 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.053 -0.404 . . . . 0.0 110.539 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.507 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.5 mm? -96.11 146.7 24.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.905 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -115.3 115.38 26.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.712 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -78.1 154.58 80.02 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.203 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 N--CA 1.46 -0.486 0 C-N-CA 122.721 2.281 . . . . 0.0 111.579 175.628 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' THR . . . . . 0.498 ' HA ' HG12 ' C' ' 74' ' ' VAL . 3.4 t . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 122.226 1.012 . . . . 0.0 112.302 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mt -102.32 155.52 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.541 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . 0.526 HG22 ' HG3' ' C' ' 71' ' ' LYS . 56.0 t -127.95 135.17 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.943 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -111.16 127.03 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 124.62 52.28 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' ILE . . . . . 0.619 HG21 HG21 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.97 131.13 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.651 179.249 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.24 129.7 66.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.748 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.634 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -165.54 160.62 17.88 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' C' ' 65' ' ' LYS . 14.7 m -144.2 153.94 42.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.792 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' C' ' 34' ' ' SER . 1.1 m-20 78.8 9.22 1.91 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.454 0.472 . . . . 0.0 112.056 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.23 163.99 13.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.624 0.726 . . . . 0.0 112.059 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -83.0 173.82 11.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.291 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -57.62 114.5 2.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.535 1.636 . . . . 0.0 107.784 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.595 ' CG2' HG13 ' C' ' 89' ' ' VAL . 4.6 mp -74.55 146.06 10.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 111.559 -2.564 . . . . 0.0 112.506 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.87 172.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.19 140.1 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -134.36 137.81 44.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.939 0.399 . . . . 0.0 110.94 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' TRP . . . . . 0.535 ' HE3' ' HD2' ' C' ' 85' ' ' TYR . 55.2 m95 -125.77 133.94 51.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -124.8 130.22 51.97 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' C' ' 50' ' ' ARG . 23.5 t -118.31 111.78 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.939 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.18 37.24 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.875 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.76 -14.3 25.91 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.1 134.16 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.22 138.52 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.102 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' ARG . . . . . 0.498 ' HB2' HG23 ' C' ' 45' ' ' VAL . 15.8 tpp180 -90.96 127.11 36.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.479 0.657 . . . . 0.0 110.879 -173.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -57.67 160.4 4.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.844 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -40.65 163.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.301 1.048 . . . . 0.0 113.307 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' C' ' 73' ' ' LYS . . . 114.51 -0.47 23.46 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -163.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.469 ' HA ' HD22 ' C' ' 72' ' ' LEU . 5.4 p -87.29 127.25 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.314 172.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 34.8 mt-10 -124.08 108.76 12.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -172.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 6.3 m -93.43 117.75 30.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . 0.635 ' HB2' HG13 ' C' ' 69' ' ' VAL . 47.1 mt-30 -100.39 171.42 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.463 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.2 144.4 89.65 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 0.0 110.651 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' PRO . . . . . 0.463 ' HB3' ' CD1' ' C' ' 68' ' ' ILE . 27.3 Cg_endo -63.08 151.23 85.83 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.557 2.838 . . . . 0.0 114.072 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 . . . . . 0 C--N 1.322 -0.604 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.072 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . 0.502 ' HA ' ' OG ' ' C' ' 34' ' ' SER . 74.4 mmtt . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.889 0.376 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -109.11 150.53 27.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.053 0.454 . . . . 0.0 110.795 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 57.5 m -137.04 126.73 25.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.96 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -112.05 134.16 55.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.872 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -115.61 127.32 73.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.365 0.602 . . . . 0.0 110.697 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 40.9 p -115.41 129.62 56.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.534 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 48.1 tttp -107.09 144.62 33.52 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -120.03 116.54 25.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.027 0.441 . . . . 0.0 110.251 177.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' LYS . . . . . 0.407 ' HD3' ' HA2' ' C' ' 53' ' ' GLY . 26.5 mtpp -77.76 112.59 14.77 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.543 HG23 ' OH ' ' C' ' 85' ' ' TYR . 9.3 p -119.98 151.71 22.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.342 0.592 . . . . 0.0 110.602 -168.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.891 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 65.9 mtt -84.04 137.43 33.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.251 -176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.32 -35.98 60.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.824 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 14.5 t -70.74 -28.31 64.61 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.368 0.267 . . . . 0.0 111.627 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' GLU . . . . . 0.891 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 7.7 mm-40 -71.44 -54.75 9.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.712 0.767 . . . . 0.0 109.137 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -64.95 -38.63 91.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.238 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.86 -18.47 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.41 . . . . 0.0 111.039 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 18.6 t -90.16 -4.48 57.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.546 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.58 25.29 70.47 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.34 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -62.22 138.82 58.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.116 0.484 . . . . 0.0 111.145 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.17 149.68 24.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.265 -172.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' TYR . . . . . 0.543 ' OH ' HG23 ' C' ' 74' ' ' VAL . 16.4 m-85 -132.7 131.05 40.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.198 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . 0.558 HG11 ' HE2' ' C' ' 99' ' ' LYS . 25.3 t -119.87 130.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 34.4 t -108.6 120.48 42.56 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.675 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 5.8 mp -116.23 147.52 41.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.63 0.581 . . . . 0.0 110.166 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' VAL . . . . . 0.619 HG21 HG21 ' C' ' 31' ' ' ILE . 12.3 t -134.0 127.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.54 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.06 144.94 51.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.082 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . 0.521 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 27.1 t70 -148.17 156.7 42.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.339 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 37.9 t -65.37 -21.68 66.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -91.9 -11.55 35.99 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 122.192 -0.318 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 40.8 mt -84.12 146.57 48.69 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.668 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 1.7 Cg_endo -84.34 -29.26 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.512 2.808 . . . . 0.0 111.651 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 27.1 p -147.19 151.62 41.23 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.903 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.42 148.05 47.86 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.532 1.488 . . . . 0.0 110.651 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' VAL . . . . . 0.601 HG11 HG12 ' C' ' 7' ' ' ILE . 27.6 m -108.57 141.1 24.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.675 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 13.7 ptmm? -142.79 153.51 43.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.32 22.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' C' ' 85' ' ' TYR . 33.5 t -121.91 149.74 42.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.409 0.624 . . . . 0.0 111.888 -173.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . 0.507 ' HB ' ' HG ' ' C' ' 11' ' ' LEU . 4.8 tp -124.03 145.64 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.413 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -130.86 162.68 29.08 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -80.14 108.5 13.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.338 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.156 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.631 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 121.162 0.506 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 19.5 m -117.82 114.58 23.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.249 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.82 117.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.19 0.519 . . . . 0.0 110.661 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m -123.15 130.92 53.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' C' ' 102' ' ' ILE . 46.8 mt -99.0 130.07 45.32 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 tp -111.47 113.8 26.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' LYS . . . . . 0.402 ' HB3' HD11 ' C' ' 102' ' ' ILE . 25.1 pttm -83.23 147.59 53.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo . . . . . 0 C--N 1.349 0.594 0 C-N-CA 125.08 3.854 . . . . 0.0 114.533 -172.227 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 121.978 0.894 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.44 153.96 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.699 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.93 134.38 63.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.216 0.531 . . . . 0.0 111.554 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' CYS . . . . . 0.546 ' HB2' ' CH2' ' C' ' 43' ' ' TRP . 35.7 t -108.88 112.85 25.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.29 115.89 31.0 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' ILE . . . . . 0.683 HG21 HG21 ' C' ' 89' ' ' VAL . 0.2 OUTLIER -126.25 128.65 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 53.8 t -114.69 131.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.744 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' TYR . . . . . 0.499 ' OH ' ' HB ' ' C' ' 68' ' ' ILE . 0.1 OUTLIER -161.13 163.63 31.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.418 -178.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -142.34 150.94 41.42 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 37.6 t70 78.67 10.99 1.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.811 0.695 . . . . 0.0 111.6 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 17.4 mt -97.97 164.66 12.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.003 0.906 . . . . 0.0 112.654 -172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -94.36 170.84 9.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.83 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.14 114.92 2.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.72 1.724 . . . . 0.0 108.257 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' ILE . . . . . 0.62 HG21 HG13 ' C' ' 89' ' ' VAL . 4.7 mp -70.12 141.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.177 -2.738 . . . . 0.0 113.555 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -103.43 124.05 48.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -108.73 141.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -173.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.5 t80 -132.5 143.6 49.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' TRP . . . . . 0.604 ' HB2' ' HD3' ' C' ' 50' ' ' ARG . 58.0 m95 -130.45 137.85 50.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -125.9 130.07 50.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.792 0.269 . . . . 0.0 111.191 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 27.6 t -121.66 113.03 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 56.89 36.17 27.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.14 0.495 . . . . 0.0 110.979 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.49 15.1 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.818 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.54 133.96 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.61 138.04 58.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' ARG . . . . . 0.604 ' HD3' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -89.92 156.14 18.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.346 -172.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -69.79 156.08 39.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.077 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -53.14 166.85 0.21 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.776 0.798 . . . . 0.0 112.321 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.15 7.31 12.71 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -160.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' VAL . . . . . 0.571 HG22 HD21 ' C' ' 72' ' ' LEU . 23.8 t -84.61 129.21 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.044 -1.578 . . . . 0.0 107.874 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 41.1 mt-10 -128.71 108.9 10.85 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 7.0 p -92.11 123.12 35.22 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -89.04 144.43 26.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' ASN . . . . . 0.403 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.1 t30 -58.37 137.4 85.29 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.774 -175.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' PRO . . . . . 0.409 ' HB3' HD11 ' C' ' 68' ' ' ILE . 31.1 Cg_exo -48.09 134.88 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.781 2.987 . . . . 0.0 112.849 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 N--CA 1.446 -0.625 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.183 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt . . . . . 0 N--CA 1.454 -0.263 0 CA-C-O 121.185 0.517 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -101.14 146.79 27.02 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -131.58 119.11 21.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.112 0.482 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ILE . . . . . 0.587 ' O ' HD12 ' C' ' 31' ' ' ILE . 1.6 mp -114.89 133.09 62.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.922 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.31 121.62 61.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 0.0 110.391 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' C' ' 29' ' ' CYS . 40.8 m -108.96 111.12 22.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.695 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 81.8 tttt -105.37 144.56 31.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.978 -174.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' LEU . . . . . 0.571 HD21 HG22 ' C' ' 54' ' ' VAL . 0.5 OUTLIER -122.49 119.59 31.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 174.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -91.53 111.17 22.57 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' C' ' 85' ' ' TYR . 8.3 p -134.33 163.62 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.095 0.474 . . . . 0.0 110.864 -168.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' MET . . . . . 0.773 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 63.2 mtt -74.16 129.1 37.17 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.442 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.9 -45.38 82.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.812 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 26.0 t -59.7 -32.72 70.78 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.916 0.486 . . . . 0.0 111.477 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' GLU . . . . . 0.773 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 26.2 mm-40 -67.38 -51.67 49.18 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -57.84 -44.26 86.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.087 177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' ASP . . . . . 0.547 ' HA ' ' HE2' ' C' ' 104' ' ' LYS . 26.7 t70 -70.88 -11.55 61.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 9.9 t -87.71 -3.68 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.5 26.28 68.15 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.487 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -65.58 149.77 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 111.057 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 27.5 mt-10 -71.24 129.08 37.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.115 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' TYR . . . . . 0.523 ' HD1' ' HE3' ' C' ' 43' ' ' TRP . 0.4 OUTLIER -128.9 119.41 24.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 16.7 t -120.48 136.39 57.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' CYS . . . . . 0.447 ' HB3' HD21 ' C' ' 11' ' ' LEU . 10.8 t -111.54 126.38 54.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -119.25 146.02 45.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.882 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' VAL . . . . . 0.683 HG21 HG21 ' C' ' 31' ' ' ILE . 39.2 t -123.54 131.09 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.8 136.56 54.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.976 0.417 . . . . 0.0 111.016 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 15.1 t70 -149.3 145.18 26.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -63.09 -18.46 63.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.119 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -101.53 5.07 41.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.9 pp -99.14 148.42 34.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.05 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.4 -34.74 1.89 Allowed 'Trans proline' 0 N--CA 1.469 0.057 0 C-N-CA 123.83 3.02 . . . . 0.0 112.841 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' THR . . . . . 0.505 ' O ' HD13 ' C' ' 94' ' ' LEU . 20.1 p -144.66 148.7 40.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.37 144.78 91.81 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.325 2.016 . . . . 0.0 111.254 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 44.1 t -94.72 116.66 36.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' LYS . . . . . 0.512 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 18.6 ptpt -127.66 149.18 50.31 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.091 -174.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.407 ' O ' HD11 ' C' ' 11' ' ' LEU . . . -155.76 135.76 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.906 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.4 t -112.8 154.61 25.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.943 0.401 . . . . 0.0 111.179 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . 0.559 ' HB ' HD13 ' C' ' 11' ' ' LEU . 5.7 tp -122.92 144.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.156 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -133.57 150.15 51.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.422 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' C' ' 80' ' ' ASP . 21.6 ttpp -90.65 136.81 32.83 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.576 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.48 1.071 0 CA-C-O 120.738 0.304 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.33 -173.36 54.87 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.489 172.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 55.6 ttp180 64.14 57.39 1.27 Allowed 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 123.571 0.748 . . . . 0.0 111.218 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -79.64 -25.35 41.41 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 172.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -103.66 90.12 3.56 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.851 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.545 ' HB2' ' HE3' ' C' ' 65' ' ' LYS . 4.4 m-20 -93.38 113.17 25.27 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 162.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.6 tp -122.18 109.83 25.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.042 172.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 5.2 m -115.45 111.56 20.97 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.192 -173.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.642 HG22 HG22 ' C' ' 31' ' ' ILE . 29.1 t -106.43 114.51 45.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.117 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 2.7 m -125.49 123.75 39.87 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' C' ' 28' ' ' VAL . 44.2 mt -99.24 135.07 41.19 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.66 ' HB3' HG22 ' C' ' 28' ' ' VAL . 3.3 tm? -108.58 125.19 51.56 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 176.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.407 ' HB2' ' HD2' ' C' ' 14' ' ' PRO . 62.2 pttt -94.92 153.66 39.88 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.473 -178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . 0.629 ' HD3' HD13 ' C' ' 27' ' ' ILE . 60.0 Cg_endo -72.56 140.68 33.31 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.046 2.497 . . . . 0.0 112.853 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.68 153.21 76.62 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.792 2.328 . . . . 0.0 111.498 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -113.65 -179.65 3.7 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.901 -0.32 . . . . 0.0 111.308 -175.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.79 -77.48 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.799 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -144.4 -84.19 0.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.741 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 47.3 mt -97.18 -41.9 11.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.328 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 48.0 p90 -87.96 156.0 19.55 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.229 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' C' ' 22' ' ' GLN . 28.2 p -104.38 112.71 25.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.881 -177.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' C' ' 21' ' ' THR . 14.4 mm-40 -166.66 78.66 0.22 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.752 0.31 . . . . 0.0 111.069 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -169.73 138.75 1.88 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.716 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 4.9 t -110.65 130.69 55.5 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.898 -0.321 . . . . 0.0 110.359 175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.456 ' O ' HG23 ' C' ' 26' ' ' THR . . . -128.43 -54.05 1.26 Allowed 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.41 170.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' THR . . . . . 0.456 HG23 ' O ' ' C' ' 25' ' ' ALA . 0.6 OUTLIER -166.48 145.2 5.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.851 177.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ILE . . . . . 0.629 HD13 ' HD3' ' C' ' 14' ' ' PRO . 20.9 mm -112.75 111.95 38.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 163.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.66 HG22 ' HB3' ' C' ' 12' ' ' LEU . 0.6 OUTLIER -119.13 142.83 32.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.685 -169.154 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' CYS . . . . . 0.488 ' HA ' HD23 ' C' ' 11' ' ' LEU . 41.1 t -115.18 113.48 23.99 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.306 170.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.23 123.39 46.64 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 174.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ILE . . . . . 0.642 HG22 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.86 130.54 73.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.932 0.872 . . . . 0.0 111.648 -178.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 52.9 t -110.75 129.38 66.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.337 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.497 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.33 161.49 27.53 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.373 0.42 . . . . 0.0 110.748 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' SER . . . . . 0.446 ' HB3' ' HA ' ' C' ' 65' ' ' LYS . 6.0 p -144.04 150.89 38.91 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.3 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' C' ' 34' ' ' SER . 67.1 m-20 75.38 11.04 3.45 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 123.524 0.515 . . . . 0.0 112.22 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 16.7 mt -91.51 168.14 11.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.554 0.692 . . . . 0.0 111.821 -175.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -96.53 171.81 8.32 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 114.628 -1.169 . . . . 0.0 108.151 172.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -56.94 115.48 2.63 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-O 123.801 1.763 . . . . 0.0 109.005 -170.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.526 ' CG2' HG13 ' C' ' 89' ' ' VAL . 4.6 mp -74.11 144.46 12.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.831 0 CA-C-N 111.247 -2.706 . . . . 0.0 113.069 -176.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.533 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 22.4 tptm -106.63 124.34 49.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.098 -0.956 . . . . 0.0 108.802 173.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.9 139.27 21.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.559 0.218 . . . . 0.0 110.618 -177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -135.53 141.1 45.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.098 0.475 . . . . 0.0 111.44 -178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' TRP . . . . . 0.801 ' HB2' ' HD2' ' C' ' 50' ' ' ARG . 51.9 m95 -129.7 136.78 50.09 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 174.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . 0.537 ' OE1' ' HA2' ' C' ' 47' ' ' GLY . 8.3 tt0 -121.47 129.31 52.88 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 21.5 t -120.92 108.06 21.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 58.03 37.06 26.53 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.216 0.532 . . . . 0.0 111.09 -178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . 0.537 ' HA2' ' OE1' ' C' ' 44' ' ' GLN . . . 78.13 -6.93 47.69 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.94 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.53 130.98 51.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.956 0.407 . . . . 0.0 111.172 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -62.4 136.34 57.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.04 -0.527 . . . . 0.0 109.846 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' ARG . . . . . 0.801 ' HD2' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -91.74 146.9 23.39 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.917 0.865 . . . . 0.0 112.412 -170.308 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 10.1 mmmm -66.14 161.4 21.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.162 175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.603 ' HG2' ' H ' ' C' ' 53' ' ' GLY . 39.4 tttm -53.92 164.33 0.61 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.698 0.761 . . . . 0.0 110.611 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . 0.603 ' H ' ' HG2' ' C' ' 52' ' ' LYS . . . 115.8 -13.28 17.55 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 106.841 -2.504 . . . . 0.0 106.841 -159.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.551 ' HA ' HD22 ' C' ' 72' ' ' LEU . 2.6 p -82.81 129.1 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 112.898 -1.651 . . . . 0.0 107.752 163.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -141.8 114.75 8.63 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 120.409 -0.517 . . . . 0.0 110.503 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 28.4 m -89.09 126.06 35.29 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.93 175.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.541 ' HB2' HG13 ' C' ' 69' ' ' VAL . 48.1 mt-30 -90.99 149.23 21.93 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' ASN . . . . . 0.425 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.3 t30 -56.39 138.73 74.85 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.134 -174.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' C' ' 58' ' ' ASN . 53.6 Cg_exo -47.52 135.84 20.83 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 124.194 3.263 . . . . 0.0 113.616 -174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' GLU . . . . . 0.538 ' HB3' ' HB ' ' C' ' 67' ' ' THR . 34.4 tt0 -102.38 141.31 35.41 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -122.15 113.06 18.97 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.218 0.532 . . . . 0.0 111.381 -173.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 46.0 m -126.44 106.95 9.83 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.878 177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.84 -114.45 5.06 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.444 -176.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 19.0 m -111.35 1.29 16.99 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.321 0.581 . . . . 0.0 109.641 173.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . 0.545 ' HE3' ' HB2' ' C' ' 6' ' ' ASP . 35.5 mmtm -97.4 138.92 34.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.13 -175.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 10.2 m -105.6 150.54 25.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-N 114.924 -1.034 . . . . 0.0 109.675 179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' C' ' 60' ' ' GLU . 66.8 m -134.39 121.62 21.4 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.275 0.56 . . . . 0.0 110.939 177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.497 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.5 mp -112.09 133.47 57.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 176.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . 0.541 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -127.75 136.36 60.6 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 120.794 0.33 . . . . 0.0 110.779 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 33.9 p -129.34 125.04 35.79 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.28 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.428 ' HD2' HG21 ' C' ' 26' ' ' THR . 52.9 mtmt -107.72 139.33 42.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.17 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.566 HD11 ' HG3' ' C' ' 50' ' ' ARG . 0.2 OUTLIER -110.29 127.52 55.05 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.912 178.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -92.1 116.75 29.21 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.468 HG11 ' CE1' ' C' ' 85' ' ' TYR . 34.5 m -134.77 163.39 36.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.007 -169.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 91.1 mmm -81.52 128.67 34.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.172 0.51 . . . . 0.0 110.107 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.91 -48.78 42.27 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.946 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 50.4 m -61.75 -29.54 70.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.457 0.571 . . . . 0.0 111.919 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -67.29 -52.2 43.52 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' TRP . . . . . 0.449 ' HZ3' HG23 ' C' ' 102' ' ' ILE . 66.0 t-105 -56.85 -46.92 81.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.06 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' ASP . . . . . 0.565 ' HA ' ' HD3' ' C' ' 104' ' ' LYS . 22.5 t70 -69.5 -15.05 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.222 -178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 5.2 t -79.1 -5.4 53.99 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 82.3 18.92 65.61 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 8.3 m -65.58 138.55 58.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.436 0.636 . . . . 0.0 111.393 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.9 mt-10 -74.76 133.52 41.97 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 114.911 -1.04 . . . . 0.0 111.541 -172.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' TYR . . . . . 0.576 ' O ' HG22 ' C' ' 102' ' ' ILE . 82.0 m-85 -129.54 115.1 16.93 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 171.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' C' ' 101' ' ' SER . 0.3 OUTLIER -132.4 140.27 48.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-O 121.376 0.608 . . . . 0.0 111.298 -176.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 7.6 t -106.87 126.74 52.7 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-N 114.375 -1.284 . . . . 0.0 109.4 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -117.32 144.35 44.98 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' VAL . . . . . 0.611 ' HB ' ' CG1' ' C' ' 98' ' ' VAL . 54.6 t -116.76 135.33 57.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.533 ' HB3' ' HB3' ' C' ' 40' ' ' LYS . 36.3 tt0 -125.28 130.33 51.8 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . 0.501 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 15.7 t70 -150.67 144.65 25.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.186 0.517 . . . . 0.0 110.046 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.5 t -66.17 -19.27 65.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.859 -174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . 0.431 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 6.6 mm-40 -92.09 -6.67 50.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.808 0.337 . . . . 0.0 110.882 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.501 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 38.7 mt -89.76 145.96 34.49 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-O 120.851 0.358 . . . . 0.0 110.531 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.44 -35.16 0.88 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.325 2.683 . . . . 0.0 111.68 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -146.21 154.04 49.45 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.102 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.56 148.81 73.39 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.739 1.626 . . . . 0.0 111.359 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' VAL . . . . . 0.611 ' CG1' ' HB ' ' C' ' 89' ' ' VAL . 10.7 p -110.56 140.01 31.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.566 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 8.6 ptpp? -137.85 151.73 48.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.951 0.405 . . . . 0.0 111.775 -171.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -159.85 127.58 4.72 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.434 174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . 0.559 ' HB3' ' HB ' ' C' ' 86' ' ' VAL . 72.2 p -107.48 160.63 15.51 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.133 -175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . 0.576 HG22 ' O ' ' C' ' 85' ' ' TYR . 3.6 tp -121.77 139.65 48.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.138 0.494 . . . . 0.0 110.077 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -114.84 145.46 42.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.054 -177.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' C' ' 80' ' ' ASP . 33.9 ttpt -73.61 110.35 7.83 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.009 0.433 . . . . 0.0 110.189 177.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.433 -0.794 . . . . 0.0 110.143 179.774 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.1 ttp . . . . . 0 N--CA 1.483 1.203 0 N-CA-C 110.272 -0.27 . . . . 0.0 110.272 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -98.03 167.49 22.87 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.944 -176.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' C' ' 3' ' ' ARG . 39.9 ttm180 -107.72 124.91 50.72 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 177.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 69.61 -67.21 0.23 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.849 0.718 . . . . 0.0 109.879 -173.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' THR . . . . . 0.476 HG23 ' O ' ' C' ' 5' ' ' THR . 7.7 t -91.3 90.72 7.86 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 122.796 1.284 . . . . 0.0 109.943 173.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -100.05 115.28 29.38 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 168.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' ILE . . . . . 0.712 HG12 HG11 ' C' ' 98' ' ' VAL . 3.3 tp -126.37 122.1 60.48 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.8 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.566 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 16.3 m -114.73 106.75 14.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.556 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 21.7 t -102.05 113.66 39.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.023 -178.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 3.5 m -112.24 110.2 20.31 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.675 HD21 ' HB ' ' C' ' 102' ' ' ILE . 57.8 tp -99.53 117.5 34.06 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 86.6 mt -111.45 118.45 35.81 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.162 0.506 . . . . 0.0 110.706 -167.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.548 ' HB3' HD11 ' C' ' 102' ' ' ILE . 14.4 ptpt -79.53 147.5 67.9 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.146 177.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . 0.47 ' HA ' ' HD3' ' C' ' 15' ' ' PRO . 18.2 Cg_endo -62.0 123.87 13.38 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.477 2.118 . . . . 0.0 111.568 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' C' ' 14' ' ' PRO . 11.5 Cg_exo -71.03 69.02 2.38 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.336 2.691 . . . . 0.0 113.0 -175.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 72.66 153.39 0.13 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.391 0.677 . . . . 0.0 111.845 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -98.45 -14.31 20.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.146 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 62.44 -165.97 0.23 Allowed 'General case' 0 N--CA 1.463 0.2 0 O-C-N 123.703 0.627 . . . . 0.0 111.402 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 48.5 mm -79.38 -43.55 23.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 174.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -109.99 114.17 27.49 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.94 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 4.2 t -75.94 133.81 40.39 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 176.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -67.26 -27.46 67.22 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.702 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 54.1 tp60 -166.35 -63.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.009 174.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 8.7 t -164.7 -178.58 5.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.353 0.597 . . . . 0.0 110.984 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.22 28.2 0.19 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.056 -170.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' THR . . . . . 0.787 ' HA ' HG12 ' C' ' 74' ' ' VAL . 5.8 t -57.46 130.33 45.83 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.802 0.811 . . . . 0.0 112.283 -166.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' ILE . . . . . 0.526 HG13 HG11 ' C' ' 74' ' ' VAL . 40.1 mt -97.33 154.74 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.704 -174.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.618 HG22 ' HG2' ' C' ' 71' ' ' LYS . 84.1 t -130.61 133.93 62.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.745 -178.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' CYS . . . . . 0.433 ' HB2' ' CZ2' ' C' ' 43' ' ' TRP . 19.3 t -115.78 112.36 21.88 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 174.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -104.97 123.33 47.59 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' ILE . . . . . 0.56 HG12 HG21 ' C' ' 89' ' ' VAL . 0.1 OUTLIER -121.78 136.06 59.91 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.445 0.64 . . . . 0.0 111.007 -176.069 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.566 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 17.9 t -114.94 132.24 64.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 114.946 -1.024 . . . . 0.0 110.084 -176.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.631 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.88 167.61 22.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.236 -179.618 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 41.8 t -141.01 150.32 42.89 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' C' ' 34' ' ' SER . 7.2 m-20 76.81 11.59 2.5 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.479 0.487 . . . . 0.0 112.085 170.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 mt -96.35 164.33 12.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.902 0.858 . . . . 0.0 112.351 -175.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' C' ' 38' ' ' ASN . 11.3 tp10 -91.81 174.1 7.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.952 -1.476 . . . . 0.0 107.394 174.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.413 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 1.2 m-80 -56.36 114.09 1.85 Allowed 'General case' 0 N--CA 1.437 -1.088 0 CA-C-O 122.667 1.222 . . . . 0.0 108.131 -176.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.629 HG21 HG13 ' C' ' 89' ' ' VAL . 5.0 mp -73.83 144.57 12.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 112.448 -2.16 . . . . 0.0 113.266 -175.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -104.86 122.94 46.81 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.087 173.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 9.9 p -102.79 144.12 14.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 120.91 0.386 . . . . 0.0 110.908 -177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.45 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.5 t80 -135.06 143.85 46.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 -179.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' TRP . . . . . 0.458 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 51.7 m95 -127.6 139.5 52.71 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . 0.501 ' HG2' ' HB ' ' C' ' 86' ' ' VAL . 4.0 pt20 -132.77 131.02 40.68 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.628 0.728 . . . . 0.0 111.11 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 0.2 OUTLIER -120.25 122.53 68.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.54 179.39 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 53.77 34.83 19.98 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.02 -174.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.65 -16.36 25.96 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.443 178.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -87.72 134.16 28.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -61.22 139.36 58.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.28 0.562 . . . . 0.0 110.195 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -89.31 117.23 28.11 Favored 'General case' 0 N--CA 1.438 -1.072 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.389 -173.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 8.0 tppt? -53.29 158.45 1.63 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.912 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -43.68 164.59 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.862 0.839 . . . . 0.0 112.723 178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.18 3.97 20.89 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 107.761 -2.136 . . . . 0.0 107.761 -155.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.407 ' HA ' HD22 ' C' ' 72' ' ' LEU . 7.6 p -88.23 132.44 33.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 113.116 -1.542 . . . . 0.0 108.351 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.48 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 86.8 tt0 -125.49 108.86 12.04 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.83 0.348 . . . . 0.0 110.459 -172.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 16.0 p -98.45 122.64 41.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.812 176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.692 ' HB2' HG13 ' C' ' 69' ' ' VAL . 42.5 mt-30 -103.06 176.27 5.2 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.236 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -75.31 150.78 85.32 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-O 121.178 0.513 . . . . 0.0 110.744 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' PRO . . . . . 0.539 ' HB3' HD11 ' C' ' 68' ' ' ILE . 43.9 Cg_endo -65.48 148.09 87.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.553 2.835 . . . . 0.0 112.989 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' GLU . . . . . 0.582 ' HG3' ' HB ' ' C' ' 67' ' ' THR . 14.4 pt-20 -117.57 149.53 40.5 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 172.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 13.7 p90 -110.58 127.58 55.29 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.261 0.553 . . . . 0.0 112.301 -170.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 55.4 p -128.17 101.64 6.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.148 173.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.03 -130.16 47.2 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.489 -176.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -84.45 -6.44 59.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.846 0.355 . . . . 0.0 110.706 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . 0.464 ' HE2' HG12 ' C' ' 32' ' ' VAL . 46.6 mtpt -97.12 153.17 18.13 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.559 0.695 . . . . 0.0 111.12 -175.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.3 m -115.59 149.06 38.84 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.021 -0.99 . . . . 0.0 109.577 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.582 ' HB ' ' HG3' ' C' ' 60' ' ' GLU . 46.2 m -132.37 122.16 24.62 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.397 0.618 . . . . 0.0 110.813 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.631 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -110.06 132.48 58.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 114.944 -1.026 . . . . 0.0 109.379 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . 0.692 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.9 p -108.5 122.47 63.08 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.552 0.692 . . . . 0.0 110.878 176.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 42.1 m -120.74 122.19 39.86 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.84 176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.618 ' HG2' HG22 ' C' ' 28' ' ' VAL . 6.8 mtpm? -106.0 152.54 23.21 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.952 -176.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' C' ' 72' ' ' LEU . 0.2 OUTLIER -119.84 114.93 22.86 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -78.36 112.1 15.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 173.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.787 HG12 ' HA ' ' C' ' 26' ' ' THR . 12.9 p -128.63 153.09 37.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.035 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.951 -167.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.643 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 97.0 mmm -72.03 129.47 38.61 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.689 0.757 . . . . 0.0 110.614 -175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -52.17 -34.11 43.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.097 -1.411 . . . . 0.0 110.793 177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -70.56 -35.27 72.99 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.283 0.633 . . . . 0.0 111.397 179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' GLU . . . . . 0.643 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 59.7 mt-10 -68.58 -52.49 31.13 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 63.9 t-105 -58.2 -42.47 86.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.801 178.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -62.37 -26.03 68.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.325 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 51.0 m -87.05 -2.39 58.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.843 0.354 . . . . 0.0 111.299 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.59 28.79 72.95 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.521 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.641 HG21 ' HB3' ' C' ' 78' ' ' GLU . 14.6 t -64.88 150.82 47.03 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' GLU . . . . . 0.495 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 32.5 mt-10 -80.64 141.86 34.55 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.069 0.461 . . . . 0.0 111.32 -175.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -137.75 127.86 25.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.754 173.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . 0.609 HG11 ' HE2' ' C' ' 99' ' ' LYS . 20.9 t -120.48 138.76 49.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 177.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 29.2 t -111.46 118.5 35.95 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.731 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.3 mp -113.28 147.06 38.32 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.677 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' VAL . . . . . 0.629 HG13 HG21 ' C' ' 39' ' ' ILE . 25.1 t -135.29 125.69 44.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 C-N-CA 122.91 0.484 . . . . 0.0 109.806 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.434 ' HB3' ' HB3' ' C' ' 97' ' ' PRO . 12.9 pt-20 -133.64 145.48 50.02 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.031 0.443 . . . . 0.0 110.697 176.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . 0.554 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 14.5 t70 -136.75 158.48 44.36 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 34.0 t -52.79 -41.7 64.37 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 123.386 0.429 . . . . 0.0 110.825 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -86.98 -1.73 58.09 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.554 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 42.8 mt -92.02 128.74 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.058 0.456 . . . . 0.0 109.988 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.87 -35.09 37.03 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 123.051 2.501 . . . . 0.0 112.206 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 4.6 p -147.52 153.67 43.95 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.944 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' PRO . . . . . 0.434 ' HB3' ' HB3' ' C' ' 90' ' ' GLU . 37.6 Cg_endo -68.83 153.39 72.97 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.27 1.98 . . . . 0.0 111.503 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' VAL . . . . . 0.712 HG11 HG12 ' C' ' 7' ' ' ILE . 13.7 p -116.79 146.53 21.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.731 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 14.1 ptmm? -141.03 156.5 46.01 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.304 -175.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.81 140.52 19.01 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 175.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 32.2 t -118.03 153.75 33.17 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.134 0.492 . . . . 0.0 111.063 -172.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . 0.675 ' HB ' HD21 ' C' ' 11' ' ' LEU . 8.0 tp -124.21 149.48 28.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.774 -174.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -142.07 152.96 43.81 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -78.38 108.39 11.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.184 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.854 0 CA-C-N 114.803 -1.09 . . . . 0.0 108.707 -177.827 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 63.6 mtt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.81 56.08 4.26 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.327 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? 53.77 65.67 1.45 Allowed 'General case' 0 N--CA 1.463 0.176 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -177.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -90.48 130.77 36.5 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.591 -172.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 2.9 t -72.72 96.6 2.05 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 122.244 1.021 . . . . 0.0 112.391 -175.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -96.97 112.65 24.31 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 161.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' ILE . . . . . 0.421 HG12 HG11 ' C' ' 98' ' ' VAL . 2.1 tp -125.21 110.75 25.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.059 -0.973 . . . . 0.0 108.673 169.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.875 ' HB2' HG13 ' C' ' 32' ' ' VAL . 51.0 m -110.31 104.49 13.29 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.374 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 p -112.54 116.6 53.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.27 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 16.0 m -121.01 127.31 51.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.591 HD21 ' HB3' ' C' ' 87' ' ' CYS . 72.2 mt -99.8 127.23 45.97 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.255 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 tt -110.06 114.69 28.41 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.663 ' HB3' HD11 ' C' ' 102' ' ' ILE . 18.9 ptpt -76.26 154.79 84.3 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.303 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . 0.548 ' HD3' HD13 ' C' ' 27' ' ' ILE . 19.0 Cg_endo -59.97 122.83 12.02 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.4 2.067 . . . . 0.0 111.685 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' C' ' 14' ' ' PRO . 17.2 Cg_endo -57.76 140.48 93.76 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.892 2.395 . . . . 0.0 111.997 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -109.87 88.74 2.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.6 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . 0.615 ' HG3' ' HB2' ' C' ' 20' ' ' TRP . 0.4 OUTLIER -104.87 157.84 16.94 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -119.86 -19.86 7.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.345 -176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 76.1 mt -80.72 -36.14 15.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.148 0.499 . . . . 0.0 110.223 175.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.615 ' HB2' ' HG3' ' C' ' 17' ' ' GLU . 84.4 m95 -111.98 172.35 6.95 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.265 -178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 41.6 m -146.98 115.07 6.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.079 174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -85.38 -167.64 1.92 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.76 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -61.77 -63.21 1.34 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.671 -176.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -165.61 -176.4 3.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.127 -0.488 . . . . 0.0 109.853 -174.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.536 ' CB ' ' HA ' ' C' ' 76' ' ' ALA . . . -71.47 26.62 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 124.032 0.933 . . . . 0.0 112.751 -177.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' THR . . . . . 0.443 ' HA ' HG22 ' C' ' 74' ' ' VAL . 5.9 t -59.3 129.4 41.87 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 121.543 0.687 . . . . 0.0 111.518 -171.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' ILE . . . . . 0.548 HD13 ' HD3' ' C' ' 14' ' ' PRO . 15.8 mm -88.87 152.39 3.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.192 -174.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 39.8 t -130.41 132.96 64.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.321 174.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 38.1 t -121.05 114.54 21.63 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.624 176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -106.52 128.54 54.19 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' C' ' 8' ' ' SER . 0.0 OUTLIER -126.53 133.51 68.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.556 0 CA-C-O 121.483 0.659 . . . . 0.0 111.373 -177.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.875 HG13 ' HB2' ' C' ' 8' ' ' SER . 2.1 p -129.05 134.73 63.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.516 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.557 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -163.5 168.18 20.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.723 -171.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' SER . . . . . 0.553 ' HB3' ' HD3' ' C' ' 65' ' ' LYS . 18.9 p -141.99 149.88 40.63 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.42 -175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' C' ' 34' ' ' SER . 4.9 m-20 77.59 11.02 2.2 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 123.756 0.66 . . . . 0.0 112.166 171.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 34.7 mt -96.18 177.51 5.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.996 0.903 . . . . 0.0 112.793 -170.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' GLU . . . . . 0.714 ' O ' HG13 ' C' ' 39' ' ' ILE . 20.4 mm-40 -105.8 173.47 6.3 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 113.72 -1.582 . . . . 0.0 109.595 177.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.76 112.73 1.94 Allowed 'General case' 0 N--CA 1.437 -1.091 0 CA-C-O 123.927 1.822 . . . . 0.0 108.773 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.721 HG21 HG13 ' C' ' 89' ' ' VAL . 51.0 mt -87.56 147.3 5.37 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 CA-C-N 110.864 -2.88 . . . . 0.0 114.126 -171.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -100.33 126.49 46.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 114.555 -1.202 . . . . 0.0 109.156 175.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 46.8 t -106.58 137.97 34.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 110.164 -0.309 . . . . 0.0 110.164 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.694 ' CB ' ' HG ' ' C' ' 88' ' ' LEU . 0.1 OUTLIER -119.31 147.84 43.85 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.929 -0.123 . . . . 0.0 110.897 -176.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' TRP . . . . . 0.808 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 65.7 m95 -137.18 132.66 34.23 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 167.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . 0.793 HE21 ' HA ' ' C' ' 44' ' ' GLN . 0.0 OUTLIER -123.27 131.3 53.62 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 177.041 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' VAL . . . . . 0.593 HG21 ' HD2' ' C' ' 50' ' ' ARG . 21.6 t -124.96 118.26 52.59 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.219 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.151 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . 0.512 ' ND2' HG12 ' C' ' 45' ' ' VAL . 57.1 m-80 57.99 33.83 23.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 -175.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.7 -1.2 31.28 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.003 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 p -116.62 138.64 46.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.719 0 CA-C-O 121.587 0.708 . . . . 0.0 111.255 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -59.11 122.21 13.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.263 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' ARG . . . . . 0.593 ' HD2' HG21 ' C' ' 45' ' ' VAL . 7.9 ptm85 -92.86 167.54 11.77 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.4 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm -64.65 159.47 21.95 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.991 -176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' C' ' 52' ' ' LYS . 0.0 OUTLIER -49.63 166.56 0.05 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.107 176.131 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 116.9 7.7 12.7 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -162.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.56 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.4 p -88.25 126.9 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 168.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.458 ' O ' ' HA ' ' C' ' 70' ' ' SER . 39.9 mt-10 -121.0 109.62 15.28 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -171.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 5.6 p -101.13 116.88 33.86 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.954 175.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.401 ' HB2' ' HB ' ' C' ' 69' ' ' VAL . 75.1 mt-30 -87.47 150.17 23.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.27 0.557 . . . . 0.0 111.074 -175.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -63.89 138.18 97.32 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.334 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' PRO . . . . . 0.716 ' HB3' HD11 ' C' ' 68' ' ' ILE . 19.4 Cg_endo -61.68 136.31 61.77 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 123.525 2.817 . . . . 0.0 113.608 -171.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -121.27 129.84 53.36 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 175.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -86.21 139.99 30.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.056 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 45.8 t -140.04 103.81 4.7 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.052 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 71.1 -105.67 1.69 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.506 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 9.5 t -112.66 2.74 16.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.131 0.491 . . . . 0.0 109.945 176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . 0.553 ' HD3' ' HB3' ' C' ' 34' ' ' SER . 72.3 mmtt -119.4 162.4 18.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.165 0.507 . . . . 0.0 111.4 -173.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . 0.493 ' O ' HG23 ' C' ' 32' ' ' VAL . 9.6 m -115.99 149.13 39.32 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 174.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 33.1 m -130.67 121.46 25.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.984 0.421 . . . . 0.0 110.827 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.716 HD11 ' HB3' ' C' ' 59' ' ' PRO . 1.5 mp -108.8 137.17 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' C' ' 57' ' ' GLN . 61.7 t -109.85 129.59 64.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.594 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 43.7 m -124.89 110.33 14.12 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.077 0.465 . . . . 0.0 110.137 177.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -106.64 145.16 32.29 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.6 118.85 27.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.871 0.367 . . . . 0.0 110.934 -179.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.633 176.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.605 HG11 ' CE1' ' C' ' 85' ' ' TYR . 24.5 m -136.41 159.66 38.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.699 -175.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.0 mtt -76.74 131.98 39.04 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.228 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . 0.536 ' HA ' ' CB ' ' C' ' 25' ' ' ALA . . . -48.98 -51.6 29.61 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 178.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 10.5 m -59.08 -30.17 67.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' GLU . . . . . 0.574 ' HG3' HG21 ' C' ' 83' ' ' THR . 6.6 tp10 -69.96 -51.18 34.77 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 178.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' TRP . . . . . 0.419 ' HE3' ' CE2' ' C' ' 85' ' ' TYR . 50.8 t-105 -56.5 -44.05 80.32 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.173 175.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.14 -6.37 42.15 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.238 -176.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' C' ' 78' ' ' GLU . 30.5 t -83.82 -7.9 59.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.335 0.588 . . . . 0.0 109.957 176.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.22 21.16 68.09 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.058 179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.574 HG21 ' HG3' ' C' ' 78' ' ' GLU . 14.9 t -69.88 157.24 37.78 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.278 0.561 . . . . 0.0 110.324 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' GLU . . . . . 0.436 ' HG3' ' H ' ' C' ' 46' ' ' ASN . 3.5 pt-20 -81.25 138.97 35.72 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.357 -0.838 . . . . 0.0 112.159 -177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' TYR . . . . . 0.605 ' CE1' HG11 ' C' ' 74' ' ' VAL . 75.8 m-85 -126.21 116.92 22.05 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.201 -1.363 . . . . 0.0 109.0 169.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . 0.808 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 33.3 t -118.57 129.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' CYS . . . . . 0.591 ' HB3' HD21 ' C' ' 11' ' ' LEU . 8.7 t -116.0 124.4 50.42 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 177.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.694 ' HG ' ' CB ' ' C' ' 42' ' ' PHE . 1.7 pp -137.39 154.78 49.92 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 119.856 -0.738 . . . . 0.0 111.327 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' VAL . . . . . 0.721 HG13 HG21 ' C' ' 39' ' ' ILE . 6.3 t -122.13 135.11 63.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.273 -173.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -131.02 138.35 49.61 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . 0.561 ' HB2' HG12 ' C' ' 39' ' ' ILE . 17.3 t70 -146.67 151.52 37.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.676 -176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 19.8 m -64.45 -20.67 66.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.162 -174.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -90.84 -8.15 50.35 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.61 0.226 . . . . 0.0 111.61 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.44 ' HA ' ' HD3' ' C' ' 95' ' ' PRO . 50.4 mt -94.24 147.77 33.94 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-O 120.958 0.408 . . . . 0.0 110.574 -177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 4.2 Cg_exo -82.12 -30.74 1.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.384 2.722 . . . . 0.0 111.481 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 26.2 p -142.7 154.3 62.59 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.203 178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' PRO . . . . . 0.475 ' HB2' HD13 ' C' ' 88' ' ' LEU . 41.4 Cg_endo -68.49 150.34 75.3 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 121.925 1.75 . . . . 0.0 110.971 174.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 47.0 t -109.06 106.14 20.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 -176.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' C' ' 88' ' ' LEU . 14.8 ptpt -111.35 149.95 30.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.327 -171.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -150.6 129.8 12.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.116 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 42.0 t -110.74 152.76 26.2 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.216 0.531 . . . . 0.0 111.734 -175.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . 0.663 HD11 ' HB3' ' C' ' 13' ' ' LYS . 11.6 tt -131.08 148.27 32.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.457 177.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -137.17 158.43 44.46 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.633 -175.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 55.8 tttp -64.04 110.4 2.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.234 177.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.296 -0.859 . . . . 0.0 109.493 179.34 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 120.975 0.417 . . . . 0.0 110.373 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.63 22.64 12.11 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 110.34 -1.104 . . . . 0.0 110.34 -170.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . 0.44 HH11 ' HD3' ' C' ' 3' ' ' ARG . 10.1 tpt180 -83.82 -52.56 6.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.912 -0.644 . . . . 0.0 110.893 -176.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -179.41 -71.65 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' THR . . . . . 0.453 HG23 ' O ' ' C' ' 5' ' ' THR . 9.0 t -96.09 91.16 5.81 Favored 'General case' 0 CA--C 1.498 -1.021 0 CA-C-O 123.052 1.406 . . . . 0.0 109.883 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -101.51 111.79 24.13 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 113.608 -1.633 . . . . 0.0 106.785 169.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' ILE . . . . . 0.579 HG12 HG11 ' C' ' 98' ' ' VAL . 2.8 tp -121.48 119.34 58.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.264 174.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 37.5 m -126.62 120.51 29.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.851 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 p -114.51 119.41 61.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.136 0.493 . . . . 0.0 110.864 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -110.09 118.03 35.32 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.579 HD21 ' HB3' ' C' ' 87' ' ' CYS . 44.1 mt -99.79 121.78 41.78 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.827 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 57.4 tp -109.97 116.16 31.09 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.478 ' NZ ' ' HB3' ' C' ' 105' ' ' ALA . 22.3 ptmt -77.9 150.3 78.12 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.658 -177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.77 136.8 17.28 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.083 2.522 . . . . 0.0 111.642 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.678 ' HB2' ' HG3' ' C' ' 17' ' ' GLU . 86.7 Cg_endo -80.52 165.3 20.7 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.75 2.3 . . . . 0.0 112.169 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -108.83 37.85 2.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . 0.678 ' HG3' ' HB2' ' C' ' 15' ' ' PRO . 40.3 mt-10 -78.85 104.02 9.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.826 -175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -80.42 3.26 21.9 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.776 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . 0.575 HG22 ' HB3' ' C' ' 17' ' ' GLU . 7.0 tp -66.26 -29.82 47.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.268 0.556 . . . . 0.0 109.726 171.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.447 ' CD1' ' HB2' ' C' ' 17' ' ' GLU . 45.5 m95 -83.6 113.22 20.68 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 175.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 12.5 p -76.38 113.3 13.81 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.57 -177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 66.68 94.03 0.07 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.998 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' GLN . . . . . 0.419 HE21 ' HB2' ' C' ' 23' ' ' GLN . 2.4 pt20 -138.42 175.96 9.11 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 175.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 11.8 p -121.84 159.55 26.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.196 0.522 . . . . 0.0 111.64 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.582 ' HB2' ' HA ' ' C' ' 76' ' ' ALA . . . -78.1 26.71 0.2 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.74 -1.118 . . . . 0.0 112.258 -176.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 5.7 t -60.59 124.76 21.35 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.903 0.859 . . . . 0.0 111.62 -171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 27.6 mt -93.52 153.53 3.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.759 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.74 133.76 67.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.309 0.576 . . . . 0.0 111.67 -178.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 45.4 t -118.4 112.05 19.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . 0.702 ' HG3' HG22 ' C' ' 69' ' ' VAL . 28.2 tt0 -113.29 120.22 40.4 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' ILE . . . . . 0.422 HD12 HG22 ' C' ' 68' ' ' ILE . 0.0 OUTLIER -121.73 133.63 67.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.427 0.632 . . . . 0.0 111.262 -166.31 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 47.3 t -117.83 130.35 72.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.761 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.763 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -160.55 164.69 31.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.712 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' SER . . . . . 0.414 ' HB2' ' HG2' ' C' ' 65' ' ' LYS . 8.7 t -144.27 147.32 33.39 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -177.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.0 t70 78.14 9.0 2.27 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.67 0.606 . . . . 0.0 111.297 174.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 19.1 mt -93.44 157.88 16.0 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.4 0.619 . . . . 0.0 111.4 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -83.59 174.11 10.84 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.219 172.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -57.19 113.05 1.56 Allowed 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 123.969 1.842 . . . . 0.0 108.373 -176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.673 HG23 HG13 ' C' ' 89' ' ' VAL . 5.2 mp -73.57 147.33 9.53 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 110.941 -2.845 . . . . 0.0 113.144 -175.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.454 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 23.6 ttmm -118.42 136.47 53.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.5 -0.773 . . . . 0.0 108.966 170.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.3 t -112.88 138.91 40.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.066 -173.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.747 ' HB3' HD23 ' C' ' 88' ' ' LEU . 5.3 t80 -119.56 150.35 40.42 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.427 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' TRP . . . . . 0.769 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 56.9 m95 -132.52 131.89 42.06 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.11 130.72 48.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 118.224 0.466 . . . . 0.0 111.046 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.15 111.16 34.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.65 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . 0.438 HD22 ' HA ' ' C' ' 46' ' ' ASN . 0.7 OUTLIER 58.79 37.29 24.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.502 0.667 . . . . 0.0 110.396 178.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.51 -9.85 33.21 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.252 -0.886 . . . . 0.0 112.569 -178.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 38.4 t -97.88 131.87 43.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 117.088 0.444 . . . . 0.0 110.348 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.99 137.91 56.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.991 0.424 . . . . 0.0 110.196 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' ARG . . . . . 0.497 ' HD3' ' N ' ' C' ' 51' ' ' LYS . 1.0 OUTLIER -89.75 136.34 33.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.943 -174.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' C' ' 50' ' ' ARG . 13.5 mptt -66.93 157.15 33.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.745 -178.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -45.31 165.79 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.884 0.849 . . . . 0.0 112.987 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 115.53 7.86 15.3 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 108.611 -1.795 . . . . 0.0 108.611 -158.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.413 ' HA ' HD22 ' C' ' 72' ' ' LEU . 7.4 p -90.95 134.57 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-N 113.268 -1.466 . . . . 0.0 108.076 173.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.66 ' HB3' ' HB2' ' C' ' 71' ' ' LYS . 33.6 tt0 -129.03 109.12 10.94 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 -175.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 18.3 p -98.69 121.68 40.94 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -96.83 152.55 18.58 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.99 0.424 . . . . 0.0 110.097 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -66.75 133.06 94.04 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.247 -176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' PRO . . . . . 0.578 ' HB3' ' CD1' ' C' ' 68' ' ' ILE . 13.2 Cg_endo -59.96 141.85 97.3 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.731 2.954 . . . . 0.0 113.488 -171.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -152.92 105.68 2.96 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.827 174.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' TRP . . . . . 0.641 ' HB3' ' O ' ' C' ' 65' ' ' LYS . 31.3 t-105 -141.98 163.72 32.12 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 166.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 39.1 m -53.86 142.84 22.91 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 168.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -49.86 -13.77 0.63 Allowed Glycine 0 CA--C 1.53 0.996 0 N-CA-C 116.567 1.387 . . . . 0.0 116.567 -168.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 2.2 p -76.29 -23.89 54.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 118.025 0.912 . . . . 0.0 111.744 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . 0.641 ' O ' ' HB3' ' C' ' 61' ' ' TRP . 53.6 mttp -145.93 165.84 27.78 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 6.0 m -118.95 150.77 39.35 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.497 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 94.1 m -131.04 120.05 22.88 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.896 0.379 . . . . 0.0 110.983 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.763 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.46 125.31 65.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . 0.702 HG22 ' HG3' ' C' ' 30' ' ' GLU . 47.0 t -106.01 122.49 59.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.308 -178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' C' ' 55' ' ' GLU . 36.2 m -120.11 130.35 54.59 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.122 0.487 . . . . 0.0 110.803 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.66 ' HB2' ' HB3' ' C' ' 55' ' ' GLU . 59.2 mttp -105.73 147.88 28.08 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 173.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.657 HD12 HG12 ' C' ' 74' ' ' VAL . 0.2 OUTLIER -125.5 114.6 19.0 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 169.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -93.89 112.67 24.55 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.657 HG12 HD12 ' C' ' 72' ' ' LEU . 4.5 m -122.01 168.54 14.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.353 -170.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.541 ' HB2' ' HG3' ' C' ' 78' ' ' GLU . 81.0 mtp -73.43 132.08 42.56 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 121.531 0.681 . . . . 0.0 109.458 175.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . 0.582 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . . . -55.43 -31.34 61.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.662 -1.153 . . . . 0.0 110.407 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -72.43 -31.66 65.66 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.769 0.828 . . . . 0.0 111.16 177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' GLU . . . . . 0.541 ' HG3' ' HB2' ' C' ' 75' ' ' MET . 69.3 mt-10 -65.56 -52.24 53.83 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 70.9 t-105 -60.66 -40.65 92.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.526 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -67.75 -18.82 65.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.244 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.8 t -87.06 -5.57 59.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.301 0.572 . . . . 0.0 109.801 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.29 28.89 72.19 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.345 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.6 t -70.71 152.58 43.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.064 0.459 . . . . 0.0 110.33 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -74.87 135.1 41.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.757 -173.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -131.6 127.08 36.34 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . 0.769 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 41.0 t -120.55 136.4 57.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' CYS . . . . . 0.579 ' HB3' HD21 ' C' ' 11' ' ' LEU . 12.4 t -115.65 130.48 56.88 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 172.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' C' ' 42' ' ' PHE . 0.0 OUTLIER -146.85 147.41 30.81 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.636 -167.032 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' VAL . . . . . 0.673 HG13 HG23 ' C' ' 39' ' ' ILE . 55.6 t -115.5 137.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 122.924 0.489 . . . . 0.0 111.193 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.497 ' HA ' HD21 ' C' ' 94' ' ' LEU . 4.9 pt-20 -129.71 133.12 46.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 171.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . 0.527 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 17.0 t70 -148.32 149.42 31.78 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.981 -176.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 17.2 m -47.0 -47.32 22.08 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.203 0.525 . . . . 0.0 111.532 -179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . 0.485 ' HB3' ' OD2' ' C' ' 91' ' ' ASP . 11.2 tp10 -83.85 -5.26 59.17 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 114.98 -1.009 . . . . 0.0 112.308 -167.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.572 ' O ' HD12 ' C' ' 94' ' ' LEU . 2.2 pp -92.97 150.55 39.5 Favored Pre-proline 0 C--N 1.329 -0.285 0 O-C-N 121.133 -0.979 . . . . 0.0 111.265 -179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.28 -35.41 1.25 Allowed 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 123.674 2.916 . . . . 0.0 112.44 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 5.5 p -147.78 151.19 38.19 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.26 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' PRO . . . . . 0.533 ' HB2' HD11 ' C' ' 88' ' ' LEU . 30.5 Cg_endo -61.78 144.69 97.24 Favored 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 122.579 2.186 . . . . 0.0 111.498 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' VAL . . . . . 0.579 HG11 HG12 ' C' ' 7' ' ' ILE . 41.8 t -107.07 102.5 14.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.622 ' HA ' ' HB2' ' C' ' 88' ' ' LEU . 10.6 ptpp? -108.36 151.29 26.22 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.371 -0.531 . . . . 0.0 110.833 -173.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.76 127.63 9.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.074 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 29.0 t -111.4 157.5 20.17 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.464 0.65 . . . . 0.0 111.393 -172.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . 0.484 ' HB ' HD13 ' C' ' 11' ' ' LEU . 5.5 tp -122.08 149.26 25.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.969 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' ARG . . . . . 0.46 ' HD3' ' N ' ' C' ' 103' ' ' ARG . 0.0 OUTLIER -131.98 151.2 51.88 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -76.0 138.89 41.21 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.18 0.514 . . . . 0.0 110.993 -177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . 0.478 ' HB3' ' NZ ' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.246 0.892 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 171.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 120.888 0.375 . . . . 0.0 110.321 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.54 168.1 31.68 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.887 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . 0.511 ' H ' ' HD2' ' C' ' 3' ' ' ARG . 0.0 OUTLIER -124.74 36.76 4.54 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.592 0.71 . . . . 0.0 109.855 179.647 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.416 ' HB2' ' OD1' ' C' ' 35' ' ' ASP . 5.4 pm0 -64.27 -28.46 69.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.476 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 8.4 m -84.91 89.55 7.6 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 122.598 1.19 . . . . 0.0 111.232 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' C' ' 33' ' ' TYR . 8.4 m-20 -117.83 115.98 26.06 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 113.158 -1.837 . . . . 0.0 106.286 161.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' ILE . . . . . 0.834 HG12 HG21 ' C' ' 98' ' ' VAL . 2.8 tp -114.0 108.08 24.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.804 0 CA-C-O 121.759 0.79 . . . . 0.0 108.892 169.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.407 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 49.2 m -120.84 116.04 24.41 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.114 -175.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.547 HG22 HG22 ' C' ' 31' ' ' ILE . 43.8 t -103.73 114.17 42.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.957 -178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 4.0 m -105.84 109.3 21.21 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.64 HD21 ' HB ' ' C' ' 102' ' ' ILE . 55.6 tp -103.02 117.13 33.9 Favored 'General case' 0 N--CA 1.423 -1.811 0 CA-C-N 115.302 -0.863 . . . . 0.0 108.745 -174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 65.6 tp -113.84 123.69 50.41 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 121.111 0.481 . . . . 0.0 110.43 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.549 ' HB3' HD11 ' C' ' 102' ' ' ILE . 21.6 pttp -86.52 152.87 55.35 Favored Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-N 115.143 -0.935 . . . . 0.0 108.908 173.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' C' ' 15' ' ' PRO . 25.4 Cg_endo -64.78 122.22 9.99 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.332 2.021 . . . . 0.0 111.508 -178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' C' ' 14' ' ' PRO . 43.1 Cg_exo -56.51 121.79 10.65 Favored 'Trans proline' 0 C--O 1.235 0.367 0 C-N-CA 123.008 2.472 . . . . 0.0 112.169 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -79.26 82.59 5.4 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.784 -178.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -88.42 113.6 24.18 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.558 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 62.85 -165.35 0.24 Allowed 'General case' 0 C--O 1.233 0.204 0 O-C-N 123.933 0.77 . . . . 0.0 110.921 -178.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 57.6 mt -83.35 -41.67 17.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.287 0.565 . . . . 0.0 110.301 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -91.11 126.32 36.16 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.404 -173.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 12.4 p -77.63 114.2 16.24 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.892 172.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -77.49 -24.7 50.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.146 0.498 . . . . 0.0 110.241 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' GLN . . . . . 0.422 ' HB3' ' H ' ' C' ' 24' ' ' THR . 24.2 mt-30 -129.77 -157.34 0.81 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.619 175.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' THR . . . . . 0.422 ' H ' ' HB3' ' C' ' 23' ' ' GLN . 11.3 p -93.56 175.84 6.59 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.481 0.657 . . . . 0.0 111.613 -174.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.36 26.37 3.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.919 -171.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' THR . . . . . 0.718 HG22 ' HA ' ' C' ' 73' ' ' LYS . 68.0 p -59.13 132.12 53.08 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.247 0.546 . . . . 0.0 112.131 -168.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 13.6 mm -89.4 152.3 3.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.664 -175.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.649 HG22 ' HG2' ' C' ' 71' ' ' LYS . 77.5 t -133.72 132.95 57.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.745 178.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 35.8 t -120.42 114.2 21.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.51 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -106.96 127.85 53.81 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' ILE . . . . . 0.624 HG21 HG21 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.46 133.33 69.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 121.719 0.771 . . . . 0.0 111.683 -177.114 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.407 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 47.6 t -112.34 130.08 66.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.553 -1.203 . . . . 0.0 109.761 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.727 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -162.25 164.9 27.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.965 0.412 . . . . 0.0 111.113 179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' SER . . . . . 0.418 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 47.4 t -139.2 150.09 45.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.985 -178.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' C' ' 34' ' ' SER . 1.6 m-20 75.78 12.25 3.02 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.515 0.509 . . . . 0.0 112.322 172.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 18.4 mt -99.03 159.77 14.73 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.714 0.769 . . . . 0.0 111.525 -174.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' C' ' 38' ' ' ASN . 22.0 tt0 -92.72 173.17 7.91 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.568 174.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.401 ' H ' ' HG2' ' C' ' 37' ' ' GLU . 5.5 p30 -55.46 115.65 2.42 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 123.849 1.785 . . . . 0.0 109.176 -173.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.623 ' CG2' HG13 ' C' ' 89' ' ' VAL . 5.0 mp -76.41 146.37 8.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 110.979 -2.828 . . . . 0.0 113.18 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.492 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 55.0 tptt -104.4 127.63 52.12 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.837 -1.074 . . . . 0.0 108.732 172.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.11 140.04 26.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 110.488 -0.19 . . . . 0.0 110.488 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.474 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.6 t80 -133.17 144.36 49.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.043 0.449 . . . . 0.0 111.559 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' TRP . . . . . 0.596 ' HA ' ' O ' ' C' ' 86' ' ' VAL . 69.1 m95 -127.09 140.7 52.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 175.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . 0.408 ' HB3' HG13 ' C' ' 86' ' ' VAL . 35.0 tt0 -128.09 131.05 49.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 111.195 177.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' VAL . . . . . 0.786 HG21 ' HE ' ' C' ' 50' ' ' ARG . 21.2 t -116.99 116.01 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.484 177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 57.58 36.62 27.0 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.213 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.07 -15.64 26.41 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.754 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -97.56 137.28 25.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 122.626 -0.338 . . . . 0.0 110.608 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -58.46 136.51 57.51 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.905 0.383 . . . . 0.0 110.311 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' ARG . . . . . 0.786 ' HE ' HG21 ' C' ' 45' ' ' VAL . 17.7 tpp180 -91.74 122.15 34.03 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.991 -178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -59.88 162.42 5.49 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.655 177.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 42.7 mtmt -42.72 164.52 0.01 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-O 122.283 1.04 . . . . 0.0 113.613 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.37 -1.03 23.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 -155.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.405 ' HA ' HD22 ' C' ' 72' ' ' LEU . 6.7 p -88.79 131.98 34.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 113.205 -1.497 . . . . 0.0 108.281 174.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' C' ' 71' ' ' LYS . 45.7 mt-10 -126.25 109.24 12.08 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.959 0.409 . . . . 0.0 110.626 -172.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 15.9 m -95.08 117.24 29.85 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.519 178.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -99.79 165.95 11.33 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.849 0.357 . . . . 0.0 110.438 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' ASN . . . . . 0.491 ' ND2' ' HD2' ' C' ' 59' ' ' PRO . 29.3 t-20 -69.18 134.47 89.35 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-O 121.899 0.857 . . . . 0.0 112.456 -175.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' PRO . . . . . 0.615 ' HA ' ' O ' ' C' ' 67' ' ' THR . 23.5 Cg_exo -55.19 134.8 65.88 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 124.173 3.249 . . . . 0.0 112.586 178.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -153.46 107.45 3.05 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.421 175.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' TRP . . . . . 0.603 ' HB3' ' O ' ' C' ' 65' ' ' LYS . 65.0 t-105 -140.63 163.92 31.57 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 166.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . 0.403 ' O ' ' N ' ' C' ' 64' ' ' SER . 48.4 m -48.19 141.74 6.02 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 166.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -67.16 33.69 0.19 Allowed Glycine 0 CA--C 1.527 0.784 0 N-CA-C 115.575 0.99 . . . . 0.0 115.575 -168.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' SER . . . . . 0.403 ' N ' ' O ' ' C' ' 62' ' ' SER . 37.1 m -112.82 -26.29 8.63 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 117.424 0.612 . . . . 0.0 109.725 171.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . 0.603 ' O ' ' HB3' ' C' ' 61' ' ' TRP . 12.6 mtpp -141.58 164.87 29.05 Favored 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 48.7 m -113.68 154.03 27.95 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.994 -0.441 . . . . 0.0 110.962 177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 85.4 m -136.45 123.46 21.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.956 0.407 . . . . 0.0 111.166 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.727 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.6 mp -108.7 132.91 55.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.594 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 54.5 t -110.3 122.1 64.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.006 0.431 . . . . 0.0 110.489 179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 27.4 t -118.17 122.78 43.9 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.628 177.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.649 ' HG2' HG22 ' C' ' 28' ' ' VAL . 32.1 mtpt -106.17 154.51 20.59 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.818 0.342 . . . . 0.0 110.426 178.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.457 ' HG ' ' CE1' ' C' ' 85' ' ' TYR . 0.2 OUTLIER -119.97 117.73 28.83 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 170.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' LYS . . . . . 0.718 ' HA ' HG22 ' C' ' 26' ' ' THR . 71.1 tttt -85.07 112.26 20.49 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' C' ' 26' ' ' THR . 12.5 p -133.62 155.99 40.91 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 121.223 0.535 . . . . 0.0 110.683 -166.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 57.9 mtm -80.24 130.37 35.16 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.861 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.04 -53.07 17.52 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.442 0.464 . . . . 0.0 111.762 -176.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 41.3 t -57.72 -32.87 67.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.909 0.484 . . . . 0.0 112.066 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' GLU . . . . . 0.618 ' HG3' HG21 ' C' ' 83' ' ' THR . 3.8 tp10 -66.11 -54.73 21.98 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' TRP . . . . . 0.464 ' CZ2' ' HA ' ' C' ' 104' ' ' LYS . 62.1 t-105 -59.31 -48.88 79.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.863 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' ASP . . . . . 0.484 ' HA ' ' HG3' ' C' ' 104' ' ' LYS . 5.5 t70 -70.27 -6.49 35.19 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.901 -174.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 41.0 t -81.23 -5.78 58.14 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.094 0.473 . . . . 0.0 109.883 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' C' ' 104' ' ' LYS . . . 82.83 20.01 62.23 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.418 -0.673 . . . . 0.0 111.418 -177.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.618 HG21 ' HG3' ' C' ' 78' ' ' GLU . 0.6 OUTLIER -63.47 145.87 54.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.14 0.495 . . . . 0.0 110.231 -177.517 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 33.8 mt-10 -81.58 135.61 35.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.455 0.645 . . . . 0.0 111.767 -176.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' TYR . . . . . 0.484 ' O ' HG22 ' C' ' 102' ' ' ILE . 1.8 m-85 -134.13 124.75 26.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.956 177.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . 0.596 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 0.2 OUTLIER -133.26 142.04 43.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.461 0.648 . . . . 0.0 111.424 179.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 18.9 t -112.37 124.53 52.69 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.167 -1.379 . . . . 0.0 109.412 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.901 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.5 mp -114.73 147.6 39.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.29 177.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' VAL . . . . . 0.624 HG21 HG21 ' C' ' 31' ' ' ILE . 11.4 t -126.44 131.62 71.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.234 0.613 . . . . 0.0 109.958 174.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 8.3 pt-20 -136.09 134.95 38.91 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.175 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . 0.523 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 7.9 t70 -147.0 151.83 37.61 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.142 0.496 . . . . 0.0 110.571 -177.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 66.4 m -68.35 -8.13 37.27 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.636 -175.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . 0.443 ' HB2' ' OD2' ' C' ' 91' ' ' ASP . 58.0 mm-40 -99.99 -4.57 29.77 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 111.163 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.571 ' C ' HD12 ' C' ' 94' ' ' LEU . 2.4 pp -108.09 158.51 33.46 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.962 -177.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' C' ' 96' ' ' THR . 5.3 Cg_endo -91.03 -34.56 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 124.831 3.687 . . . . 0.0 112.784 -173.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.546 ' H ' ' HD2' ' C' ' 95' ' ' PRO . 33.2 p -141.38 145.84 39.79 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.53 148.47 66.66 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 121.954 1.769 . . . . 0.0 111.142 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' VAL . . . . . 0.834 HG21 HG12 ' C' ' 7' ' ' ILE . 40.3 t -110.61 139.11 35.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -175.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.901 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 24.9 pttm -144.15 157.53 44.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.467 0.651 . . . . 0.0 112.593 -174.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -158.06 137.02 11.46 Favored 'General case' 0 CA--C 1.502 -0.872 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.862 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 75.2 p -114.65 149.94 35.91 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.994 -172.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . 0.64 ' HB ' HD21 ' C' ' 11' ' ' LEU . 3.9 tp -122.71 153.2 27.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 -175.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' ARG . . . . . 0.454 ' N ' HG13 ' C' ' 102' ' ' ILE . 12.8 ptp180 -125.14 156.67 37.98 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' LYS . . . . . 0.546 ' HB3' ' HA2' ' C' ' 82' ' ' GLY . 8.1 tmtm? -78.84 122.88 26.63 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.998 0.428 . . . . 0.0 110.968 -173.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . 0.473 ' HB3' ' HE2' ' C' ' 13' ' ' LYS . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 172.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.69 0.281 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.27 50.77 48.57 Favored Glycine 0 N--CA 1.448 -0.553 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.849 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 -110.93 156.08 21.72 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 61.65 -86.53 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.676 0.61 . . . . 0.0 110.895 -174.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' THR . . . . . 0.417 HG23 HD21 ' C' ' 36' ' ' LEU . 10.6 m -116.13 95.67 5.2 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.029 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' C' ' 33' ' ' TYR . 30.3 t70 -112.63 120.54 41.9 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.325 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 tp -142.48 129.34 18.9 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.101 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.565 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 26.8 t -120.87 121.1 37.36 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.441 -177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.812 HG22 HG22 ' C' ' 31' ' ' ILE . 41.2 t -119.0 123.72 71.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.499 -177.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.0 t -146.89 146.66 30.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.723 0.296 . . . . 0.0 110.473 177.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.464 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.2 mm? -97.1 145.08 26.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.323 0.582 . . . . 0.0 111.104 179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.532 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 63.0 tp -115.24 117.59 30.9 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.431 ' HB3' HD11 ' C' ' 102' ' ' ILE . 43.3 pttt -91.12 155.31 44.81 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-O 120.797 0.332 . . . . 0.0 110.475 -177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . 0.607 ' HD3' HD13 ' C' ' 27' ' ' ILE . 74.5 Cg_endo -79.97 132.46 9.54 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.805 2.337 . . . . 0.0 111.161 176.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' C' ' 14' ' ' PRO . 7.4 Cg_exo -73.4 177.62 7.69 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.868 2.378 . . . . 0.0 112.114 178.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' C' ' 21' ' ' THR . 46.4 m-85 65.48 46.69 2.44 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.397 0.618 . . . . 0.0 111.564 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . 0.907 ' HG2' ' HE1' ' C' ' 79' ' ' TRP . 0.0 OUTLIER -127.06 -12.34 5.82 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.961 171.036 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -70.82 -79.43 0.07 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.101 -176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 64.0 mt -101.97 -56.4 5.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.304 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 52.2 m95 -102.26 134.75 45.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.644 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' C' ' 16' ' ' PHE . 11.6 p -99.89 153.95 18.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.034 0.445 . . . . 0.0 112.096 -176.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -150.16 50.14 0.9 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.556 0.693 . . . . 0.0 109.63 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' GLN . . . . . 0.425 ' HB3' ' H ' ' C' ' 24' ' ' THR . 21.9 mt-30 57.22 -148.83 0.48 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.312 178.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' THR . . . . . 0.641 ' HB ' ' CA ' ' C' ' 76' ' ' ALA . 8.8 t -116.95 147.9 41.86 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.435 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.42 -53.32 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.929 -0.708 . . . . 0.0 111.835 172.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -169.78 160.33 8.56 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.667 0.27 . . . . 0.0 111.669 177.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' ILE . . . . . 0.607 HD13 ' HD3' ' C' ' 14' ' ' PRO . 22.8 mm -117.37 117.89 56.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 164.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 79.3 t -112.64 134.78 54.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.441 -0.904 . . . . 0.0 112.103 -170.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' CYS . . . . . 0.402 ' HB2' ' CH2' ' C' ' 43' ' ' TRP . 52.3 t -111.62 114.45 27.51 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.108 171.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -96.15 125.42 40.66 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' ILE . . . . . 0.812 HG22 HG22 ' C' ' 9' ' ' VAL . 0.0 OUTLIER -123.59 124.59 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 CA-C-O 121.985 0.898 . . . . 0.0 111.48 176.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -114.18 128.85 70.98 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 114.243 -1.344 . . . . 0.0 108.699 176.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.553 ' CE2' HD13 ' C' ' 68' ' ' ILE . 49.0 p90 -147.41 165.11 31.19 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.421 0.629 . . . . 0.0 111.732 -176.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 12.7 t -143.77 143.67 31.47 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.873 170.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.7 t70 79.62 9.56 1.53 Allowed 'General case' 0 N--CA 1.473 0.712 0 O-C-N 123.605 0.565 . . . . 0.0 112.298 171.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.417 HD21 HG23 ' C' ' 5' ' ' THR . 21.2 mt -93.25 160.58 14.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.658 0.742 . . . . 0.0 112.217 -175.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' GLU . . . . . 0.59 ' O ' HG13 ' C' ' 39' ' ' ILE . 6.2 tp10 -99.74 172.96 6.94 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.705 -1.134 . . . . 0.0 108.496 176.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.45 ' H ' ' HG3' ' C' ' 37' ' ' GLU . 2.7 m-80 -55.03 110.81 0.72 Allowed 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 123.604 1.669 . . . . 0.0 109.109 -170.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.59 HG13 ' O ' ' C' ' 37' ' ' GLU . 17.3 mt -77.3 142.82 13.72 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 110.486 -3.052 . . . . 0.0 113.165 -174.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . 0.662 ' HB3' ' HG3' ' C' ' 90' ' ' GLU . 29.2 tptp -105.42 123.68 48.28 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.823 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 44.4 t -99.15 139.03 21.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.282 -177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.458 ' CE1' ' HG2' ' C' ' 49' ' ' GLU . 47.5 t80 -133.24 139.83 47.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.048 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' TRP . . . . . 0.402 ' CH2' ' HB2' ' C' ' 29' ' ' CYS . 71.4 m95 -125.37 137.48 54.03 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -126.94 129.66 48.58 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 117.933 0.333 . . . . 0.0 110.126 177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 25.0 t -120.83 116.72 50.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.323 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . 0.528 ' HA ' ' OE1' ' C' ' 84' ' ' GLU . 3.2 m120 54.53 37.17 27.42 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.123 0.487 . . . . 0.0 111.808 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.04 -16.3 38.69 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.277 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . 0.411 HG12 ' O ' ' C' ' 45' ' ' VAL . 15.0 p -104.64 142.06 18.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 117.624 0.712 . . . . 0.0 110.721 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . 0.458 ' HG2' ' CE1' ' C' ' 42' ' ' PHE . 41.5 mt-10 -60.4 138.17 58.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.407 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' ARG . . . . . 0.482 ' HB2' HG23 ' C' ' 45' ' ' VAL . 13.2 tpp180 -91.29 124.27 35.36 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-O 121.362 0.601 . . . . 0.0 110.077 -175.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -59.76 162.71 5.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 114.607 -1.179 . . . . 0.0 110.738 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -41.77 163.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.05 0.929 . . . . 0.0 112.898 -178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 114.68 -0.48 23.23 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -158.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.555 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.5 p -89.74 129.68 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 113.637 -1.281 . . . . 0.0 108.133 171.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.602 ' HB3' ' HG3' ' C' ' 71' ' ' LYS . 31.0 tt0 -141.88 110.29 6.02 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.082 0.468 . . . . 0.0 110.179 -169.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 30.0 p -94.81 134.22 37.67 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.313 178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -89.95 149.39 22.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -58.26 145.78 73.2 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.169 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' PRO . . . . . 0.493 ' HB3' HD11 ' C' ' 68' ' ' ILE . 19.1 Cg_endo -57.74 136.64 76.77 Favored 'Trans proline' 0 C--O 1.232 0.213 0 C-N-CA 123.728 2.952 . . . . 0.0 113.474 -174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -107.54 129.28 54.99 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -108.09 120.65 42.92 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 0.0 111.924 -172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 22.7 t -124.47 102.31 7.58 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.363 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 65.87 -113.34 5.68 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.679 -0.772 . . . . 0.0 111.388 -176.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 78.3 p -110.69 5.45 20.92 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.078 0.466 . . . . 0.0 110.594 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -98.53 130.84 45.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.847 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 8.8 m -102.09 146.51 27.82 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.037 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 28.8 m -133.31 119.72 20.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.106 0.479 . . . . 0.0 110.874 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.553 HD13 ' CE2' ' C' ' 33' ' ' TYR . 1.7 mp -115.13 127.14 72.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.172 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 57.6 t -105.17 121.37 57.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 38.9 m -111.79 113.02 25.12 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.602 ' HG3' ' HB3' ' C' ' 55' ' ' GLU . 13.0 ptmt -106.17 139.82 40.08 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.156 0.503 . . . . 0.0 110.241 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -113.5 127.13 55.98 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.499 -0.773 . . . . 0.0 108.921 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -87.91 116.95 26.43 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.427 HG12 HD12 ' C' ' 72' ' ' LEU . 21.3 m -130.52 157.54 42.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.719 -0.218 . . . . 0.0 110.621 -171.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.462 ' O ' ' HB2' ' C' ' 78' ' ' GLU . 55.2 mtt -83.1 135.49 34.81 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.216 0.323 . . . . 0.0 110.57 178.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . 0.641 ' CA ' ' HB ' ' C' ' 24' ' ' THR . . . -47.59 -54.91 10.45 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' C' ' 81' ' ' SER . 5.3 m -57.09 -29.38 63.45 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 122.718 0.407 . . . . 0.0 112.093 -178.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' C' ' 75' ' ' MET . 5.5 mm-40 -65.37 -54.12 33.52 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 174.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' TRP . . . . . 0.907 ' HE1' ' HG2' ' C' ' 17' ' ' GLU . 53.2 t-105 -58.78 -44.8 90.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.321 -1.309 . . . . 0.0 110.764 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -68.54 -19.82 64.52 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.725 -0.671 . . . . 0.0 111.043 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' C' ' 77' ' ' SER . 6.6 t -80.89 -4.98 56.74 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.14 26.71 70.03 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.024 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . 0.451 HG23 ' CE2' ' C' ' 85' ' ' TYR . 12.8 t -64.83 144.99 56.88 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 121.367 0.604 . . . . 0.0 110.377 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' C' ' 46' ' ' ASN . 12.7 mt-10 -74.84 133.7 41.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.323 -174.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' TYR . . . . . 0.664 ' HB2' ' CG2' ' C' ' 102' ' ' ILE . 83.5 m-85 -126.24 118.08 24.4 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 170.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.62 133.3 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' CYS . . . . . 0.497 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 32.5 t -108.72 116.24 31.62 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.858 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 6.8 mp -110.56 145.1 38.38 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.069 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' VAL . . . . . 0.612 HG21 HG21 ' C' ' 31' ' ' ILE . 40.8 t -125.65 131.29 72.2 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 C-N-CA 123.38 0.672 . . . . 0.0 109.469 176.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.662 ' HG3' ' HB3' ' C' ' 40' ' ' LYS . 9.7 pt-20 -131.17 137.13 48.86 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.924 0.393 . . . . 0.0 110.28 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . 0.505 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 14.6 t0 -149.89 154.23 38.0 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.535 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 23.4 m -67.76 -7.72 29.78 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.634 -172.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -100.5 -9.3 22.23 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.583 ' O ' HD12 ' C' ' 94' ' ' LEU . 2.4 pp -97.75 149.22 35.5 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.627 -175.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -79.27 -33.19 1.47 Allowed 'Trans proline' 0 C--N 1.334 -0.193 0 C-N-CA 123.941 3.094 . . . . 0.0 112.88 -177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.454 ' O ' HD13 ' C' ' 94' ' ' LEU . 4.7 p -144.85 152.81 53.02 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.437 -178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -66.46 139.94 55.77 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.007 1.804 . . . . 0.0 111.283 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 27.4 t -102.05 124.36 55.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -175.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.858 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 22.6 pttp -134.39 156.55 48.33 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 119.766 -0.774 . . . . 0.0 112.24 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.13 138.1 17.21 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.255 176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t -117.45 151.49 36.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.115 0.483 . . . . 0.0 111.718 -173.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . 0.664 ' CG2' ' HB2' ' C' ' 85' ' ' TYR . 3.6 tp -123.95 143.92 35.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.652 177.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 8.6 ptp180 -133.26 157.11 46.25 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' LYS . . . . . 0.5 ' HE3' ' HB2' ' C' ' 17' ' ' GLU . 81.8 tttt -68.3 105.63 2.2 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.078 0.861 . . . . 0.0 109.203 -174.92 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 121.112 0.482 . . . . 0.0 110.331 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.66 -115.89 2.38 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.892 -0.671 . . . . 0.0 111.453 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -84.22 67.75 9.89 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.377 0.608 . . . . 0.0 110.564 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -92.62 -27.34 17.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.141 177.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 8.3 m -115.65 91.24 3.54 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.283 -173.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . 0.705 ' O ' ' HA ' ' C' ' 33' ' ' TYR . 1.6 m-20 -96.41 112.86 24.46 Favored 'General case' 0 N--CA 1.43 -1.451 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 165.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' ILE . . . . . 0.487 ' HA ' ' O ' ' C' ' 32' ' ' VAL . 1.7 tp -115.1 108.24 24.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-N 114.865 -1.061 . . . . 0.0 109.184 165.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . . . . . . . . . 26.9 t -131.73 134.42 45.86 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.414 -177.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -119.29 123.37 71.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.042 0.449 . . . . 0.0 110.236 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 11.7 m -117.89 123.33 45.59 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.554 ' HB3' HD12 ' C' ' 102' ' ' ILE . 91.1 mt -99.76 126.18 45.79 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.473 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . 0.519 ' HB3' ' HB ' ' C' ' 28' ' ' VAL . 49.6 tp -104.42 114.93 29.49 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.825 ' HB3' HD11 ' C' ' 102' ' ' ILE . 9.6 ptpp? -91.37 150.77 41.94 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . 0.467 ' HA ' ' HD3' ' C' ' 15' ' ' PRO . 37.0 Cg_endo -70.55 119.37 6.29 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.934 1.756 . . . . 0.0 110.632 175.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' C' ' 14' ' ' PRO . 8.6 Cg_exo -72.11 52.34 1.84 Allowed 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 123.45 2.767 . . . . 0.0 112.383 -177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . 0.475 ' HA ' ' O ' ' C' ' 20' ' ' TRP . 59.9 t80 -60.97 -56.98 14.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.686 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 66.1 -65.87 0.18 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.67 -178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -177.27 -43.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.579 179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 10.5 tp -101.16 -16.47 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.154 -173.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.475 ' O ' ' HA ' ' C' ' 16' ' ' PHE . 97.5 m95 -93.8 114.6 26.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.953 0.406 . . . . 0.0 111.316 -176.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 48.6 m -122.68 114.03 20.03 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.621 174.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -110.96 72.42 0.78 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 68.41 -68.13 0.18 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.041 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 13.8 p -137.81 170.38 16.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.557 0.694 . . . . 0.0 111.433 -179.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.546 ' CB ' ' HA ' ' C' ' 76' ' ' ALA . . . -85.51 27.35 0.84 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.659 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 8.4 t -59.0 130.0 44.89 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.819 0.818 . . . . 0.0 111.607 -168.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 19.2 mm -93.21 148.59 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.586 -176.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' C' ' 12' ' ' LEU . 45.6 t -128.47 131.88 68.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.338 175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 42.0 t -114.99 111.68 21.5 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -102.72 121.93 43.43 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' ILE . . . . . 0.592 HD12 ' O ' ' C' ' 68' ' ' ILE . 0.1 OUTLIER -124.68 130.79 73.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-O 121.849 0.833 . . . . 0.0 111.227 -176.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' C' ' 7' ' ' ILE . 60.2 t -110.6 131.23 62.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.496 -177.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.705 ' HA ' ' O ' ' C' ' 6' ' ' ASP . 0.1 OUTLIER -164.67 161.92 21.06 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.403 0.439 . . . . 0.0 110.529 -179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' SER . . . . . 0.553 ' O ' ' HB2' ' C' ' 35' ' ' ASP . 11.6 t -142.59 155.34 44.96 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.553 ' HB2' ' O ' ' C' ' 34' ' ' SER . 0.9 OUTLIER 81.6 9.96 0.87 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.814 0.697 . . . . 0.0 111.832 177.412 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . 0.422 ' HB2' HD11 ' C' ' 39' ' ' ILE . 22.8 mt -105.22 142.9 34.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.456 0.645 . . . . 0.0 112.105 -172.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' GLU . . . . . 0.562 ' O ' HG13 ' C' ' 39' ' ' ILE . 29.8 mm-40 -95.95 179.11 5.2 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-N 114.836 -1.074 . . . . 0.0 108.585 172.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.662 HD22 ' N ' ' C' ' 38' ' ' ASN . 0.7 OUTLIER -54.26 112.36 0.96 Allowed 'General case' 0 N--CA 1.436 -1.173 0 CA-C-O 124.053 1.882 . . . . 0.0 109.654 -156.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.562 HG13 ' O ' ' C' ' 37' ' ' GLU . 11.1 mt -83.17 146.83 6.43 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-N 110.15 -3.205 . . . . 0.0 112.584 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -112.37 134.68 53.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.634 176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 48.6 t -111.0 131.43 62.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.843 -175.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.445 ' HE1' ' HG2' ' C' ' 49' ' ' GLU . 53.2 t80 -122.66 142.17 50.95 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.136 -176.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' TRP . . . . . 0.549 ' CE2' HD23 ' C' ' 72' ' ' LEU . 50.3 m95 -132.02 137.55 47.89 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 175.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -124.84 131.24 53.46 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 122.155 -0.341 . . . . 0.0 110.739 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' C' ' 50' ' ' ARG . 60.6 t -123.03 117.26 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 177.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 55.69 35.89 26.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.62 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.21 -15.85 36.96 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.331 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 20.6 m -110.16 145.19 16.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-N 117.492 0.646 . . . . 0.0 111.645 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . 0.445 ' HG2' ' HE1' ' C' ' 42' ' ' PHE . 47.8 mt-10 -61.14 127.54 32.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.646 172.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' ARG . . . . . 0.569 ' HD3' HD11 ' C' ' 72' ' ' LEU . 5.4 ptm180 -92.15 166.13 12.8 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.379 -0.929 . . . . 0.0 109.373 -177.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' LYS . . . . . 0.484 ' HA ' ' HD2' ' C' ' 51' ' ' LYS . 31.7 tptt -75.67 163.01 27.74 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.309 -171.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.473 ' HG3' ' H ' ' C' ' 53' ' ' GLY . 22.4 tptp -45.51 164.12 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.84 0.828 . . . . 0.0 111.914 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . 0.473 ' H ' ' HG3' ' C' ' 52' ' ' LYS . . . 115.36 -9.17 20.17 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 -161.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.82 HG22 HD21 ' C' ' 72' ' ' LEU . 48.8 t -77.27 118.73 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-N 113.339 -1.431 . . . . 0.0 107.794 165.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -133.47 144.29 49.36 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.19 -170.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 1.6 p -130.25 130.09 44.15 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.448 177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -87.57 158.14 18.97 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.453 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -58.05 150.28 51.68 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.482 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' PRO . . . . . 0.523 ' HB3' HD11 ' C' ' 68' ' ' ILE . 37.4 Cg_endo -63.12 139.74 74.48 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 123.147 2.565 . . . . 0.0 113.133 -177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -114.09 149.07 36.09 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -111.69 132.31 54.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.101 0.477 . . . . 0.0 111.548 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 27.7 m -135.37 103.77 5.61 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.698 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 70.25 -110.74 3.44 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 42.3 m -111.01 6.49 21.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.178 0.513 . . . . 0.0 109.803 174.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 28.6 mmtp -106.21 160.2 15.52 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.146 -173.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 15.4 m -113.68 152.73 30.05 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.427 176.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 64.4 m -135.31 120.44 18.83 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.377 0.608 . . . . 0.0 111.009 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.592 ' O ' HD12 ' C' ' 31' ' ' ILE . 1.6 mp -110.81 130.94 63.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.888 177.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 58.8 t -106.6 122.54 60.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.394 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -111.3 122.82 48.85 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 177.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -106.86 143.76 34.49 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.82 HD21 HG22 ' C' ' 54' ' ' VAL . 0.1 OUTLIER -124.71 114.57 19.48 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 120.674 -0.411 . . . . 0.0 111.032 175.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -84.44 114.59 22.02 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.523 HG11 ' CE1' ' C' ' 85' ' ' TYR . 16.4 m -133.19 161.61 41.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.719 -173.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 65.8 mtt -77.75 128.71 34.48 Favored 'General case' 0 C--O 1.241 0.616 0 CA-C-O 121.539 0.685 . . . . 0.0 109.589 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . 0.546 ' HA ' ' CB ' ' C' ' 25' ' ' ALA . . . -58.21 -42.96 87.35 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.078 -174.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 7.0 m -61.9 -30.5 70.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.527 0.331 . . . . 0.0 111.435 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -68.32 -51.66 42.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' TRP . . . . . 0.445 ' HZ3' HG23 ' C' ' 102' ' ' ILE . 63.4 t-105 -57.62 -44.15 85.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.766 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -65.1 -17.01 64.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.347 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 22.6 t -81.73 -4.71 57.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.905 0.383 . . . . 0.0 110.772 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 79.84 21.72 65.4 Favored Glycine 0 N--CA 1.451 -0.345 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 41.5 m -66.22 143.41 57.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.874 -0.663 . . . . 0.0 112.01 -177.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -71.16 131.81 44.1 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.824 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' TYR . . . . . 0.523 ' CE1' HG11 ' C' ' 74' ' ' VAL . 67.3 m-85 -130.53 116.21 17.85 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.023 169.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 11.3 t -120.43 135.93 59.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' CYS . . . . . . . . . . . . . 9.1 t -109.09 127.66 54.33 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.559 HD13 ' O ' ' C' ' 98' ' ' VAL . 1.9 mm? -123.13 144.84 49.06 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.823 -176.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' C' ' 98' ' ' VAL . 69.7 t -122.89 132.78 70.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.115 175.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -127.85 133.82 49.38 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.523 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . 0.655 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 28.4 t70 -153.16 150.44 29.07 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.253 0.549 . . . . 0.0 110.575 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 21.9 t -66.24 -15.17 62.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.752 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 53.4 mm-40 -95.62 -7.65 37.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 118.243 0.474 . . . . 0.0 112.156 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.5 pp -92.62 149.39 37.96 Favored Pre-proline 0 C--N 1.326 -0.415 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.108 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.36 -35.17 0.65 Allowed 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 123.86 3.04 . . . . 0.0 112.453 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.433 ' O ' HD13 ' C' ' 94' ' ' LEU . 16.0 p -142.6 149.32 50.16 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.256 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' PRO . . . . . 0.535 ' HB2' HD12 ' C' ' 88' ' ' LEU . 52.0 Cg_endo -66.24 143.34 70.43 Favored 'Trans proline' 0 N--CA 1.464 -0.215 0 C-N-CA 122.308 2.005 . . . . 0.0 111.258 -179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' C' ' 89' ' ' VAL . 47.7 t -91.39 106.54 17.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -175.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.406 ' HB3' HD11 ' C' ' 88' ' ' LEU . 11.1 ptpp? -107.84 142.81 37.33 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.422 -174.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.65 120.14 5.54 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 173.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' C' ' 86' ' ' VAL . 39.4 t -105.51 156.37 18.29 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.047 0.451 . . . . 0.0 110.69 -176.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . 0.825 HD11 ' HB3' ' C' ' 13' ' ' LYS . 14.0 tt -123.83 147.01 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.008 -176.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -133.68 144.51 49.21 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.293 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -85.19 143.61 28.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.96 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.213 -0.898 . . . . 0.0 109.702 173.197 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptp . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.761 0.315 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -175.77 -166.37 33.14 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.778 -177.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . 0.425 ' NE ' ' HA ' ' C' ' 3' ' ' ARG . 4.8 mmp_? 53.76 69.5 0.7 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 122.335 0.254 . . . . 0.0 110.441 -178.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -50.21 110.0 0.36 Allowed 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.635 0.585 . . . . 0.0 111.491 -177.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' THR . . . . . 0.452 HG23 ' O ' ' C' ' 5' ' ' THR . 5.8 t -88.73 91.32 8.77 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 122.98 1.371 . . . . 0.0 110.557 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -99.72 115.92 30.6 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 113.809 -1.541 . . . . 0.0 107.519 168.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' ILE . . . . . 0.533 HG12 HG11 ' C' ' 98' ' ' VAL . 3.7 tp -129.33 115.18 34.39 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 112.595 -2.093 . . . . 0.0 109.094 172.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 13.7 m -116.33 114.95 25.03 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.922 -174.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 18.1 t -114.27 115.01 48.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 13.2 m -131.88 132.53 43.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.075 0.464 . . . . 0.0 109.88 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.66 HD13 ' HB ' ' C' ' 102' ' ' ILE . 17.5 mt -99.5 136.56 39.25 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.293 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 61.6 tp -110.86 115.19 29.1 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -77.24 150.43 80.33 Favored Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.975 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . 0.535 ' HB2' ' HD3' ' C' ' 15' ' ' PRO . 82.6 Cg_exo -41.75 -52.62 3.78 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.924 2.416 . . . . 0.0 113.39 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . 0.535 ' HD3' ' HB2' ' C' ' 14' ' ' PRO . 55.0 Cg_endo -71.72 94.3 0.7 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 121.436 1.424 . . . . 0.0 111.959 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -53.7 -36.41 62.2 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.109 177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . 0.479 ' HG3' HG22 ' C' ' 19' ' ' ILE . 9.0 tp10 -117.71 136.68 53.19 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 170.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -70.26 -7.68 44.24 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -169.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . 0.479 HG22 ' HG3' ' C' ' 17' ' ' GLU . 10.7 tp -83.71 -17.78 10.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.86 0.362 . . . . 0.0 111.092 -178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 60.4 m95 -107.69 114.09 27.82 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 34.1 m -103.61 113.26 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.984 -0.746 . . . . 0.0 108.984 170.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -127.62 164.2 22.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.249 -176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -58.26 132.58 54.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.149 0.499 . . . . 0.0 109.887 176.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' THR . . . . . 1.041 ' HB ' ' HA ' ' C' ' 76' ' ' ALA . 58.6 m -93.58 132.35 37.98 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.711 -0.677 . . . . 0.0 112.165 -168.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.07 -18.04 5.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.556 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' C' ' 72' ' ' LEU . 10.1 t -161.41 144.33 12.39 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -175.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' ILE . . . . . 0.809 HG13 HG11 ' C' ' 74' ' ' VAL . 60.6 mt -120.19 152.36 23.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 168.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -131.08 135.55 59.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.911 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 51.3 t -107.82 117.71 34.83 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 170.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -105.12 118.39 36.41 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.57 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' ILE . . . . . 0.523 HG21 HG11 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -120.01 130.86 73.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.677 0.751 . . . . 0.0 111.309 -178.511 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 21.7 t -117.72 132.59 67.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.254 -176.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.957 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -151.79 170.03 20.79 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 175.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' SER . . . . . 0.504 ' HB2' ' HG2' ' C' ' 65' ' ' LYS . 32.2 t -124.09 141.48 52.01 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.396 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 13.8 t0 71.01 11.11 7.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.258 -0.883 . . . . 0.0 113.184 169.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 8.3 mt -111.69 129.64 56.04 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 121.28 -0.888 . . . . 0.0 110.708 -176.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -145.33 91.28 2.11 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 118.526 -1.27 . . . . 0.0 111.705 160.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . 0.636 ' O ' ' HA ' ' C' ' 91' ' ' ASP . 0.5 OUTLIER -147.29 106.38 3.87 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 136.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.441 HD12 ' CZ ' ' C' ' 33' ' ' TYR . 5.5 mm -115.28 112.53 40.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 118.977 -1.089 . . . . 0.0 113.721 -169.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -108.16 123.57 48.93 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.138 172.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 42.0 t -110.67 142.78 22.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.103 0.478 . . . . 0.0 111.479 -177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.432 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 50.3 t80 -129.88 143.55 50.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -128.94 137.94 51.69 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . 0.426 ' HG2' ' HB ' ' C' ' 86' ' ' VAL . 4.4 pt20 -131.23 131.45 43.94 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.229 0.538 . . . . 0.0 111.409 177.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' VAL . . . . . 0.634 HG23 ' HB2' ' C' ' 50' ' ' ARG . 13.8 t -104.08 109.14 26.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.858 177.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 6.5 m120 54.31 42.26 31.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.635 0.731 . . . . 0.0 110.693 -175.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.62 -16.98 16.51 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.857 -1.065 . . . . 0.0 113.922 177.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . 0.563 HG12 ' O ' ' C' ' 45' ' ' VAL . 10.0 p -97.85 138.58 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 118.297 1.049 . . . . 0.0 110.521 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -57.72 139.44 53.84 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.379 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' ARG . . . . . 0.634 ' HB2' HG23 ' C' ' 45' ' ' VAL . 16.2 tpt180 -90.98 124.13 34.99 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.845 -176.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' LYS . . . . . 0.636 ' HD2' ' H ' ' C' ' 51' ' ' LYS . 3.1 mptp? -70.45 161.31 30.77 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.966 -177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' C' ' 52' ' ' LYS . 45.5 mmtm -42.19 162.66 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 122.484 1.135 . . . . 0.0 114.011 -170.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 113.52 -9.58 24.06 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 107.793 -2.123 . . . . 0.0 107.793 -158.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.54 ' HA ' HD22 ' C' ' 72' ' ' LEU . 3.3 p -87.77 128.16 40.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 113.707 -1.246 . . . . 0.0 109.095 172.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -140.02 110.29 6.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.054 0.454 . . . . 0.0 110.17 -175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 29.8 m -89.22 130.95 35.55 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 175.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.615 ' HB2' HG13 ' C' ' 69' ' ' VAL . 23.7 mt-30 -105.31 172.57 6.72 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -175.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -76.92 153.19 82.87 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-O 120.827 0.346 . . . . 0.0 110.293 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' PRO . . . . . 0.627 ' HA ' ' O ' ' C' ' 67' ' ' THR . 60.6 Cg_endo -70.21 149.43 64.01 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 123.537 2.825 . . . . 0.0 113.424 -177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -154.25 106.64 2.8 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 170.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' TRP . . . . . 0.637 ' HB3' ' O ' ' C' ' 65' ' ' LYS . 26.8 t-105 -140.89 165.83 26.44 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 165.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 10.7 t -52.72 155.34 2.32 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 168.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . -61.36 0.44 1.37 Allowed Glycine 0 CA--C 1.525 0.712 0 N-CA-C 115.611 1.005 . . . . 0.0 115.611 -168.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 5.3 p -89.28 -25.8 21.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 117.759 0.78 . . . . 0.0 111.705 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . 0.637 ' O ' ' HB3' ' C' ' 61' ' ' TRP . 84.3 mttt -145.47 167.62 22.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.844 0.354 . . . . 0.0 110.57 -176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.8 m -118.2 148.21 42.6 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.973 0.416 . . . . 0.0 110.147 177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.627 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 93.9 m -132.71 121.07 22.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.007 0.432 . . . . 0.0 111.057 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.957 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -108.62 127.89 64.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.889 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' C' ' 57' ' ' GLN . 0.7 OUTLIER -111.46 122.87 66.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.448 -0.797 . . . . 0.0 110.726 179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 23.3 t -111.28 125.43 53.82 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.706 176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -107.22 138.52 43.26 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.35 -174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.558 HD11 ' HG2' ' C' ' 50' ' ' ARG . 0.2 OUTLIER -120.07 122.1 40.32 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 176.153 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 3.5 mmmp? -77.87 121.0 23.54 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.809 HG11 HG13 ' C' ' 27' ' ' ILE . 9.9 p -143.37 148.94 18.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.716 -170.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -89.81 140.1 29.93 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.874 -176.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . 1.041 ' HA ' ' HB ' ' C' ' 24' ' ' THR . . . -43.99 -55.39 4.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 4.9 m -57.03 -33.86 67.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 118.557 0.617 . . . . 0.0 112.285 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -63.94 -53.76 45.24 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 176.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -58.09 -44.03 87.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.557 -1.656 . . . . 0.0 110.768 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' ASP . . . . . 0.547 ' HA ' ' HD2' ' C' ' 104' ' ' LYS . 24.5 t70 -70.25 -17.24 63.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.323 -176.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 66.3 m -86.38 -3.01 58.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.381 . . . . 0.0 110.402 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 70.68 28.87 70.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.184 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 14.8 t -64.71 143.18 58.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.041 0.448 . . . . 0.0 109.973 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 35.8 mt-10 -75.49 130.1 38.34 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.595 -174.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -128.05 120.79 28.21 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.325 175.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' C' ' 101' ' ' SER . 26.7 t -120.25 135.76 59.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 19.5 p -115.39 129.2 56.51 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 120.397 -0.521 . . . . 0.0 109.637 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.558 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.9 mp -120.24 148.61 43.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.287 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' VAL . . . . . 0.523 HG11 HG21 ' C' ' 31' ' ' ILE . 5.9 p -143.72 127.52 13.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 121.354 0.597 . . . . 0.0 111.448 176.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -110.77 153.39 25.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.053 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' C' ' 38' ' ' ASN . 11.3 t70 -142.69 148.03 36.66 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 22.7 t -62.31 -21.31 65.16 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -97.2 0.09 47.72 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.55 ' C ' HD12 ' C' ' 94' ' ' LEU . 2.6 pp -103.86 158.64 31.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' C' ' 96' ' ' THR . 1.8 Cg_endo -88.21 -35.33 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 123.874 3.049 . . . . 0.0 113.294 -168.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.423 ' O ' HD13 ' C' ' 94' ' ' LEU . 16.7 p -147.28 153.64 44.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.43 151.99 79.71 Favored 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 122.294 1.996 . . . . 0.0 112.112 179.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 19.2 m -122.19 147.13 26.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' C' ' 87' ' ' CYS . 0.4 OUTLIER -135.08 161.48 35.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.181 0.515 . . . . 0.0 112.367 -169.692 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -152.18 140.99 21.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 169.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . 0.46 ' HB2' HG22 ' C' ' 86' ' ' VAL . 39.7 t -120.56 149.14 42.9 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 117.989 0.358 . . . . 0.0 110.708 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . 0.66 ' HB ' HD13 ' C' ' 11' ' ' LEU . 2.9 tp -125.03 142.12 42.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.181 0.515 . . . . 0.0 110.879 -177.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 15.7 tpp180 -123.69 153.91 40.16 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' LYS . . . . . 0.547 ' HD2' ' HA ' ' C' ' 80' ' ' ASP . 76.0 tttt -64.39 107.04 1.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.454 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.149 -0.929 . . . . 0.0 109.407 -176.869 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.737 0.303 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.01 170.46 14.22 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 40.6 ttt180 -140.93 -80.64 0.25 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 117.045 0.423 . . . . 0.0 110.023 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -100.89 -16.31 17.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.332 0.587 . . . . 0.0 109.94 178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 9.0 t -93.0 151.12 20.08 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.339 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -111.05 122.34 47.65 Favored 'General case' 0 N--CA 1.442 -0.841 0 CA-C-O 121.645 0.736 . . . . 0.0 109.191 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' ILE . . . . . 0.601 HG12 HG11 ' C' ' 98' ' ' VAL . 3.3 tp -134.69 124.11 43.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.656 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' C' ' 31' ' ' ILE . 47.2 t -120.47 125.06 46.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' C' ' 31' ' ' ILE . 3.0 p -128.57 125.32 63.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.108 176.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 44.9 m -148.28 148.61 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.053 -0.404 . . . . 0.0 110.539 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.507 ' HG ' ' HB ' ' C' ' 102' ' ' ILE . 3.5 mm? -96.11 146.7 24.44 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 121.225 0.536 . . . . 0.0 110.905 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 92.4 mt -115.3 115.38 26.55 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.093 -0.958 . . . . 0.0 108.712 172.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -78.1 154.58 80.02 Favored Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.203 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . 0.434 ' HG3' ' O ' ' C' ' 25' ' ' ALA . 73.8 Cg_endo -75.68 118.42 5.09 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.721 2.281 . . . . 0.0 111.579 175.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -67.03 144.75 71.06 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.611 2.207 . . . . 0.0 111.521 178.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -79.45 74.8 6.08 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -78.65 101.91 7.73 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.618 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 67.16 -179.04 0.21 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.263 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 8.3 tp -101.06 -21.58 5.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.561 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . . . . . . . . . 78.7 m95 -98.42 121.88 40.91 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 5.3 t -155.35 135.64 13.15 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.975 0.417 . . . . 0.0 111.02 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -110.11 15.25 22.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.936 0.874 . . . . 0.0 109.136 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -111.27 167.55 10.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.547 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 17.1 p -96.49 171.79 8.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.536 0.684 . . . . 0.0 111.258 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' C' ' 14' ' ' PRO . . . -78.08 30.31 0.17 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.927 -173.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' THR . . . . . 0.498 ' HA ' HG12 ' C' ' 74' ' ' VAL . 3.4 t -55.46 129.09 37.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.226 1.012 . . . . 0.0 112.302 -164.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mt -102.32 155.52 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.541 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . 0.526 HG22 ' HG3' ' C' ' 71' ' ' LYS . 56.0 t -127.95 135.17 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.943 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' CYS . . . . . . . . . . . . . 47.1 t -111.16 127.03 55.45 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 172.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -114.7 124.62 52.28 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' ILE . . . . . 0.619 HG21 HG21 ' C' ' 89' ' ' VAL . 0.0 OUTLIER -122.97 131.13 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.651 179.249 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 48.3 t -111.24 129.7 66.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.748 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.634 ' HE1' HD13 ' C' ' 68' ' ' ILE . 0.1 OUTLIER -165.54 160.62 17.88 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 120.793 0.33 . . . . 0.0 111.024 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' C' ' 65' ' ' LYS . 14.7 m -144.2 153.94 42.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.792 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' C' ' 34' ' ' SER . 1.1 m-20 78.8 9.22 1.91 Allowed 'General case' 0 N--CA 1.473 0.689 0 O-C-N 123.454 0.472 . . . . 0.0 112.056 174.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 20.4 mt -94.23 163.99 13.22 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.624 0.726 . . . . 0.0 112.059 -174.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -83.0 173.82 11.43 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.291 171.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -57.62 114.5 2.29 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 123.535 1.636 . . . . 0.0 107.784 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.595 ' CG2' HG13 ' C' ' 89' ' ' VAL . 4.6 mp -74.55 146.06 10.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.802 0 CA-C-N 111.559 -2.564 . . . . 0.0 112.506 -177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 57.5 tptt -107.37 123.89 49.02 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.87 172.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 8.1 p -94.19 140.1 17.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.34 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -134.36 137.81 44.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.939 0.399 . . . . 0.0 110.94 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' TRP . . . . . 0.535 ' HE3' ' HD2' ' C' ' 85' ' ' TYR . 55.2 m95 -125.77 133.94 51.89 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -124.8 130.22 51.97 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' VAL . . . . . 0.498 HG23 ' HB2' ' C' ' 50' ' ' ARG . 23.5 t -118.31 111.78 35.5 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.939 -178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 58.18 37.24 26.25 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.875 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.76 -14.3 25.91 Favored Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.895 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 41.4 t -97.1 134.16 35.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -60.22 138.52 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.908 0.385 . . . . 0.0 110.102 176.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' ARG . . . . . 0.498 ' HB2' HG23 ' C' ' 45' ' ' VAL . 15.8 tpp180 -90.96 127.11 36.28 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.479 0.657 . . . . 0.0 110.879 -173.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 22.0 tptm -57.67 160.4 4.42 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.844 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -40.65 163.02 0.01 OUTLIER 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.301 1.048 . . . . 0.0 113.307 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . 0.407 ' HA2' ' HD3' ' C' ' 73' ' ' LYS . . . 114.51 -0.47 23.46 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 -163.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.469 ' HA ' HD22 ' C' ' 72' ' ' LEU . 5.4 p -87.29 127.25 40.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 114.18 -1.01 . . . . 0.0 108.314 172.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 34.8 mt-10 -124.08 108.76 12.69 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -172.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 6.3 m -93.43 117.75 30.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . 0.635 ' HB2' HG13 ' C' ' 69' ' ' VAL . 47.1 mt-30 -100.39 171.42 7.77 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.463 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -71.2 144.4 89.65 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.114 0.483 . . . . 0.0 110.651 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' PRO . . . . . 0.463 ' HB3' ' CD1' ' C' ' 68' ' ' ILE . 27.3 Cg_endo -63.08 151.23 85.83 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.557 2.838 . . . . 0.0 114.072 -176.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -103.4 123.22 46.44 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 174.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -104.26 113.95 27.85 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.777 0.322 . . . . 0.0 111.822 -169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 13.7 m -113.14 101.1 9.12 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.88 -108.36 1.84 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.705 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 56.1 m -110.9 6.62 21.34 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.927 0.394 . . . . 0.0 110.908 176.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . 0.502 ' HA ' ' OG ' ' C' ' 34' ' ' SER . 74.4 mmtt -99.17 134.35 42.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.108 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 16.6 m -109.11 150.53 27.7 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.053 0.454 . . . . 0.0 110.795 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' C' ' 59' ' ' PRO . 57.5 m -137.04 126.73 25.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.96 177.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' C' ' 33' ' ' TYR . 1.7 mp -112.05 134.16 55.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.872 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . 0.635 HG13 ' HB2' ' C' ' 57' ' ' GLN . 1.5 p -115.61 127.32 73.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-O 121.365 0.602 . . . . 0.0 110.697 176.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . . . . . . . . . 40.9 p -115.41 129.62 56.63 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.534 175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 48.1 tttp -107.09 144.62 33.52 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -177.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.469 HD22 ' HA ' ' C' ' 54' ' ' VAL . 0.2 OUTLIER -120.03 116.54 25.94 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.027 0.441 . . . . 0.0 110.251 177.681 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' LYS . . . . . 0.407 ' HD3' ' HA2' ' C' ' 53' ' ' GLY . 26.5 mtpp -77.76 112.59 14.77 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.543 HG23 ' OH ' ' C' ' 85' ' ' TYR . 9.3 p -119.98 151.71 22.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 121.342 0.592 . . . . 0.0 110.602 -168.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.891 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 65.9 mtt -84.04 137.43 33.59 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.251 -176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.32 -35.98 60.78 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.824 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 14.5 t -70.74 -28.31 64.61 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.368 0.267 . . . . 0.0 111.627 178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' GLU . . . . . 0.891 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 7.7 mm-40 -71.44 -54.75 9.61 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.712 0.767 . . . . 0.0 109.137 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' TRP . . . . . . . . . . . . . 73.6 t-105 -64.95 -38.63 91.61 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.238 -177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -65.86 -18.47 65.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.41 . . . . 0.0 111.039 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 18.6 t -90.16 -4.48 57.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.999 0.428 . . . . 0.0 110.546 -179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.58 25.29 70.47 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.34 -175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 17.9 m -62.22 138.82 58.48 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.116 0.484 . . . . 0.0 111.145 -177.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -86.17 149.68 24.93 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.265 -172.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' TYR . . . . . 0.543 ' OH ' HG23 ' C' ' 74' ' ' VAL . 16.4 m-85 -132.7 131.05 40.84 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.198 173.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . 0.558 HG11 ' HE2' ' C' ' 99' ' ' LYS . 25.3 t -119.87 130.17 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 174.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' CYS . . . . . 0.511 ' O ' ' HA ' ' C' ' 99' ' ' LYS . 34.4 t -108.6 120.48 42.56 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 -178.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.675 ' HG ' ' HB3' ' C' ' 99' ' ' LYS . 5.8 mp -116.23 147.52 41.38 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 123.63 0.581 . . . . 0.0 110.166 -179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' VAL . . . . . 0.619 HG21 HG21 ' C' ' 31' ' ' ILE . 12.3 t -134.0 127.77 52.18 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.54 174.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -128.06 144.94 51.13 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.082 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . 0.521 ' HB3' ' HG ' ' C' ' 94' ' ' LEU . 27.1 t70 -148.17 156.7 42.89 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.339 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 37.9 t -65.37 -21.68 66.71 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.834 -174.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -91.9 -11.55 35.99 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 122.192 -0.318 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.521 ' HG ' ' HB3' ' C' ' 91' ' ' ASP . 40.8 mt -84.12 146.57 48.69 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 121.144 0.497 . . . . 0.0 111.668 -173.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' C' ' 94' ' ' LEU . 1.7 Cg_endo -84.34 -29.26 0.9 Allowed 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.512 2.808 . . . . 0.0 111.651 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . . . . . . . . . 27.1 p -147.19 151.62 41.23 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.903 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -72.42 148.05 47.86 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 121.532 1.488 . . . . 0.0 110.651 174.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' VAL . . . . . 0.601 HG11 HG12 ' C' ' 7' ' ' ILE . 27.6 m -108.57 141.1 24.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.675 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 13.7 ptmm? -142.79 153.51 43.33 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.28 0.562 . . . . 0.0 111.714 -176.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -153.46 144.32 22.76 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' C' ' 85' ' ' TYR . 33.5 t -121.91 149.74 42.98 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.409 0.624 . . . . 0.0 111.888 -173.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . 0.507 ' HB ' ' HG ' ' C' ' 11' ' ' LEU . 4.8 tp -124.03 145.64 30.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.413 177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 52.0 mtt180 -130.86 162.68 29.08 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 5.8 ttpp -80.14 108.5 13.78 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.091 -0.644 . . . . 0.0 110.338 -178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.309 -1.156 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.631 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 121.021 0.439 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' GLY . . . . . . . . . . . . . . . 164.99 73.57 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -58.78 -58.27 9.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.622 0.249 . . . . 0.0 111.175 -175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -96.63 -52.27 3.99 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.276 0.56 . . . . 0.0 110.197 177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' THR . . . . . . . . . . . . . 6.0 t -107.21 94.91 5.35 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 122.693 1.235 . . . . 0.0 111.294 -177.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -96.9 113.15 24.67 Favored 'General case' 0 N--CA 1.431 -1.423 0 CA-C-N 113.624 -1.625 . . . . 0.0 106.863 165.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.3 122.39 50.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-N 114.278 -1.328 . . . . 0.0 110.105 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' SER . . . . . 0.402 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 19.5 m -117.82 114.58 23.48 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.249 -178.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' VAL . . . . . . . . . . . . . 5.8 p -113.82 117.34 55.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.19 0.519 . . . . 0.0 110.661 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' SER . . . . . . . . . . . . . 5.5 m -123.15 130.92 53.41 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . 0.559 HD13 ' HB ' ' C' ' 102' ' ' ILE . 46.8 mt -99.0 130.07 45.32 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 38.8 tp -111.47 113.8 26.49 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . 0.402 ' HB3' HD11 ' C' ' 102' ' ' ILE . 25.1 pttm -83.23 147.59 53.96 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -34.23 103.33 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 125.08 3.854 . . . . 0.0 114.533 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -79.45 109.91 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 123.117 2.545 . . . . 0.0 111.085 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -87.55 -27.49 22.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.908 0.385 . . . . 0.0 110.674 -176.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -99.63 79.91 2.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.093 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' GLU . . . . . 0.46 ' HG3' ' H ' ' C' ' 20' ' ' TRP . 11.0 pt-20 -160.18 -170.84 2.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.396 171.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' ILE . . . . . . . . . . . . . 8.2 tp -62.61 -34.08 63.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.934 0.397 . . . . 0.0 110.737 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' TRP . . . . . 0.46 ' H ' ' HG3' ' C' ' 18' ' ' GLU . 50.1 m95 -93.55 114.35 26.68 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' THR . . . . . . . . . . . . . 16.4 m -83.4 125.6 31.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.19 0.519 . . . . 0.0 110.483 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -81.35 89.38 6.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.311 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -74.84 -14.31 60.66 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.393 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' THR . . . . . . . . . . . . . 7.6 p -120.5 -178.77 3.78 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.373 174.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.982 ' HB2' ' HA ' ' C' ' 76' ' ' ALA . . . -95.22 24.71 4.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.249 -176.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' THR . . . . . . . . . . . . . 9.6 t -59.78 126.18 26.55 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.978 0.894 . . . . 0.0 111.907 -168.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' ILE . . . . . . . . . . . . . 24.1 mt -105.44 153.96 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.699 -176.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' VAL . . . . . . . . . . . . . 52.9 t -129.93 134.38 63.07 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-O 121.216 0.531 . . . . 0.0 111.554 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' CYS . . . . . 0.546 ' HB2' ' CH2' ' C' ' 43' ' ' TRP . 35.7 t -108.88 112.85 25.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 172.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.29 115.89 31.0 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' ILE . . . . . 0.683 HG21 HG21 ' C' ' 89' ' ' VAL . 0.2 OUTLIER -126.25 128.65 71.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-O 121.885 0.85 . . . . 0.0 111.658 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' C' ' 8' ' ' SER . 53.8 t -114.69 131.07 67.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 113.887 -1.506 . . . . 0.0 109.744 -177.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' TYR . . . . . 0.499 ' OH ' ' HB ' ' C' ' 68' ' ' ILE . 0.1 OUTLIER -161.13 163.63 31.19 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.418 -178.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -142.34 150.94 41.42 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 37.6 t70 78.67 10.99 1.69 Allowed 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.811 0.695 . . . . 0.0 111.6 174.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' LEU . . . . . . . . . . . . . 17.4 mt -97.97 164.66 12.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 122.003 0.906 . . . . 0.0 112.654 -172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -94.36 170.84 9.21 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 113.769 -1.56 . . . . 0.0 108.83 174.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -58.14 114.92 2.6 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-O 123.72 1.724 . . . . 0.0 108.257 -174.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' ILE . . . . . 0.62 HG21 HG13 ' C' ' 89' ' ' VAL . 4.7 mp -70.12 141.89 16.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-N 111.177 -2.738 . . . . 0.0 113.555 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -103.43 124.05 48.0 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.441 170.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 41.1 t -108.73 141.35 24.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -173.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.428 ' HB3' ' HB2' ' C' ' 88' ' ' LEU . 55.5 t80 -132.5 143.6 49.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.004 0.43 . . . . 0.0 111.176 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' TRP . . . . . 0.604 ' HB2' ' HD3' ' C' ' 50' ' ' ARG . 58.0 m95 -130.45 137.85 50.01 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -125.9 130.07 50.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.792 0.269 . . . . 0.0 111.191 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' C' ' 84' ' ' GLU . 27.6 t -121.66 113.03 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.225 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 176.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 56.89 36.17 27.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.14 0.495 . . . . 0.0 110.979 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.87 -15.49 15.1 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.818 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' VAL . . . . . . . . . . . . . 39.0 t -95.54 133.96 34.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -60.61 138.04 58.1 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 174.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' ARG . . . . . 0.604 ' HD3' ' HB2' ' C' ' 43' ' ' TRP . 0.0 OUTLIER -89.92 156.14 18.65 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.346 -172.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' LYS . . . . . . . . . . . . . 50.0 mmtm -69.79 156.08 39.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.077 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -53.14 166.85 0.21 Allowed 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.776 0.798 . . . . 0.0 112.321 177.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.15 7.31 12.71 Favored Glycine 0 CA--C 1.504 -0.634 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -160.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' VAL . . . . . 0.571 HG22 HD21 ' C' ' 72' ' ' LEU . 23.8 t -84.61 129.21 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 CA-C-N 113.044 -1.578 . . . . 0.0 107.874 170.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' GLU . . . . . 0.535 ' HB2' ' HB3' ' C' ' 71' ' ' LYS . 41.1 mt-10 -128.71 108.9 10.85 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 -175.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' THR . . . . . . . . . . . . . 7.0 p -92.11 123.12 35.22 Favored 'General case' 0 C--N 1.311 -1.065 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 174.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -89.04 144.43 26.15 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' ASN . . . . . 0.403 ' CG ' ' HD2' ' C' ' 59' ' ' PRO . 6.1 t30 -58.37 137.4 85.29 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.774 -175.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' PRO . . . . . 0.409 ' HB3' HD11 ' C' ' 68' ' ' ILE . 31.1 Cg_exo -48.09 134.88 24.41 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.781 2.987 . . . . 0.0 112.849 -175.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -121.55 124.32 44.1 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -87.73 109.03 19.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.032 0.444 . . . . 0.0 110.395 -172.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' SER . . . . . . . . . . . . . 12.3 m -96.78 102.64 14.46 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.984 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' GLY . . . . . . . . . . . . . . . 66.28 -109.45 2.91 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.181 -179.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 27.6 t -110.93 6.89 21.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.124 0.487 . . . . 0.0 110.232 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -118.29 158.09 25.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.185 0.517 . . . . 0.0 110.91 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' SER . . . . . . . . . . . . . 14.6 m -101.14 146.79 27.02 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.584 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' THR . . . . . . . . . . . . . 32.6 m -131.58 119.11 21.01 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.112 0.482 . . . . 0.0 110.357 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ILE . . . . . 0.587 ' O ' HD12 ' C' ' 31' ' ' ILE . 1.6 mp -114.89 133.09 62.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.922 178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' VAL . . . . . . . . . . . . . 48.2 t -108.31 121.62 61.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-O 120.96 0.41 . . . . 0.0 110.391 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' SER . . . . . 0.533 ' HB2' ' HB3' ' C' ' 29' ' ' CYS . 40.8 m -108.96 111.12 22.63 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.695 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' C' ' 55' ' ' GLU . 81.8 tttt -105.37 144.56 31.98 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.978 -174.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' LEU . . . . . 0.571 HD21 HG22 ' C' ' 54' ' ' VAL . 0.5 OUTLIER -122.49 119.59 31.38 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.879 0.371 . . . . 0.0 110.333 174.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -91.53 111.17 22.57 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 173.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' VAL . . . . . 0.42 HG21 ' CE2' ' C' ' 85' ' ' TYR . 8.3 p -134.33 163.62 36.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.095 0.474 . . . . 0.0 110.864 -168.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.773 ' HB2' ' HG2' ' C' ' 78' ' ' GLU . 63.2 mtt -74.16 129.1 37.17 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.442 -177.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' ALA . . . . . 0.982 ' HA ' ' HB2' ' C' ' 25' ' ' ALA . . . -56.9 -45.38 82.66 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.436 -1.257 . . . . 0.0 111.812 -176.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' SER . . . . . . . . . . . . . 26.0 t -59.7 -32.72 70.78 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.916 0.486 . . . . 0.0 111.477 178.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' GLU . . . . . 0.773 ' HG2' ' HB2' ' C' ' 75' ' ' MET . 26.2 mm-40 -67.38 -51.67 49.18 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' TRP . . . . . 0.45 ' CB ' ' HB1' ' C' ' 25' ' ' ALA . 56.3 t-105 -57.84 -44.26 86.39 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.087 177.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' ASP . . . . . 0.547 ' HA ' ' HE2' ' C' ' 104' ' ' LYS . 26.7 t70 -70.88 -11.55 61.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.786 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' SER . . . . . . . . . . . . . 9.9 t -87.71 -3.68 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.04 0.447 . . . . 0.0 110.06 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . 74.5 26.28 68.15 Favored Glycine 0 C--N 1.335 0.528 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.487 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' THR . . . . . . . . . . . . . 7.3 t -65.58 149.77 49.53 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.064 0.459 . . . . 0.0 111.057 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' C' ' 45' ' ' VAL . 27.5 mt-10 -71.24 129.08 37.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.115 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' TYR . . . . . 0.523 ' HD1' ' HE3' ' C' ' 43' ' ' TRP . 0.4 OUTLIER -128.9 119.41 24.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 170.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' C' ' 43' ' ' TRP . 16.7 t -120.48 136.39 57.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' CYS . . . . . 0.447 ' HB3' HD21 ' C' ' 11' ' ' LEU . 10.8 t -111.54 126.38 54.92 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' C' ' 98' ' ' VAL . 6.7 mp -119.25 146.02 45.59 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.198 -0.456 . . . . 0.0 109.882 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' VAL . . . . . 0.683 HG21 HG21 ' C' ' 31' ' ' ILE . 39.2 t -123.54 131.09 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 C-N-CA 123.55 0.74 . . . . 0.0 109.45 176.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -123.8 136.56 54.48 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.976 0.417 . . . . 0.0 111.016 -177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' ASP . . . . . 0.673 ' O ' ' HG ' ' C' ' 94' ' ' LEU . 15.1 t70 -149.3 145.18 26.92 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 176.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' SER . . . . . . . . . . . . . 29.0 t -63.09 -18.46 63.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.119 -174.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -101.53 5.07 41.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' LEU . . . . . 0.673 ' HG ' ' O ' ' C' ' 91' ' ' ASP . 2.9 pp -99.14 148.42 34.6 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 119.913 -0.715 . . . . 0.0 111.05 175.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -77.4 -34.74 1.89 Allowed 'Trans proline' 0 N--CA 1.469 0.057 0 C-N-CA 123.83 3.02 . . . . 0.0 112.841 -177.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' THR . . . . . 0.505 ' O ' HD13 ' C' ' 94' ' ' LEU . 20.1 p -144.66 148.7 40.8 Favored Pre-proline 0 C--N 1.324 -0.531 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.37 144.78 91.81 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.325 2.016 . . . . 0.0 111.254 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' C' ' 88' ' ' LEU . 44.1 t -94.72 116.66 36.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -175.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' LYS . . . . . 0.512 ' HB3' ' HG ' ' C' ' 88' ' ' LEU . 18.6 ptpt -127.66 149.18 50.31 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 120.07 -0.652 . . . . 0.0 112.091 -174.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.407 ' O ' HD11 ' C' ' 11' ' ' LEU . . . -155.76 135.76 12.85 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.906 176.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' SER . . . . . . . . . . . . . 48.4 t -112.8 154.61 25.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.943 0.401 . . . . 0.0 111.179 -176.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . 0.559 ' HB ' HD13 ' C' ' 11' ' ' LEU . 5.7 tp -122.92 144.32 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.156 -177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' ARG . . . . . . . . . . . . . 75.2 mtp180 -133.57 150.15 51.64 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.422 173.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' C' ' 80' ' ' ASP . 21.6 ttpp -90.65 136.81 32.83 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 174.576 . . . . . . . . 0 0 . 1 stop_ save_